,sentence,Mot,Label
0,1,Use,O
1,1,of,O
2,1,smoking,B-Procedure
3,1,cessation,I-Procedure
4,1,medications,B-Procedure
5,1,or,O
6,1,interventions,B-Procedure
7,1,in,O
8,1,last,O
9,1,30,O
10,1,days,O
11,2,Unstable,O
12,2,medical,O
13,2,illness,O
14,2,that,O
15,2,requires,O
16,2,immediate,O
17,2,medical,O
18,2,care,O
19,3,AUDIT,O
20,3,score,O
21,3,of,O
22,3,<,O
23,3,5,O
24,3,or,O
25,3,>,O
26,3,26,O
27,4,Pregnancy,B-Condition
28,4,or,O
29,4,other,O
30,4,Nicotine,B-Procedure
31,4,Replacement,I-Procedure
32,4,Therapy,I-Procedure
33,4,(,O
34,4,NRT,B-Procedure
35,4,),O
36,4,contraindications,B-Condition
37,5,Current,O
38,5,history,O
39,5,or,O
40,5,in,O
41,5,past,O
42,5,6,O
43,5,months,O
44,5,of,O
45,5,psychotic,B-Condition
46,5,disorder,I-Condition
47,5,or,O
48,5,major,B-Condition
49,5,depressive,I-Condition
50,5,disorders,I-Condition
51,5,that,O
52,5,is,O
53,5,not,O
54,5,stable,O
55,5,on,O
56,5,treatment,O
57,5,for,O
58,5,past,O
59,5,3,O
60,5,months,O
61,6,Cognitive,B-Condition
62,6,impairment,I-Condition
63,7,Currently,O
64,7,Homeless,B-Person
65,8,Smoked,B-Observation
66,8,at,O
67,8,least,O
68,8,100,O
69,8,cigarettes,O
70,8,in,O
71,8,lifetime,O
72,9,AUDIT,O
73,9,score,O
74,9,of,O
75,9,>,O
76,9,or,O
77,9,equal,O
78,9,to,O
79,9,5,O
80,9,",",O
81,9,<,O
82,9,or,O
83,9,equal,O
84,9,to,O
85,9,26,O
86,10,Aged,B-Person
87,10,18,O
88,10,years,O
89,10,or,O
90,10,older,O
91,11,Willing,O
92,11,to,O
93,11,attend,O
94,11,study,O
95,11,sessions,O
96,11,and,O
97,11,follow,O
98,11,other,O
99,11,study,O
100,11,protocol,O
101,12,Died,B-Observation
102,12,before,O
103,12,TAVI,O
104,13,Not,O
105,13,willing,O
106,13,to,O
107,13,participate,O
108,14,Age,B-Person
109,14,=,O
110,14,75,O
111,14,years,O
112,14,",",O
113,15,Severe,O
114,15,",",O
115,15,symptomatic,O
116,15,aortic,B-Condition
117,15,stenosis,I-Condition
118,15,",",O
119,16,High,O
120,16,risk,O
121,16,for,O
122,16,cardiac,B-Procedure
123,16,surgery,I-Procedure
124,16,(,O
125,16,STS,O
126,16,and,O
127,16,logistic,O
128,16,Euroscore,O
129,16,),O
130,16,",",O
131,17,According,O
132,17,multidisciplinary,O
133,17,(,O
134,17,heart,O
135,17,),O
136,17,team,O
137,17,decision,O
138,17,TAVI,O
139,17,is,O
140,17,preferable,O
141,17,",",O
142,18,Willing,O
143,18,to,O
144,18,participate,O
145,19,type,B-Condition
146,19,1,I-Condition
147,19,diabetic,I-Condition
148,19,or,O
149,19,non,B-Condition
150,19,-,I-Condition
151,19,diabetic,I-Condition
152,20,type,B-Condition
153,20,2,I-Condition
154,20,diabetic,I-Condition
155,20,",",O
156,20,age,B-Person
157,20,18,O
158,20,and,O
159,20,over,O
160,20,",",O
161,20,informed,O
162,20,consent,O
163,20,",",O
164,21,Evidence,O
165,21,of,O
166,21,decompensated,O
167,21,liver,B-Condition
168,21,disease,I-Condition
169,21,(,O
170,21,Childs,O
171,21,B,O
172,21,-,O
173,21,C,O
174,21,),O
175,21,",",O
176,21,hepato,B-Condition
177,21,-,I-Condition
178,21,cellular,I-Condition
179,21,carcinoma,I-Condition
180,21,",",O
181,21,pre,O
182,21,-,O
183,21,existing,O
184,21,severe,O
185,21,depression,B-Condition
186,21,or,O
187,21,other,O
188,21,psychiatric,B-Condition
189,21,disease,I-Condition
190,21,",",O
191,21,significant,O
192,21,cardiac,B-Condition
193,21,disease,I-Condition
194,21,",",O
195,21,significant,O
196,21,renal,B-Condition
197,21,disease,I-Condition
198,21,",",O
199,21,seizure,B-Condition
200,21,disorders,I-Condition
201,21,or,O
202,21,severe,O
203,21,retinopathy,B-Condition
204,21,.,O
205,22,received,O
206,22,telbivudine,B-Drug
207,22,as,O
208,22,the,O
209,22,antiviral,B-Procedure
210,22,therapy,I-Procedure
211,22,or,O
212,22,have,O
213,22,received,O
214,22,more,O
215,22,than,O
216,22,one,O
217,22,NA,B-Condition
218,22,in,O
219,22,the,O
220,22,past,O
221,22,.,O
222,23,received,O
223,23,interferon,B-Drug
224,23,or,O
225,23,peginterferon,B-Drug
226,23,treatment,B-Procedure
227,23,in,O
228,23,the,O
229,23,past,O
230,23,.,O
231,24,received,O
232,24,antiviral,B-Procedure
233,24,therapy,I-Procedure
234,24,for,O
235,24,any,O
236,24,systemic,B-Drug
237,24,anti,I-Drug
238,24,-,I-Drug
239,24,viral,I-Drug
240,24,",",O
241,24,anti,B-Procedure
242,24,-,I-Procedure
243,24,neoplastic,I-Procedure
244,24,or,I-Procedure
245,24,immuno,I-Procedure
246,24,-,I-Procedure
247,24,modulatory,I-Procedure
248,24,treatment,I-Procedure
249,24,(,O
250,24,including,O
251,24,supraphysiologic,O
252,24,doses,O
253,24,of,O
254,24,steroids,B-Drug
255,24,and,O
256,24,radiation,B-Procedure
257,24,),O
258,24,within,O
259,24,the,O
260,24,past,O
261,24,6,O
262,24,months,O
263,24,.,O
264,25,Positive,O
265,25,test,O
266,25,at,O
267,25,screening,O
268,25,for,O
269,25,anti,O
270,25,-,O
271,25,HIV,O
272,25,",",O
273,25,anti,O
274,25,-,O
275,25,HCV,O
276,25,.,O
277,26,Patients,O
278,26,who,O
279,26,are,O
280,26,expected,B-Mood
281,26,to,I-Mood
282,26,need,I-Mood
283,26,systemic,B-Procedure
284,26,antiviral,I-Procedure
285,26,therapy,I-Procedure
286,26,other,O
287,26,than,O
288,26,that,O
289,26,provided,O
290,26,by,O
291,26,the,O
292,26,study,O
293,26,at,O
294,26,any,O
295,26,time,O
296,26,during,O
297,26,their,O
298,26,participation,O
299,26,in,O
300,26,the,O
301,26,study,O
302,26,are,O
303,26,also,O
304,26,excluded,O
305,26,.,O
306,26,Exception,O
307,26,:,O
308,26,patients,O
309,26,who,O
310,26,have,O
311,26,had,O
312,26,a,O
313,26,limited,O
314,26,(,O
315,26,<,O
316,26,=,O
317,26,7,O
318,26,days,O
319,26,),O
320,26,course,O
321,26,of,O
322,26,acyclovir,B-Drug
323,26,for,O
324,26,herpetic,B-Condition
325,26,lesions,I-Condition
326,26,more,O
327,26,than,O
328,26,1,O
329,26,month,O
330,26,prior,O
331,26,to,O
332,26,the,O
333,26,first,O
334,26,administration,O
335,26,of,O
336,26,test,O
337,26,drug,O
338,26,are,O
339,26,not,B-Mood
340,26,excluded,I-Mood
341,26,.,O
342,27,Serum,O
343,27,total,O
344,27,bilirubin,O
345,27,>,O
346,27,3,O
347,27,times,O
348,27,the,O
349,27,upper,O
350,27,limit,O
351,27,of,O
352,27,normal,O
353,27,at,O
354,27,screening,O
355,27,.,O
356,28,History,O
357,28,or,O
358,28,other,O
359,28,evidence,O
360,28,of,O
361,28,bleeding,B-Condition
362,28,from,O
363,28,esophageal,B-Condition
364,28,varices,I-Condition
365,28,or,O
366,28,other,O
367,28,conditions,B-Condition
368,28,consistent,I-Condition
369,28,with,I-Condition
370,28,decompensated,I-Condition
371,28,liver,I-Condition
372,28,disease,I-Condition
373,28,.,O
374,29,History,O
375,29,or,O
376,29,other,O
377,29,evidence,O
378,29,of,O
379,29,a,O
380,29,medical,B-Condition
381,29,condition,I-Condition
382,29,associated,O
383,29,with,O
384,29,chronic,B-Condition
385,29,liver,I-Condition
386,29,disease,I-Condition
387,29,other,O
388,29,than,O
389,29,HBV,B-Condition
390,29,(,O
391,29,e.g.,O
392,29,",",O
393,29,hemochromatosis,B-Condition
394,29,",",O
395,29,autoimmune,B-Condition
396,29,hepatitis,I-Condition
397,29,",",O
398,29,metabolic,B-Condition
399,29,liver,I-Condition
400,29,diseases,I-Condition
401,29,including,O
402,29,Wilson,B-Condition
403,29,'s,I-Condition
404,29,and,O
405,29,alpha1,B-Condition
406,29,-,I-Condition
407,29,antitrypsin,I-Condition
408,29,deficiency,I-Condition
409,29,",",O
410,29,alcoholic,B-Condition
411,29,liver,I-Condition
412,29,disease,I-Condition
413,29,",",O
414,29,toxin,B-Condition
415,29,exposures,I-Condition
416,29,",",O
417,29,thalassemia,B-Condition
418,29,),O
419,29,.,O
420,30,Women,B-Person
421,30,with,O
422,30,ongoing,O
423,30,pregnancy,B-Condition
424,30,or,O
425,30,who,O
426,30,are,O
427,30,breast,B-Observation
428,30,feeding,I-Observation
429,30,.,O
430,31,Neutrophil,O
431,31,count,O
432,31,<,O
433,31,1500,O
434,31,cells,O
435,31,/,O
436,31,mm3,O
437,31,or,O
438,31,platelet,O
439,31,count,O
440,31,<,O
441,31,"90,000",O
442,31,cells,O
443,31,/,O
444,31,mm3,O
445,31,at,O
446,31,screening,O
447,31,.,O
448,32,Hemoglobin,O
449,32,<,O
450,32,11.5,O
451,32,g,O
452,32,/,O
453,32,dL,O
454,32,for,O
455,32,females,B-Person
456,32,and,O
457,32,<,O
458,32,12.5,O
459,32,g,O
460,32,/,O
461,32,dL,O
462,32,for,O
463,32,men,B-Person
464,32,at,O
465,32,screening,O
466,32,.,O
467,33,Serum,O
468,33,creatinine,O
469,33,level,O
470,33,>,O
471,33,120,O
472,33,umol,O
473,33,/,O
474,33,ml,O
475,33,for,O
476,33,men,B-Person
477,33,and,O
478,33,>,O
479,33,105,O
480,33,umol,O
481,33,/,O
482,33,ml,O
483,33,for,O
484,33,women,B-Person
485,33,at,O
486,33,screening,O
487,33,.,O
488,34,History,O
489,34,of,O
490,34,severe,O
491,34,psychiatric,B-Condition
492,34,disease,I-Condition
493,34,",",O
494,34,especially,O
495,34,depression,B-Condition
496,34,.,O
497,34,Severe,O
498,34,psychiatric,B-Condition
499,34,disease,I-Condition
500,34,is,O
501,34,defined,O
502,34,as,O
503,34,major,B-Condition
504,34,depression,I-Condition
505,34,or,O
506,34,psychosis,B-Condition
507,34,",",O
508,34,a,O
509,34,period,O
510,34,of,O
511,34,treatment,B-Procedure
512,34,with,O
513,34,an,O
514,34,antidepressant,B-Drug
515,34,medication,I-Drug
516,34,or,O
517,34,major,B-Drug
518,34,tranquilizer,I-Drug
519,34,at,O
520,34,therapeutic,O
521,34,doses,O
522,34,for,O
523,34,depression,B-Condition
524,34,or,O
525,34,psychosis,B-Condition
526,34,for,O
527,34,at,O
528,34,least,O
529,34,3,O
530,34,months,O
531,34,",",O
532,34,a,O
533,34,suicidal,B-Condition
534,34,attempt,I-Condition
535,34,",",O
536,34,hospitalization,B-Procedure
537,34,for,O
538,34,psychiatric,B-Condition
539,34,disease,I-Condition
540,34,",",O
541,34,or,O
542,34,a,O
543,34,period,O
544,34,of,O
545,34,disability,B-Condition
546,34,due,O
547,34,to,O
548,34,a,O
549,34,psychiatric,B-Condition
550,34,disease,I-Condition
551,34,.,O
552,35,History,O
553,35,of,O
554,35,immunologically,B-Condition
555,35,mediated,I-Condition
556,35,disease,I-Condition
557,35,(,O
558,35,e.g.,O
559,35,",",O
560,35,inflammatory,B-Condition
561,35,bowel,I-Condition
562,35,disease,I-Condition
563,35,",",O
564,35,idiopathic,B-Condition
565,35,thrombocytopenic,I-Condition
566,35,purpura,I-Condition
567,35,",",O
568,35,lupus,B-Condition
569,35,erythematosus,I-Condition
570,35,",",O
571,35,autoimmune,B-Condition
572,35,hemolytic,I-Condition
573,35,anemia,I-Condition
574,35,",",O
575,35,scleroderma,B-Condition
576,35,",",O
577,35,severe,O
578,35,psoriasis,B-Condition
579,35,",",O
580,35,rheumatoid,B-Condition
581,35,arthritis,I-Condition
582,35,),O
583,35,.,O
584,36,History,O
585,36,or,O
586,36,other,O
587,36,evidence,O
588,36,of,O
589,36,chronic,B-Condition
590,36,pulmonary,I-Condition
591,36,disease,I-Condition
592,36,associated,O
593,36,with,O
594,36,functional,B-Condition
595,36,limitation,I-Condition
596,36,.,O
597,36,Severe,O
598,36,cardiac,B-Condition
599,36,disease,I-Condition
600,36,(,O
601,36,e.g.,O
602,36,",",O
603,36,NYHA,O
604,36,Functional,O
605,36,Class,O
606,36,III,O
607,36,or,O
608,36,IV,O
609,36,",",O
610,36,myocardial,B-Condition
611,36,infarction,I-Condition
612,36,within,O
613,36,6,O
614,36,months,O
615,36,",",O
616,36,ventricular,B-Condition
617,36,tachyarrhythmias,I-Condition
618,36,requiring,O
619,36,ongoing,O
620,36,treatment,B-Procedure
621,36,",",O
622,36,unstable,B-Condition
623,36,angina,I-Condition
624,36,or,O
625,36,other,O
626,36,significant,O
627,36,cardiovascular,B-Condition
628,36,diseases,I-Condition
629,36,),O
630,36,.,O
631,37,History,O
632,37,of,O
633,37,a,O
634,37,severe,O
635,37,seizure,B-Condition
636,37,disorder,I-Condition
637,37,or,O
638,37,current,O
639,37,anticonvulsant,B-Drug
640,37,use,O
641,37,.,O
642,38,Evidence,O
643,38,of,O
644,38,an,O
645,38,active,O
646,38,or,O
647,38,suspected,B-Mood
648,38,cancer,B-Condition
649,38,or,O
650,38,a,O
651,38,history,O
652,38,of,O
653,38,malignancy,B-Condition
654,38,where,O
655,38,the,O
656,38,risk,O
657,38,of,O
658,38,recurrence,O
659,38,is,O
660,38,>,O
661,38,=,O
662,38,20,O
663,38,%,O
664,38,within,O
665,38,2,O
666,38,years,O
667,38,.,O
668,38,Patients,O
669,38,with,O
670,38,a,O
671,38,lesion,B-Condition
672,38,suspicious,B-Mood
673,38,of,O
674,38,hepatic,B-Condition
675,38,malignancy,I-Condition
676,38,on,O
677,38,a,O
678,38,screening,B-Procedure
679,38,imaging,I-Procedure
680,38,study,I-Procedure
681,38,will,O
682,38,only,O
683,38,be,O
684,38,eligible,O
685,38,if,O
686,38,the,O
687,38,likelihood,O
688,38,of,O
689,38,carcinoma,O
690,38,is,O
691,38,<,O
692,38,=,O
693,38,10,O
694,38,%,O
695,38,following,O
696,38,an,O
697,38,appropriate,O
698,38,evaluation,O
699,38,.,O
700,39,History,O
701,39,of,O
702,39,having,O
703,39,received,O
704,39,any,O
705,39,systemic,O
706,39,anti,B-Procedure
707,39,-,I-Procedure
708,39,neoplastic,I-Procedure
709,39,(,I-Procedure
710,39,including,I-Procedure
711,39,radiation,I-Procedure
712,39,),I-Procedure
713,39,or,I-Procedure
714,39,immunomodulatory,I-Procedure
715,39,treatment,I-Procedure
716,39,(,O
717,39,including,O
718,39,systemic,O
719,39,corticosteroids,B-Drug
720,39,),O
721,39,<,O
722,39,=,O
723,39,6,O
724,39,months,O
725,39,prior,O
726,39,to,O
727,39,the,O
728,39,first,O
729,39,dose,O
730,39,of,O
731,39,study,O
732,39,drug,O
733,39,or,O
734,39,the,O
735,39,expectation,B-Mood
736,39,that,O
737,39,such,O
738,39,treatment,B-Procedure
739,39,will,B-Mood
740,39,be,I-Mood
741,39,needed,I-Mood
742,39,at,O
743,39,any,O
744,39,time,O
745,39,during,O
746,39,the,O
747,39,study,O
748,39,.,O
749,40,Major,B-Procedure
750,40,organ,I-Procedure
751,40,transplantation,I-Procedure
752,40,.,O
753,41,Thyroid,B-Condition
754,41,disease,I-Condition
755,41,with,O
756,41,thyroid,O
757,41,function,O
758,41,poorly,O
759,41,controlled,O
760,41,on,O
761,41,prescribed,O
762,41,medications,O
763,41,.,O
764,41,Patients,O
765,41,with,O
766,41,abnormal,O
767,41,thyroid,O
768,41,stimulating,O
769,41,hormone,O
770,41,or,O
771,41,T4,O
772,41,concentrations,O
773,41,",",O
774,41,with,O
775,41,elevation,O
776,41,of,O
777,41,antibodies,O
778,41,to,O
779,41,thyroid,O
780,41,peroxidase,O
781,41,and,O
782,41,any,O
783,41,clinical,B-Condition
784,41,manifestations,I-Condition
785,41,of,I-Condition
786,41,thyroid,I-Condition
787,41,disease,I-Condition
788,41,are,O
789,41,excluded,O
790,41,.,O
791,42,History,O
792,42,or,O
793,42,other,O
794,42,evidence,O
795,42,of,O
796,42,severe,O
797,42,retinopathy,B-Condition
798,42,(,O
799,42,e.g.,O
800,42,CMV,B-Condition
801,42,retinitis,I-Condition
802,42,",",O
803,42,macula,B-Condition
804,42,degeneration,I-Condition
805,42,),O
806,42,or,O
807,42,clinically,O
808,42,relevant,O
809,42,ophthalmological,B-Condition
810,42,disorder,I-Condition
811,42,due,O
812,42,to,O
813,42,diabetes,B-Condition
814,42,mellitus,I-Condition
815,42,or,O
816,42,hypertension,B-Condition
817,43,Inability,O
818,43,or,O
819,43,unwillingness,O
820,43,to,O
821,43,provide,O
822,43,informed,O
823,43,consent,O
824,43,or,O
825,43,abide,O
826,43,by,O
827,43,the,O
828,43,requirements,O
829,43,of,O
830,43,the,O
831,43,study,O
832,43,.,O
833,44,History,O
834,44,or,O
835,44,other,O
836,44,evidence,O
837,44,of,O
838,44,severe,O
839,44,illness,O
840,44,or,O
841,44,any,O
842,44,other,O
843,44,conditions,O
844,44,which,O
845,44,would,O
846,44,make,O
847,44,the,O
848,44,patient,O
849,44,",",O
850,44,in,O
851,44,the,O
852,44,opinion,O
853,44,of,O
854,44,the,O
855,44,investigator,O
856,44,",",O
857,44,unsuitable,O
858,44,for,O
859,44,the,O
860,44,study,O
861,44,.,O
862,45,Patients,O
863,45,with,O
864,45,a,O
865,45,value,O
866,45,of,O
867,45,alpha,O
868,45,-,O
869,45,fetoprotein,O
870,45,>,O
871,45,100,O
872,45,ng,O
873,45,/,O
874,45,mL,O
875,45,are,O
876,45,excluded,O
877,45,",",O
878,45,unless,O
879,45,stability,B-Condition
880,45,(,O
881,45,less,O
882,45,than,O
883,45,10,O
884,45,%,O
885,45,increase,O
886,45,),O
887,45,has,O
888,45,been,O
889,45,documented,O
890,45,over,O
891,45,at,O
892,45,least,O
893,45,the,O
894,45,previous,O
895,45,3,O
896,45,months,O
897,45,.,O
898,46,Evidence,O
899,46,of,O
900,46,drug,B-Condition
901,46,and/or,I-Condition
902,46,alcohol,I-Condition
903,46,abuse,I-Condition
904,46,(,O
905,46,20g,O
906,46,/,O
907,46,day,O
908,46,for,O
909,46,women,B-Person
910,46,&,O
911,46,30g,O
912,46,/,O
913,46,day,O
914,46,for,O
915,46,men,B-Person
916,46,),O
917,46,.,O
918,47,Patients,O
919,47,included,O
920,47,in,O
921,47,another,O
922,47,trial,O
923,47,or,O
924,47,having,O
925,47,been,O
926,47,given,O
927,47,investigational,O
928,47,drugs,O
929,47,within,O
930,47,12,O
931,47,weeks,O
932,47,prior,O
933,47,to,O
934,47,screening,O
935,48,Any,O
936,48,known,O
937,48,history,O
938,48,of,O
939,48,hypersensitivity,B-Condition
940,48,to,O
941,48,interferon,B-Drug
942,48,.,O
943,49,Male,B-Person
944,49,&,O
945,49,female,B-Person
946,49,patients,O
947,49,>,O
948,49,=,O
949,49,18,O
950,49,and,O
951,49,<,O
952,49,70,O
953,49,years,O
954,49,of,O
955,49,age,B-Person
956,50,Positive,O
957,50,HBeAg,O
958,50,before,O
959,50,starting,O
960,50,NA,O
961,50,treatment,O
962,51,Treated,B-Procedure
963,51,by,O
964,51,a,O
965,51,single,O
966,51,NA,B-Drug
967,51,(,O
968,51,lamivudine,B-Drug
969,51,",",O
970,51,adefovir,B-Drug
971,51,",",O
972,51,entecavir,B-Drug
973,51,or,O
974,51,tenofovir,B-Drug
975,51,),O
976,51,for,O
977,51,6,O
978,51,months,O
979,51,to,O
980,51,5,O
981,51,years,O
982,52,Developed,O
983,52,HBeAg,O
984,52,seroconversion,O
985,52,(,O
986,52,HBeAg,O
987,52,negative,O
988,52,and,O
989,52,ant,O
990,52,-,O
991,52,HBe,O
992,52,negative,O
993,52,),O
994,52,with,O
995,52,undetectable,O
996,52,HBV,O
997,52,DNA,O
998,52,by,O
999,52,PCR,B-Procedure
1000,52,based,I-Procedure
1001,52,assay,I-Procedure
1002,52,on,O
1003,52,NA,B-Drug
1004,52,treatment,B-Procedure
1005,52,.,O
1006,53,Negative,O
1007,53,urine,O
1008,53,or,O
1009,53,serum,O
1010,53,pregnancy,O
1011,53,test,O
1012,53,(,O
1013,53,for,O
1014,53,women,B-Person
1015,53,of,O
1016,53,childbearing,B-Condition
1017,53,potential,I-Condition
1018,53,),O
1019,53,documented,O
1020,53,within,O
1021,53,the,O
1022,53,24,O
1023,53,-,O
1024,53,hour,O
1025,53,period,O
1026,53,prior,O
1027,53,to,O
1028,53,the,O
1029,53,first,O
1030,53,dose,O
1031,53,of,O
1032,53,test,O
1033,53,drug,O
1034,53,.,O
1035,53,Additionally,O
1036,53,",",O
1037,53,all,O
1038,53,females,O
1039,53,must,O
1040,53,be,O
1041,53,using,O
1042,53,reliable,O
1043,53,contraception,O
1044,53,during,O
1045,53,the,O
1046,53,study,O
1047,53,and,O
1048,53,for,O
1049,53,3,O
1050,53,months,O
1051,53,after,O
1052,53,treatment,O
1053,53,completion,O
1054,54,Spondylolisthesis,B-Condition
1055,54,Grade,O
1056,54,II,O
1057,54,or,O
1058,54,higher,O
1059,54,.,O
1060,55,Subject,O
1061,55,requires,O
1062,55,uni,O
1063,55,or,O
1064,55,bilateral,O
1065,55,facetectomy,B-Procedure
1066,55,to,O
1067,55,treat,O
1068,55,leg,O
1069,55,/,O
1070,55,back,B-Condition
1071,55,pain,I-Condition
1072,55,.,O
1073,56,Subject,O
1074,56,has,O
1075,56,back,B-Condition
1076,56,or,I-Condition
1077,56,non,I-Condition
1078,56,-,I-Condition
1079,56,radicular,I-Condition
1080,56,leg,I-Condition
1081,56,pain,I-Condition
1082,56,of,O
1083,56,unknown,O
1084,56,etiology,O
1085,56,.,O
1086,57,Prior,O
1087,57,surgery,B-Procedure
1088,57,at,O
1089,57,the,O
1090,57,index,O
1091,57,lumbar,O
1092,57,level,O
1093,57,.,O
1094,58,Subject,O
1095,58,requiring,B-Mood
1096,58,a,O
1097,58,spine,B-Procedure
1098,58,DEXA,I-Procedure
1099,58,(,O
1100,58,i.e.,O
1101,58,",",O
1102,58,patients,O
1103,58,with,O
1104,58,SCORE,O
1105,58,of,O
1106,58,=,O
1107,58,6,O
1108,58,),O
1109,58,with,O
1110,58,a,O
1111,58,T,O
1112,58,Score,O
1113,58,less,O
1114,58,than,O
1115,58,-2.0,O
1116,58,at,O
1117,58,the,O
1118,58,index,O
1119,58,level,O
1120,58,.,O
1121,58,For,O
1122,58,patients,O
1123,58,with,O
1124,58,a,O
1125,58,herniation,B-Condition
1126,58,at,O
1127,58,L5,O
1128,58,/,O
1129,58,S1,O
1130,58,",",O
1131,58,the,O
1132,58,average,O
1133,58,T,O
1134,58,score,O
1135,58,of,O
1136,58,L1,O
1137,58,-,O
1138,58,L4,O
1139,58,shall,O
1140,58,be,O
1141,58,used,O
1142,58,.,O
1143,59,Subject,O
1144,59,has,O
1145,59,clinically,B-Condition
1146,59,compromised,I-Condition
1147,59,vertebral,I-Condition
1148,59,bodies,I-Condition
1149,59,at,O
1150,59,the,O
1151,59,index,O
1152,59,level(s,O
1153,59,),O
1154,59,due,O
1155,59,to,O
1156,59,any,O
1157,59,traumatic,B-Condition
1158,59,",",I-Condition
1159,59,neoplastic,I-Condition
1160,59,",",I-Condition
1161,59,metabolic,I-Condition
1162,59,",",I-Condition
1163,59,or,I-Condition
1164,59,infectious,I-Condition
1165,59,pathology,I-Condition
1166,59,.,O
1167,60,Subject,O
1168,60,has,O
1169,60,sustained,O
1170,60,pathologic,O
1171,60,fractures,B-Condition
1172,60,of,I-Condition
1173,60,the,I-Condition
1174,60,vertebra,I-Condition
1175,60,or,O
1176,60,multiple,O
1177,60,fractures,B-Condition
1178,60,of,I-Condition
1179,60,the,I-Condition
1180,60,vertebra,I-Condition
1181,60,or,I-Condition
1182,60,hip,I-Condition
1183,60,.,O
1184,61,Subject,O
1185,61,has,O
1186,61,scoliosis,B-Condition
1187,61,of,O
1188,61,greater,O
1189,61,than,O
1190,61,ten,O
1191,61,(,O
1192,61,10,O
1193,61,),O
1194,61,degrees,O
1195,61,(,O
1196,61,both,O
1197,61,angular,O
1198,61,and,O
1199,61,rotational,O
1200,61,),O
1201,61,.,O
1202,62,Any,O
1203,62,metabolic,B-Condition
1204,62,disease,I-Condition
1205,62,bone,B-Condition
1206,62,disease,I-Condition
1207,62,that,O
1208,62,has,O
1209,62,not,O
1210,62,been,B-Observation
1211,62,stabilized,I-Observation
1212,62,for,O
1213,62,at,O
1214,62,least,O
1215,62,three,O
1216,62,months,O
1217,62,(,O
1218,62,e.g.,O
1219,62,",",O
1220,62,Paget,B-Condition
1221,62,'s,I-Condition
1222,62,disease,I-Condition
1223,62,",",O
1224,62,osteomalacia,B-Condition
1225,62,",",O
1226,62,osteogenesis,B-Condition
1227,62,imperfecta,I-Condition
1228,62,",",O
1229,62,thyroid,B-Condition
1230,62,and/or,O
1231,62,parathyroid,B-Condition
1232,62,gland,I-Condition
1233,62,disorder,I-Condition
1234,62,",",O
1235,62,etc,O
1236,62,.,O
1237,62,),O
1238,62,.,O
1239,63,Subject,O
1240,63,has,O
1241,63,an,O
1242,63,active,O
1243,63,infection,B-Condition
1244,63,either,O
1245,63,systemic,O
1246,63,or,O
1247,63,local,O
1248,63,.,O
1249,64,Subject,O
1250,64,has,O
1251,64,cauda,B-Condition
1252,64,equina,I-Condition
1253,64,syndrome,I-Condition
1254,64,or,O
1255,64,neurogenic,B-Condition
1256,64,bowel,I-Condition
1257,64,/,I-Condition
1258,64,bladder,I-Condition
1259,64,dysfunction,I-Condition
1260,64,.,O
1261,65,Subject,O
1262,65,has,O
1263,65,severe,O
1264,65,arterial,B-Condition
1265,65,insufficiency,I-Condition
1266,65,of,O
1267,65,the,O
1268,65,legs,O
1269,65,(,O
1270,65,Screening,B-Procedure
1271,65,on,I-Procedure
1272,65,physical,I-Procedure
1273,65,examination=,I-Procedure
1274,65,patients,O
1275,65,with,O
1276,65,diminution,B-Condition
1277,65,or,I-Condition
1278,65,absence,I-Condition
1279,65,of,I-Condition
1280,65,dorsalis,I-Condition
1281,65,pedis,I-Condition
1282,65,or,I-Condition
1283,65,posterior,I-Condition
1284,65,tibialis,I-Condition
1285,65,pulses,I-Condition
1286,65,.,O
1287,65,If,O
1288,65,diminished,B-Observation
1289,65,or,O
1290,65,absent,B-Observation
1291,65,by,O
1292,65,palpation,B-Procedure
1293,65,",",O
1294,65,then,O
1295,65,an,O
1296,65,arterial,B-Procedure
1297,65,ultrasound,I-Procedure
1298,65,is,O
1299,65,required,O
1300,65,with,O
1301,65,vascular,B-Procedure
1302,65,plethysmography,I-Procedure
1303,65,.,O
1304,65,If,O
1305,65,the,O
1306,65,absolute,O
1307,65,arterial,O
1308,65,pressure,O
1309,65,is,O
1310,65,below,O
1311,65,50,O
1312,65,mm,O
1313,65,of,O
1314,65,Hg,O
1315,65,at,O
1316,65,the,O
1317,65,calf,O
1318,65,or,O
1319,65,ankle,O
1320,65,level,O
1321,65,",",O
1322,65,then,O
1323,65,the,O
1324,65,patient,O
1325,65,is,O
1326,65,to,O
1327,65,be,O
1328,65,excluded,O
1329,65,),O
1330,65,or,O
1331,65,other,O
1332,65,peripheral,B-Condition
1333,65,vascular,I-Condition
1334,65,disease,I-Condition
1335,65,),O
1336,65,.,O
1337,66,Subject,O
1338,66,has,O
1339,66,significant,O
1340,66,peripheral,B-Condition
1341,66,neuropathy,I-Condition
1342,66,",",O
1343,66,patient,O
1344,66,defined,O
1345,66,as,O
1346,66,a,O
1347,66,patient,O
1348,66,with,O
1349,66,Type,O
1350,66,I,O
1351,66,or,O
1352,66,Type,O
1353,66,II,O
1354,66,diabetes,B-Condition
1355,66,or,O
1356,66,similar,O
1357,66,systemic,B-Condition
1358,66,metabolic,I-Condition
1359,66,condition,I-Condition
1360,66,causing,O
1361,66,decreased,B-Condition
1362,66,sensation,I-Condition
1363,66,in,O
1364,66,a,O
1365,66,stocking,O
1366,66,-,O
1367,66,like,O
1368,66,or,O
1369,66,non,O
1370,66,-,O
1371,66,radicular,O
1372,66,and,O
1373,66,non,O
1374,66,-,O
1375,66,dermatomal,O
1376,66,distribution,O
1377,66,in,O
1378,66,the,O
1379,66,lower,O
1380,66,extremities,O
1381,66,.,O
1382,67,Subject,O
1383,67,has,O
1384,67,insulin,O
1385,67,-,O
1386,67,dependent,O
1387,67,diabetes,B-Condition
1388,67,mellitus,I-Condition
1389,67,.,O
1390,68,Subject,O
1391,68,is,O
1392,68,morbidly,B-Condition
1393,68,obese,I-Condition
1394,68,(,O
1395,68,defined,O
1396,68,as,O
1397,68,a,O
1398,68,body,O
1399,68,mass,O
1400,68,index,O
1401,68,>,O
1402,68,40,O
1403,68,",",O
1404,68,or,O
1405,68,weighs,O
1406,68,more,O
1407,68,than,O
1408,68,100,O
1409,68,lbs,O
1410,68,over,O
1411,68,ideal,O
1412,68,body,O
1413,68,weight,O
1414,68,),O
1415,68,.,O
1416,69,Subject,O
1417,69,has,O
1418,69,been,O
1419,69,diagnosed,O
1420,69,with,O
1421,69,active,O
1422,69,hepatitis,B-Condition
1423,69,",",O
1424,69,AIDS,B-Condition
1425,69,",",O
1426,69,or,O
1427,69,HIV,B-Condition
1428,69,.,O
1429,70,Subject,O
1430,70,has,O
1431,70,been,O
1432,70,diagnosed,O
1433,70,with,O
1434,70,rheumatoid,B-Condition
1435,70,arthritis,I-Condition
1436,70,or,O
1437,70,other,O
1438,70,autoimmune,B-Condition
1439,70,disease,I-Condition
1440,70,.,O
1441,71,Subject,O
1442,71,has,O
1443,71,a,O
1444,71,known,O
1445,71,allergy,B-Condition
1446,71,to,O
1447,71,titanium,B-Drug
1448,71,",",O
1449,71,polyethylene,B-Drug
1450,71,or,O
1451,71,polyester,B-Drug
1452,71,materials,O
1453,71,.,O
1454,72,Subject,O
1455,72,is,O
1456,72,pregnant,B-Condition
1457,72,or,O
1458,72,interested,B-Mood
1459,72,in,I-Mood
1460,72,becoming,I-Mood
1461,72,pregnant,B-Condition
1462,72,in,O
1463,72,the,O
1464,72,next,O
1465,72,two,O
1466,72,(,O
1467,72,2,O
1468,72,),O
1469,72,years,O
1470,72,.,O
1471,73,Subject,O
1472,73,has,O
1473,73,active,O
1474,73,tuberculosis,B-Condition
1475,73,or,O
1476,73,has,O
1477,73,had,O
1478,73,tuberculosis,B-Condition
1479,73,in,O
1480,73,the,O
1481,73,past,O
1482,73,three,O
1483,73,(,O
1484,73,3,O
1485,73,),O
1486,73,years,O
1487,73,.,O
1488,74,Subject,O
1489,74,has,O
1490,74,a,O
1491,74,history,B-Observation
1492,74,of,O
1493,74,active,B-Condition
1494,74,malignancy,I-Condition
1495,74,:,O
1496,74,A,O
1497,74,patient,O
1498,74,with,O
1499,74,a,O
1500,74,history,O
1501,74,of,O
1502,74,any,O
1503,74,invasive,O
1504,74,malignancy,B-Condition
1505,74,(,O
1506,74,except,O
1507,74,non,B-Condition
1508,74,-,I-Condition
1509,74,melanoma,I-Condition
1510,74,skin,I-Condition
1511,74,cancer,I-Condition
1512,74,),O
1513,74,",",O
1514,74,unless,O
1515,74,he,O
1516,74,/,O
1517,74,she,O
1518,74,has,O
1519,74,been,O
1520,74,treated,B-Condition
1521,74,with,I-Condition
1522,74,curative,I-Condition
1523,74,intent,I-Condition
1524,74,and,O
1525,74,there,O
1526,74,have,O
1527,74,been,O
1528,74,no,O
1529,74,signs,B-Condition
1530,74,or,I-Condition
1531,74,symptoms,I-Condition
1532,74,of,I-Condition
1533,74,the,I-Condition
1534,74,malignancy,I-Condition
1535,74,for,O
1536,74,at,O
1537,74,least,O
1538,74,two,O
1539,74,(,O
1540,74,2,O
1541,74,),O
1542,74,years,O
1543,74,.,O
1544,75,Subject,O
1545,75,is,O
1546,75,immunologically,B-Condition
1547,75,suppressed,I-Condition
1548,75,",",O
1549,75,received,O
1550,75,steroids,B-Drug
1551,75,>,O
1552,75,1,O
1553,75,month,O
1554,75,over,O
1555,75,the,O
1556,75,past,O
1557,75,year,O
1558,75,.,O
1559,76,Currently,O
1560,76,taking,O
1561,76,anticoagulants,B-Drug
1562,76,",",O
1563,76,other,O
1564,76,than,O
1565,76,aspirin,B-Drug
1566,76,",",O
1567,76,unless,O
1568,76,the,O
1569,76,patient,O
1570,76,can,O
1571,76,be,O
1572,76,taken,O
1573,76,off,O
1574,76,the,O
1575,76,anticoagulant,O
1576,76,for,O
1577,76,surgery,O
1578,76,.,O
1579,77,Subject,O
1580,77,has,O
1581,77,a,O
1582,77,current,O
1583,77,chemical,B-Condition
1584,77,/,I-Condition
1585,77,alcohol,I-Condition
1586,77,dependency,I-Condition
1587,77,or,O
1588,77,significant,O
1589,77,psychosocial,B-Condition
1590,77,disturbance,I-Condition
1591,77,.,O
1592,78,Subject,O
1593,78,has,O
1594,78,a,O
1595,78,life,B-Observation
1596,78,expectancy,I-Observation
1597,78,of,O
1598,78,less,O
1599,78,than,O
1600,78,three,O
1601,78,(,O
1602,78,3,O
1603,78,),O
1604,78,years,O
1605,78,.,O
1606,79,Subject,O
1607,79,is,O
1608,79,currently,O
1609,79,involved,O
1610,79,in,O
1611,79,another,O
1612,79,investigational,O
1613,79,study,O
1614,79,.,O
1615,80,Subject,O
1616,80,is,O
1617,80,incarcerated,B-Observation
1618,80,.,O
1619,81,Age,B-Person
1620,81,18,O
1621,81,to,O
1622,81,75,O
1623,81,years,O
1624,81,old,O
1625,81,(,O
1626,81,male,B-Person
1627,81,or,O
1628,81,female,B-Person
1629,81,),O
1630,81,.,O
1631,82,Patients,O
1632,82,with,O
1633,82,posterior,O
1634,82,or,O
1635,82,posterolateral,O
1636,82,disc,B-Condition
1637,82,herniations,I-Condition
1638,82,at,O
1639,82,one,O
1640,82,level,O
1641,82,between,O
1642,82,L1,O
1643,82,and,O
1644,82,S1,O
1645,82,with,O
1646,82,radiographic,B-Procedure
1647,82,confirmation,O
1648,82,of,O
1649,82,neural,B-Condition
1650,82,compression,I-Condition
1651,82,using,O
1652,82,CT,B-Procedure
1653,82,and/or,O
1654,82,MRI,B-Procedure
1655,82,.,O
1656,83,At,O
1657,83,least,O
1658,83,six,O
1659,83,(,O
1660,83,6,O
1661,83,),O
1662,83,weeks,O
1663,83,of,O
1664,83,failed,O
1665,83,",",O
1666,83,conservative,O
1667,83,treatment,B-Procedure
1668,83,prior,O
1669,83,to,O
1670,83,surgery,O
1671,83,",",O
1672,83,or,O
1673,83,requires,O
1674,83,immediate,O
1675,83,surgery,B-Procedure
1676,83,to,O
1677,83,prevent,B-Mood
1678,83,permanent,B-Condition
1679,83,disability,I-Condition
1680,83,.,O
1681,84,Minimum,O
1682,84,posterior,O
1683,84,disc,O
1684,84,height,O
1685,84,of,O
1686,84,5,O
1687,84,mm,O
1688,84,at,O
1689,84,the,O
1690,84,index,O
1691,84,level(s,O
1692,84,),O
1693,84,.,O
1694,85,Lower,B-Condition
1695,85,back,I-Condition
1696,85,pain,I-Condition
1697,85,and/or,O
1698,85,sciatica,B-Condition
1699,85,with,O
1700,85,or,O
1701,85,without,O
1702,85,spinal,B-Condition
1703,85,claudication,I-Condition
1704,85,.,O
1705,86,Oswestry,O
1706,86,Questionnaire,O
1707,86,score,O
1708,86,of,O
1709,86,at,O
1710,86,least,O
1711,86,40/100,O
1712,86,at,O
1713,86,baseline,O
1714,86,.,O
1715,87,VAS,O
1716,87,leg,O
1717,87,pain,O
1718,87,of,O
1719,87,at,O
1720,87,least,O
1721,87,40/100,O
1722,87,at,O
1723,87,baseline,O
1724,87,.,O
1725,88,Psychosocially,O
1726,88,",",O
1727,88,mentally,O
1728,88,and,O
1729,88,physically,O
1730,88,able,O
1731,88,to,O
1732,88,fully,O
1733,88,comply,O
1734,88,with,O
1735,88,the,O
1736,88,clinical,O
1737,88,protocol,O
1738,88,and,O
1739,88,willing,O
1740,88,to,O
1741,88,adhere,O
1742,88,to,O
1743,88,follow,O
1744,88,-,O
1745,88,up,O
1746,88,schedule,O
1747,88,and,O
1748,88,requirements,O
1749,88,.,O
1750,89,Age,B-Person
1751,89,<,O
1752,89,18,O
1753,89,years,O
1754,89,old,O
1755,90,Patient,O
1756,90,unable,O
1757,90,to,O
1758,90,communicate,O
1759,90,or,O
1760,90,to,O
1761,90,understand,O
1762,90,the,O
1763,90,study,O
1764,91,Patient,O
1765,91,refusing,O
1766,91,to,O
1767,91,participate,O
1768,91,to,O
1769,91,the,O
1770,91,study,O
1771,92,contraindication,B-Condition
1772,92,to,O
1773,92,laparoscopy,B-Procedure
1774,93,women,B-Person
1775,94,proven,O
1776,94,pelvic,B-Condition
1777,94,floor,I-Condition
1778,94,dysfunction,I-Condition
1779,95,informed,O
1780,95,consent,O
1781,96,1,O
1782,96,.,O
1783,96,Patients,O
1784,96,with,O
1785,96,other,B-Condition
1786,96,uncontrolled,I-Condition
1787,96,infections,I-Condition
1788,96,(,O
1789,96,see,O
1790,96,2.3.2,O
1791,96,for,O
1792,96,definitions,O
1793,96,),O
1794,97,2,O
1795,97,.,O
1796,97,Patients,O
1797,97,who,O
1798,97,received,O
1799,97,ATG,B-Drug
1800,97,",",O
1801,97,Campath,B-Drug
1802,97,",",O
1803,97,or,O
1804,97,other,O
1805,97,T,B-Drug
1806,97,cell,I-Drug
1807,97,immunosuppressive,I-Drug
1808,97,monoclonal,I-Drug
1809,97,antibodies,I-Drug
1810,97,in,O
1811,97,the,O
1812,97,last,O
1813,97,28,O
1814,97,days,O
1815,98,3,O
1816,98,.,O
1817,98,Received,O
1818,98,donor,B-Procedure
1819,98,lymphocyte,I-Procedure
1820,98,infusion,I-Procedure
1821,98,in,O
1822,98,last,O
1823,98,28,O
1824,98,days,O
1825,99,4,O
1826,99,.,O
1827,99,Diagnosis,O
1828,99,of,O
1829,99,Omenn,B-Condition
1830,99,'s,I-Condition
1831,99,syndrome,I-Condition
1832,99,or,O
1833,99,MHC,B-Condition
1834,99,class,I-Condition
1835,99,I,I-Condition
1836,99,deficiency,I-Condition
1837,100,5,O
1838,100,.,O
1839,100,Active,O
1840,100,and,O
1841,100,uncontrolled,O
1842,100,malignancy,B-Condition
1843,101,6,O
1844,101,.,O
1845,101,Pregnant,B-Condition
1846,101,or,O
1847,101,lactating,B-Condition
1848,102,7,O
1849,102,.,O
1850,102,Unable,O
1851,102,to,O
1852,102,wean,B-Procedure
1853,102,steroids,B-Drug
1854,102,to,O
1855,102,≤0.5,O
1856,102,mg,O
1857,102,/,O
1858,102,kg,O
1859,102,/,O
1860,102,day,O
1861,102,prednisone,B-Drug
1862,102,.,O
1863,103,8,O
1864,103,.,O
1865,103,Patients,O
1866,103,with,O
1867,103,Grade,O
1868,103,3,O
1869,103,hyperbilirubinemia,B-Condition
1870,104,1,O
1871,104,.,O
1872,104,Diagnosis,O
1873,104,of,O
1874,104,primary,B-Condition
1875,104,immunodeficiency,I-Condition
1876,104,with,O
1877,104,established,O
1878,104,plan,O
1879,104,to,O
1880,104,undergo,O
1881,104,myeloablative,O
1882,104,or,O
1883,104,non,B-Procedure
1884,104,-,I-Procedure
1885,104,myeloablative,I-Procedure
1886,104,allogeneic,I-Procedure
1887,104,hematopoietic,I-Procedure
1888,104,stem,I-Procedure
1889,104,cell,I-Procedure
1890,104,transplant,I-Procedure
1891,104,for,O
1892,104,treatment,O
1893,104,thereof,O
1894,104,or,O
1895,104,diagnosis,O
1896,104,of,O
1897,104,a,O
1898,104,form,O
1899,104,of,O
1900,104,primary,B-Condition
1901,104,immunodeficiency,I-Condition
1902,104,for,O
1903,104,which,O
1904,104,hematopoietic,B-Procedure
1905,104,stem,I-Procedure
1906,104,cell,I-Procedure
1907,104,transplantation,I-Procedure
1908,104,is,O
1909,104,not,O
1910,104,indicated,O
1911,104,.,O
1912,105,2,O
1913,105,.,O
1914,105,Active,O
1915,105,infection,O
1916,105,with,O
1917,105,EBV,B-Condition
1918,105,",",O
1919,105,CMV,B-Condition
1920,105,",",O
1921,105,and/or,O
1922,105,Adenovirus,B-Condition
1923,105,",",O
1924,105,unable,O
1925,105,to,O
1926,105,be,O
1927,105,successfully,O
1928,105,controlled,O
1929,105,with,O
1930,105,standard,B-Procedure
1931,105,therapy,I-Procedure
1932,105,.,O
1933,106,3,O
1934,106,.,O
1935,106,Steroids,B-Drug
1936,106,less,O
1937,106,than,O
1938,106,0.5,O
1939,106,mg,O
1940,106,/,O
1941,106,kg,O
1942,106,/,O
1943,106,day,O
1944,106,prednisone,B-Drug
1945,107,4,O
1946,107,.,O
1947,107,Karnofsky,O
1948,107,/,O
1949,107,Lansky,O
1950,107,score,O
1951,107,of,O
1952,107,≥,O
1953,107,50,O
1954,108,5,O
1955,108,.,O
1956,108,ANC,O
1957,108,greater,O
1958,108,than,O
1959,108,500/µL.,O
1960,109,6,O
1961,109,.,O
1962,109,Bilirubin,O
1963,109,<,O
1964,109,2x,O
1965,109,",",O
1966,109,AST,O
1967,109,<,O
1968,109,3x,O
1969,109,",",O
1970,109,Serum,O
1971,109,creatinine,O
1972,109,<,O
1973,109,2x,O
1974,109,upper,O
1975,109,limit,O
1976,109,of,O
1977,109,normal,O
1978,109,",",O
1979,109,Hgb,O
1980,109,>,O
1981,109,8.0,O
1982,110,7,O
1983,110,.,O
1984,110,Pulse,O
1985,110,oximetry,O
1986,110,of,O
1987,110,>,O
1988,110,90,O
1989,110,%,O
1990,110,on,O
1991,110,room,O
1992,110,air,O
1993,111,8,O
1994,111,.,O
1995,111,Negative,O
1996,111,pregnancy,O
1997,111,test,O
1998,111,(,O
1999,111,if,O
2000,111,female,B-Person
2001,111,of,O
2002,111,childbearing,B-Condition
2003,111,potential,I-Condition
2004,111,),O
2005,112,9,O
2006,112,.,O
2007,112,Patient,O
2008,112,or,O
2009,112,parent,O
2010,112,/,O
2011,112,guardian,O
2012,112,capable,O
2013,112,of,O
2014,112,providing,O
2015,112,informed,O
2016,112,consent,O
2017,112,.,O
2018,113,Prior,O
2019,113,treatment,B-Procedure
2020,113,with,O
2021,113,more,O
2022,113,than,O
2023,113,6,O
2024,113,cycles,O
2025,113,of,O
2026,113,traditional,O
2027,113,alkylating,O
2028,113,agent,O
2029,113,-,O
2030,113,based,O
2031,113,chemotherapy,B-Procedure
2032,113,regimens,I-Procedure
2033,114,Prior,O
2034,114,treatment,B-Procedure
2035,114,with,O
2036,114,more,O
2037,114,than,O
2038,114,2,O
2039,114,cycles,O
2040,114,of,O
2041,114,carboplating,O
2042,114,-,O
2043,114,based,O
2044,114,chemotherapy,B-Procedure
2045,114,regimens,I-Procedure
2046,115,For,O
2047,115,colorectal,B-Condition
2048,115,cancer,I-Condition
2049,115,patients,O
2050,115,in,O
2051,115,the,O
2052,115,expanded,O
2053,115,cohorts,O
2054,115,",",O
2055,115,prior,O
2056,115,treatment,B-Procedure
2057,115,with,O
2058,115,more,O
2059,115,than,O
2060,115,2,O
2061,115,systemic,B-Procedure
2062,115,chemotherapy,I-Procedure
2063,115,regimens,I-Procedure
2064,115,in,O
2065,115,the,O
2066,115,metastatic,O
2067,115,setting,O
2068,116,Advanced,B-Condition
2069,116,solid,I-Condition
2070,116,tumor,I-Condition
2071,116,malignancy,I-Condition
2072,116,(,O
2073,116,during,O
2074,116,expansion,O
2075,116,at,O
2076,116,the,O
2077,116,maximum,O
2078,116,tolerated,O
2079,116,dose,O
2080,116,",",O
2081,116,entry,O
2082,116,will,O
2083,116,be,O
2084,116,limited,O
2085,116,to,O
2086,116,patients,O
2087,116,wtih,O
2088,116,adenocarcinoma,O
2089,116,of,O
2090,116,the,O
2091,116,colon,O
2092,116,or,O
2093,116,rectum,O
2094,116,),O
2095,117,Eastern,O
2096,117,Cooperative,O
2097,117,Oncology,O
2098,117,Group,O
2099,117,(,O
2100,117,ECOG,O
2101,117,),O
2102,117,0,O
2103,117,or,O
2104,117,1,O
2105,118,Current,O
2106,118,pregnancy,B-Condition
2107,118,or,O
2108,118,lactation,B-Condition
2109,119,Liver,B-Condition
2110,119,disease,I-Condition
2111,119,or,O
2112,119,elevated,B-Condition
2113,119,liver,I-Condition
2114,119,enzymes,I-Condition
2115,120,Established,O
2116,120,diagnosis,O
2117,120,of,O
2118,120,diabetes,B-Condition
2119,120,mellitus,I-Condition
2120,121,Abnormal,B-Condition
2121,121,serum,I-Condition
2122,121,glucose,I-Condition
2123,121,levels,I-Condition
2124,121,either,O
2125,121,at,O
2126,121,fasting,O
2127,121,or,O
2128,121,after,O
2129,121,the,O
2130,121,2,B-Procedure
2131,121,-,I-Procedure
2132,121,hr,I-Procedure
2133,121,oral,I-Procedure
2134,121,glucose,I-Procedure
2135,121,tolerance,I-Procedure
2136,121,test,I-Procedure
2137,121,meeting,O
2138,121,criteria,O
2139,121,for,O
2140,121,the,O
2141,121,diagnosis,O
2142,121,of,O
2143,121,diabetes,B-Condition
2144,121,mellitus,I-Condition
2145,121,according,O
2146,121,to,O
2147,121,the,O
2148,121,American,O
2149,121,Diabetes,O
2150,121,Association,O
2151,121,.,O
2152,122,Insulin,B-Procedure
2153,122,sensitizing,I-Procedure
2154,122,treatment,I-Procedure
2155,122,within,O
2156,122,3,O
2157,122,months,O
2158,122,prior,O
2159,122,to,O
2160,122,or,O
2161,122,during,O
2162,122,the,O
2163,122,eight,O
2164,122,week,O
2165,122,study,O
2166,122,period,O
2167,122,.,O
2168,123,Hormonal,O
2169,123,treatment,O
2170,123,involving,O
2171,123,estrogen,B-Drug
2172,123,or,O
2173,123,progesterone,B-Drug
2174,123,3,O
2175,123,months,O
2176,123,prior,O
2177,123,to,O
2178,123,or,O
2179,123,during,O
2180,123,the,O
2181,123,study,O
2182,123,period,O
2183,123,",",O
2184,123,with,O
2185,123,the,O
2186,123,exception,O
2187,123,of,O
2188,123,medroxyprogesterone,B-Drug
2189,123,acetate,I-Drug
2190,123,for,O
2191,123,withdrawal,B-Condition
2192,123,bleeding,I-Condition
2193,123,.,O
2194,124,Systemic,B-Drug
2195,124,or,I-Drug
2196,124,inhaled,I-Drug
2197,124,corticosteroids,I-Drug
2198,124,.,O
2199,125,Known,O
2200,125,hypersensitive,B-Condition
2201,125,reaction,I-Condition
2202,125,to,I-Condition
2203,125,cinnamon,I-Condition
2204,125,.,O
2205,126,Patients,O
2206,126,with,O
2207,126,seizure,B-Condition
2208,126,disorders,I-Condition
2209,126,",",O
2210,126,known,O
2211,126,cardiovascular,B-Condition
2212,126,disease,I-Condition
2213,126,",",O
2214,126,or,O
2215,126,cerebrovascular,B-Condition
2216,126,disease,I-Condition
2217,126,.,O
2218,127,Body,O
2219,127,mass,O
2220,127,index,O
2221,127,(,O
2222,127,BMI)range,O
2223,127,20,O
2224,127,-,O
2225,127,50,O
2226,127,(,O
2227,127,excluding,O
2228,127,all,O
2229,127,women,O
2230,127,with,O
2231,127,BMI,O
2232,127,under,O
2233,127,20,O
2234,127,or,O
2235,127,over,O
2236,127,50,O
2237,127,),O
2238,127,.,O
2239,128,Patients,O
2240,128,aged,B-Person
2241,128,greater,O
2242,128,than,O
2243,128,18,O
2244,128,years,O
2245,128,of,O
2246,128,age,B-Person
2247,129,Ability,O
2248,129,to,O
2249,129,understand,O
2250,129,and,O
2251,129,willingness,O
2252,129,to,O
2253,129,comply,O
2254,129,with,O
2255,129,the,O
2256,129,study,O
2257,129,protocol,O
2258,130,Written,O
2259,130,informed,O
2260,130,consent,O
2261,131,Patients,O
2262,131,meeting,O
2263,131,the,O
2264,131,Rotterdam,O
2265,131,PCOS,O
2266,131,workshop,O
2267,131,criteria,O
2268,131,for,O
2269,131,polycystic,O
2270,131,ovary,O
2271,131,syndrome,O
2272,131,",",O
2273,131,defined,O
2274,131,by,O
2275,131,oligomenorrhea,B-Condition
2276,131,or,O
2277,131,amenorrhea,B-Condition
2278,131,and,O
2279,131,at,O
2280,131,least,O
2281,131,one,O
2282,131,of,O
2283,131,the,O
2284,131,following,O
2285,131,two,O
2286,131,signs,O
2287,131,:,O
2288,131,clinical,O
2289,131,or,O
2290,131,biochemical,O
2291,131,evidence,O
2292,131,of,O
2293,131,hyperandrogenism,B-Condition
2294,131,or,O
2295,131,ultrasound,B-Procedure
2296,131,finding,O
2297,131,of,O
2298,131,polycystic,B-Condition
2299,131,appearing,I-Condition
2300,131,ovaries,I-Condition
2301,131,.,O
2302,132,Cases,O
2303,132,of,O
2304,132,rectal,B-Condition
2305,132,tumours,I-Condition
2306,132,below,O
2307,132,12,O
2308,132,cm,O
2309,132,from,O
2310,132,anal,O
2311,132,verge,O
2312,132,",",O
2313,132,or,O
2314,132,locally,B-Condition
2315,132,advanced,I-Condition
2316,132,tumours,I-Condition
2317,132,invading,B-Condition
2318,132,blood,I-Condition
2319,132,vessels,I-Condition
2320,132,",",O
2321,132,nerves,O
2322,132,or,O
2323,132,bone,O
2324,132,.,O
2325,133,Multiple,B-Condition
2326,133,bone,I-Condition
2327,133,metastasis,I-Condition
2328,133,or,O
2329,133,central,B-Condition
2330,133,nervous,I-Condition
2331,133,system,I-Condition
2332,133,metastasis,I-Condition
2333,134,Other,O
2334,134,neoplastic,B-Condition
2335,134,disease,I-Condition
2336,134,in,O
2337,134,the,O
2338,134,5,O
2339,134,previous,O
2340,134,years,O
2341,134,",",O
2342,134,except,O
2343,134,squamous,B-Condition
2344,134,or,I-Condition
2345,134,basal,I-Condition
2346,134,cell,I-Condition
2347,134,skin,I-Condition
2348,134,carcinoma,I-Condition
2349,134,or,O
2350,134,cervical,B-Condition
2351,134,"""",I-Condition
2352,134,in,I-Condition
2353,134,situ,I-Condition
2354,134,"""",I-Condition
2355,134,carcinoma,I-Condition
2356,135,Significant,O
2357,135,heart,B-Condition
2358,135,disease,I-Condition
2359,135,(,O
2360,135,chronic,B-Condition
2361,135,congestive,I-Condition
2362,135,heart,I-Condition
2363,135,failure,I-Condition
2364,135,",",O
2365,135,symptomatic,B-Condition
2366,135,coronary,I-Condition
2367,135,disease,I-Condition
2368,135,),O
2369,135,or,O
2370,135,myocardial,B-Condition
2371,135,infarction,I-Condition
2372,135,in,O
2373,135,the,O
2374,135,previous,O
2375,135,6,O
2376,135,months,O
2377,136,Peripheral,B-Condition
2378,136,neuropathy,I-Condition
2379,137,Patients,O
2380,137,who,O
2381,137,do,O
2382,137,not,O
2383,137,give,O
2384,137,informed,O
2385,137,consent,O
2386,138,colorectal,B-Condition
2387,138,cancer,I-Condition
2388,138,above,O
2389,138,to,O
2390,138,12,O
2391,138,cm,O
2392,138,from,O
2393,138,the,O
2394,138,anal,O
2395,138,verge,O
2396,139,unresectable,O
2397,139,synchronous,O
2398,139,metastases,B-Condition
2399,140,no,O
2400,140,contraindications,B-Condition
2401,140,for,O
2402,140,chemotherapy,B-Procedure
2403,141,absence,O
2404,141,of,O
2405,141,peritoneal,B-Condition
2406,141,carcinomatosis,I-Condition
2407,141,",",O
2408,141,central,B-Condition
2409,141,nervous,I-Condition
2410,141,system,I-Condition
2411,141,o,I-Condition
2412,141,bone,I-Condition
2413,141,metastasis,I-Condition
2414,141,.,O
2415,142,performance,O
2416,142,status,O
2417,142,ECOG,O
2418,142,=,O
2419,142,2,O
2420,142,(,O
2421,142,Eastern,O
2422,142,Cooperative,O
2423,142,Oncology,O
2424,142,Group,O
2425,142,),O
2426,143,uncontrolled,O
2427,143,concomitant,O
2428,143,medical,B-Condition
2429,143,conditions,I-Condition
2430,143,that,I-Condition
2431,143,may,I-Condition
2432,143,compromise,I-Condition
2433,143,to,I-Condition
2434,143,chemotherapy,I-Condition
2435,144,significant,O
2436,144,symptomatic,O
2437,144,cardiac,B-Condition
2438,144,disease,I-Condition
2439,145,not,O
2440,145,pregnancy,B-Condition
2441,145,or,O
2442,145,breastfeeding,B-Observation
2443,146,Acute,B-Condition
2444,146,coronary,I-Condition
2445,146,syndrome,I-Condition
2446,146,within,O
2447,146,1,O
2448,146,month,O
2449,147,Heart,B-Condition
2450,147,failure,I-Condition
2451,147,NYHA,O
2452,147,III,O
2453,147,to,O
2454,147,IV,O
2455,148,Contraindication,B-Condition
2456,148,to,O
2457,148,Aspirin,B-Drug
2458,149,On,O
2459,149,anticoagulant,B-Procedure
2460,149,therapy,I-Procedure
2461,150,Emergent,B-Procedure
2462,150,surgery,I-Procedure
2463,151,Cardiac,B-Procedure
2464,151,surgery,I-Procedure
2465,152,High,B-Condition
2466,152,bleeding,I-Condition
2467,152,risk,I-Condition
2468,152,surgeries,I-Condition
2469,152,",",O
2470,152,e.g.,O
2471,152,",",O
2472,152,Intra,B-Condition
2473,152,-,I-Condition
2474,152,cranial,I-Condition
2475,152,surgery,I-Condition
2476,152,",",O
2477,152,Intra,B-Condition
2478,152,-,I-Condition
2479,152,spinal,I-Condition
2480,152,surgery,I-Condition
2481,152,",",O
2482,152,Retinal,B-Condition
2483,152,surgery,I-Condition
2484,153,Pregnancy,B-Condition
2485,153,or,O
2486,153,breast,B-Condition
2487,153,-,I-Condition
2488,153,feeding,I-Condition
2489,154,Life,B-Observation
2490,154,expectancy,I-Observation
2491,154,less,O
2492,154,than,O
2493,154,1year,O
2494,155,Planned,B-Mood
2495,155,non,B-Condition
2496,155,-,I-Condition
2497,155,cardiac,I-Condition
2498,155,surgery,I-Condition
2499,155,at,O
2500,155,least,O
2501,155,after,O
2502,155,12,O
2503,155,months,O
2504,155,of,O
2505,155,implantation,B-Procedure
2506,155,of,O
2507,155,drug,O
2508,155,eluting,O
2509,155,stent,O
2510,156,Low,O
2511,156,or,O
2512,156,intermediate,B-Procedure
2513,156,risk,I-Procedure
2514,156,level,I-Procedure
2515,156,surgery,I-Procedure
2516,157,Written,B-Observation
2517,157,informed,I-Observation
2518,157,consent,I-Observation
2519,158,age,B-Person
2520,158,less,O
2521,158,than,O
2522,158,13,O
2523,158,years,O
2524,158,at,O
2525,158,time,O
2526,158,of,O
2527,158,procedure,O
2528,159,use,O
2529,159,of,O
2530,159,pain,B-Drug
2531,159,medication,I-Drug
2532,159,prior,O
2533,159,to,O
2534,159,procedure,O
2535,160,pectus,B-Condition
2536,160,carinatum,I-Condition
2537,160,",",O
2538,160,Poland,B-Condition
2539,160,'s,I-Condition
2540,160,syndrome,I-Condition
2541,160,",",O
2542,160,or,O
2543,160,any,O
2544,160,chest,B-Condition
2545,160,wall,I-Condition
2546,160,anomaly,I-Condition
2547,160,other,O
2548,160,than,O
2549,160,pectus,B-Condition
2550,160,excavatum,I-Condition
2551,161,previous,O
2552,161,repair,B-Procedure
2553,161,of,I-Procedure
2554,161,pectus,I-Procedure
2555,161,excavatum,I-Procedure
2556,161,by,O
2557,161,any,O
2558,161,technique,O
2559,162,previous,O
2560,162,thoracic,B-Procedure
2561,162,surgery,I-Procedure
2562,163,congenital,B-Condition
2563,163,heart,I-Condition
2564,163,disease,I-Condition
2565,164,bleeding,B-Condition
2566,164,dyscrasia,I-Condition
2567,165,major,O
2568,165,anesthetic,B-Condition
2569,165,risk,I-Condition
2570,165,factors,I-Condition
2571,165,or,O
2572,165,history,O
2573,165,of,O
2574,165,previous,O
2575,165,problem,B-Condition
2576,165,with,I-Condition
2577,165,anesthesia,I-Condition
2578,166,pregnancy,B-Condition
2579,167,inability,B-Condition
2580,167,to,I-Condition
2581,167,communicate,I-Condition
2582,167,in,I-Condition
2583,167,English,I-Condition
2584,168,scheduled,B-Mood
2585,168,for,O
2586,168,Nuss,B-Procedure
2587,168,procedure,I-Procedure
2588,168,for,O
2589,168,pectus,B-Condition
2590,168,excavatum,I-Condition
2591,168,correction,O
2592,169,at,O
2593,169,least,O
2594,169,13,O
2595,169,years,O
2596,169,old,B-Person
2597,169,at,O
2598,169,the,O
2599,169,time,O
2600,169,of,O
2601,169,the,O
2602,169,procedure,O
2603,170,Ductal,B-Condition
2604,170,carcinoma,I-Condition
2605,170,in,I-Condition
2606,170,situ,I-Condition
2607,170,(,O
2608,170,DCIS,B-Condition
2609,170,;,O
2610,170,stage,O
2611,170,0,O
2612,170,cancer,B-Condition
2613,170,),O
2614,170,",",O
2615,171,Advanced,O
2616,171,or,O
2617,171,distant,O
2618,171,metastatic,O
2619,171,stage,O
2620,171,",",O
2621,172,Receiving,O
2622,172,any,O
2623,172,neoadjuvant,B-Procedure
2624,172,therapy,I-Procedure
2625,172,",",O
2626,173,History,B-Observation
2627,173,of,O
2628,173,receiving,O
2629,173,any,O
2630,173,antibiotics,B-Drug
2631,173,within,O
2632,173,prior,O
2633,173,3,O
2634,173,months,O
2635,173,",",O
2636,174,History,B-Observation
2637,174,of,O
2638,174,immunodeficiency,B-Condition
2639,174,",",O
2640,175,Having,O
2641,175,a,O
2642,175,remote,B-Condition
2643,175,infection,I-Condition
2644,175,",",O
2645,176,History,B-Observation
2646,176,of,O
2647,176,reaction,B-Condition
2648,176,to,O
2649,176,study,B-Drug
2650,176,antibiotics,I-Drug
2651,176,",",O
2652,177,Denial,O
2653,177,of,O
2654,177,signing,O
2655,177,the,O
2656,177,consent,O
2657,177,form,O
2658,177,.,O
2659,178,Women,B-Person
2660,178,at,O
2661,178,any,B-Person
2662,178,age,I-Person
2663,178,with,O
2664,178,early,O
2665,178,stage,O
2666,178,breast,B-Condition
2667,178,cancer,I-Condition
2668,178,(,O
2669,178,stage,O
2670,178,I,O
2671,178,-,O
2672,178,II,O
2673,178,),O
2674,178,and,O
2675,178,American,O
2676,178,Society,O
2677,178,of,O
2678,178,Anesthesiologists,O
2679,178,(,O
2680,178,ASA,O
2681,178,),O
2682,178,score,O
2683,178,of,O
2684,178,I,O
2685,178,-,O
2686,178,II,O
2687,178,.,O
2688,179,Patients,O
2689,179,with,O
2690,179,renal,B-Condition
2691,179,impairment,I-Condition
2692,179,(,O
2693,179,serum,O
2694,179,creatinine,O
2695,179,more,O
2696,179,than,O
2697,179,twice,O
2698,179,the,O
2699,179,upper,O
2700,179,limit,O
2701,179,of,O
2702,179,normal,O
2703,179,),O
2704,179,.,O
2705,180,Patients,O
2706,180,with,O
2707,180,heart,B-Condition
2708,180,failure,I-Condition
2709,180,.,O
2710,181,Patients,O
2711,181,with,O
2712,181,sepsis,B-Condition
2713,181,or,O
2714,181,active,B-Condition
2715,181,infection,I-Condition
2716,181,.,O
2717,182,Patients,O
2718,182,with,O
2719,182,diabetes,B-Condition
2720,182,mellitus,I-Condition
2721,182,(,O
2722,182,either,O
2723,182,primary,O
2724,182,or,O
2725,182,secondary,O
2726,182,to,O
2727,182,thalassemia,O
2728,182,),O
2729,182,.,O
2730,183,regular,O
2731,183,consumption,O
2732,183,of,O
2733,183,medication,B-Drug
2734,183,with,O
2735,183,potential,O
2736,183,hepatotoxicity,B-Condition
2737,183,.,O
2738,184,regular,O
2739,184,herbal,B-Procedure
2740,184,medicine,I-Procedure
2741,184,or,O
2742,184,antioxidant,B-Drug
2743,184,supplementation,I-Drug
2744,184,.,O
2745,185,patients,O
2746,185,with,O
2747,185,gastrointestinal,O
2748,185,conditions,O
2749,185,preventing,O
2750,185,adsorption,O
2751,185,of,O
2752,185,oral,O
2753,185,medication,O
2754,185,.,O
2755,186,Diagnosed,O
2756,186,with,O
2757,186,Beta,B-Condition
2758,186,-,I-Condition
2759,186,Thalassemia,I-Condition
2760,186,Major,I-Condition
2761,186,and,O
2762,186,receiving,O
2763,186,regular,O
2764,186,blood,B-Procedure
2765,186,transfusion,I-Procedure
2766,186,and,O
2767,186,on,O
2768,186,iron,B-Procedure
2769,186,chelating,I-Procedure
2770,186,therapy,I-Procedure
2771,186,.,O
2772,187,Weight,B-Person
2773,187,:,O
2774,187,equal,O
2775,187,to,O
2776,187,or,O
2777,187,over,O
2778,187,35,O
2779,187,kg,O
2780,187,.,O
2781,188,Normal,O
2782,188,renal,B-Condition
2783,188,function,I-Condition
2784,188,.,O
2785,189,Unwillingness,O
2786,189,or,O
2787,189,inability,O
2788,189,to,O
2789,189,comply,O
2790,189,with,O
2791,189,the,O
2792,189,procedures,O
2793,189,described,O
2794,189,in,O
2795,189,this,O
2796,189,protocol,O
2797,190,Planned,B-Mood
2798,190,cardiac,B-Procedure
2799,190,surgery,I-Procedure
2800,190,or,O
2801,190,planned,B-Mood
2802,190,major,O
2803,190,non,O
2804,190,-,O
2805,190,cardiac,O
2806,190,surgery,B-Procedure
2807,190,within,O
2808,190,the,O
2809,190,study,O
2810,190,period,O
2811,190,.,O
2812,191,Stroke,B-Procedure
2813,191,or,I-Procedure
2814,191,coronary,I-Procedure
2815,191,revascularization,I-Procedure
2816,191,in,O
2817,191,the,O
2818,191,past,O
2819,191,6,O
2820,191,months,O
2821,191,.,O
2822,192,Clinically,O
2823,192,significant,O
2824,192,pulmonary,B-Condition
2825,192,disease,I-Condition
2826,192,.,O
2827,193,Untreated,O
2828,193,hyperthyroidism,B-Condition
2829,193,",",O
2830,193,or,O
2831,193,hypothyroidism,B-Condition
2832,193,.,O
2833,194,A,O
2834,194,diagnosis,O
2835,194,of,O
2836,194,cancer,B-Condition
2837,194,(,O
2838,194,other,O
2839,194,than,O
2840,194,superficial,B-Condition
2841,194,squamous,I-Condition
2842,194,or,I-Condition
2843,194,basal,I-Condition
2844,194,cell,I-Condition
2845,194,skin,I-Condition
2846,194,cancer,I-Condition
2847,194,),O
2848,194,in,O
2849,194,the,O
2850,194,past,O
2851,194,3,O
2852,194,years,O
2853,194,or,O
2854,194,current,O
2855,194,treatment,B-Procedure
2856,194,for,O
2857,194,the,O
2858,194,active,O
2859,194,cancer,B-Condition
2860,194,.,O
2861,195,Female,O
2862,195,of,O
2863,195,child,O
2864,195,-,O
2865,195,bearing,O
2866,195,potential,O
2867,195,who,O
2868,195,do,O
2869,195,not,O
2870,195,use,O
2871,195,adequate,O
2872,195,contraception,O
2873,195,and,O
2874,195,women,O
2875,195,who,O
2876,195,are,O
2877,195,pregnant,O
2878,195,or,O
2879,195,breast,O
2880,195,-,O
2881,195,feeding,O
2882,196,Any,O
2883,196,clinically,O
2884,196,significant,O
2885,196,abnormality,O
2886,196,identified,O
2887,196,at,O
2888,196,the,O
2889,196,screening,O
2890,196,visit,O
2891,196,",",O
2892,196,physical,O
2893,196,examination,O
2894,196,",",O
2895,196,laboratory,O
2896,196,tests,O
2897,196,",",O
2898,196,or,O
2899,196,electrocardiogram,O
2900,196,which,O
2901,196,",",O
2902,196,in,O
2903,196,the,O
2904,196,judgment,O
2905,196,of,O
2906,196,the,O
2907,196,Investigator,O
2908,196,",",O
2909,196,would,O
2910,196,preclude,O
2911,196,safe,O
2912,196,completion,O
2913,196,of,O
2914,196,the,O
2915,196,study,O
2916,196,.,O
2917,197,LV,O
2918,197,ejection,O
2919,197,fraction,O
2920,197,<,O
2921,197,50,O
2922,197,%,O
2923,197,.,O
2924,198,Significant,O
2925,198,renal,B-Condition
2926,198,disease,I-Condition
2927,198,manifested,O
2928,198,by,O
2929,198,serum,O
2930,198,creatinine,O
2931,198,>,O
2932,198,2.5,O
2933,198,mg,O
2934,198,/,O
2935,198,dL,O
2936,199,Hepatic,B-Condition
2937,199,disease,I-Condition
2938,199,or,O
2939,199,biliary,B-Condition
2940,199,tract,I-Condition
2941,199,obstruction,I-Condition
2942,199,",",O
2943,199,or,O
2944,199,significant,O
2945,199,hepatic,B-Condition
2946,199,enzyme,I-Condition
2947,199,elevation,I-Condition
2948,199,(,O
2949,199,ALT,O
2950,199,or,O
2951,199,AST,O
2952,199,>,O
2953,199,3,O
2954,199,times,O
2955,199,upper,O
2956,199,limit,O
2957,199,of,O
2958,199,normal,O
2959,199,),O
2960,199,.,O
2961,200,History,O
2962,200,of,O
2963,200,intolerance,B-Condition
2964,200,to,O
2965,200,ARB,B-Drug
2966,200,or,O
2967,200,amlodipine,B-Drug
2968,200,.,O
2969,201,Hypertrophic,B-Condition
2970,201,or,I-Condition
2971,201,restrictive,I-Condition
2972,201,cardiomyopathy,I-Condition
2973,201,.,O
2974,202,Moderate,O
2975,202,or,O
2976,202,severe,O
2977,202,valvular,B-Condition
2978,202,disease,I-Condition
2979,202,.,O
2980,203,Constrictive,B-Condition
2981,203,pericarditis,I-Condition
2982,204,Atrial,B-Condition
2983,204,fibrillation,I-Condition
2984,204,with,O
2985,204,a,O
2986,204,heart,O
2987,204,rate,O
2988,204,>,O
2989,204,120,O
2990,204,/,O
2991,204,min,O
2992,204,.,O
2993,205,Sitting,O
2994,205,systolic,B-Condition
2995,205,BP,I-Condition
2996,205,<,O
2997,205,100,O
2998,205,mmHg,O
2999,206,Controlled,O
3000,206,hypertension,B-Condition
3001,206,:,O
3002,206,systolic,O
3003,206,BP,O
3004,206,<,O
3005,206,150,O
3006,206,and,O
3007,206,diastolic,O
3008,206,BP,O
3009,206,<,O
3010,206,90,O
3011,206,mmHg,O
3012,206,in,O
3013,206,persons,O
3014,206,aged,B-Person
3015,206,60,O
3016,206,years,O
3017,206,or,O
3018,206,older,O
3019,206,",",O
3020,206,systolic,O
3021,206,BP,O
3022,206,<,O
3023,206,140,O
3024,206,and,O
3025,206,diastolic,O
3026,206,BP,O
3027,206,<,O
3028,206,90,O
3029,206,mmHg,O
3030,206,in,O
3031,206,persons,O
3032,206,40,O
3033,206,through,O
3034,206,59,O
3035,206,years,B-Person
3036,206,according,O
3037,206,to,O
3038,206,the,O
3039,206,JNC,O
3040,206,8th,O
3041,206,guideline,O
3042,207,Evidence,O
3043,207,of,O
3044,207,diastolic,B-Condition
3045,207,dysfunction,I-Condition
3046,207,showing,O
3047,207,E,O
3048,207,/,O
3049,207,E,O
3050,207,',O
3051,207,>,O
3052,207,10,O
3053,208,The,O
3054,208,patient,O
3055,208,agrees,O
3056,208,to,O
3057,208,the,O
3058,208,study,O
3059,208,protocol,O
3060,208,and,O
3061,208,the,O
3062,208,schedule,O
3063,208,of,O
3064,208,clinical,O
3065,208,and,O
3066,208,echocardiographic,O
3067,208,follow,O
3068,208,-,O
3069,208,up,O
3070,208,",",O
3071,208,and,O
3072,208,provides,O
3073,208,informed,O
3074,208,",",O
3075,208,written,O
3076,208,consent,O
3077,208,",",O
3078,208,as,O
3079,208,approved,O
3080,208,by,O
3081,208,the,O
3082,208,appropriate,O
3083,208,Institutional,O
3084,208,Review,O
3085,208,Board,O
3086,208,/,O
3087,208,Ethical,O
3088,208,Committee,O
3089,208,of,O
3090,208,the,O
3091,208,respective,O
3092,208,clinical,O
3093,208,site,O
3094,209,NA,O
3095,210,Patients,O
3096,210,who,O
3097,210,are,O
3098,210,19,O
3099,210,years,B-Person
3100,210,or,O
3101,210,older,O
3102,210,on,O
3103,210,screening,O
3104,211,Patients,O
3105,211,with,O
3106,211,type,B-Condition
3107,211,2,I-Condition
3108,211,diabetes,I-Condition
3109,211,mellitus,I-Condition
3110,212,Patients,O
3111,212,with,O
3112,212,7.0,O
3113,212,%,O
3114,212,=,O
3115,212,HbA1c,O
3116,212,=,O
3117,212,11.0,O
3118,212,%,O
3119,212,at,O
3120,212,the,O
3121,212,screening,O
3122,212,visit,O
3123,213,Patients,O
3124,213,with,O
3125,213,Fasting,O
3126,213,Plasma,O
3127,213,Glucose,O
3128,213,<,O
3129,213,15mmol,O
3130,213,/,O
3131,213,L(270mg,O
3132,213,/,O
3133,213,dL,O
3134,213,),O
3135,213,on,O
3136,213,screening,O
3137,214,Patient,O
3138,214,has,O
3139,214,participated,O
3140,214,in,O
3141,214,a,O
3142,214,combination,O
3143,214,trial,O
3144,214,where,O
3145,214,ruxolitinib,O
3146,214,was,O
3147,214,dispensed,O
3148,214,in,O
3149,214,combination,O
3150,214,with,O
3151,214,another,O
3152,214,study,O
3153,214,medication,O
3154,214,and,O
3155,214,the,O
3156,214,patient,O
3157,214,is,O
3158,214,still,O
3159,214,receiving,O
3160,214,combination,O
3161,214,therapy,O
3162,214,.,O
3163,215,Pregnant,O
3164,215,or,O
3165,215,nursing,O
3166,215,(,O
3167,215,lactating,O
3168,215,),O
3169,215,women,O
3170,215,",",O
3171,215,where,O
3172,215,pregnancy,O
3173,215,is,O
3174,215,defined,O
3175,215,as,O
3176,215,the,O
3177,215,state,O
3178,215,of,O
3179,215,a,O
3180,215,female,O
3181,215,after,O
3182,215,conception,O
3183,215,and,O
3184,215,until,O
3185,215,the,O
3186,215,termination,O
3187,215,of,O
3188,215,gestation,O
3189,215,",",O
3190,215,confirmed,O
3191,215,by,O
3192,215,a,O
3193,215,positive,O
3194,215,hCG,O
3195,215,laboratory,O
3196,215,test,O
3197,215,.,O
3198,216,Women,O
3199,216,of,O
3200,216,child,O
3201,216,-,O
3202,216,bearing,O
3203,216,potential,O
3204,216,",",O
3205,216,defined,O
3206,216,as,O
3207,216,all,O
3208,216,women,O
3209,216,physiologically,O
3210,216,capable,O
3211,216,of,O
3212,216,becoming,O
3213,216,pregnant,O
3214,216,",",O
3215,216,unless,O
3216,216,they,O
3217,216,are,O
3218,216,using,O
3219,216,highly,O
3220,216,effective,O
3221,216,methods,O
3222,216,of,O
3223,216,contraception,O
3224,216,throughout,O
3225,216,the,O
3226,216,study,O
3227,216,duration,O
3228,216,inclusive,O
3229,216,of,O
3230,216,the,O
3231,216,30,O
3232,216,-,O
3233,216,day,O
3234,216,safety,O
3235,216,follow,O
3236,216,up,O
3237,216,.,O
3238,217,Patient,O
3239,217,is,O
3240,217,currently,O
3241,217,enrolled,O
3242,217,in,O
3243,217,a,O
3244,217,Novartis,O
3245,217,OGD,O
3246,217,or,O
3247,217,GMA,O
3248,217,-,O
3249,217,sponsored,O
3250,217,or,O
3251,217,Incyte,O
3252,217,-,O
3253,217,sponsored,O
3254,217,clinical,O
3255,217,study,O
3256,217,(,O
3257,217,where,O
3258,217,Incyte,O
3259,217,can,O
3260,217,delegate,O
3261,217,the,O
3262,217,sponsorship,O
3263,217,to,O
3264,217,a,O
3265,217,preferred,O
3266,217,CRO,O
3267,217,",",O
3268,217,if,O
3269,217,applicable,O
3270,217,),O
3271,217,that,O
3272,217,is,O
3273,217,approved,O
3274,217,to,O
3275,217,enroll,O
3276,217,into,O
3277,217,this,O
3278,217,rollover,O
3279,217,study,O
3280,217,",",O
3281,217,is,O
3282,217,receiving,O
3283,217,ruxolitinib,O
3284,217,and,O
3285,217,has,O
3286,217,fulfilled,O
3287,217,all,O
3288,217,of,O
3289,217,the,O
3290,217,requirements,O
3291,217,of,O
3292,217,the,O
3293,217,parent,O
3294,217,protocol,O
3295,217,.,O
3296,218,Patient,O
3297,218,is,O
3298,218,currently,O
3299,218,benefiting,O
3300,218,from,O
3301,218,the,O
3302,218,treatment,O
3303,218,with,O
3304,218,ruxolitinib,B-Drug
3305,218,",",O
3306,218,as,O
3307,218,determined,O
3308,218,by,O
3309,218,the,O
3310,218,investigator,O
3311,219,Patient,O
3312,219,has,O
3313,219,demonstrated,O
3314,219,compliance,O
3315,219,",",O
3316,219,as,O
3317,219,assessed,O
3318,219,by,O
3319,219,the,O
3320,219,investigator,O
3321,219,",",O
3322,219,with,O
3323,219,the,O
3324,219,parent,O
3325,219,study,O
3326,219,protocol,O
3327,219,requirements,O
3328,219,Willingness,O
3329,219,and,O
3330,219,ability,O
3331,219,to,O
3332,219,comply,O
3333,219,with,O
3334,219,scheduled,O
3335,219,visits,O
3336,219,",",O
3337,219,treatment,O
3338,219,plans,O
3339,219,and,O
3340,219,any,O
3341,219,other,O
3342,219,study,O
3343,219,procedures,O
3344,220,Patient,O
3345,220,currently,O
3346,220,has,O
3347,220,no,O
3348,220,evidence,O
3349,220,of,O
3350,220,progressive,B-Condition
3351,220,disease,I-Condition
3352,220,",",O
3353,220,as,O
3354,220,determined,O
3355,220,by,O
3356,220,the,O
3357,220,investigator,O
3358,220,",",O
3359,220,following,O
3360,220,previous,O
3361,220,treatment,O
3362,220,with,O
3363,220,ruxolitinib,B-Drug
3364,221,Written,O
3365,221,informed,O
3366,221,consent,O
3367,221,obtained,O
3368,221,prior,O
3369,221,to,O
3370,221,enrolling,O
3371,221,in,O
3372,221,roll,O
3373,221,-,O
3374,221,over,O
3375,221,study,O
3376,221,and,O
3377,221,receiving,O
3378,221,study,O
3379,221,medication,O
3380,221,.,O
3381,221,If,O
3382,221,consent,O
3383,221,can,O
3384,221,not,O
3385,221,be,O
3386,221,expressed,O
3387,221,in,O
3388,221,writing,O
3389,221,",",O
3390,221,it,O
3391,221,must,O
3392,221,be,O
3393,221,formally,O
3394,221,documented,O
3395,221,and,O
3396,221,witnessed,O
3397,221,",",O
3398,221,ideally,O
3399,221,via,O
3400,221,an,O
3401,221,independent,O
3402,221,trusted,O
3403,221,witness,O
3404,221,.,O
3405,222,Volunteers,O
3406,222,must,O
3407,222,not,O
3408,222,have,O
3409,222,been,O
3410,222,vaccinated,B-Procedure
3411,222,against,O
3412,222,HPV,B-Condition
3413,222,-,I-Condition
3414,222,Gardasil-9,I-Condition
3415,222,(,O
3416,222,both,O
3417,222,partners,O
3418,222,),O
3419,223,Any,B-Observation
3420,223,history,I-Observation
3421,223,of,O
3422,223,cervical,O
3423,223,",",O
3424,223,penile,B-Condition
3425,223,",",I-Condition
3426,223,oral,I-Condition
3427,223,or,I-Condition
3428,223,anal,I-Condition
3429,223,cancers,I-Condition
3430,224,Being,O
3431,224,pregnant,B-Condition
3432,224,or,O
3433,224,plan,B-Mood
3434,224,on,I-Mood
3435,224,immediately,I-Mood
3436,224,becoming,I-Mood
3437,224,pregnant,B-Condition
3438,225,Couple,O
3439,225,must,O
3440,225,have,O
3441,225,been,O
3442,225,in,O
3443,225,a,O
3444,225,new,B-Observation
3445,225,relationship,I-Observation
3446,225,that,O
3447,225,started,O
3448,225,no,O
3449,225,more,O
3450,225,than,O
3451,225,six,O
3452,225,months,O
3453,225,prior,O
3454,225,to,O
3455,225,study,O
3456,225,entry,O
3457,226,Both,O
3458,226,partners,O
3459,226,plan,B-Mood
3460,226,on,I-Mood
3461,226,remaining,B-Observation
3462,226,in,I-Observation
3463,226,Montreal,I-Observation
3464,226,for,O
3465,226,at,O
3466,226,least,O
3467,226,1,O
3468,226,year,O
3469,227,Plan,B-Mood
3470,227,on,I-Mood
3471,227,having,B-Observation
3472,227,continued,I-Observation
3473,227,sexual,I-Observation
3474,227,contact,I-Observation
3475,227,with,I-Observation
3476,227,partner,I-Observation
3477,228,Be,O
3478,228,willing,O
3479,228,to,O
3480,228,comply,O
3481,228,with,O
3482,228,study,O
3483,228,procedures,O
3484,229,Patients,O
3485,229,Level,O
3486,229,III,O
3487,229,or,O
3488,229,greater,O
3489,229,on,O
3490,229,the,O
3491,229,American,O
3492,229,Society,O
3493,229,of,O
3494,229,Anesthesiologists,O
3495,229,(,O
3496,229,ASA,O
3497,229,),O
3498,229,physical,O
3499,229,status,O
3500,229,classification,O
3501,229,system,O
3502,229,(,O
3503,229,as,O
3504,229,determined,O
3505,229,by,O
3506,229,the,O
3507,229,anesthesiologist,O
3508,229,),O
3509,230,Patients,O
3510,230,with,O
3511,230,chronic,B-Condition
3512,230,conditions,I-Condition
3513,230,that,O
3514,230,would,O
3515,230,limit,B-Observation
3516,230,our,I-Observation
3517,230,ability,I-Observation
3518,230,to,I-Observation
3519,230,develop,I-Observation
3520,230,the,I-Observation
3521,230,study,I-Observation
3522,230,according,I-Observation
3523,230,to,I-Observation
3524,230,objectives,I-Observation
3525,230,",",O
3526,230,such,O
3527,230,as,O
3528,230,neurodevelopmental,B-Condition
3529,230,conditions,I-Condition
3530,230,preventing,B-Condition
3531,230,patients,O
3532,230,from,O
3533,230,understanding,B-Observation
3534,230,the,I-Observation
3535,230,Oucher,I-Observation
3536,230,tool,I-Observation
3537,231,Hepatic,B-Condition
3538,231,or,I-Condition
3539,231,renal,I-Condition
3540,231,disease,I-Condition
3541,232,cardiac,B-Condition
3542,232,disease,I-Condition
3543,233,active,O
3544,233,infection,B-Condition
3545,234,diabetes,B-Condition
3546,234,mellitus,I-Condition
3547,235,sickle,B-Condition
3548,235,cell,I-Condition
3549,235,disease,I-Condition
3550,236,known,O
3551,236,coagulation,B-Condition
3552,236,disorders,I-Condition
3553,237,pre-,O
3554,237,operative,O
3555,237,treatment,B-Procedure
3556,237,with,O
3557,237,anti,B-Drug
3558,237,-,I-Drug
3559,237,emetics,I-Drug
3560,237,",",O
3561,237,steroids,B-Drug
3562,237,",",O
3563,237,or,O
3564,237,analgesics,B-Drug
3565,238,Acetaminophen,B-Drug
3566,238,allergy,B-Condition
3567,238,or,O
3568,238,already,O
3569,238,receiving,O
3570,238,acetaminophen,B-Drug
3571,238,within,O
3572,238,24,O
3573,238,h,O
3574,238,of,O
3575,238,surgery,O
3576,239,Complicating,B-Condition
3577,239,health,I-Condition
3578,239,factors,I-Condition
3579,239,precluding,B-Condition
3580,239,the,O
3581,239,use,O
3582,239,of,O
3583,239,opioids,B-Drug
3584,239,or,O
3585,239,acetaminophen,B-Drug
3586,240,any,O
3587,240,other,B-Condition
3588,240,factors,I-Condition
3589,240,which,O
3590,240,would,O
3591,240,interfere,B-Condition
3592,240,with,O
3593,240,pain,B-Procedure
3594,240,assessment,I-Procedure
3595,240,and,O
3596,240,management,B-Procedure
3597,241,Patients,O
3598,241,weighing,O
3599,241,more,O
3600,241,than,O
3601,241,30,O
3602,241,kg,O
3603,241,that,O
3604,241,would,O
3605,241,exceed,O
3606,241,maximum,O
3607,241,dexamethasone,O
3608,241,dose,O
3609,242,Patients,O
3610,242,who,O
3611,242,live,O
3612,242,without,O
3613,242,a,O
3614,242,home,O
3615,242,telephone,O
3616,243,patient,O
3617,243,living,O
3618,243,without,O
3619,243,parental,O
3620,243,supervision,O
3621,243,.,O
3622,244,Healthy,B-Condition
3623,244,patients,O
3624,245,aged,B-Person
3625,245,3,O
3626,245,-,O
3627,245,13,O
3628,245,years,O
3629,246,Level,O
3630,246,I,O
3631,246,or,O
3632,246,level,O
3633,246,II,O
3634,246,on,O
3635,246,the,O
3636,246,American,O
3637,246,Society,O
3638,246,of,O
3639,246,Anesthesiologists,O
3640,246,(,O
3641,246,ASA,O
3642,246,),O
3643,246,physical,O
3644,246,status,O
3645,246,classification,O
3646,246,system,O
3647,246,(,O
3648,246,as,O
3649,246,determined,O
3650,246,by,O
3651,246,the,O
3652,246,anesthesiologist,O
3653,246,),O
3654,247,obstructive,B-Condition
3655,247,sleep,I-Condition
3656,247,apnea,I-Condition
3657,247,or,O
3658,247,recurrent,O
3659,247,throat,B-Condition
3660,247,infections,I-Condition
3661,248,undergoing,O
3662,248,elective,O
3663,248,tonsillectomy,B-Condition
3664,248,with,O
3665,248,or,O
3666,248,without,O
3667,248,adenoidectomy,B-Condition
3668,249,Parents,O
3669,249,who,O
3670,249,agree,O
3671,249,to,O
3672,249,complete,O
3673,249,documentation,O
3674,249,and,O
3675,249,follow,O
3676,249,up,O
3677,249,at,O
3678,249,14,O
3679,249,days,O
3680,249,post,O
3681,249,-,O
3682,249,operation,O
3683,249,.,O
3684,250,Uncontrolled,O
3685,250,medical,B-Condition
3686,250,problems,I-Condition
3687,250,including,O
3688,250,pulmonary,B-Condition
3689,250,",",I-Condition
3690,250,cardiovascular,I-Condition
3691,250,or,I-Condition
3692,250,orthopedic,I-Condition
3693,250,disease,I-Condition
3694,251,Any,O
3695,251,debilitating,B-Condition
3696,251,disease,I-Condition
3697,251,prior,O
3698,251,to,O
3699,251,the,O
3700,251,SCI,O
3701,251,that,O
3702,251,caused,O
3703,251,exercise,B-Condition
3704,251,intolerance,I-Condition
3705,252,Premorbid,O
3706,252,",",O
3707,252,ongoing,O
3708,252,major,B-Condition
3709,252,depression,I-Condition
3710,252,or,O
3711,252,psychosis,B-Condition
3712,252,",",O
3713,252,altered,B-Condition
3714,252,cognitive,I-Condition
3715,252,status,I-Condition
3716,253,History,B-Observation
3717,253,of,O
3718,253,head,B-Condition
3719,253,injury,I-Condition
3720,253,or,O
3721,253,stroke,B-Condition
3722,254,Metal,O
3723,254,plate,O
3724,254,in,O
3725,254,skull,O
3726,255,History,B-Observation
3727,255,of,O
3728,255,seizures,B-Condition
3729,256,Receiving,O
3730,256,drugs,B-Drug
3731,256,acting,I-Drug
3732,256,primarily,I-Drug
3733,256,on,I-Drug
3734,256,the,I-Drug
3735,256,central,I-Drug
3736,256,nervous,I-Drug
3737,256,system,I-Drug
3738,256,",",O
3739,256,which,O
3740,256,lower,O
3741,256,the,O
3742,256,seizure,O
3743,256,threshold,O
3744,256,(,O
3745,256,see,O
3746,256,appendix,O
3747,256,2,O
3748,256,),O
3749,257,Pregnant,B-Condition
3750,257,females,B-Person
3751,258,Ongoing,O
3752,258,cord,B-Condition
3753,258,compression,I-Condition
3754,258,or,O
3755,258,a,O
3756,258,syrinx,B-Condition
3757,258,in,O
3758,258,the,O
3759,258,spinal,O
3760,258,cord,O
3761,258,or,O
3762,258,who,O
3763,258,suffer,O
3764,258,from,O
3765,258,a,O
3766,258,spinal,B-Condition
3767,258,cord,I-Condition
3768,258,disease,I-Condition
3769,258,such,O
3770,258,as,O
3771,258,spinal,B-Condition
3772,258,stenosis,I-Condition
3773,258,",",O
3774,258,spina,B-Condition
3775,258,bifida,I-Condition
3776,258,",",O
3777,258,MS,B-Condition
3778,258,",",O
3779,258,or,O
3780,258,herniated,B-Condition
3781,258,disk,I-Condition
3782,259,Individuals,O
3783,259,with,O
3784,259,scalp,O
3785,259,shrapnel,O
3786,259,",",O
3787,259,cochlear,O
3788,259,implants,O
3789,259,",",O
3790,259,or,O
3791,259,aneurysm,O
3792,259,clips,O
3793,259,.,O
3794,260,Male,B-Person
3795,260,and,O
3796,260,females,B-Person
3797,260,between,O
3798,260,ages,B-Person
3799,260,18,O
3800,260,-,O
3801,260,85,O
3802,260,years,O
3803,261,Right,B-Condition
3804,261,handed,I-Condition
3805,262,Able,B-Mood
3806,262,to,I-Mood
3807,262,complete,B-Procedure
3808,262,precision,I-Procedure
3809,262,grips,I-Procedure
3810,262,with,I-Procedure
3811,262,both,I-Procedure
3812,262,hands,I-Procedure
3813,263,Able,B-Mood
3814,263,to,I-Mood
3815,263,complete,B-Procedure
3816,263,full,I-Procedure
3817,263,wrist,I-Procedure
3818,263,flexion,I-Procedure
3819,263,-,I-Procedure
3820,263,extension,I-Procedure
3821,263,bilaterally,I-Procedure
3822,264,Able,B-Mood
3823,264,to,I-Mood
3824,264,walk,B-Procedure
3825,264,unassisted,I-Procedure
3826,265,Able,B-Mood
3827,265,to,I-Mood
3828,265,complete,B-Procedure
3829,265,full,I-Procedure
3830,265,ankle,I-Procedure
3831,265,flexion,I-Procedure
3832,265,-,I-Procedure
3833,265,extension,I-Procedure
3834,265,bilaterally,I-Procedure
3835,266,Male,B-Person
3836,266,and,O
3837,266,females,B-Person
3838,266,between,O
3839,266,ages,B-Person
3840,266,18,O
3841,266,-,O
3842,266,85,O
3843,266,years,O
3844,267,SCI,B-Condition
3845,267,(,O
3846,267,2,O
3847,267,months,O
3848,267,of,O
3849,267,injury,O
3850,267,),O
3851,268,Spinal,B-Condition
3852,268,Cord,I-Condition
3853,268,injury,I-Condition
3854,268,at,O
3855,268,or,O
3856,268,above,O
3857,268,L5,O
3858,269,The,B-Mood
3859,269,ability,I-Mood
3860,269,to,I-Mood
3861,269,produce,B-Procedure
3862,269,a,I-Procedure
3863,269,visible,I-Procedure
3864,269,precision,I-Procedure
3865,269,grip,I-Procedure
3866,269,force,I-Procedure
3867,269,with,I-Procedure
3868,269,one,I-Procedure
3869,269,hand,I-Procedure
3870,270,Able,B-Mood
3871,270,to,I-Mood
3872,270,perform,O
3873,270,some,O
3874,270,small,B-Procedure
3875,270,wrist,I-Procedure
3876,270,flexion,I-Procedure
3877,270,and,I-Procedure
3878,270,extension,I-Procedure
3879,271,The,B-Mood
3880,271,ability,I-Mood
3881,271,to,I-Mood
3882,271,perform,O
3883,271,a,O
3884,271,small,B-Procedure
3885,271,visible,I-Procedure
3886,271,contraction,I-Procedure
3887,271,with,I-Procedure
3888,271,dorsiflexion,I-Procedure
3889,271,and,I-Procedure
3890,271,hip,I-Procedure
3891,271,flexor,I-Procedure
3892,271,muscles,I-Procedure
3893,272,No,O
3894,272,subjects,O
3895,272,will,O
3896,272,be,O
3897,272,excluded,O
3898,272,based,O
3899,272,on,O
3900,272,their,O
3901,272,race,O
3902,272,",",O
3903,272,religion,O
3904,272,",",O
3905,272,ethnicity,O
3906,272,",",O
3907,272,gender,O
3908,272,or,O
3909,272,HIV,O
3910,272,status,O
3911,272,.,O
3912,273,ASIA,O
3913,273,A,O
3914,273,",",O
3915,273,B,O
3916,273,",",O
3917,273,C,O
3918,273,",",O
3919,273,or,O
3920,273,D,O
3921,274,current,O
3922,274,alcohol,B-Condition
3923,274,abuse,I-Condition
3924,274,or,O
3925,274,drug,B-Condition
3926,274,dependence,I-Condition
3927,275,pregnancy,B-Condition
3928,276,active,O
3929,276,opportunistic,B-Condition
3930,276,infection,I-Condition
3931,276,or,O
3932,276,significant,O
3933,276,co,B-Condition
3934,276,-,I-Condition
3935,276,morbidities,I-Condition
3936,277,current,O
3937,277,prohibited,O
3938,277,concomitant,O
3939,277,medication,B-Drug
3940,278,a,O
3941,278,likelihood,O
3942,278,of,O
3943,278,diminished,O
3944,278,response,O
3945,278,to,O
3946,278,any,O
3947,278,of,O
3948,278,the,O
3949,278,study,O
3950,278,treatment,O
3951,278,arms,O
3952,278,",",O
3953,278,in,O
3954,278,the,O
3955,278,opinion,O
3956,278,of,O
3957,278,the,O
3958,278,investigator,O
3959,278,",",O
3960,278,based,O
3961,278,on,O
3962,278,HIV,O
3963,278,genotypic,O
3964,278,resistance,O
3965,278,testing,O
3966,279,HIV-1,B-Condition
3967,279,infected,I-Condition
3968,279,males,B-Person
3969,279,or,O
3970,279,females,B-Person
3971,280,over,O
3972,280,18,O
3973,280,years,O
3974,280,of,O
3975,280,age,B-Person
3976,281,signed,O
3977,281,informed,O
3978,281,consent,O
3979,282,currently,O
3980,282,receiving,O
3981,282,a,O
3982,282,stable,O
3983,282,antiretroviral,B-Procedure
3984,282,regimen,I-Procedure
3985,282,comprising,O
3986,282,of,O
3987,282,:,O
3988,283,two,O
3989,283,or,O
3990,283,more,O
3991,283,licensed,O
3992,283,NRTIs,B-Drug
3993,284,one,O
3994,284,licensed,O
3995,284,NNRTI,B-Drug
3996,284,or,O
3997,284,boosted,B-Drug
3998,284,protease,I-Drug
3999,284,inhibitor,I-Drug
4000,285,no,O
4001,285,previous,O
4002,285,protease,B-Condition
4003,285,inhibitor,I-Condition
4004,285,resistance,I-Condition
4005,285,documented,O
4006,285,on,O
4007,285,HIV-1,B-Procedure
4008,285,genotypic,I-Procedure
4009,285,resistance,I-Procedure
4010,285,testing,I-Procedure
4011,286,failure,B-Condition
4012,286,of,I-Condition
4013,286,current,I-Condition
4014,286,antiretroviral,I-Condition
4015,286,regimen,I-Condition
4016,286,due,O
4017,286,to,O
4018,286,:,O
4019,287,toxicity,B-Condition
4020,287,",",O
4021,287,intolerance,B-Condition
4022,287,or,O
4023,287,virological,B-Condition
4024,287,failure,I-Condition
4025,287,if,O
4026,287,receiving,O
4027,287,an,O
4028,287,NNRTI,B-Procedure
4029,287,containing,I-Procedure
4030,287,regimen,I-Procedure
4031,287,at,O
4032,287,screening,O
4033,288,toxicity,B-Condition
4034,288,or,O
4035,288,intolerance,B-Condition
4036,288,if,O
4037,288,receiving,O
4038,288,a,O
4039,288,boosted,B-Procedure
4040,288,-,I-Procedure
4041,288,protease,I-Procedure
4042,288,inhibitor,I-Procedure
4043,288,regimen,I-Procedure
4044,288,at,O
4045,288,screening,O
4046,288,(,O
4047,288,with,O
4048,288,plasma,O
4049,288,HIV,O
4050,288,RNA,O
4051,288,<,O
4052,288,400,O
4053,288,copies,O
4054,288,/,O
4055,288,mL,O
4056,288,at,O
4057,288,screening,O
4058,288,),O
4059,289,willing,B-Observation
4060,289,to,O
4061,289,modify,O
4062,289,antiretroviral,B-Procedure
4063,289,therapy,I-Procedure
4064,289,",",O
4065,289,in,O
4066,289,accordance,O
4067,289,with,O
4068,289,the,O
4069,289,randomisation,O
4070,289,assignment,O
4071,290,no,O
4072,290,previous,O
4073,290,exposure,O
4074,290,to,O
4075,290,etravirine,B-Drug
4076,291,subjects,O
4077,291,in,O
4078,291,good,B-Condition
4079,291,health,I-Condition
4080,291,upon,O
4081,291,medical,B-Observation
4082,291,history,I-Observation
4083,291,",",O
4084,291,physical,B-Procedure
4085,291,exam,I-Procedure
4086,291,",",O
4087,291,and,O
4088,291,laboratory,B-Procedure
4089,291,testing,I-Procedure
4090,291,in,O
4091,291,the,O
4092,291,opinion,O
4093,291,of,O
4094,291,the,O
4095,291,investigator,O
4096,292,have,O
4097,292,no,O
4098,292,serologic,B-Condition
4099,292,evidence,I-Condition
4100,292,of,I-Condition
4101,292,active,I-Condition
4102,292,HBV,I-Condition
4103,292,infection,I-Condition
4104,292,evidenced,O
4105,292,by,O
4106,292,negative,O
4107,292,hepatitis,O
4108,292,B,O
4109,292,surface,O
4110,292,antigen,O
4111,293,female,B-Person
4112,293,subjects,O
4113,293,who,O
4114,293,are,O
4115,293,heterosexually,B-Condition
4116,293,active,I-Condition
4117,293,and,O
4118,293,of,O
4119,293,childbearing,B-Condition
4120,293,potential,I-Condition
4121,293,(,O
4122,293,i.e.,O
4123,293,",",O
4124,293,not,O
4125,293,surgically,B-Condition
4126,293,sterile,I-Condition
4127,293,or,O
4128,293,at,O
4129,293,least,O
4130,293,two,O
4131,293,years,O
4132,293,post,B-Condition
4133,293,menopausal,I-Condition
4134,293,),O
4135,293,must,O
4136,293,practice,O
4137,293,contraception,B-Procedure
4138,293,as,O
4139,293,follows,O
4140,293,from,O
4141,293,screening,O
4142,293,through,O
4143,293,completion,O
4144,293,of,O
4145,293,the,O
4146,293,study,O
4147,293,:,O
4148,294,barrier,O
4149,294,contraceptives,O
4150,294,(,O
4151,294,condom,O
4152,294,",",O
4153,294,diaphragm,O
4154,294,with,O
4155,294,spermicide,O
4156,294,),O
4157,295,IUD,O
4158,295,or,O
4159,295,Depo,O
4160,295,PLUS,O
4161,295,a,O
4162,295,barrier,O
4163,295,contraceptive,O
4164,296,female,B-Person
4165,296,subjects,O
4166,296,of,O
4167,296,childbearing,B-Condition
4168,296,potential,I-Condition
4169,296,must,O
4170,296,have,O
4171,296,a,O
4172,296,negative,O
4173,296,pregnancy,O
4174,296,test,O
4175,296,.,O
4176,297,Women,B-Person
4177,297,with,O
4178,297,multi,B-Condition
4179,297,-,I-Condition
4180,297,fetal,I-Condition
4181,297,pregnancy,I-Condition
4182,297,",",O
4183,297,diabetes,B-Condition
4184,297,mellitus,I-Condition
4185,297,",",O
4186,297,chronic,B-Condition
4187,297,hypertension,I-Condition
4188,297,",",O
4189,297,or,O
4190,297,chronic,B-Condition
4191,297,renal,I-Condition
4192,297,disease,I-Condition
4193,298,primigravida,B-Condition
4194,298,",",O
4195,298,singleton,B-Condition
4196,298,pregnancy,I-Condition
4197,298,",",O
4198,298,maternal,B-Person
4199,298,age,I-Person
4200,298,18,O
4201,298,-,O
4202,298,35,O
4203,298,years,O
4204,298,",",O
4205,298,and,O
4206,298,pregnancy,O
4207,298,duration,O
4208,298,16,O
4209,298,-,O
4210,298,20,O
4211,298,weeks,O
4212,298,at,O
4213,298,the,O
4214,298,time,O
4215,298,of,O
4216,298,study,O
4217,298,inclusion,O
4218,298,.,O
4219,299,Active,O
4220,299,alcohol,O
4221,299,or,O
4222,299,drug,O
4223,299,use,O
4224,299,or,O
4225,299,dependence,O
4226,299,which,O
4227,299,may,O
4228,299,interfere,O
4229,299,with,O
4230,299,adherence,O
4231,299,to,O
4232,299,study,O
4233,299,requirements,O
4234,300,HIV,B-Condition
4235,300,-,I-Condition
4236,300,infected,I-Condition
4237,300,at,O
4238,300,screening,O
4239,300,or,O
4240,300,enrollment,O
4241,301,Estimated,O
4242,301,CrCl,O
4243,301,<,O
4244,301,60,O
4245,301,mL,O
4246,301,/,O
4247,301,min,O
4248,302,Past,O
4249,302,participation,O
4250,302,in,O
4251,302,an,O
4252,302,HIV,O
4253,302,vaccine,O
4254,302,study,O
4255,303,Positive,O
4256,303,Hepatitis,O
4257,303,B,O
4258,303,surface,O
4259,303,antigen,O
4260,303,test,O
4261,304,Underlying,O
4262,304,medical,B-Condition
4263,304,condition,I-Condition
4264,304,with,O
4265,304,survival,B-Condition
4266,304,unlikely,I-Condition
4267,304,during,O
4268,304,follow,O
4269,304,-,O
4270,304,up,O
4271,304,period,O
4272,305,Any,O
4273,305,condition,B-Condition
4274,305,that,O
4275,305,in,O
4276,305,the,O
4277,305,opinion,O
4278,305,of,O
4279,305,study,O
4280,305,staff,O
4281,305,would,O
4282,305,make,O
4283,305,participation,O
4284,305,in,O
4285,305,the,O
4286,305,study,O
4287,305,unsafe,O
4288,305,or,O
4289,305,interfere,O
4290,305,with,O
4291,305,achieving,O
4292,305,study,O
4293,305,objectives,O
4294,306,Pregnant,B-Condition
4295,306,or,O
4296,306,breast,B-Observation
4297,306,feeding,I-Observation
4298,307,Actively,O
4299,307,trying,O
4300,307,to,O
4301,307,achieve,O
4302,307,pregnancy,O
4303,308,18,O
4304,308,-,O
4305,308,64,O
4306,308,years,O
4307,308,old,B-Person
4308,309,Able,O
4309,309,to,O
4310,309,give,O
4311,309,consent,O
4312,310,unprotected,B-Observation
4313,310,sex,I-Observation
4314,310,(,O
4315,310,in,O
4316,310,past,O
4317,310,6,O
4318,310,months,O
4319,310,),O
4320,310,with,O
4321,310,1,O
4322,310,or,O
4323,310,more,O
4324,310,men,B-Person
4325,310,of,I-Person
4326,310,unknown,I-Person
4327,310,HIV,I-Person
4328,310,status,I-Person
4329,311,evaluated,B-Procedure
4330,311,for,I-Procedure
4331,311,an,I-Procedure
4332,311,STI,I-Procedure
4333,311,within,O
4334,311,6,O
4335,311,months,O
4336,311,prior,O
4337,311,to,O
4338,311,screening,O
4339,312,sex,B-Observation
4340,312,in,O
4341,312,last,O
4342,312,6,O
4343,312,months,O
4344,312,with,O
4345,312,an,O
4346,312,HIV,B-Person
4347,312,-,I-Person
4348,312,infected,I-Person
4349,312,partner,I-Person
4350,313,IDU,B-Person
4351,313,with,O
4352,313,report,O
4353,313,of,O
4354,313,using,B-Observation
4355,313,previously,I-Observation
4356,313,used,I-Observation
4357,313,or,I-Observation
4358,313,shared,I-Observation
4359,313,needles,I-Observation
4360,313,in,O
4361,313,past,O
4362,313,6,O
4363,313,months,O
4364,313,or,O
4365,313,has,O
4366,313,been,O
4367,313,in,O
4368,313,a,O
4369,313,methadone,B-Drug
4370,313,",",O
4371,313,buprenorphine,B-Drug
4372,313,",",O
4373,313,or,O
4374,313,suboxone,B-Drug
4375,313,treatment,B-Procedure
4376,313,program,I-Procedure
4377,313,in,O
4378,313,past,O
4379,313,6,O
4380,313,months,O
4381,313,or,O
4382,313,engaging,B-Observation
4383,313,in,I-Observation
4384,313,high,I-Observation
4385,313,-,I-Observation
4386,313,risk,I-Observation
4387,313,sexual,I-Observation
4388,313,behaviors,I-Observation
4389,314,individuals,O
4390,314,engaging,O
4391,314,in,O
4392,314,transactional,B-Observation
4393,314,sex,I-Observation
4394,314,(,O
4395,314,i.e,O
4396,314,sex,B-Observation
4397,314,for,I-Observation
4398,314,money,I-Observation
4399,314,",",I-Observation
4400,314,drugs,I-Observation
4401,314,",",I-Observation
4402,314,or,I-Observation
4403,314,housing,I-Observation
4404,314,),O
4405,315,Infrequently,B-Observation
4406,315,uses,I-Observation
4407,315,condoms,I-Observation
4408,315,during,I-Observation
4409,315,sex,I-Observation
4410,315,with,O
4411,315,1,O
4412,315,or,O
4413,315,more,O
4414,315,partners,B-Person
4415,315,of,I-Person
4416,315,unknown,I-Person
4417,315,HIV,I-Person
4418,315,status,I-Person
4419,315,who,O
4420,315,are,O
4421,315,known,O
4422,315,to,O
4423,315,be,O
4424,315,at,B-Observation
4425,315,substantial,I-Observation
4426,315,risk,I-Observation
4427,315,of,I-Observation
4428,315,HIV,I-Observation
4429,315,infection,I-Observation
4430,315,(,O
4431,315,IDU,B-Person
4432,315,or,O
4433,315,bisexual,B-Person
4434,315,male,I-Person
4435,315,partner,I-Person
4436,315,),O
4437,316,CrCl,O
4438,316,=,O
4439,316,60,O
4440,316,ml,O
4441,316,/,O
4442,316,min,O
4443,317,HIV-,B-Condition
4444,317,uninfected,I-Condition
4445,317,women,B-Person
4446,317,desiring,B-Mood
4447,317,PrEP,B-Procedure
4448,318,ASA,O
4449,318,4,O
4450,318,or,O
4451,318,5,O
4452,319,revision,B-Procedure
4453,319,hip,I-Procedure
4454,319,arthroplasty,I-Procedure
4455,320,diagnosis,O
4456,320,of,O
4457,320,chronic,B-Condition
4458,320,pain,I-Condition
4459,321,daily,O
4460,321,chronic,O
4461,321,opioid,B-Drug
4462,321,use,O
4463,321,(,O
4464,321,over,O
4465,321,3,O
4466,321,months,O
4467,321,of,O
4468,321,continuous,O
4469,321,opioid,O
4470,321,use,O
4471,321,),O
4472,322,inability,O
4473,322,to,O
4474,322,communicate,O
4475,322,pain,O
4476,322,scores,O
4477,322,or,O
4478,322,need,O
4479,322,for,O
4480,322,analgesia,O
4481,323,acute,O
4482,323,hip,B-Condition
4483,323,fracture,I-Condition
4484,324,Infection,B-Condition
4485,324,at,O
4486,324,the,O
4487,324,site,O
4488,324,of,O
4489,324,block,O
4490,324,placement,O
4491,325,Age,B-Person
4492,325,under,O
4493,325,18,O
4494,325,years,O
4495,325,old,O
4496,325,or,O
4497,325,greater,O
4498,325,than,O
4499,325,75,O
4500,325,years,O
4501,325,old,O
4502,326,Pregnant,O
4503,326,women,O
4504,327,Intolerance,B-Condition
4505,327,/,O
4506,327,allergy,B-Condition
4507,327,to,O
4508,327,local,B-Drug
4509,327,anesthetics,I-Drug
4510,328,Weight,B-Person
4511,328,<,O
4512,328,50,O
4513,328,kg,O
4514,329,Suspected,O
4515,329,",",O
4516,329,or,O
4517,329,known,O
4518,329,addiction,B-Condition
4519,329,to,O
4520,329,or,O
4521,329,abuse,B-Condition
4522,329,of,O
4523,329,illicit,O
4524,329,drug(s,O
4525,329,),O
4526,329,",",O
4527,329,prescription,O
4528,329,medicine(s,O
4529,329,),O
4530,329,",",O
4531,329,or,O
4532,329,alcohol,O
4533,329,within,O
4534,329,the,O
4535,329,past,O
4536,329,2,O
4537,329,years,O
4538,329,.,O
4539,330,Uncontrolled,O
4540,330,anxiety,B-Condition
4541,330,",",O
4542,330,schizophrenia,B-Condition
4543,330,",",O
4544,330,or,O
4545,330,other,O
4546,330,psychiatric,B-Condition
4547,330,disorder,I-Condition
4548,330,that,O
4549,330,",",O
4550,330,in,O
4551,330,the,O
4552,330,opinion,O
4553,330,of,O
4554,330,the,O
4555,330,investigator,O
4556,330,",",O
4557,330,may,O
4558,330,interfere,O
4559,330,with,O
4560,330,study,O
4561,330,assessments,O
4562,330,or,O
4563,330,compliance,O
4564,331,Current,O
4565,331,or,O
4566,331,historical,O
4567,331,evidence,O
4568,331,of,O
4569,331,any,O
4570,331,clinically,O
4571,331,significant,O
4572,331,disease,O
4573,331,or,O
4574,331,condition,O
4575,331,that,O
4576,331,",",O
4577,331,in,O
4578,331,the,O
4579,331,opinion,O
4580,331,of,O
4581,331,the,O
4582,331,investigator,O
4583,331,",",O
4584,331,may,O
4585,331,increase,O
4586,331,the,O
4587,331,risk,O
4588,331,of,O
4589,331,surgery,O
4590,331,or,O
4591,331,complicate,O
4592,331,the,O
4593,331,subject,O
4594,331,'s,O
4595,331,postoperative,O
4596,331,course,O
4597,331,.,O
4598,332,English,O
4599,332,speaking,O
4600,333,between,O
4601,333,18,O
4602,333,and,O
4603,333,75,O
4604,333,years,O
4605,333,old,B-Person
4606,334,American,O
4607,334,Society,O
4608,334,of,O
4609,334,Anesthesiologists,O
4610,334,(,O
4611,334,ASA,O
4612,334,),O
4613,334,1,O
4614,334,-,O
4615,334,3,O
4616,334,patients,O
4617,334,undergoing,O
4618,334,primary,B-Procedure
4619,334,total,I-Procedure
4620,334,hip,I-Procedure
4621,334,arthroplasty,I-Procedure
4622,335,Allergy,B-Condition
4623,335,or,O
4624,335,hypersensitivity,B-Condition
4625,335,to,O
4626,335,bupivacaine,B-Drug
4627,336,Pregnancy,B-Condition
4628,337,Incarceration,B-Person
4629,338,Age,B-Person
4630,338,<,O
4631,338,18,O
4632,338,years,O
4633,339,Indwelling,O
4634,339,continuous,O
4635,339,thoracic,B-Procedure
4636,339,epidural,I-Procedure
4637,339,analgesia,I-Procedure
4638,340,Patients,O
4639,340,undergoing,O
4640,340,SSRF,B-Procedure
4641,340,at,O
4642,340,Denver,O
4643,340,Health,O
4644,340,Medical,O
4645,340,Center,O
4646,341,eGFR,O
4647,341,<,O
4648,341,45,O
4649,341,ml,O
4650,341,/,O
4651,341,min,O
4652,342,structural,O
4653,342,and,O
4654,342,functional,O
4655,342,urogenital,B-Condition
4656,342,abnormalities,I-Condition
4657,342,",",O
4658,342,that,O
4659,342,predispose,B-Observation
4660,342,for,I-Observation
4661,342,urogenital,I-Observation
4662,342,infections,I-Observation
4663,343,Investigational,B-Procedure
4664,343,product,I-Procedure
4665,343,use,I-Procedure
4666,343,in,O
4667,343,the,O
4668,343,last,O
4669,343,6,O
4670,343,months,O
4671,344,SGLT2,B-Drug
4672,344,inhibitor,I-Drug
4673,344,",",O
4674,344,TZD,B-Drug
4675,344,",",O
4676,344,DPP4,B-Drug
4677,344,inhibitor,I-Drug
4678,344,and,O
4679,344,GLP1,B-Drug
4680,344,RA,I-Drug
4681,344,use,O
4682,344,within,O
4683,344,the,O
4684,344,past,O
4685,344,6,O
4686,344,months,O
4687,345,DKA(Diabetic,B-Condition
4688,345,Ketoacidosis,I-Condition
4689,345,),O
4690,345,or,O
4691,345,HHS(Hyperosmoloar,B-Condition
4692,345,Hyperglycaemic,I-Condition
4693,345,Syndrome,I-Condition
4694,345,),O
4695,345,within,O
4696,345,the,O
4697,345,last,O
4698,345,6,O
4699,345,months,O
4700,346,Pregnancy,O
4701,347,Presence,O
4702,347,of,O
4703,347,major,B-Observation
4704,347,contraindications,I-Observation
4705,347,to,O
4706,347,magnetic,B-Procedure
4707,347,resonance,I-Procedure
4708,347,imaging,I-Procedure
4709,347,(,O
4710,347,cardiac,O
4711,347,pacemakers,O
4712,347,",",O
4713,347,claustrophobia,B-Condition
4714,347,",",O
4715,347,foreign,B-Observation
4716,347,bodies,I-Observation
4717,347,and,O
4718,347,implanted,O
4719,347,medical,O
4720,347,devices,O
4721,347,with,O
4722,347,ferromagnetic,O
4723,347,properties,O
4724,347,),O
4725,347,.,O
4726,348,Liver,B-Condition
4727,348,cirrhosis,I-Condition
4728,349,Type,B-Condition
4729,349,1,I-Condition
4730,349,diabetes,I-Condition
4731,350,Severe,O
4732,350,uncorrected,O
4733,350,insulin,B-Condition
4734,350,insufficiency,I-Condition
4735,351,Significant,O
4736,351,alcohol,B-Observation
4737,351,intake,I-Observation
4738,352,HIV,B-Condition
4739,352,infection,I-Condition
4740,353,Use,O
4741,353,of,O
4742,353,Traditional,B-Procedure
4743,353,Chinese,I-Procedure
4744,353,Medication,I-Procedure
4745,353,or,O
4746,353,alternative,B-Procedure
4747,353,therapies,I-Procedure
4748,354,Coexisting,O
4749,354,causes,O
4750,354,of,O
4751,354,chronic,B-Condition
4752,354,liver,I-Condition
4753,354,disease,I-Condition
4754,354,-,O
4755,354,chronic,B-Condition
4756,354,viral,I-Condition
4757,354,hepatitis(B,I-Condition
4758,354,&,I-Condition
4759,354,C,I-Condition
4760,354,),O
4761,354,",",O
4762,354,autoimmune,B-Condition
4763,354,liver,I-Condition
4764,354,disease,I-Condition
4765,354,",",O
4766,354,hemochromatosis,B-Condition
4767,354,",",O
4768,354,Wilson,B-Condition
4769,354,'s,I-Condition
4770,354,etc,O
4771,354,.,O
4772,355,Use,O
4773,355,of,O
4774,355,medications,B-Drug
4775,355,associated,O
4776,355,with,O
4777,355,steatosis,B-Condition
4778,355,eg,O
4779,355,.,O
4780,355,Methotrexate,B-Drug
4781,355,",",O
4782,355,anticonvulsants,B-Drug
4783,355,",",O
4784,355,antiretroviral,B-Drug
4785,355,therapy,I-Drug
4786,355,etc,O
4787,355,.,O
4788,356,h,O
4789,356,/,O
4790,356,o,O
4791,356,stroke,B-Condition
4792,357,Steroid,B-Drug
4793,357,therapy,I-Drug
4794,358,Endogenous,O
4795,358,Cushing,B-Condition
4796,358,'s,I-Condition
4797,359,Familial,B-Condition
4798,359,hypertriglyceridemia,I-Condition
4799,360,biopsy,B-Procedure
4800,360,proven,O
4801,360,NASH,B-Condition
4802,361,Type,B-Condition
4803,361,2,I-Condition
4804,361,DM,I-Condition
4805,362,HbA1c,O
4806,362,:>,O
4807,362,6.5,O
4808,362,%,O
4809,363,BMI,O
4810,363,<,O
4811,363,45kg,O
4812,363,/,O
4813,363,m2,O
4814,364,Any,O
4815,364,anti,B-Drug
4816,364,-,I-Drug
4817,364,diabetic,I-Drug
4818,364,agent,I-Drug
4819,364,except,O
4820,364,SGLT2,B-Drug
4821,364,inhibitors,I-Drug
4822,364,",",O
4823,364,TZDs(thiazolidinediones,B-Drug
4824,364,),O
4825,364,",",O
4826,364,DPP4(Dipeptidyl,B-Drug
4827,364,peptidase4,I-Drug
4828,364,),I-Drug
4829,364,inhibitors,I-Drug
4830,364,and,O
4831,364,GLP1,B-Drug
4832,364,RAs(Glucagon,I-Drug
4833,364,-,I-Drug
4834,364,like,I-Drug
4835,364,Peptide,I-Drug
4836,364,1,I-Drug
4837,364,-,I-Drug
4838,364,Receptor,I-Drug
4839,364,Agonists,I-Drug
4840,364,),O
4841,365,Hypersensitivity,B-Condition
4842,365,to,O
4843,365,the,O
4844,365,active,B-Drug
4845,365,substance,I-Drug
4846,365,",",O
4847,365,to,O
4848,365,FCM,B-Drug
4849,365,or,O
4850,365,any,O
4851,365,of,O
4852,365,its,O
4853,365,excipients,B-Drug
4854,366,Known,O
4855,366,serious,O
4856,366,hypersensitivity,B-Condition
4857,366,to,O
4858,366,other,O
4859,366,parenteral,B-Drug
4860,366,iron,I-Drug
4861,366,products,I-Drug
4862,367,Anaemia,B-Condition
4863,367,not,O
4864,367,attributed,B-Mood
4865,367,to,I-Mood
4866,367,iron,B-Drug
4867,367,deficiency,I-Drug
4868,367,",",O
4869,367,e.g.,O
4870,367,other,O
4871,367,microcytic,B-Condition
4872,367,anaemia,I-Condition
4873,368,Evidence,O
4874,368,of,O
4875,368,iron,B-Condition
4876,368,overload,I-Condition
4877,368,or,O
4878,368,disturbances,B-Condition
4879,368,in,I-Condition
4880,368,the,I-Condition
4881,368,utilisation,I-Condition
4882,368,of,I-Condition
4883,368,iron,I-Condition
4884,369,Patients,O
4885,369,aged,B-Person
4886,369,at,O
4887,369,least,O
4888,369,18,O
4889,369,years,O
4890,370,Patients,O
4891,370,with,O
4892,370,chronic,B-Condition
4893,370,heart,I-Condition
4894,370,failure,I-Condition
4895,370,present,O
4896,370,for,O
4897,370,at,O
4898,370,least,O
4899,370,12,O
4900,370,months,O
4901,371,Confirmed,O
4902,371,presence,O
4903,371,of,O
4904,371,iron,B-Condition
4905,371,deficiency,I-Condition
4906,372,Serum,O
4907,372,haemoglobin,O
4908,372,of,O
4909,372,9.5,O
4910,372,to,O
4911,372,14.0,O
4912,372,g,O
4913,372,/,O
4914,372,dL,O
4915,373,Patients,O
4916,373,with,O
4917,373,a,O
4918,373,history,O
4919,373,of,O
4920,373,an,O
4921,373,untreated,O
4922,373,malignancy,B-Condition
4923,373,(,O
4924,373,except,O
4925,373,local,B-Condition
4926,373,skin,I-Condition
4927,373,cancers,I-Condition
4928,373,),O
4929,374,Ischemic,B-Condition
4930,374,stroke,I-Condition
4931,374,(,O
4932,374,determined,O
4933,374,using,O
4934,374,the,O
4935,374,Questionnaire,O
4936,374,for,O
4937,374,Verifying,O
4938,374,Stroke,O
4939,374,-,O
4940,374,Free,O
4941,374,Status,O
4942,374,(,O
4943,374,QVSFS,O
4944,374,),O
4945,375,Patients,O
4946,375,on,O
4947,375,renal,B-Procedure
4948,375,dialysis,I-Procedure
4949,375,or,O
4950,375,with,O
4951,375,end,B-Condition
4952,375,-,I-Condition
4953,375,stage,I-Condition
4954,375,hepatic,I-Condition
4955,375,dysfunction,I-Condition
4956,376,Acute,O
4957,376,infection,B-Condition
4958,376,/,O
4959,376,inflammation,B-Condition
4960,376,(,O
4961,376,Temperature,O
4962,376,>,O
4963,376,101.5,O
4964,376,F,O
4965,376,",",O
4966,376,and/or,O
4967,376,WBC,O
4968,376,>,O
4969,376,15,O
4970,376,",",O
4971,376,000,O
4972,376,),O
4973,377,Inability,O
4974,377,to,O
4975,377,obtain,O
4976,377,informed,O
4977,377,consent,O
4978,377,from,O
4979,377,patient,O
4980,377,or,O
4981,377,next,O
4982,377,of,O
4983,377,kin,O
4984,378,Anticoagulant,B-Drug
4985,378,use,O
4986,378,(,O
4987,378,warfarin,B-Drug
4988,378,or,O
4989,378,heparin,B-Drug
4990,378,),O
4991,379,Diagnosis,O
4992,379,of,O
4993,379,heart,B-Condition
4994,379,failure,I-Condition
4995,379,according,O
4996,379,to,O
4997,379,Framingham,O
4998,379,criteria,O
4999,380,Informed,O
5000,380,consent,O
5001,381,Age,B-Person
5002,381,18,O
5003,381,years,O
5004,381,or,O
5005,381,above,O
5006,382,Anticoagulant,B-Drug
5007,382,therapy,O
5008,382,during,O
5009,382,the,O
5010,382,past,O
5011,382,1,O
5012,382,week,O
5013,382,of,O
5014,382,the,O
5015,382,procedure,B-Procedure
5016,383,Known,O
5017,383,coagulopathy,B-Condition
5018,384,History,B-Observation
5019,384,of,O
5020,384,liver,B-Condition
5021,384,cirrhosis,I-Condition
5022,384,",",O
5023,384,chronic,B-Condition
5024,384,kidney,I-Condition
5025,384,disease,I-Condition
5026,384,",",O
5027,384,malignancy,B-Condition
5028,384,",",O
5029,384,inflammatory,B-Condition
5030,384,bowel,I-Condition
5031,384,disease,I-Condition
5032,384,",",O
5033,384,significant,B-Condition
5034,384,infectious,I-Condition
5035,384,disease,I-Condition
5036,384,",",O
5037,384,polyposis,B-Condition
5038,384,syndrome,I-Condition
5039,385,Subjects,O
5040,385,over,O
5041,385,the,O
5042,385,age,B-Person
5043,385,of,O
5044,385,18,O
5045,385,years,O
5046,385,who,O
5047,385,agree,O
5048,385,informed,O
5049,385,consent,O
5050,385,and,O
5051,385,who,O
5052,385,have,O
5053,385,at,O
5054,385,least,O
5055,385,one,O
5056,385,polyp,B-Condition
5057,385,of,O
5058,385,eligible,O
5059,385,size,O
5060,385,(,O
5061,385,6,O
5062,385,-,O
5063,385,10,O
5064,385,mm,O
5065,385,),O
5066,386,Patients,O
5067,386,with,O
5068,386,second,O
5069,386,primary,B-Condition
5070,386,cancer,I-Condition
5071,386,",",I-Condition
5072,386,except,O
5073,386,:,O
5074,386,adequately,O
5075,386,treated,B-Mood
5076,386,non,B-Condition
5077,386,-,I-Condition
5078,386,melanoma,I-Condition
5079,386,skin,I-Condition
5080,386,cancer,I-Condition
5081,386,",",O
5082,386,curatively,O
5083,386,treated,B-Mood
5084,386,in,B-Condition
5085,386,-,I-Condition
5086,386,situ,I-Condition
5087,386,cancer,I-Condition
5088,386,of,I-Condition
5089,386,the,I-Condition
5090,386,cervix,I-Condition
5091,386,",",O
5092,386,or,O
5093,386,other,O
5094,386,solid,B-Condition
5095,386,tumor,I-Condition
5096,386,curatively,O
5097,386,treated,O
5098,386,with,O
5099,386,no,O
5100,386,evidence,O
5101,386,of,O
5102,386,disease,O
5103,386,for,O
5104,386,<,O
5105,386,=,O
5106,386,5,O
5107,386,years,O
5108,386,.,O
5109,387,Has,O
5110,387,known,O
5111,387,active,O
5112,387,central,O
5113,387,nervous,O
5114,387,system(CNS,O
5115,387,),O
5116,387,metastases,B-Condition
5117,388,Has,O
5118,388,an,O
5119,388,active,B-Condition
5120,388,infection,I-Condition
5121,388,requiring,O
5122,388,systemic,O
5123,388,therapy,O
5124,389,Pregnancy,O
5125,389,or,O
5126,389,breast,O
5127,389,feeding,O
5128,390,Patients,O
5129,390,with,O
5130,390,cardiac,B-Condition
5131,390,problem,I-Condition
5132,391,Any,O
5133,391,previous,O
5134,391,treatment,O
5135,391,with,O
5136,391,sunitinib,B-Drug
5137,392,Provision,O
5138,392,of,O
5139,392,fully,O
5140,392,informed,O
5141,392,consent,O
5142,392,prior,O
5143,392,to,O
5144,392,study,O
5145,392,specific,O
5146,392,procedures,O
5147,392,.,O
5148,393,Patients,O
5149,393,must,O
5150,393,be,O
5151,393,>,O
5152,393,=,O
5153,393,19,O
5154,393,years,O
5155,393,of,O
5156,393,age,B-Person
5157,394,RET,O
5158,394,fusion,O
5159,394,positive,O
5160,394,or,O
5161,394,FGFR2,O
5162,394,fusion,O
5163,394,/,O
5164,394,other,O
5165,394,FGFR,O
5166,394,mutation,O
5167,394,Refractory,O
5168,394,solid,B-Condition
5169,394,tumor,I-Condition
5170,394,and/or,O
5171,394,specific,O
5172,394,sensitivity,O
5173,394,to,O
5174,394,Sunitinib,B-Drug
5175,394,by,O
5176,394,Avatar,O
5177,394,scan,O
5178,394,that,O
5179,394,has,O
5180,394,progressed,O
5181,394,following,O
5182,394,standard,O
5183,394,therapy,O
5184,394,or,O
5185,394,that,O
5186,394,has,O
5187,394,not,O
5188,394,responded,O
5189,394,to,O
5190,394,standard,O
5191,394,therapy,O
5192,394,or,O
5193,394,for,O
5194,394,which,O
5195,394,there,O
5196,394,is,O
5197,394,no,O
5198,394,standard,O
5199,394,therapy,O
5200,394,.,O
5201,395,ECOG,O
5202,395,Performance,O
5203,395,status0,O
5204,395,-,O
5205,395,2,O
5206,396,Have,O
5207,396,measurable,O
5208,396,or,O
5209,396,evaluated,O
5210,396,disease,O
5211,396,based,O
5212,396,on,O
5213,396,RECIST,O
5214,396,1.1,O
5215,396,as,O
5216,396,determined,O
5217,396,by,O
5218,396,investigator,O
5219,396,.,O
5220,397,Absolute,O
5221,397,neutrophil,O
5222,397,count,O
5223,397,>,O
5224,397,=,O
5225,397,1.5,O
5226,397,x,O
5227,397,109,O
5228,397,/,O
5229,397,L,O
5230,397,",",O
5231,397,Hemoglobin,O
5232,397,>,O
5233,397,=,O
5234,397,9g,O
5235,397,/,O
5236,397,dL,O
5237,397,",",O
5238,397,Platelets>=100,O
5239,397,x,O
5240,397,109,O
5241,397,/,O
5242,397,L,O
5243,397,Bilirubin,O
5244,397,<,O
5245,397,=,O
5246,397,1.5,O
5247,397,x,O
5248,397,upper,O
5249,397,limit,O
5250,397,of,O
5251,397,normal,O
5252,397,AST,O
5253,397,/,O
5254,397,ALT,O
5255,397,<,O
5256,397,=,O
5257,397,2.5,O
5258,397,X,O
5259,397,upper,O
5260,397,limit,O
5261,397,of,O
5262,397,normal(5.0,O
5263,397,x,O
5264,397,upper,O
5265,397,limit,O
5266,397,of,O
5267,397,normal,O
5268,397,",",O
5269,397,for,O
5270,397,subject,O
5271,397,with,O
5272,397,liver,B-Condition
5273,397,metastases,I-Condition
5274,397,),O
5275,397,Creatinine<=,O
5276,397,1.5,O
5277,397,X,O
5278,397,UNL,O
5279,398,Patients,O
5280,398,of,O
5281,398,child,B-Observation
5282,398,-,I-Observation
5283,398,bearing,I-Observation
5284,398,potential,I-Observation
5285,398,should,O
5286,398,be,O
5287,398,using,O
5288,398,adequate,B-Procedure
5289,398,contraceptive,I-Procedure
5290,398,measures,I-Procedure
5291,398,should,O
5292,398,not,O
5293,398,be,O
5294,398,breast,B-Condition
5295,398,feeding,I-Condition
5296,398,and,O
5297,398,must,O
5298,398,have,O
5299,398,a,O
5300,398,negative,O
5301,398,pregnancy,O
5302,398,test,O
5303,398,prior,O
5304,398,to,O
5305,398,start,O
5306,398,of,O
5307,398,dosing,O
5308,399,Adequate,B-Condition
5309,399,heart,I-Condition
5310,399,function,I-Condition
5311,400,Pregnant,B-Condition
5312,400,.,O
5313,401,Not,O
5314,401,have,O
5315,401,informed,O
5316,401,consent,O
5317,401,for,O
5318,401,the,O
5319,401,present,O
5320,401,clinical,O
5321,401,trial,O
5322,401,",",O
5323,401,or,O
5324,401,do,O
5325,401,not,O
5326,401,fully,O
5327,401,understand,O
5328,401,the,O
5329,401,meaning,O
5330,401,of,O
5331,401,informed,O
5332,401,consent,O
5333,401,.,O
5334,402,With,O
5335,402,acute,B-Condition
5336,402,myocardial,I-Condition
5337,402,infarction,I-Condition
5338,402,with,O
5339,402,ST,B-Condition
5340,402,segment,I-Condition
5341,402,elevation,I-Condition
5342,402,in,O
5343,402,the,O
5344,402,first,O
5345,402,12,O
5346,402,hours,O
5347,402,from,O
5348,402,the,O
5349,402,onset,O
5350,402,of,O
5351,402,symptoms,O
5352,402,.,O
5353,403,With,O
5354,403,any,O
5355,403,acute,B-Condition
5356,403,coronary,I-Condition
5357,403,syndrome,I-Condition
5358,403,complicated,O
5359,403,with,O
5360,403,acute,B-Condition
5361,403,pulmonary,I-Condition
5362,403,edema,I-Condition
5363,403,",",O
5364,403,cardiogenic,B-Condition
5365,403,shock,I-Condition
5366,403,and,O
5367,403,/,O
5368,403,or,O
5369,403,malignant,O
5370,403,ventricular,B-Condition
5371,403,arrhythmias,I-Condition
5372,403,.,O
5373,404,In,O
5374,404,which,O
5375,404,a,O
5376,404,cardiac,B-Procedure
5377,404,catheterization,I-Procedure
5378,404,is,O
5379,404,planned,O
5380,404,a,O
5381,404,priori,O
5382,404,to,O
5383,404,be,O
5384,404,performed,O
5385,404,via,O
5386,404,femoral,O
5387,404,",",O
5388,404,brachial,O
5389,404,or,O
5390,404,ulnar,O
5391,404,.,O
5392,405,Patients,O
5393,405,in,O
5394,405,whom,O
5395,405,first,O
5396,405,attempt,O
5397,405,of,O
5398,405,arterial,O
5399,405,puncture,O
5400,405,is,O
5401,405,performed,O
5402,405,by,O
5403,405,2nd,O
5404,405,year,O
5405,405,interventional,O
5406,405,cardiology,O
5407,405,fellow,O
5408,405,or,O
5409,405,by,O
5410,405,physician,O
5411,405,in,O
5412,405,charge,O
5413,405,.,O
5414,406,Participating,O
5415,406,in,O
5416,406,another,O
5417,406,clinical,O
5418,406,trial,O
5419,406,.,O
5420,407,Be,O
5421,407,allergic,B-Condition
5422,407,or,O
5423,407,have,O
5424,407,contraindications,B-Condition
5425,407,to,O
5426,407,nitroglycerin,B-Drug
5427,407,or,O
5428,407,other,O
5429,407,nitrates,B-Drug
5430,407,.,O
5431,408,Any,O
5432,408,phosphodiesterase,B-Drug
5433,408,5,I-Drug
5434,408,inhibitor,I-Drug
5435,408,(,O
5436,408,sildenafil,B-Drug
5437,408,",",O
5438,408,tadalafil,B-Drug
5439,408,",",O
5440,408,avanafil,B-Drug
5441,408,",",O
5442,408,vardenafil,B-Drug
5443,408,),O
5444,408,has,O
5445,408,been,O
5446,408,taken,O
5447,408,within,O
5448,408,72,O
5449,408,hours,O
5450,408,prior,O
5451,408,to,O
5452,408,the,O
5453,408,study,O
5454,408,.,O
5455,409,Men,B-Person
5456,409,and,O
5457,409,women,B-Person
5458,409,older,O
5459,409,than,O
5460,409,18,O
5461,409,years,B-Person
5462,409,",",O
5463,409,scheduled,B-Mood
5464,409,consecutively,O
5465,409,to,O
5466,409,perform,O
5467,409,a,O
5468,409,coronary,B-Procedure
5469,409,procedure,I-Procedure
5470,409,in,O
5471,409,the,O
5472,409,department,O
5473,409,of,O
5474,409,hemodynamics,O
5475,409,of,O
5476,409,the,O
5477,409,National,O
5478,409,Institute,O
5479,409,of,O
5480,409,Cardiology,O
5481,409,"""",O
5482,409,Ignacio,O
5483,409,Chavez,O
5484,409,"""",O
5485,409,.,O
5486,410,Patients,O
5487,410,may,O
5488,410,have,O
5489,410,any,O
5490,410,of,O
5491,410,the,O
5492,410,following,O
5493,410,indications,B-Condition
5494,410,for,O
5495,410,cardiac,B-Procedure
5496,410,catheterization,I-Procedure
5497,410,:,O
5498,410,Thoracic,B-Condition
5499,410,pain,I-Condition
5500,410,under,O
5501,410,study,O
5502,410,.,O
5503,410,Stable,O
5504,410,chronic,B-Condition
5505,410,coronary,I-Condition
5506,410,disease,I-Condition
5507,410,.,O
5508,410,Acute,B-Condition
5509,410,myocardial,I-Condition
5510,410,infarction,I-Condition
5511,410,with,O
5512,410,ST,B-Condition
5513,410,segment,I-Condition
5514,410,elevation,I-Condition
5515,410,",",O
5516,410,not,O
5517,410,perfused,O
5518,410,(,O
5519,410,without,O
5520,410,timely,O
5521,410,reperfusion,B-Procedure
5522,410,therapy,I-Procedure
5523,410,),O
5524,410,with,O
5525,410,less,O
5526,410,than,O
5527,410,4,O
5528,410,weeks,O
5529,410,of,O
5530,410,evolution,O
5531,410,.,O
5532,410,Acute,B-Condition
5533,410,myocardial,I-Condition
5534,410,infarction,I-Condition
5535,410,with,O
5536,410,ST,B-Condition
5537,410,-,I-Condition
5538,410,segment,I-Condition
5539,410,elevation,I-Condition
5540,410,",",O
5541,410,successful,O
5542,410,thrombolytic,B-Procedure
5543,410,therapy,I-Procedure
5544,410,",",O
5545,410,which,O
5546,410,will,B-Mood
5547,410,undergo,I-Mood
5548,410,drug,B-Procedure
5549,410,-,I-Procedure
5550,410,invasive,I-Procedure
5551,410,therapy,I-Procedure
5552,410,.,O
5553,410,Acute,B-Condition
5554,410,myocardial,I-Condition
5555,410,infarction,I-Condition
5556,410,without,O
5557,410,ST,B-Condition
5558,410,segment,I-Condition
5559,410,elevation,I-Condition
5560,410,.,O
5561,410,Unstable,B-Condition
5562,410,angina,I-Condition
5563,410,.,O
5564,410,Any,O
5565,410,acute,B-Condition
5566,410,coronary,I-Condition
5567,410,syndrome,I-Condition
5568,410,",",O
5569,410,to,O
5570,410,intervene,B-Procedure
5571,410,non,O
5572,410,-,O
5573,410,infarct,O
5574,410,-,O
5575,410,related,O
5576,410,artery,O
5577,410,.,O
5578,410,Disease,B-Condition
5579,410,of,O
5580,410,any,O
5581,410,heart,O
5582,410,valve,O
5583,410,.,O
5584,410,Myocarditis,B-Condition
5585,410,or,O
5586,410,pericarditis,B-Condition
5587,410,.,O
5588,410,Dilated,O
5589,410,cardiomyopathy,B-Condition
5590,410,.,O
5591,410,Patients,O
5592,410,in,O
5593,410,renal,B-Condition
5594,410,or,I-Condition
5595,410,cardiac,I-Condition
5596,410,transplantation,I-Condition
5597,410,protocol,O
5598,410,for,O
5599,410,any,O
5600,410,etiology,O
5601,410,.,O
5602,410,Congenital,B-Condition
5603,410,heart,I-Condition
5604,410,disease,I-Condition
5605,410,that,O
5606,410,requires,O
5607,410,knowing,O
5608,410,the,O
5609,410,coronary,O
5610,410,anatomy,O
5611,410,prior,O
5612,410,to,O
5613,410,surgical,O
5614,410,correction,O
5615,410,.,O
5616,411,The,O
5617,411,planned,O
5618,411,procedure,B-Procedure
5619,411,can,O
5620,411,be,O
5621,411,any,O
5622,411,of,O
5623,411,the,O
5624,411,following,O
5625,411,:,O
5626,411,For,O
5627,411,diagnostic,O
5628,411,purposes,O
5629,411,(,O
5630,411,coronary,B-Procedure
5631,411,angiography,I-Procedure
5632,411,only,O
5633,411,",",O
5634,411,left,B-Procedure
5635,411,catheterization,I-Procedure
5636,411,",",O
5637,411,left,B-Procedure
5638,411,and,I-Procedure
5639,411,right,I-Procedure
5640,411,catheterization,I-Procedure
5641,411,),O
5642,411,.,O
5643,411,For,O
5644,411,therapeutic,O
5645,411,purposes,O
5646,411,:,O
5647,411,percutaneous,B-Procedure
5648,411,coronary,I-Procedure
5649,411,intervention,I-Procedure
5650,411,(,O
5651,411,PCI,B-Procedure
5652,411,),O
5653,411,",",O
5654,411,with,O
5655,411,or,O
5656,411,without,O
5657,411,stent,B-Procedure
5658,411,placement,I-Procedure
5659,411,.,O
5660,412,A,O
5661,412,priori,O
5662,412,access,B-Procedure
5663,412,must,O
5664,412,be,O
5665,412,right,O
5666,412,or,O
5667,412,left,O
5668,412,radial,O
5669,412,artery,O
5670,412,.,O
5671,413,Radial,O
5672,413,arterial,O
5673,413,pulse,B-Condition
5674,413,may,O
5675,413,be,O
5676,413,present,O
5677,413,or,O
5678,413,absent,O
5679,413,by,O
5680,413,palpation,O
5681,413,.,O
5682,414,Modified,O
5683,414,Allen,O
5684,414,or,O
5685,414,Barbeau,O
5686,414,test,O
5687,414,should,O
5688,414,be,O
5689,414,positive,O
5690,414,(,O
5691,414,presence,O
5692,414,of,O
5693,414,collateral,B-Condition
5694,414,palmar,I-Condition
5695,414,flow,I-Condition
5696,414,),O
5697,414,.,O
5698,415,presence,O
5699,415,of,O
5700,415,subacute,O
5701,415,or,O
5702,415,chronic,O
5703,415,DVT,B-Condition
5704,415,more,O
5705,415,than,O
5706,415,21,O
5707,415,days,O
5708,415,in,O
5709,415,duration,O
5710,415,",",O
5711,415,inability,B-Condition
5712,415,to,I-Condition
5713,415,lie,I-Condition
5714,415,in,I-Condition
5715,415,the,I-Condition
5716,415,prone,I-Condition
5717,415,position,I-Condition
5718,415,required,O
5719,415,for,O
5720,415,intervention,O
5721,415,",",O
5722,415,terminal,B-Condition
5723,415,systemic,I-Condition
5724,415,disease,I-Condition
5725,415,requiring,B-Mood
5726,415,palliative,B-Procedure
5727,415,treatment,I-Procedure
5728,415,",",O
5729,415,active,O
5730,415,bleeding,B-Condition
5731,415,(,O
5732,415,from,O
5733,415,a,O
5734,415,gastric,B-Condition
5735,415,/,I-Condition
5736,415,duodenal,I-Condition
5737,415,ulcer,I-Condition
5738,415,or,O
5739,415,the,O
5740,415,cerebrovascular,O
5741,415,system,O
5742,415,),O
5743,415,",",O
5744,415,a,O
5745,415,haemorrhagic,B-Condition
5746,415,stroke,I-Condition
5747,415,within,O
5748,415,the,O
5749,415,previous,O
5750,415,year,O
5751,415,",",O
5752,415,an,O
5753,415,impaired,B-Condition
5754,415,bleeding,I-Condition
5755,415,-,I-Condition
5756,415,clotting,I-Condition
5757,415,profile,I-Condition
5758,415,",",O
5759,415,and,O
5760,415,any,O
5761,415,haemophilic,B-Condition
5762,415,disorder,I-Condition
5763,415,",",O
5764,415,or,O
5765,415,pregnancy,B-Condition
5766,415,.,O
5767,416,proven,O
5768,416,acute,O
5769,416,deep,B-Condition
5770,416,venous,I-Condition
5771,416,thrombosis,I-Condition
5772,416,",",O
5773,416,less,O
5774,416,than,O
5775,416,21,O
5776,416,days,O
5777,416,and,O
5778,416,who,O
5779,416,were,O
5780,416,referred,B-Mood
5781,416,to,I-Mood
5782,416,the,O
5783,416,interventional,O
5784,416,radiology,O
5785,416,department,O
5786,416,.,O
5787,417,Preoperative,O
5788,417,use,O
5789,417,of,O
5790,417,an,O
5791,417,anticoagulant,B-Drug
5792,417,(,O
5793,417,Plavix,B-Drug
5794,417,",",O
5795,417,warfarin,B-Drug
5796,417,",",O
5797,417,lovenox,B-Drug
5798,417,",",O
5799,417,etc,O
5800,417,.,O
5801,417,),O
5802,418,History,O
5803,418,of,O
5804,418,hypersensitivity,B-Condition
5805,418,to,O
5806,418,EACA,B-Drug
5807,419,History,O
5808,419,of,O
5809,419,thromboembolic,B-Condition
5810,419,event,I-Condition
5811,419,(,O
5812,419,e.g.,O
5813,419,",",O
5814,419,PE,B-Condition
5815,419,or,O
5816,419,DVT,B-Condition
5817,419,),O
5818,420,History,O
5819,420,of,O
5820,420,renal,B-Condition
5821,420,insufficiency,I-Condition
5822,420,or,I-Condition
5823,420,failure,I-Condition
5824,421,Congenital,O
5825,421,or,O
5826,421,acquired,O
5827,421,coagulopathy,B-Condition
5828,421,as,O
5829,421,evidence,O
5830,421,by,O
5831,421,INR,O
5832,421,>,O
5833,421,1.4,O
5834,421,or,O
5835,421,PTT,O
5836,421,>,O
5837,421,1.4,O
5838,421,times,O
5839,421,normal,O
5840,421,",",O
5841,421,or,O
5842,421,Platelets,O
5843,421,<,O
5844,421,"150,000",O
5845,421,/,O
5846,421,mm3,O
5847,421,on,O
5848,421,preoperative,B-Procedure
5849,421,laboratory,I-Procedure
5850,421,testing,I-Procedure
5851,422,Use,O
5852,422,of,O
5853,422,hormone,B-Procedure
5854,422,replacement,I-Procedure
5855,422,therapy,I-Procedure
5856,422,or,O
5857,422,hormonal,B-Drug
5858,422,contraceptive,I-Drug
5859,422,agents,I-Drug
5860,422,within,O
5861,422,days,O
5862,422,prior,O
5863,422,to,O
5864,422,surgery,O
5865,423,Use,O
5866,423,of,O
5867,423,acetylsalicylic,B-Drug
5868,423,acid,I-Drug
5869,423,(,O
5870,423,ASA,B-Drug
5871,423,),O
5872,423,",",O
5873,423,antiplatelet,B-Drug
5874,423,agents,I-Drug
5875,423,within,O
5876,423,7,O
5877,423,days,O
5878,423,prior,O
5879,423,to,O
5880,423,surgery,O
5881,424,Pregnant,B-Condition
5882,425,Breastfeeding,B-Observation
5883,426,Not,O
5884,426,received,O
5885,426,neuraxial,B-Procedure
5886,426,anesthesia,I-Procedure
5887,427,Scheduled,B-Mood
5888,427,for,I-Mood
5889,427,bilateral,O
5890,427,varus,B-Procedure
5891,427,rotational,I-Procedure
5892,427,osteotomy,I-Procedure
5893,427,(,O
5894,427,VRO,B-Procedure
5895,427,),O
5896,427,with,O
5897,427,or,O
5898,427,without,O
5899,427,associated,O
5900,427,soft,O
5901,427,tissue,O
5902,427,and,O
5903,427,osseous,B-Procedure
5904,427,procedures,I-Procedure
5905,428,preterm,B-Condition
5906,428,delivery,I-Condition
5907,428,(,O
5908,428,<,O
5909,428,37,O
5910,428,weeks,O
5911,428,of,O
5912,428,gestation,O
5913,428,),O
5914,429,birth,O
5915,429,weight,O
5916,429,<,O
5917,429,2500,O
5918,429,g,O
5919,430,multiple,B-Condition
5920,430,pregnancy,I-Condition
5921,431,major,B-Condition
5922,431,illness,I-Condition
5923,431,or,O
5924,431,congenital,B-Condition
5925,431,anomaly,I-Condition
5926,432,being,O
5927,432,<,O
5928,432,50,O
5929,432,%,O
5930,432,breastfed,B-Observation
5931,432,at,O
5932,432,the,O
5933,432,time,O
5934,432,of,O
5935,432,inclusion,O
5936,433,food,B-Condition
5937,433,allergy,I-Condition
5938,434,anaemia,B-Condition
5939,434,(,O
5940,434,Hb,O
5941,434,<,O
5942,434,105,O
5943,434,g,O
5944,434,/,O
5945,434,L,O
5946,434,[,O
5947,434,10.5,O
5948,434,g,O
5949,434,/,O
5950,434,dL,O
5951,434,],O
5952,434,),O
5953,434,at,O
5954,434,inclusion,O
5955,434,",",O
5956,434,lack,O
5957,434,of,O
5958,434,informed,O
5959,434,consent,O
5960,435,Term,B-Condition
5961,435,singleton,I-Condition
5962,435,infants,I-Condition
5963,435,(,O
5964,435,>,O
5965,435,37,O
5966,435,weeks,O
5967,435,gestational,O
5968,435,age,O
5969,435,),O
5970,436,Birth,O
5971,436,weight,O
5972,436,>,O
5973,436,2500,O
5974,436,g,O
5975,437,Healthy,B-Condition
5976,437,at,O
5977,437,inclusion,O
5978,438,Breastfed,B-Condition
5979,438,exclusively,O
5980,438,or,O
5981,438,predominantly,O
5982,438,(,O
5983,438,>,O
5984,438,50,O
5985,438,%,O
5986,438,meals,O
5987,438,),O
5988,438,at,O
5989,438,inclusion,O
5990,439,No,O
5991,439,previous,O
5992,439,iron,B-Procedure
5993,439,supplementation,I-Procedure
5994,440,No,O
5995,440,previous,O
5996,440,blood,B-Procedure
5997,440,transfusion,I-Procedure
5998,441,Informed,O
5999,441,consent,O
6000,441,given,O
6001,442,Presence,O
6002,442,of,O
6003,442,another,O
6004,442,vaginal,B-Condition
6005,442,infection,I-Condition
6006,442,or,O
6007,442,STD,B-Condition
6008,443,Allergy,B-Condition
6009,443,to,O
6010,443,metronidazole,B-Drug
6011,444,Pregnant,B-Condition
6012,444,or,O
6013,444,nursing,B-Condition
6014,445,Use,O
6015,445,of,O
6016,445,oral,B-Drug
6017,445,or,I-Drug
6018,445,intravaginal,I-Drug
6019,445,antibiotics,I-Drug
6020,445,within,O
6021,445,the,O
6022,445,past,O
6023,445,2,O
6024,445,weeks,O
6025,446,HIV,B-Condition
6026,446,or,O
6027,446,other,O
6028,446,chronic,B-Condition
6029,446,disease,I-Condition
6030,447,Inability,B-Observation
6031,447,to,I-Observation
6032,447,keep,I-Observation
6033,447,return,I-Observation
6034,447,appointments,I-Observation
6035,448,Contraindications,B-Condition
6036,448,for,O
6037,448,Lactobacillus,B-Drug
6038,448,Vaginal,I-Drug
6039,448,Suppositories(those,I-Drug
6040,448,without,O
6041,448,sexual,B-Observation
6042,448,history,I-Observation
6043,448,),O
6044,449,Women,B-Person
6045,449,be,O
6046,449,at,O
6047,449,least,O
6048,449,18,O
6049,449,years,O
6050,449,of,O
6051,449,age,B-Person
6052,450,Have,O
6053,450,symptoms,B-Mood
6054,450,of,I-Mood
6055,450,vaginal,B-Condition
6056,450,odor,I-Condition
6057,450,and,I-Condition
6058,450,or,I-Condition
6059,450,/,I-Condition
6060,450,discharge,I-Condition
6061,451,Meet,O
6062,451,the,O
6063,451,clinical,O
6064,451,(,O
6065,451,Amsel,O
6066,451,),O
6067,451,criteria,O
6068,451,for,O
6069,451,BV,B-Condition
6070,452,Willing,B-Mood
6071,452,to,I-Mood
6072,452,participate,B-Observation
6073,452,in,I-Observation
6074,452,research,I-Observation
6075,453,abnormal,B-Condition
6076,453,renal,I-Condition
6077,453,function,I-Condition
6078,454,currently,O
6079,454,pregnant,B-Condition
6080,454,",",O
6081,454,or,O
6082,454,trying,B-Mood
6083,454,to,I-Mood
6084,454,become,I-Mood
6085,454,pregnant,B-Condition
6086,455,being,O
6087,455,treated,B-Procedure
6088,455,with,O
6089,455,a,O
6090,455,beta,B-Drug
6091,455,-,I-Drug
6092,455,blocker,I-Drug
6093,456,use,O
6094,456,of,O
6095,456,illicit,B-Drug
6096,456,drugs,I-Drug
6097,457,systolic,O
6098,457,blood,O
6099,457,pressure,O
6100,457,between,O
6101,457,140,O
6102,457,-,O
6103,457,160,O
6104,457,mmHG,O
6105,458,between,O
6106,458,18,O
6107,458,-,O
6108,458,80,O
6109,458,years,O
6110,458,old,B-Person
6111,459,Born,B-Person
6112,459,prior,O
6113,459,to,O
6114,459,34,O
6115,459,weeks,O
6116,460,Neonatal,O
6117,460,intensive,O
6118,460,care,O
6119,460,unit,O
6120,460,admission,O
6121,461,Serious,O
6122,461,medical,B-Condition
6123,461,comorbidities,I-Condition
6124,462,Primary,O
6125,462,substance,B-Observation
6126,462,exposure,I-Observation
6127,462,in,O
6128,462,-,O
6129,462,utero,O
6130,462,was,O
6131,462,buprenorphine,O
6132,462,",",O
6133,462,or,O
6134,462,was,O
6135,462,not,O
6136,462,opioids,B-Drug
6137,463,Born,B-Person
6138,463,at,O
6139,463,University,O
6140,463,of,O
6141,463,New,O
6142,463,Mexico,O
6143,463,Hospital,O
6144,464,Greater,O
6145,464,than,O
6146,464,34,O
6147,464,weeks,O
6148,464,gestation,B-Condition
6149,465,Primary,O
6150,465,in,O
6151,465,-,O
6152,465,utero,O
6153,465,drug,B-Observation
6154,465,exposure,I-Observation
6155,465,was,O
6156,465,opioids,B-Drug
6157,465,other,O
6158,465,than,O
6159,465,buprenorphine,B-Drug
6160,466,Maternal,O
6161,466,or,O
6162,466,infant,O
6163,466,urine,O
6164,466,drug,O
6165,466,screen,O
6166,466,positive,O
6167,466,for,O
6168,466,methadone,O
6169,466,and/or,O
6170,466,opioids,O
6171,466,on,O
6172,466,admission,O
6173,467,Pregnancy,B-Condition
6174,468,Tuberculosis,B-Condition
6175,469,Hepatitis,B-Condition
6176,469,B,I-Condition
6177,469,or,I-Condition
6178,469,C,I-Condition
6179,469,carrier,I-Condition
6180,469,status,O
6181,470,Human,O
6182,470,immunodeficiency,O
6183,470,virus,O
6184,470,-,O
6185,470,positive,O
6186,470,status,O
6187,471,Retransplantation,B-Procedure
6188,471,or,O
6189,471,multiorgan,O
6190,471,transplantation,B-Procedure
6191,472,History,O
6192,472,of,O
6193,472,rheumatoid,B-Condition
6194,472,arthritis,I-Condition
6195,473,Use,O
6196,473,of,O
6197,473,drugs,O
6198,473,that,O
6199,473,might,O
6200,473,have,O
6201,473,enhanced,O
6202,473,or,O
6203,473,inhibited,O
6204,473,CYP3A4,O
6205,473,or,O
6206,473,P,O
6207,473,-,O
6208,473,gp,O
6209,473,activity,O
6210,474,De,O
6211,474,novo,O
6212,474,kidney,B-Procedure
6213,474,transplants,I-Procedure
6214,475,20,O
6215,475,-,O
6216,475,65,O
6217,475,years,O
6218,475,old,B-Person
6219,476,aspartate,O
6220,476,aminotransferase,O
6221,476,/,O
6222,476,alanine,O
6223,476,aminotransferase,O
6224,476,within,O
6225,476,2,O
6226,476,times,O
6227,476,the,O
6228,476,upper,O
6229,476,limit,O
6230,476,of,O
6231,476,normal,O
6232,476,range,O
6233,477,Personal,O
6234,477,or,O
6235,477,family,O
6236,477,history,O
6237,477,of,O
6238,477,pancreatitis,B-Condition
6239,478,Medullary,B-Condition
6240,478,thyroid,I-Condition
6241,478,carcinoma,I-Condition
6242,478,(,O
6243,478,MTC,B-Condition
6244,478,),O
6245,478,or,O
6246,478,Multiple,B-Condition
6247,478,Endocrine,I-Condition
6248,478,Neoplasia,I-Condition
6249,478,Syndrome,I-Condition
6250,478,Type,I-Condition
6251,478,2,I-Condition
6252,478,(,O
6253,478,MEN,B-Condition
6254,478,2,I-Condition
6255,478,),O
6256,479,Gastroparesis,B-Condition
6257,480,Allergy,B-Condition
6258,480,to,O
6259,480,liraglutide,B-Drug
6260,480,or,O
6261,480,any,O
6262,480,of,O
6263,480,the,O
6264,480,active,O
6265,480,ingredients,O
6266,480,in,O
6267,480,liraglutide,O
6268,480,or,O
6269,480,other,O
6270,480,GLP-1,B-Drug
6271,480,analogue,I-Drug
6272,481,Weight,B-Observation
6273,481,loss,I-Observation
6274,481,drugs,O
6275,481,other,O
6276,481,than,O
6277,481,metformin,B-Drug
6278,482,Type,B-Condition
6279,482,1,I-Condition
6280,482,diabetes,I-Condition
6281,482,mellitus,I-Condition
6282,482,or,O
6283,482,diabetic,B-Condition
6284,482,ketoacidosis,I-Condition
6285,483,Known,O
6286,483,major,O
6287,483,cognitive,B-Condition
6288,483,deficit,I-Condition
6289,483,dementia,B-Condition
6290,483,",",O
6291,483,history,O
6292,483,of,O
6293,483,head,B-Condition
6294,483,trauma,I-Condition
6295,483,with,O
6296,483,loss,B-Condition
6297,483,of,I-Condition
6298,483,consciousness,I-Condition
6299,483,>,O
6300,483,30,O
6301,483,min,O
6302,483,",",O
6303,483,history,O
6304,483,of,O
6305,483,stroke,B-Condition
6306,483,",",O
6307,483,current,O
6308,483,central,B-Condition
6309,483,nervous,I-Condition
6310,483,system,I-Condition
6311,483,(,I-Condition
6312,483,CNS,I-Condition
6313,483,),I-Condition
6314,483,disorder,I-Condition
6315,483,such,O
6316,483,as,O
6317,483,seizures,B-Condition
6318,483,or,O
6319,483,opportunistic,B-Condition
6320,483,CNS,I-Condition
6321,483,infection,I-Condition
6322,484,Renal,B-Condition
6323,484,insufficiency,I-Condition
6324,484,defined,O
6325,484,as,O
6326,484,creatinine,O
6327,484,clearance,O
6328,484,<,O
6329,484,60,O
6330,484,mL,O
6331,484,/,O
6332,484,min,O
6333,485,Active,O
6334,485,opportunistic,B-Condition
6335,485,infections,I-Condition
6336,486,Pregnancy,O
6337,486,or,O
6338,486,breastfeeding,O
6339,487,Unstable,O
6340,487,cardiovascular,O
6341,487,disease,O
6342,487,with,O
6343,487,hospitalization,O
6344,487,within,O
6345,487,1,O
6346,487,year,O
6347,487,for,O
6348,487,acute,B-Condition
6349,487,coronary,I-Condition
6350,487,syndrome,I-Condition
6351,488,Decompensated,B-Condition
6352,488,heart,I-Condition
6353,488,failure,I-Condition
6354,489,Substance,B-Condition
6355,489,abuse,I-Condition
6356,490,Active,O
6357,490,alcohol,B-Observation
6358,490,or,O
6359,490,opioid,B-Procedure
6360,490,substitution,I-Procedure
6361,490,therapy,I-Procedure
6362,491,Serious,O
6363,491,or,O
6364,491,unstable,O
6365,491,medical,O
6366,491,or,O
6367,491,psychological,O
6368,491,conditions,O
6369,491,that,O
6370,491,would,O
6371,491,compromise,O
6372,491,the,O
6373,491,subject,O
6374,491,'s,O
6375,491,safety,O
6376,491,for,O
6377,491,successful,O
6378,491,participation,O
6379,492,HIV,B-Condition
6380,492,controlled,O
6381,492,on,O
6382,492,therapy,O
6383,492,for,O
6384,492,at,O
6385,492,least,O
6386,492,12,O
6387,492,weeks,O
6388,493,Viral,O
6389,493,load,O
6390,493,<,O
6391,493,200,O
6392,493,copies,O
6393,494,BMI,B-Person
6394,494,>,O
6395,494,27,O
6396,494,to,O
6397,494,45,O
6398,495,Diagnosis,O
6399,495,of,O
6400,495,DM,B-Condition
6401,495,type,I-Condition
6402,495,2,I-Condition
6403,495,with,O
6404,495,A1,O
6405,495,-,O
6406,495,C,O
6407,495,>,O
6408,495,7,O
6409,495,to,O
6410,495,15,O
6411,496,Participants,O
6412,496,must,O
6413,496,be,O
6414,496,willing,O
6415,496,to,O
6416,496,comply,O
6417,496,with,O
6418,496,all,O
6419,496,study,O
6420,496,related,O
6421,496,procedures,O
6422,497,Known,O
6423,497,other,O
6424,497,respiratory,B-Condition
6425,497,disorders,I-Condition
6426,497,or,O
6427,497,signs,B-Condition
6428,497,for,I-Condition
6429,497,other,I-Condition
6430,497,respiratory,I-Condition
6431,497,disorders,I-Condition
6432,497,(,O
6433,497,e.g.,O
6434,497,asthma,B-Condition
6435,497,",",O
6436,497,lung,B-Condition
6437,497,cancer,I-Condition
6438,497,",",O
6439,497,sarcoidosis,B-Condition
6440,497,",",O
6441,497,tuberculosis,B-Condition
6442,497,",",O
6443,497,lung,B-Condition
6444,497,fibrosis,I-Condition
6445,497,",",O
6446,497,cystic,B-Condition
6447,497,fibrosis,I-Condition
6448,497,",",O
6449,497,bronchoectasis,B-Condition
6450,497,),O
6451,497,.,O
6452,498,Known,O
6453,498,history,O
6454,498,of,O
6455,498,significant,O
6456,498,inflammatory,B-Condition
6457,498,disease,I-Condition
6458,498,",",O
6459,498,other,O
6460,498,than,O
6461,498,COPD,B-Condition
6462,498,(,O
6463,498,e.g.,O
6464,498,rheumatoid,B-Condition
6465,498,arthritis,I-Condition
6466,498,and,O
6467,498,systemic,B-Condition
6468,498,lupus,I-Condition
6469,498,erythematosus,I-Condition
6470,498,),O
6471,498,.,O
6472,499,Known,O
6473,499,to,O
6474,499,be,O
6475,499,severely,O
6476,499,alpha-1,B-Condition
6477,499,-,I-Condition
6478,499,antitrypsin,I-Condition
6479,499,deficient,I-Condition
6480,499,(,O
6481,499,PI,O
6482,499,SZ,O
6483,499,or,O
6484,499,ZZ,O
6485,499,),O
6486,500,Having,O
6487,500,undergone,O
6488,500,lung,B-Procedure
6489,500,surgery,I-Procedure
6490,500,(,O
6491,500,e.g.,O
6492,500,lung,B-Procedure
6493,500,resection,I-Procedure
6494,500,including,O
6495,500,lung,B-Procedure
6496,500,volume,I-Procedure
6497,500,reduction,I-Procedure
6498,500,surgery,I-Procedure
6499,500,",",O
6500,500,lung,B-Procedure
6501,500,transplant,I-Procedure
6502,500,),O
6503,500,or,O
6504,500,subjects,O
6505,500,scheduled,B-Observation
6506,500,for,O
6507,500,surgery,B-Procedure
6508,500,.,O
6509,501,Concurrent,O
6510,501,medication,B-Drug
6511,501,from,I-Drug
6512,501,Visit,I-Drug
6513,501,1,I-Drug
6514,501,and,O
6515,501,for,O
6516,501,the,O
6517,501,duration,O
6518,501,of,O
6519,501,the,O
6520,501,study,O
6521,501,with,O
6522,501,any,O
6523,501,of,O
6524,501,the,O
6525,501,prohibited,O
6526,501,medications,O
6527,501,:,O
6528,501,monoamine,B-Drug
6529,501,oxidase,I-Drug
6530,501,inhibitors,I-Drug
6531,501,and,O
6532,501,tricyclic,B-Drug
6533,501,antidepressants,I-Drug
6534,501,",",O
6535,501,and,O
6536,501,ritonavir,B-Drug
6537,501,(,O
6538,501,a,O
6539,501,highly,O
6540,501,potent,O
6541,501,cytochrome,B-Drug
6542,501,P450,I-Drug
6543,501,3A4,I-Drug
6544,501,inhibitor,I-Drug
6545,501,),O
6546,501,.,O
6547,502,Subjects,O
6548,502,receiving,O
6549,502,chronic,B-Procedure
6550,502,or,I-Procedure
6551,502,prophylactic,I-Procedure
6552,502,antibiotic,I-Procedure
6553,502,therapy,I-Procedure
6554,502,.,O
6555,503,Serious,O
6556,503,",",O
6557,503,uncontrolled,B-Condition
6558,503,disease,I-Condition
6559,503,(,O
6560,503,including,O
6561,503,serious,O
6562,503,psychological,B-Condition
6563,503,disorders,I-Condition
6564,503,),O
6565,503,likely,O
6566,503,to,O
6567,503,interfere,O
6568,503,with,O
6569,503,the,O
6570,503,study,O
6571,503,or,O
6572,503,impact,O
6573,503,on,O
6574,503,subject,O
6575,503,safety,O
6576,503,.,O
6577,504,Have,O
6578,504,",",O
6579,504,in,O
6580,504,the,O
6581,504,opinion,O
6582,504,of,O
6583,504,the,O
6584,504,investigator,O
6585,504,",",O
6586,504,evidence,O
6587,504,of,O
6588,504,alcohol,B-Condition
6589,504,",",I-Condition
6590,504,drug,I-Condition
6591,504,or,I-Condition
6592,504,solvent,I-Condition
6593,504,abuse,I-Condition
6594,504,.,O
6595,505,History,B-Observation
6596,505,of,I-Observation
6597,505,depression,B-Condition
6598,505,.,O
6599,506,History,O
6600,506,or,O
6601,506,presence,O
6602,506,of,O
6603,506,clinically,O
6604,506,significant,O
6605,506,drug,B-Condition
6606,506,sensitivity,I-Condition
6607,506,or,O
6608,506,clinically,O
6609,506,significant,O
6610,506,allergic,B-Condition
6611,506,reaction,I-Condition
6612,506,to,O
6613,506,corticosteroids,B-Drug
6614,506,or,O
6615,506,salmeterol,B-Drug
6616,506,.,O
6617,507,Moderate,O
6618,507,or,O
6619,507,severe,O
6620,507,COPD,B-Condition
6621,507,exacerbation,I-Condition
6622,507,(,O
6623,507,requiring,O
6624,507,corticosteroids,B-Drug
6625,507,or,O
6626,507,increased,O
6627,507,dosage,O
6628,507,of,O
6629,507,corticosteroids,B-Drug
6630,507,and/or,O
6631,507,antibiotics,B-Drug
6632,507,or,O
6633,507,hospitalization,O
6634,507,),O
6635,507,within,O
6636,507,the,O
6637,507,4,O
6638,507,weeks,O
6639,507,prior,O
6640,507,to,O
6641,507,Visit,O
6642,507,1,O
6643,508,Lower,B-Condition
6644,508,respiratory,I-Condition
6645,508,tract,I-Condition
6646,508,infection,I-Condition
6647,508,within,O
6648,508,the,O
6649,508,4,O
6650,508,weeks,O
6651,508,prior,O
6652,508,to,O
6653,508,Visit,O
6654,508,1,O
6655,508,.,O
6656,509,Pregnant,B-Condition
6657,509,or,O
6658,509,lactating,B-Condition
6659,509,female,B-Person
6660,509,and,O
6661,509,female,B-Person
6662,509,of,O
6663,509,childbearing,B-Condition
6664,509,potential,I-Condition
6665,509,.,O
6666,510,Subject,O
6667,510,is,O
6668,510,a,O
6669,510,participating,O
6670,510,investigator,O
6671,510,",",O
6672,510,sub,O
6673,510,-,O
6674,510,investigator,O
6675,510,",",O
6676,510,study,O
6677,510,coordinator,O
6678,510,",",O
6679,510,or,O
6680,510,other,O
6681,510,employee,O
6682,510,of,O
6683,510,a,O
6684,510,participating,O
6685,510,investigator,O
6686,510,",",O
6687,510,or,O
6688,510,is,O
6689,510,an,O
6690,510,immediate,O
6691,510,family,O
6692,510,member,O
6693,510,of,O
6694,510,the,O
6695,510,before,O
6696,510,mentioned,O
6697,510,.,O
6698,510,Subject,O
6699,510,is,O
6700,510,an,O
6701,510,employee,O
6702,510,of,O
6703,510,GlaxoSmithKline,O
6704,510,(,O
6705,510,GSK,O
6706,510,),O
6707,510,.,O
6708,511,Subject,O
6709,511,participated,B-Observation
6710,511,in,I-Observation
6711,511,an,I-Observation
6712,511,investigational,I-Observation
6713,511,drug,I-Observation
6714,511,study,I-Observation
6715,511,within,O
6716,511,30,O
6717,511,days,O
6718,511,prior,O
6719,511,to,O
6720,511,Visit,O
6721,511,1,O
6722,512,Subject,O
6723,512,must,O
6724,512,have,O
6725,512,a,O
6726,512,diagnosis,O
6727,512,of,O
6728,512,COPD,B-Condition
6729,512,based,O
6730,512,on,O
6731,512,the,O
6732,512,American,O
6733,512,Thoracic,O
6734,512,Society,O
6735,512,(,O
6736,512,ATS)/,O
6737,512,European,O
6738,512,Respiratory,O
6739,512,Society,O
6740,512,(,O
6741,512,ERS,O
6742,512,),O
6743,512,criteria,O
6744,512,.,O
6745,513,Male,B-Person
6746,513,or,O
6747,513,female,B-Person
6748,513,subjects,O
6749,513,",",O
6750,513,aged,B-Person
6751,513,>,O
6752,513,=,O
6753,513,40,O
6754,513,years,O
6755,513,.,O
6756,513,Females,B-Person
6757,513,must,O
6758,513,be,O
6759,513,of,O
6760,513,Non,O
6761,513,Child,B-Condition
6762,513,Bearing,I-Condition
6763,513,Potential,I-Condition
6764,513,.,O
6765,513,The,O
6766,513,definition,O
6767,513,of,O
6768,513,Non,O
6769,513,Child,B-Condition
6770,513,Bearing,I-Condition
6771,513,Potential,I-Condition
6772,513,is,O
6773,513,as,O
6774,513,following,O
6775,513,:,O
6776,513,Females,B-Person
6777,513,",",O
6778,513,regardless,O
6779,513,of,O
6780,513,their,O
6781,513,age,O
6782,513,",",O
6783,513,with,O
6784,513,functioning,B-Condition
6785,513,ovaries,I-Condition
6786,513,and,O
6787,513,who,O
6788,513,have,O
6789,513,a,O
6790,513,current,O
6791,513,documented,O
6792,513,tubal,B-Condition
6793,513,ligation,I-Condition
6794,513,or,O
6795,513,hysterectomy,B-Condition
6796,513,",",O
6797,513,or,O
6798,513,females,B-Person
6799,513,who,O
6800,513,are,O
6801,513,post,B-Condition
6802,513,-,I-Condition
6803,513,menopausal,I-Condition
6804,513,.,O
6805,514,Have,O
6806,514,diagnosed,O
6807,514,COPD,B-Condition
6808,514,stage,O
6809,514,III,O
6810,514,or,O
6811,514,IV,O
6812,514,according,O
6813,514,to,O
6814,514,GOLD,O
6815,514,criteria,O
6816,514,:,O
6817,514,a,O
6818,514,baseline,O
6819,514,post,O
6820,514,-,O
6821,514,bronchodilator,O
6822,514,Forced,O
6823,514,Expiratory,O
6824,514,Volume,O
6825,514,",",O
6826,514,measured,O
6827,514,at,O
6828,514,1,O
6829,514,second,O
6830,514,(,O
6831,514,FEV1,O
6832,514,),O
6833,514,<,O
6834,514,50,O
6835,514,%,O
6836,514,of,O
6837,514,predicted,O
6838,514,normal,O
6839,514,and,O
6840,514,a,O
6841,514,baseline,O
6842,514,post-,O
6843,514,bronchodilator,O
6844,514,FEV1,O
6845,514,/,O
6846,514,Inspiratory,O
6847,514,Vital,O
6848,514,Capacity,O
6849,514,(,O
6850,514,IVC,O
6851,514,),O
6852,514,ratio,O
6853,514,<,O
6854,514,70,O
6855,514,%,O
6856,514,.,O
6857,515,Have,O
6858,515,experienced,O
6859,515,at,O
6860,515,least,O
6861,515,2,O
6862,515,moderate,O
6863,515,or,O
6864,515,severe,O
6865,515,COPD,B-Condition
6866,515,exacerbations,I-Condition
6867,515,leading,O
6868,515,to,O
6869,515,medical,O
6870,515,consultation,O
6871,515,(,O
6872,515,requiring,O
6873,515,oral,B-Drug
6874,515,corticosteroids,I-Drug
6875,515,or,O
6876,515,increasing,O
6877,515,dosage,O
6878,515,of,O
6879,515,oral,B-Drug
6880,515,corticosteroids,I-Drug
6881,515,and/or,O
6882,515,antibiotics,B-Drug
6883,515,or,O
6884,515,hospitalization,O
6885,515,),O
6886,515,within,O
6887,515,the,O
6888,515,12,O
6889,515,months,O
6890,515,preceding,O
6891,515,Visit,O
6892,515,1,O
6893,515,.,O
6894,516,Have,O
6895,516,stable,O
6896,516,COPD,B-Drug
6897,516,medication,I-Drug
6898,516,within,O
6899,516,4,O
6900,516,weeks,O
6901,516,prior,O
6902,516,to,O
6903,516,Visit,O
6904,516,1,O
6905,516,(,O
6906,516,no,O
6907,516,new,O
6908,516,medication,O
6909,516,added,O
6910,516,and,O
6911,516,no,O
6912,516,dosage,O
6913,516,changes,O
6914,516,in,O
6915,516,medication,O
6916,516,),O
6917,516,.,O
6918,517,Current,O
6919,517,or,O
6920,517,ex,O
6921,517,-,O
6922,517,smokers,B-Condition
6923,517,with,O
6924,517,a,O
6925,517,smoking,O
6926,517,history,O
6927,517,of,O
6928,517,at,O
6929,517,least,O
6930,517,10,O
6931,517,pack,O
6932,517,years,O
6933,517,(,O
6934,517,number,O
6935,517,of,O
6936,517,pack,O
6937,517,years,O
6938,517,=,O
6939,517,[,O
6940,517,number,O
6941,517,of,O
6942,517,cigarettes,O
6943,517,per,O
6944,517,day,O
6945,517,/,O
6946,517,20,O
6947,517,],O
6948,517,x,O
6949,517,number,O
6950,517,of,O
6951,517,years,O
6952,517,smoked,O
6953,517,",",O
6954,517,e.g.,O
6955,517,",",O
6956,517,20,O
6957,517,cigarettes,O
6958,517,per,O
6959,517,day,O
6960,517,for,O
6961,517,10,O
6962,517,years,O
6963,517,",",O
6964,517,or,O
6965,517,10,O
6966,517,cigarettes,O
6967,517,per,O
6968,517,day,O
6969,517,for,O
6970,517,20,O
6971,517,years,O
6972,517,),O
6973,517,.,O
6974,518,Are,O
6975,518,currently,O
6976,518,managed,B-Observation
6977,518,at,I-Observation
6978,518,home,I-Observation
6979,518,(,O
6980,518,outpatients,B-Observation
6981,518,),O
6982,518,",",O
6983,518,are,O
6984,518,ambulatory,B-Condition
6985,518,and,O
6986,518,able,B-Observation
6987,518,to,I-Observation
6988,518,travel,I-Observation
6989,518,to,I-Observation
6990,518,the,I-Observation
6991,518,clinic,I-Observation
6992,518,.,O
6993,518,Subjects,O
6994,518,can,O
6995,518,be,O
6996,518,treated,O
6997,518,with,O
6998,518,all,O
6999,518,relevant,O
7000,518,COPD,B-Drug
7001,518,medication,I-Drug
7002,518,.,O
7003,518,This,O
7004,518,includes,O
7005,518,vaccines,B-Drug
7006,518,",",O
7007,518,inhaled,B-Drug
7008,518,short,I-Drug
7009,518,-,I-Drug
7010,518,acting,I-Drug
7011,518,beta-2,I-Drug
7012,518,-,I-Drug
7013,518,agonists,I-Drug
7014,518,as,O
7015,518,needed,O
7016,518,",",O
7017,518,short,B-Drug
7018,518,-,I-Drug
7019,518,acting,I-Drug
7020,518,or,O
7021,518,long,B-Drug
7022,518,-,I-Drug
7023,518,acting,I-Drug
7024,518,anticholinergics,I-Drug
7025,518,(,O
7026,518,tiotropium,B-Drug
7027,518,),O
7028,518,",",O
7029,518,systemic,B-Drug
7030,518,beta-2,I-Drug
7031,518,-,I-Drug
7032,518,agonists,I-Drug
7033,518,",",O
7034,518,theophylline,B-Drug
7035,518,",",O
7036,518,mucolytics,B-Drug
7037,518,",",O
7038,518,antioxidants,B-Drug
7039,518,",",O
7040,518,beta-1,B-Drug
7041,518,-,I-Drug
7042,518,agonists,I-Drug
7043,518,(,O
7044,518,for,O
7045,518,cardiovascular,B-Condition
7046,518,indication,I-Condition
7047,518,),O
7048,518,",",O
7049,518,non,B-Condition
7050,518,-,I-Condition
7051,518,invasive,I-Condition
7052,518,ventilation,I-Condition
7053,518,",",O
7054,518,long,O
7055,518,term,O
7056,518,oxygen,B-Procedure
7057,518,therapy,I-Procedure
7058,518,and,O
7059,518,can,O
7060,518,have,O
7061,518,Cor,B-Condition
7062,518,Pulmonale,I-Condition
7063,518,.,O
7064,519,A,O
7065,519,signed,O
7066,519,and,O
7067,519,dated,O
7068,519,written,B-Observation
7069,519,informed,I-Observation
7070,519,consent,I-Observation
7071,519,is,O
7072,519,obtained,O
7073,519,prior,O
7074,519,to,O
7075,519,participation,O
7076,519,.,O
7077,520,Able,B-Observation
7078,520,to,I-Observation
7079,520,comply,I-Observation
7080,520,with,I-Observation
7081,520,the,I-Observation
7082,520,requirements,I-Observation
7083,520,of,I-Observation
7084,520,the,I-Observation
7085,520,protocol,I-Observation
7086,520,and,O
7087,520,be,O
7088,520,available,B-Observation
7089,520,for,I-Observation
7090,520,study,I-Observation
7091,520,visits,I-Observation
7092,520,over,O
7093,520,52,O
7094,520,weeks,O
7095,520,.,O
7096,521,Patients,O
7097,521,incapable,B-Observation
7098,521,to,I-Observation
7099,521,understanding,I-Observation
7100,521,and,O
7101,521,will,O
7102,521,;,O
7103,522,Patients,O
7104,522,participating,O
7105,522,in,O
7106,522,previous,O
7107,522,",",O
7108,522,concurrent,O
7109,522,or,O
7110,522,not,O
7111,522,",",O
7112,522,trials,O
7113,522,(,O
7114,522,ongoing,O
7115,522,or,O
7116,522,completed,O
7117,522,within,O
7118,522,three,O
7119,522,months,O
7120,522,),O
7121,522,;,O
7122,523,Patients,O
7123,523,surgically,B-Procedure
7124,523,treated,I-Procedure
7125,523,for,O
7126,523,the,B-Condition
7127,523,same,I-Condition
7128,523,defect,I-Condition
7129,523,within,O
7130,523,one,O
7131,523,year,O
7132,523,;,O
7133,524,Patients,O
7134,524,affected,O
7135,524,by,O
7136,524,malignancy,B-Condition
7137,524,;,O
7138,525,Patients,O
7139,525,affected,O
7140,525,by,O
7141,525,metabolic,B-Condition
7142,525,or,I-Condition
7143,525,thyroid,I-Condition
7144,525,disorders,I-Condition
7145,525,;,O
7146,526,Patients,O
7147,526,used,O
7148,526,to,O
7149,526,alcohol,B-Condition
7150,526,or,I-Condition
7151,526,drug,I-Condition
7152,526,(,I-Condition
7153,526,medication,I-Condition
7154,526,),I-Condition
7155,526,abuse,I-Condition
7156,526,;,O
7157,527,Patients,O
7158,527,affected,O
7159,527,by,O
7160,527,synovitis,B-Condition
7161,527,;,O
7162,528,Varus,B-Condition
7163,528,or,I-Condition
7164,528,valgus,I-Condition
7165,528,misalignment,I-Condition
7166,528,exceeding,O
7167,528,15,O
7168,528,°,O
7169,528,;,O
7170,529,Body,O
7171,529,Mass,O
7172,529,Index,O
7173,529,>,O
7174,529,40,O
7175,529,;,O
7176,530,Patients,O
7177,530,with,O
7178,530,trauma,B-Procedure
7179,530,within,O
7180,530,6,O
7181,530,months,O
7182,530,pre,O
7183,530,-,O
7184,530,operative,B-Procedure
7185,530,.,O
7186,531,Patients,O
7187,531,provided,B-Observation
7188,531,written,I-Observation
7189,531,informed,I-Observation
7190,531,consent,I-Observation
7191,531,;,O
7192,532,Patients,O
7193,532,aged,B-Person
7194,532,between,O
7195,532,18,O
7196,532,and,O
7197,532,75,O
7198,532,years,O
7199,532,;,O
7200,533,Knee,O
7201,533,symptomatic,O
7202,533,OA,O
7203,533,(,O
7204,533,Kellgren,O
7205,533,-,O
7206,533,Lawrence,O
7207,533,grade,O
7208,533,1,O
7209,533,-,O
7210,533,4,O
7211,533,),O
7212,534,Failure,B-Observation
7213,534,of,O
7214,534,conservative,B-Procedure
7215,534,treatment,I-Procedure
7216,534,for,O
7217,534,at,O
7218,534,least,O
7219,534,3,O
7220,534,months,O
7221,534,;,O
7222,535,Patients,O
7223,535,agreed,B-Observation
7224,535,to,I-Observation
7225,535,actively,I-Observation
7226,535,participate,I-Observation
7227,535,in,I-Observation
7228,535,the,I-Observation
7229,535,rehabilitation,I-Observation
7230,535,protocol,I-Observation
7231,535,and,I-Observation
7232,535,follow,I-Observation
7233,535,-,I-Observation
7234,535,up,I-Observation
7235,535,program,I-Observation
7236,535,;,O
7237,536,Male,B-Person
7238,536,or,O
7239,536,female,B-Person
7240,536,patients,O
7241,536,;,O
7242,537,Women,B-Person
7243,537,of,O
7244,537,childbearing,B-Observation
7245,537,age,I-Observation
7246,537,had,O
7247,537,to,O
7248,537,use,O
7249,537,a,O
7250,537,proven,O
7251,537,method,B-Observation
7252,537,to,I-Observation
7253,537,prevent,I-Observation
7254,537,pregnancy,I-Observation
7255,537,",",O
7256,537,before,O
7257,537,the,O
7258,537,surgical,B-Procedure
7259,537,treatment,I-Procedure
7260,537,.,O
7261,538,Active,O
7262,538,opioid,B-Condition
7263,538,dependence,I-Condition
7264,539,Acute,O
7265,539,or,O
7266,539,chronic,O
7267,539,pain,B-Condition
7268,539,requiring,O
7269,539,opioid,B-Procedure
7270,539,treatment,I-Procedure
7271,540,Acute,B-Condition
7272,540,liver,I-Condition
7273,540,injury,I-Condition
7274,540,(,O
7275,540,liver,O
7276,540,aminotransferase,O
7277,540,concentrations,O
7278,540,>,O
7279,540,5,O
7280,540,times,O
7281,540,the,O
7282,540,upper,O
7283,540,limit,O
7284,540,of,O
7285,540,normal,O
7286,540,),O
7287,541,Health,B-Condition
7288,541,condition,I-Condition
7289,541,considered,O
7290,541,unsafe,O
7291,541,for,O
7292,541,inclusion,O
7293,541,(,O
7294,541,at,O
7295,541,discretion,O
7296,541,of,O
7297,541,PI,O
7298,541,and/or,O
7299,541,attending,O
7300,541,physician,O
7301,541,),O
7302,542,Lack,O
7303,542,of,O
7304,542,capacity,B-Observation
7305,542,or,I-Observation
7306,542,willingness,I-Observation
7307,542,to,I-Observation
7308,542,consent,I-Observation
7309,543,Currently,O
7310,543,prescribed,O
7311,543,pharmacotherapy,B-Procedure
7312,543,for,O
7313,543,alcohol,B-Condition
7314,543,dependence,I-Condition
7315,543,(,O
7316,543,not,O
7317,543,including,O
7318,543,treatment,B-Procedure
7319,543,of,O
7320,543,acute,B-Condition
7321,543,alcohol,I-Condition
7322,543,withdrawal,I-Condition
7323,543,syndrome,I-Condition
7324,543,),O
7325,544,Previous,O
7326,544,significant,O
7327,544,adverse,B-Condition
7328,544,reaction,I-Condition
7329,544,to,O
7330,544,naltrexone,B-Drug
7331,544,or,O
7332,544,diluent,B-Drug
7333,545,Pregnant,B-Condition
7334,545,",",O
7335,545,nursing,B-Condition
7336,545,",",O
7337,545,or,O
7338,545,not,O
7339,545,using,O
7340,545,effective,O
7341,545,methods,O
7342,545,of,O
7343,545,birth,B-Procedure
7344,545,control,I-Procedure
7345,546,Prisoners,B-Person
7346,546,(,O
7347,546,as,O
7348,546,defined,O
7349,546,by,O
7350,546,Office,O
7351,546,of,O
7352,546,Human,O
7353,546,Research,O
7354,546,Protection,O
7355,546,),O
7356,546,at,O
7357,546,the,O
7358,546,time,O
7359,546,of,O
7360,546,enrollment,O
7361,546,ARE,O
7362,546,NOT,O
7363,546,ELIGIBLE,O
7364,546,for,O
7365,546,study,O
7366,546,entry,O
7367,546,.,O
7368,546,However,O
7369,546,",",O
7370,546,subjects,O
7371,546,who,O
7372,546,become,O
7373,546,prisoners,O
7374,546,after,O
7375,546,being,O
7376,546,enrolled,O
7377,546,will,O
7378,546,be,O
7379,546,included,O
7380,546,and,O
7381,546,not,O
7382,546,be,O
7383,546,withdrawn,O
7384,546,from,O
7385,546,the,O
7386,546,study,O
7387,546,.,O
7388,546,Patients,O
7389,546,on,O
7390,546,parole,O
7391,546,or,O
7392,546,probation,O
7393,546,are,O
7394,546,eligible,O
7395,546,for,O
7396,546,enrollment,O
7397,546,.,O
7398,547,English,B-Observation
7399,547,or,I-Observation
7400,547,Spanish,I-Observation
7401,547,speaking,I-Observation
7402,547,*,O
7403,548,Emergency,O
7404,548,Department,O
7405,548,patient,O
7406,549,Aged,B-Person
7407,549,18,O
7408,549,-,O
7409,549,80,O
7410,550,Have,O
7411,550,had,O
7412,550,>,O
7413,550,4,O
7414,550,emergency,O
7415,550,department,O
7416,550,visits,O
7417,550,within,O
7418,550,12,O
7419,550,months,O
7420,550,for,O
7421,550,2,O
7422,550,consecutive,O
7423,550,12,O
7424,550,-,O
7425,550,month,O
7426,550,periods,O
7427,550,.,O
7428,550,Period,O
7429,550,of,O
7430,550,time,O
7431,550,can,O
7432,550,be,O
7433,550,extended,O
7434,550,by,O
7435,550,up,O
7436,550,to,O
7437,550,6,O
7438,550,months,O
7439,550,if,O
7440,550,incarcerated,B-Person
7441,550,or,O
7442,550,institutionalized,B-Person
7443,550,for,O
7444,550,≥,O
7445,550,6,O
7446,550,months,O
7447,550,.,O
7448,551,Meet,O
7449,551,Diagnostic,O
7450,551,and,O
7451,551,Statistical,O
7452,551,Manual,O
7453,551,version,O
7454,551,IV,O
7455,551,(,O
7456,551,DSM,O
7457,551,-,O
7458,551,IV,O
7459,551,),O
7460,551,criteria,O
7461,551,for,O
7462,551,alcohol,B-Condition
7463,551,dependence,I-Condition
7464,551,or,O
7465,551,&,O
7466,551,DSM,O
7467,551,-,O
7468,551,V,O
7469,551,criteria,O
7470,551,for,O
7471,551,alcohol,B-Condition
7472,551,use,I-Condition
7473,551,disorder,I-Condition
7474,551,",",O
7475,551,severe,O
7476,551,.,O
7477,552,Have,O
7478,552,≥2,O
7479,552,days,O
7480,552,/,O
7481,552,week,O
7482,552,of,O
7483,552,heavy,B-Condition
7484,552,drinking,I-Condition
7485,552,(,O
7486,552,>,O
7487,552,4,O
7488,552,drinks,O
7489,552,/,O
7490,552,day,O
7491,552,),O
7492,553,Capable,B-Mood
7493,553,of,I-Mood
7494,553,giving,I-Mood
7495,553,informed,B-Observation
7496,553,consent,I-Observation
7497,553,.,O
7498,554,Patients,O
7499,554,with,O
7500,554,any,O
7501,554,other,O
7502,554,primary,O
7503,554,DSM,O
7504,554,-,O
7505,554,IV,O
7506,554,psychiatric,B-Condition
7507,554,diagnosis,I-Condition
7508,554,in,O
7509,554,addition,O
7510,554,to,O
7511,554,Obsessive,B-Condition
7512,554,Compulsive,I-Condition
7513,554,Disorder,I-Condition
7514,554,.,O
7515,555,Patients,O
7516,555,who,O
7517,555,currently,O
7518,555,fulfil,O
7519,555,criteria,O
7520,555,for,O
7521,555,DSM,O
7522,555,-,O
7523,555,IV,O
7524,555,eating,B-Condition
7525,555,disorder,I-Condition
7526,555,",",O
7527,555,body,B-Condition
7528,555,dysmorphic,I-Condition
7529,555,disorder,I-Condition
7530,555,",",O
7531,555,current,O
7532,555,alcohol,B-Condition
7533,555,or,I-Condition
7534,555,substance,I-Condition
7535,555,abuse,I-Condition
7536,555,",",O
7537,555,or,O
7538,555,who,O
7539,555,have,O
7540,555,a,O
7541,555,lifetime,O
7542,555,history,O
7543,555,of,O
7544,555,bipolar,B-Condition
7545,555,disorder,I-Condition
7546,555,.,O
7547,555,Patients,O
7548,555,with,O
7549,555,a,O
7550,555,history,O
7551,555,of,O
7552,555,Schizophrenia,B-Condition
7553,555,and,O
7554,555,other,O
7555,555,psychotic,B-Condition
7556,555,disorders,I-Condition
7557,555,",",O
7558,555,Delirium,B-Condition
7559,555,",",O
7560,555,Dementia,B-Condition
7561,555,",",O
7562,555,and,O
7563,555,Amnestic,B-Condition
7564,555,and,O
7565,555,other,O
7566,555,cognitive,B-Condition
7567,555,disorders,I-Condition
7568,555,.,O
7569,556,Subjects,O
7570,556,with,O
7571,556,a,O
7572,556,concurrent,O
7573,556,Axis,O
7574,556,II,O
7575,556,Cluster,O
7576,556,A,O
7577,556,Personality,B-Condition
7578,556,Disorder,I-Condition
7579,557,Borderline,B-Condition
7580,557,or,I-Condition
7581,557,Antisocial,I-Condition
7582,557,Personality,I-Condition
7583,557,Disorder,I-Condition
7584,557,.,O
7585,558,Subjects,O
7586,558,who,O
7587,558,based,O
7588,558,on,O
7589,558,history,O
7590,558,or,O
7591,558,mental,B-Procedure
7592,558,status,I-Procedure
7593,558,examination,I-Procedure
7594,558,have,O
7595,558,a,O
7596,558,significant,O
7597,558,risk,B-Observation
7598,558,of,I-Observation
7599,558,committing,I-Observation
7600,558,suicide,I-Observation
7601,558,",",O
7602,558,in,O
7603,558,the,O
7604,558,investigator,O
7605,558,'s,O
7606,558,opinion,O
7607,558,.,O
7608,559,Subjects,O
7609,559,with,O
7610,559,a,O
7611,559,history,O
7612,559,of,O
7613,559,more,O
7614,559,than,O
7615,559,three,O
7616,559,adequate,O
7617,559,trials,O
7618,559,with,O
7619,559,an,O
7620,559,SSRI,O
7621,559,.,O
7622,560,Subjects,O
7623,560,who,O
7624,560,have,O
7625,560,had,O
7626,560,an,O
7627,560,adequate,O
7628,560,trial,O
7629,560,of,O
7630,560,pregabalin,O
7631,560,.,O
7632,561,Subjects,O
7633,561,who,O
7634,561,have,O
7635,561,initiated,O
7636,561,psychotherapy,B-Procedure
7637,561,in,O
7638,561,the,O
7639,561,last,O
7640,561,4,O
7641,561,months,O
7642,561,prior,O
7643,561,to,O
7644,561,the,O
7645,561,first,O
7646,561,visit,O
7647,561,.,O
7648,562,Subjects,O
7649,562,who,O
7650,562,",",O
7651,562,during,O
7652,562,the,O
7653,562,course,O
7654,562,of,O
7655,562,the,O
7656,562,study,O
7657,562,",",O
7658,562,would,O
7659,562,be,O
7660,562,likely,O
7661,562,to,O
7662,562,require,O
7663,562,treatment,O
7664,562,with,O
7665,562,prohibited,O
7666,562,concomitant,O
7667,562,therapy,O
7668,562,.,O
7669,563,Prior,O
7670,563,use,O
7671,563,of,O
7672,563,or,O
7673,563,a,O
7674,563,known,O
7675,563,allergy,B-Condition
7676,563,or,O
7677,563,hypersensitivity,B-Condition
7678,563,to,O
7679,563,pregabalin,B-Drug
7680,563,.,O
7681,564,Subjects,O
7682,564,who,O
7683,564,have,O
7684,564,participated,O
7685,564,in,O
7686,564,any,O
7687,564,clinical,O
7688,564,trial,O
7689,564,within,O
7690,564,30,O
7691,564,days,O
7692,564,prior,O
7693,564,to,O
7694,564,entering,O
7695,564,the,O
7696,564,study,O
7697,564,",",O
7698,564,or,O
7699,564,in,O
7700,564,a,O
7701,564,clinical,O
7702,564,trial,O
7703,564,involving,O
7704,564,a,O
7705,564,psychotropic,O
7706,564,medication,O
7707,564,within,O
7708,564,the,O
7709,564,6,O
7710,564,months,O
7711,564,prior,O
7712,564,to,O
7713,564,entering,O
7714,564,the,O
7715,564,study,O
7716,564,.,O
7717,565,Any,O
7718,565,subject,O
7719,565,who,O
7720,565,has,O
7721,565,been,O
7722,565,taking,O
7723,565,benzodiazepines,O
7724,565,before,O
7725,565,entering,O
7726,565,the,O
7727,565,study,O
7728,565,who,O
7729,565,:,O
7730,565,1,O
7731,565,),O
7732,565,can,O
7733,565,not,O
7734,565,tolerate,O
7735,565,being,O
7736,565,free,O
7737,565,of,O
7738,565,benzodiazepines,O
7739,565,for,O
7740,565,4,O
7741,565,weeks,O
7742,565,",",O
7743,565,or,O
7744,565,2,O
7745,565,),O
7746,565,has,O
7747,565,signs,O
7748,565,or,O
7749,565,symptoms,O
7750,565,of,O
7751,565,benzodiazepine,O
7752,565,withdrawal,O
7753,565,or,O
7754,565,rebound,O
7755,565,at,O
7756,565,the,O
7757,565,end,O
7758,565,of,O
7759,565,those,O
7760,565,4,O
7761,565,weeks,O
7762,565,.,O
7763,565,Should,O
7764,565,a,O
7765,565,patient,O
7766,565,entering,O
7767,565,the,O
7768,565,study,O
7769,565,",",O
7770,565,who,O
7771,565,is,O
7772,565,currently,O
7773,565,on,O
7774,565,benzodiazepines,O
7775,565,develop,O
7776,565,discontinuation,O
7777,565,symptoms,O
7778,565,with,O
7779,565,discontinuation,O
7780,565,of,O
7781,565,their,O
7782,565,benzodiazepine,O
7783,565,",",O
7784,565,we,O
7785,565,will,O
7786,565,treat,O
7787,565,these,O
7788,565,symptoms,O
7789,565,with,O
7790,565,a,O
7791,565,more,O
7792,565,gradual,O
7793,565,benzodiazepine,O
7794,565,taper,O
7795,565,.,O
7796,565,Study,O
7797,565,will,O
7798,565,be,O
7799,565,delayed,O
7800,565,until,O
7801,565,the,O
7802,565,patient,O
7803,565,is,O
7804,565,able,O
7805,565,to,O
7806,565,tolerate,O
7807,565,the,O
7808,565,discontinuation,O
7809,565,for,O
7810,565,4,O
7811,565,weeks,O
7812,565,.,O
7813,566,Patients,O
7814,566,with,O
7815,566,a,O
7816,566,current,O
7817,566,seizure,B-Condition
7818,566,disorder,I-Condition
7819,566,",",O
7820,566,organic,B-Condition
7821,566,brain,I-Condition
7822,566,disorder,I-Condition
7823,566,or,O
7824,566,a,O
7825,566,history,B-Condition
7826,566,of,I-Condition
7827,566,seizure,I-Condition
7828,566,disorders,I-Condition
7829,566,(,O
7830,566,except,O
7831,566,for,O
7832,566,febrile,B-Condition
7833,566,seizures,I-Condition
7834,566,in,O
7835,566,childhood,O
7836,566,),O
7837,566,.,O
7838,567,Patients,O
7839,567,with,O
7840,567,thyroid,B-Condition
7841,567,pathology,I-Condition
7842,567,",",O
7843,567,the,O
7844,567,treatment,B-Procedure
7845,567,of,O
7846,567,which,O
7847,567,has,O
7848,567,not,O
7849,567,been,O
7850,567,stabilized,O
7851,567,for,O
7852,567,at,O
7853,567,least,O
7854,567,three,O
7855,567,months,O
7856,567,.,O
7857,568,Patients,O
7858,568,on,O
7859,568,neuroleptic,B-Drug
7860,568,drugs,I-Drug
7861,568,in,O
7862,568,the,O
7863,568,two,O
7864,568,months,O
7865,568,prior,O
7866,568,to,O
7867,568,study,O
7868,568,entry,O
7869,568,or,O
7870,568,cognitive,B-Procedure
7871,568,behavioural,I-Procedure
7872,568,therapy,I-Procedure
7873,568,specific,O
7874,568,to,O
7875,568,OCD,B-Condition
7876,568,within,O
7877,568,four,O
7878,568,weeks,O
7879,568,of,O
7880,568,study,O
7881,568,entry,O
7882,569,Pregnant,O
7883,569,or,O
7884,569,lactating,O
7885,569,females,O
7886,569,",",O
7887,569,or,O
7888,569,if,O
7889,569,sexually,O
7890,569,active,O
7891,569,and,O
7892,569,of,O
7893,569,childbearing,O
7894,569,potential,O
7895,569,",",O
7896,569,not,O
7897,569,using,O
7898,569,adequate,O
7899,569,methods,O
7900,569,of,O
7901,569,birth,O
7902,569,control,O
7903,569,.,O
7904,570,Patients,O
7905,570,with,O
7906,570,a,O
7907,570,history,O
7908,570,or,O
7909,570,evidence,O
7910,570,of,O
7911,570,a,O
7912,570,medical,O
7913,570,condition,O
7914,570,that,O
7915,570,would,O
7916,570,expose,O
7917,570,them,O
7918,570,to,O
7919,570,an,O
7920,570,increased,O
7921,570,risk,O
7922,570,of,O
7923,570,a,O
7924,570,significant,O
7925,570,adverse,O
7926,570,event,O
7927,570,or,O
7928,570,interfere,O
7929,570,with,O
7930,570,assessments,O
7931,570,of,O
7932,570,safety,O
7933,570,and,O
7934,570,efficacy,O
7935,570,during,O
7936,570,the,O
7937,570,trial,O
7938,570,.,O
7939,571,Patients,O
7940,571,receiving,O
7941,571,psychotropics,B-Drug
7942,571,of,O
7943,571,any,O
7944,571,kind,O
7945,571,",",O
7946,571,including,O
7947,571,betablockers,B-Drug
7948,571,and,O
7949,571,other,O
7950,571,anticonvulsants,B-Drug
7951,571,.,O
7952,571,Sleep,B-Drug
7953,571,medication,I-Drug
7954,571,such,O
7955,571,as,O
7956,571,oral,O
7957,571,chloral,B-Drug
7958,571,-,I-Drug
7959,571,hydrate,I-Drug
7960,571,or,O
7961,571,zopiclone,B-Drug
7962,571,are,O
7963,571,acceptable,O
7964,571,.,O
7965,572,Patients,O
7966,572,using,O
7967,572,any,O
7968,572,herbal,B-Procedure
7969,572,psychoactive,I-Procedure
7970,572,treatments,I-Procedure
7971,572,",",O
7972,572,e.g.,O
7973,572,St,B-Drug
7974,572,John,I-Drug
7975,572,'s,I-Drug
7976,572,Wort,I-Drug
7977,572,",",O
7978,572,Valerian,B-Drug
7979,572,",",O
7980,572,Kava,B-Drug
7981,572,Kava,I-Drug
7982,572,",",O
7983,572,L,B-Drug
7984,572,-,I-Drug
7985,572,tryptophan,I-Drug
7986,572,.,O
7987,573,Patients,O
7988,573,with,O
7989,573,any,O
7990,573,condition,O
7991,573,or,O
7992,573,on,O
7993,573,any,O
7994,573,therapy,O
7995,573,that,O
7996,573,",",O
7997,573,in,O
7998,573,the,O
7999,573,investigator,O
8000,573,'s,O
8001,573,opinion,O
8002,573,",",O
8003,573,or,O
8004,573,as,O
8005,573,indicated,O
8006,573,in,O
8007,573,the,O
8008,573,pregabalin,O
8009,573,product,O
8010,573,label,O
8011,573,",",O
8012,573,may,O
8013,573,pose,O
8014,573,a,O
8015,573,risk,O
8016,573,to,O
8017,573,the,O
8018,573,subject,O
8019,573,.,O
8020,574,Patients,O
8021,574,who,O
8022,574,have,O
8023,574,had,O
8024,574,a,O
8025,574,major,O
8026,574,life,O
8027,574,event,O
8028,574,in,O
8029,574,the,O
8030,574,past,O
8031,574,three,O
8032,574,months,O
8033,574,",",O
8034,574,which,O
8035,574,in,O
8036,574,the,O
8037,574,judgement,O
8038,574,of,O
8039,574,the,O
8040,574,investigator,O
8041,574,is,O
8042,574,influencing,O
8043,574,their,O
8044,574,current,O
8045,574,condition,O
8046,574,.,O
8047,575,Patients,O
8048,575,having,O
8049,575,clinically,O
8050,575,significant,O
8051,575,abnormal,O
8052,575,laboratory,O
8053,575,",",O
8054,575,or,O
8055,575,ECG,O
8056,575,findings,O
8057,575,not,O
8058,575,resolved,O
8059,575,by,O
8060,575,further,O
8061,575,examinations,O
8062,575,.,O
8063,576,Must,O
8064,576,be,O
8065,576,an,O
8066,576,outpatient,O
8067,576,with,O
8068,576,a,O
8069,576,primary,O
8070,576,DSM,O
8071,576,-,O
8072,576,IV,O
8073,576,Obsessive,B-Condition
8074,576,-,I-Condition
8075,576,Compulsive,I-Condition
8076,576,Disorder,I-Condition
8077,576,.,O
8078,576,Patients,O
8079,576,must,O
8080,576,have,O
8081,576,a,O
8082,576,score,O
8083,576,of,O
8084,576,greater,O
8085,576,than,O
8086,576,20,O
8087,576,on,O
8088,576,the,O
8089,576,Yale,O
8090,576,-,O
8091,576,Brown,O
8092,576,Obsessive,O
8093,576,Compulsive,O
8094,576,Scale,O
8095,576,(,O
8096,576,Y,O
8097,576,-,O
8098,576,BOCS,O
8099,576,;,O
8100,576,Goodman,O
8101,576,et,O
8102,576,al,O
8103,576,.,O
8104,576,",",O
8105,576,1989b,O
8106,576,),O
8107,576,.,O
8108,577,Diagnosis,O
8109,577,of,O
8110,577,comorbid,O
8111,577,DSM,O
8112,577,-,O
8113,577,IV,O
8114,577,major,B-Condition
8115,577,depressive,I-Condition
8116,577,episode,I-Condition
8117,577,will,O
8118,577,be,O
8119,577,allowed,O
8120,577,in,O
8121,577,the,O
8122,577,study,O
8123,577,provided,O
8124,577,that,O
8125,577,the,O
8126,577,diagnosis,O
8127,577,is,O
8128,577,secondary,O
8129,577,to,O
8130,577,OCD,B-Condition
8131,577,",",O
8132,577,they,O
8133,577,have,O
8134,577,a,O
8135,577,baseline,O
8136,577,Montgomery,O
8137,577,Depression,O
8138,577,Rating,O
8139,577,Scale,O
8140,577,(,O
8141,577,MADRS,O
8142,577,),O
8143,577,score,O
8144,577,of,O
8145,577,less,O
8146,577,than,O
8147,577,or,O
8148,577,equal,O
8149,577,to,O
8150,577,19,O
8151,577,",",O
8152,577,and,O
8153,577,the,O
8154,577,onset,B-Condition
8155,577,of,I-Condition
8156,577,OCD,I-Condition
8157,577,predates,O
8158,577,the,O
8159,577,onset,O
8160,577,of,O
8161,577,the,O
8162,577,current,O
8163,577,episode,O
8164,577,of,O
8165,577,depression,O
8166,577,by,O
8167,577,five,O
8168,577,or,O
8169,577,more,O
8170,577,years,O
8171,577,.,O
8172,578,The,O
8173,578,ability,O
8174,578,to,O
8175,578,comprehend,O
8176,578,and,O
8177,578,comply,O
8178,578,with,O
8179,578,protocol,O
8180,578,requirements,O
8181,578,.,O
8182,579,Written,O
8183,579,consent,O
8184,579,must,O
8185,579,be,O
8186,579,provided,O
8187,579,prior,O
8188,579,to,O
8189,579,study,O
8190,579,entry,O
8191,579,.,O
8192,580,All,O
8193,580,women,B-Person
8194,580,of,O
8195,580,childbearing,B-Condition
8196,580,potential,I-Condition
8197,580,(,O
8198,580,WOCBP,B-Condition
8199,580,),O
8200,580,must,O
8201,580,be,O
8202,580,practicing,O
8203,580,a,O
8204,580,medically,O
8205,580,acceptable,O
8206,580,method,O
8207,580,of,O
8208,580,birth,B-Procedure
8209,580,control,I-Procedure
8210,581,All,O
8211,581,female,O
8212,581,subjects,O
8213,581,of,O
8214,581,childbearing,O
8215,581,potential,O
8216,581,(,O
8217,581,WOCBP,O
8218,581,),O
8219,581,",",O
8220,581,including,O
8221,581,those,O
8222,581,who,O
8223,581,are,O
8224,581,practicing,O
8225,581,a,O
8226,581,medically,O
8227,581,acceptable,O
8228,581,method,O
8229,581,of,O
8230,581,birth,O
8231,581,control,O
8232,581,",",O
8233,581,must,O
8234,581,have,O
8235,581,a,O
8236,581,negative,O
8237,581,serum,O
8238,581,pregnancy,O
8239,581,test,O
8240,581,within,O
8241,581,72,O
8242,581,hours,O
8243,581,prior,O
8244,581,to,O
8245,581,the,O
8246,581,start,O
8247,581,of,O
8248,581,study,O
8249,581,medication,O
8250,581,.,O
8251,582,Less,O
8252,582,than,O
8253,582,18,O
8254,582,years,O
8255,582,of,O
8256,582,age,B-Person
8257,582,;,O
8258,583,Pregnancy,B-Condition
8259,583,;,O
8260,584,Chronic,O
8261,584,use,O
8262,584,of,O
8263,584,vitamin,B-Drug
8264,584,K,I-Drug
8265,584,antagonists,I-Drug
8266,584,or,O
8267,584,direct,B-Drug
8268,584,thrombin,I-Drug
8269,584,inhibitors,I-Drug
8270,584,",",O
8271,584,or,O
8272,584,oral,B-Drug
8273,584,Xa,I-Drug
8274,584,-,I-Drug
8275,584,factor,I-Drug
8276,584,antagonists,I-Drug
8277,584,;,O
8278,585,Hypersensitivity,B-Condition
8279,585,to,O
8280,585,antiplatelet,B-Drug
8281,585,and/or,I-Drug
8282,585,anticoagulant,I-Drug
8283,585,drugs,I-Drug
8284,585,;,O
8285,586,Active,O
8286,586,bleeding,B-Condition
8287,586,or,O
8288,586,high,B-Condition
8289,586,bleeding,I-Condition
8290,586,risk,I-Condition
8291,586,(,O
8292,586,severe,O
8293,586,liver,B-Condition
8294,586,failure,I-Condition
8295,586,",",O
8296,586,active,O
8297,586,peptic,B-Condition
8298,586,ulcer,I-Condition
8299,586,",",O
8300,586,creatinine,O
8301,586,clearance,O
8302,586,<,O
8303,586,30,O
8304,586,mL,O
8305,586,/,O
8306,586,min,O
8307,586,",",O
8308,586,platelets,O
8309,586,count,O
8310,586,<,O
8311,586,100.000,O
8312,586,mm3,O
8313,586,),O
8314,586,;,O
8315,587,Uncontrolled,O
8316,587,systemic,B-Condition
8317,587,hypertension,I-Condition
8318,587,;,O
8319,588,Cardiogenic,B-Condition
8320,588,shock,I-Condition
8321,588,;,O
8322,589,Previous,O
8323,589,myocardial,B-Procedure
8324,589,revascularization,I-Procedure
8325,589,surgery,I-Procedure
8326,589,with,O
8327,589,=,O
8328,589,1,O
8329,589,internal,O
8330,589,mammary,O
8331,589,or,O
8332,589,radial,O
8333,589,artery,O
8334,589,graft,O
8335,589,;,O
8336,590,Documented,O
8337,590,chronic,O
8338,590,peripheral,B-Condition
8339,590,arterial,I-Condition
8340,590,disease,I-Condition
8341,590,preventing,O
8342,590,the,O
8343,590,use,O
8344,590,of,O
8345,590,the,O
8346,590,femoral,B-Procedure
8347,590,technique,I-Procedure
8348,590,;,O
8349,591,Severe,O
8350,591,concomitant,O
8351,591,disease,B-Condition
8352,591,with,O
8353,591,life,B-Observation
8354,591,expectancy,I-Observation
8355,591,below,O
8356,591,12,O
8357,591,months,O
8358,591,;,O
8359,592,Participation,O
8360,592,in,O
8361,592,drug,O
8362,592,or,O
8363,592,devices,O
8364,592,investigative,O
8365,592,clinical,O
8366,592,trials,O
8367,592,in,O
8368,592,the,O
8369,592,last,O
8370,592,30,O
8371,592,days,O
8372,592,;,O
8373,593,Medical,O
8374,593,",",O
8375,593,geographic,O
8376,593,or,O
8377,593,social,O
8378,593,conditions,O
8379,593,impairing,O
8380,593,the,O
8381,593,participation,O
8382,593,in,O
8383,593,the,O
8384,593,study,O
8385,593,or,O
8386,593,inability,O
8387,593,to,O
8388,593,understand,O
8389,593,and,O
8390,593,sign,O
8391,593,the,O
8392,593,informed,O
8393,593,consent,O
8394,593,term,O
8395,593,.,O
8396,594,ST,O
8397,594,-,O
8398,594,segment,O
8399,594,elevation,O
8400,594,acute,B-Condition
8401,594,myocardial,I-Condition
8402,594,infarction,I-Condition
8403,594,patients,O
8404,594,during,O
8405,594,the,O
8406,594,first,O
8407,594,12,O
8408,594,hours,O
8409,594,of,O
8410,594,sympton,O
8411,594,onset,O
8412,594,;,O
8413,595,Intention,B-Mood
8414,595,to,I-Mood
8415,595,perform,I-Mood
8416,595,primary,O
8417,595,percutaneous,B-Condition
8418,595,coronary,I-Condition
8419,595,intervention,I-Condition
8420,595,;,O
8421,596,Signed,O
8422,596,informed,O
8423,596,consent,O
8424,596,;,O
8425,597,Patient,O
8426,597,eligible,B-Mood
8427,597,for,I-Mood
8428,597,transradial,O
8429,597,and,O
8430,597,transfemoral,O
8431,597,primary,O
8432,597,percutaneous,B-Procedure
8433,597,coronary,I-Procedure
8434,597,intervention,I-Procedure
8435,597,",",O
8436,597,being,O
8437,597,pre,O
8438,597,-,O
8439,597,requisites,O
8440,597,:,O
8441,597,(,O
8442,597,a,O
8443,597,),O
8444,597,familiarity,O
8445,597,of,O
8446,597,the,O
8447,597,operator,O
8448,597,with,O
8449,597,the,O
8450,597,radial,O
8451,597,and,O
8452,597,femoral,O
8453,597,techniques,O
8454,597,using,O
8455,597,vascular,O
8456,597,closure,O
8457,597,devices,O
8458,597,",",O
8459,597,(,O
8460,597,b,O
8461,597,),O
8462,597,agreement,O
8463,597,of,O
8464,597,the,O
8465,597,operator,O
8466,597,to,O
8467,597,use,O
8468,597,the,O
8469,597,access,O
8470,597,route,O
8471,597,determined,O
8472,597,by,O
8473,597,the,O
8474,597,randomization,O
8475,597,process,O
8476,597,.,O
8477,598,No,O
8478,598,positive,O
8479,598,HIV,O
8480,598,1,O
8481,598,or,O
8482,598,HIV,O
8483,598,2,O
8484,598,test,O
8485,598,at,O
8486,598,screening,O
8487,599,no,O
8488,599,history,B-Observation
8489,599,of,O
8490,599,significant,O
8491,599,skin,B-Condition
8492,599,disease,I-Condition
8493,599,such,O
8494,599,as,O
8495,599,",",O
8496,599,but,O
8497,599,not,O
8498,599,limited,O
8499,599,to,O
8500,599,rash,B-Condition
8501,599,or,O
8502,599,eruptions,B-Condition
8503,599,",",O
8504,599,drug,B-Condition
8505,599,allergies,I-Condition
8506,599,",",O
8507,599,food,B-Condition
8508,599,allergy,I-Condition
8509,599,",",O
8510,599,dermatitis,B-Condition
8511,599,",",O
8512,599,eczema,B-Condition
8513,599,",",O
8514,599,psoriasis,B-Condition
8515,599,",",O
8516,599,or,O
8517,599,urticaria,B-Condition
8518,600,no,O
8519,600,history,B-Observation
8520,600,of,O
8521,600,allergy,B-Condition
8522,600,to,O
8523,600,drugs,O
8524,600,such,O
8525,600,as,O
8526,600,",",O
8527,600,but,O
8528,600,not,O
8529,600,limited,O
8530,600,to,O
8531,600,",",O
8532,600,sulphonamides,B-Drug
8533,600,and,O
8534,600,penicillins,B-Drug
8535,601,no,O
8536,601,previously,O
8537,601,demonstrated,O
8538,601,clinically,O
8539,601,significant,O
8540,601,allergy,B-Condition
8541,601,or,O
8542,601,hypersensitivity,B-Condition
8543,601,to,O
8544,601,any,O
8545,601,of,O
8546,601,the,O
8547,601,excipients,B-Drug
8548,601,of,I-Drug
8549,601,the,I-Drug
8550,601,investigational,I-Drug
8551,601,medication,I-Drug
8552,601,administered,O
8553,601,in,O
8554,601,this,O
8555,601,trial,O
8556,602,no,O
8557,602,female,B-Person
8558,602,subject,O
8559,602,of,O
8560,602,childbearing,B-Condition
8561,602,potential,I-Condition
8562,602,without,O
8563,602,use,O
8564,602,of,O
8565,602,effective,O
8566,602,nonhormonal,B-Procedure
8567,602,birth,I-Procedure
8568,602,control,I-Procedure
8569,602,methods,O
8570,602,",",O
8571,602,or,O
8572,602,not,O
8573,602,willing,B-Mood
8574,602,to,I-Mood
8575,602,continue,I-Mood
8576,602,practicing,I-Mood
8577,602,these,O
8578,602,birth,B-Procedure
8579,602,control,I-Procedure
8580,602,methods,I-Procedure
8581,602,for,O
8582,602,at,O
8583,602,least,O
8584,602,30,O
8585,602,days,O
8586,602,after,O
8587,602,the,O
8588,602,end,O
8589,602,of,O
8590,602,the,O
8591,602,treatment,O
8592,602,period,O
8593,603,no,O
8594,603,positive,O
8595,603,pregnancy,B-Procedure
8596,603,test,I-Procedure
8597,603,or,O
8598,603,breast,B-Observation
8599,603,feeding,I-Observation
8600,603,at,O
8601,603,screening,O
8602,604,Non,O
8603,604,-,O
8604,604,smoking,B-Condition
8605,604,",",O
8606,604,or,O
8607,604,smoking,B-Condition
8608,604,no,O
8609,604,more,O
8610,604,than,O
8611,604,10,O
8612,604,cigarettes,B-Observation
8613,604,",",O
8614,604,or,O
8615,604,2,O
8616,604,cigars,B-Observation
8617,604,",",O
8618,604,or,O
8619,604,2,O
8620,604,pipes,B-Observation
8621,604,per,O
8622,604,day,O
8623,604,for,O
8624,604,at,O
8625,604,least,O
8626,604,3,O
8627,604,months,O
8628,604,prior,O
8629,604,to,O
8630,604,selection,O
8631,605,Normal,B-Condition
8632,605,weight,I-Condition
8633,605,as,O
8634,605,defined,O
8635,605,by,O
8636,605,a,O
8637,605,Body,O
8638,605,Mass,O
8639,605,Index,O
8640,605,(,O
8641,605,BMI,O
8642,605,",",O
8643,605,weight,O
8644,605,in,O
8645,605,kg,O
8646,605,divided,O
8647,605,by,O
8648,605,the,O
8649,605,square,O
8650,605,of,O
8651,605,height,O
8652,605,in,O
8653,605,meters,O
8654,605,),O
8655,605,of,O
8656,605,18.0,O
8657,605,to,O
8658,605,30.0,O
8659,605,kg,O
8660,605,/,O
8661,605,m2,O
8662,605,",",O
8663,605,extremes,O
8664,605,included,O
8665,606,Able,B-Observation
8666,606,to,I-Observation
8667,606,comply,I-Observation
8668,606,with,I-Observation
8669,606,protocol,I-Observation
8670,606,requirements,I-Observation
8671,606,.,O
8672,606,Healthy,B-Condition
8673,606,on,O
8674,606,the,O
8675,606,basis,O
8676,606,of,O
8677,606,a,O
8678,606,medical,B-Procedure
8679,606,evaluation,I-Procedure
8680,606,that,O
8681,606,reveals,O
8682,606,the,O
8683,606,absence,O
8684,606,of,O
8685,606,any,O
8686,606,clinically,O
8687,606,relevant,O
8688,606,abnormality,B-Condition
8689,606,and,O
8690,606,includes,O
8691,606,a,O
8692,606,physical,B-Procedure
8693,606,examination,I-Procedure
8694,606,",",O
8695,606,medical,B-Procedure
8696,606,history,I-Procedure
8697,606,",",O
8698,606,electrocardiogram,B-Procedure
8699,606,(,O
8700,606,ECG,B-Procedure
8701,606,),O
8702,606,",",O
8703,606,vital,B-Procedure
8704,606,signs,I-Procedure
8705,606,",",O
8706,606,and,O
8707,606,the,O
8708,606,results,O
8709,606,of,O
8710,606,blood,B-Procedure
8711,606,biochemistry,I-Procedure
8712,606,",",I-Procedure
8713,606,blood,I-Procedure
8714,606,coagulation,I-Procedure
8715,606,",",I-Procedure
8716,606,and,I-Procedure
8717,606,hematology,I-Procedure
8718,606,tests,I-Procedure
8719,606,and,O
8720,606,a,O
8721,606,urinalysis,B-Procedure
8722,606,carried,O
8723,606,out,O
8724,606,at,O
8725,606,screening,O
8726,606,.,O
8727,607,Type,B-Condition
8728,607,1,I-Condition
8729,607,diabetes,I-Condition
8730,608,Known,O
8731,608,peripheral,B-Condition
8732,608,artery,I-Condition
8733,608,disease,I-Condition
8734,609,Liver,O
8735,609,enzymes,O
8736,609,equal,O
8737,609,or,O
8738,609,more,O
8739,609,than,O
8740,609,1.5,O
8741,609,times,O
8742,609,the,O
8743,609,upper,O
8744,609,limit,O
8745,609,of,O
8746,609,normal,O
8747,610,Chronic,B-Condition
8748,610,heart,I-Condition
8749,610,failure,I-Condition
8750,610,NYHA,O
8751,610,class,O
8752,610,III,O
8753,610,or,O
8754,610,IV,O
8755,611,Current,O
8756,611,haemodialysis,B-Procedure
8757,611,or,O
8758,611,peritoneal,B-Procedure
8759,611,dialysis,I-Procedure
8760,612,End,B-Condition
8761,612,stage,I-Condition
8762,612,liver,I-Condition
8763,612,disease,I-Condition
8764,612,",",O
8765,612,defined,O
8766,612,as,O
8767,612,acute,B-Condition
8768,612,or,I-Condition
8769,612,chronic,I-Condition
8770,612,liver,I-Condition
8771,612,disease,I-Condition
8772,612,and,O
8773,612,recent,O
8774,612,history,O
8775,612,of,O
8776,612,one,O
8777,612,of,O
8778,612,the,O
8779,612,following,O
8780,612,:,O
8781,612,ascites,B-Condition
8782,612,",",O
8783,612,encephalopathy,B-Condition
8784,612,",",O
8785,612,variceal,B-Condition
8786,612,bleeding,I-Condition
8787,612,",",O
8788,612,bilirubin,O
8789,612,equal,O
8790,612,or,O
8791,612,greater,O
8792,612,than,O
8793,612,2.0,O
8794,612,mg,O
8795,612,/,O
8796,612,dL,O
8797,612,",",O
8798,612,albumin,O
8799,612,equal,O
8800,612,or,O
8801,612,less,O
8802,612,than,O
8803,612,3.5,O
8804,612,g/,O
8805,612,dL,O
8806,612,",",O
8807,612,prothrombin,O
8808,612,time,O
8809,612,greater,O
8810,612,or,O
8811,612,equal,O
8812,612,to,O
8813,612,4,O
8814,612,seconds,O
8815,612,",",O
8816,612,INR,O
8817,612,greater,O
8818,612,than,O
8819,612,or,O
8820,612,equal,O
8821,612,to,O
8822,612,1.7,O
8823,612,or,O
8824,612,prior,O
8825,612,liver,B-Procedure
8826,612,transplant,I-Procedure
8827,613,Known,B-Mood
8828,613,or,O
8829,613,suspected,B-Mood
8830,613,hypersensitivity,B-Condition
8831,613,to,O
8832,613,trial,B-Drug
8833,613,products,I-Drug
8834,613,or,O
8835,613,related,B-Drug
8836,613,products,I-Drug
8837,614,Female,O
8838,614,of,O
8839,614,child,O
8840,614,-,O
8841,614,bearing,O
8842,614,potential,O
8843,614,who,O
8844,614,is,O
8845,614,pregnant,O
8846,614,",",O
8847,614,breast,O
8848,614,-,O
8849,614,feeding,O
8850,614,or,O
8851,614,intends,O
8852,614,to,O
8853,614,become,O
8854,614,pregnant,O
8855,614,or,O
8856,614,is,O
8857,614,not,O
8858,614,using,O
8859,614,adequate,O
8860,614,contraceptive,O
8861,614,methods,O
8862,614,as,O
8863,614,required,O
8864,614,by,O
8865,614,law,O
8866,614,or,O
8867,614,local,O
8868,614,practice,O
8869,614,.,O
8870,615,Expected,O
8871,615,simultaneous,O
8872,615,participation,O
8873,615,in,O
8874,615,any,O
8875,615,other,O
8876,615,clinical,O
8877,615,trial,O
8878,615,of,O
8879,615,an,O
8880,615,investigational,O
8881,615,medicinal,O
8882,615,product,O
8883,615,.,O
8884,616,Receipt,O
8885,616,of,O
8886,616,any,O
8887,616,investigational,O
8888,616,medicinal,O
8889,616,product,O
8890,616,within,O
8891,616,30,O
8892,616,days,O
8893,616,before,O
8894,616,randomization,O
8895,617,Current,O
8896,617,or,O
8897,617,past,O
8898,617,(,O
8899,617,within,O
8900,617,the,O
8901,617,last,O
8902,617,5,O
8903,617,years,O
8904,617,),O
8905,617,malignant,B-Condition
8906,617,neoplasms,I-Condition
8907,617,(,O
8908,617,except,O
8909,617,basal,B-Condition
8910,617,cell,I-Condition
8911,617,and,I-Condition
8912,617,squamous,I-Condition
8913,617,cell,I-Condition
8914,617,skin,I-Condition
8915,617,carcinoma,I-Condition
8916,617,),O
8917,618,Any,O
8918,618,condition,O
8919,618,that,O
8920,618,in,O
8921,618,the,O
8922,618,investigator,O
8923,618,'s,O
8924,618,opinion,O
8925,618,would,O
8926,618,make,O
8927,618,the,O
8928,618,subject,O
8929,618,unable,O
8930,618,to,O
8931,618,adhere,O
8932,618,to,O
8933,618,the,O
8934,618,trial,O
8935,618,visit,O
8936,618,schedule,O
8937,618,and,O
8938,618,procedures,O
8939,619,Known,O
8940,619,history,O
8941,619,of,O
8942,619,non,O
8943,619,-,O
8944,619,compliance,O
8945,619,to,O
8946,619,treatment,O
8947,619,.,O
8948,620,use,O
8949,620,of,O
8950,620,basal,B-Drug
8951,620,-,I-Drug
8952,620,bolus,I-Drug
8953,620,insulin,I-Drug
8954,621,onset,O
8955,621,of,O
8956,621,diabetes,O
8957,621,after,O
8958,621,age,O
8959,621,30,O
8960,622,BMI,O
8961,622,less,O
8962,622,than,O
8963,622,35,O
8964,623,eGFR,O
8965,623,at,O
8966,623,least,O
8967,623,60,O
8968,623,ml,O
8969,623,/,O
8970,623,mn,O
8971,624,Hb,O
8972,624,A1c,O
8973,624,7.0,O
8974,624,-,O
8975,624,10.0,O
8976,624,%,O
8977,625,willingness,O
8978,625,to,O
8979,625,perform,O
8980,625,home,O
8981,625,glucose,O
8982,625,monitoring,O
8983,626,willingness,O
8984,626,to,O
8985,626,transmit,O
8986,626,glucose,O
8987,626,and,O
8988,626,medication,O
8989,626,information,O
8990,626,weekly,O
8991,627,Use,O
8992,627,of,O
8993,627,investigational,O
8994,627,drugs,O
8995,627,either,O
8996,627,within,O
8997,627,5,O
8998,627,half,O
8999,627,-,O
9000,627,lives,O
9001,627,of,O
9002,627,enrollment,O
9003,627,",",O
9004,627,or,O
9005,627,within,O
9006,627,30,O
9007,627,days,O
9008,627,",",O
9009,627,or,O
9010,627,until,O
9011,627,the,O
9012,627,expected,O
9013,627,pharmacodynamic,O
9014,627,effect,O
9015,627,has,O
9016,627,returned,O
9017,627,to,O
9018,627,baseline,O
9019,627,",",O
9020,627,whichever,O
9021,627,is,O
9022,627,longer,O
9023,627,.,O
9024,628,Major,B-Procedure
9025,628,surgery,I-Procedure
9026,628,in,O
9027,628,the,O
9028,628,last,O
9029,628,3,O
9030,628,months,O
9031,628,prior,O
9032,628,to,O
9033,628,baseline,O
9034,628,or,O
9035,628,planned,O
9036,628,major,O
9037,628,surgery,O
9038,628,or,O
9039,628,cardiac,O
9040,628,intervention,O
9041,628,during,O
9042,628,the,O
9043,628,study,O
9044,628,.,O
9045,629,Cancer,B-Condition
9046,629,or,O
9047,629,other,O
9048,629,significant,O
9049,629,co,B-Condition
9050,629,-,I-Condition
9051,629,morbidities,I-Condition
9052,629,implying,O
9053,629,that,O
9054,629,the,O
9055,629,patient,O
9056,629,'s,O
9057,629,condition,O
9058,629,is,O
9059,629,unstable,O
9060,629,.,O
9061,630,Comorbidities,B-Condition
9062,630,that,O
9063,630,can,O
9064,630,be,O
9065,630,associated,O
9066,630,with,O
9067,630,elevated,O
9068,630,natriuretic,O
9069,630,peptide,O
9070,630,(,O
9071,630,NP,O
9072,630,),O
9073,630,levels,O
9074,630,:,O
9075,630,renal,B-Condition
9076,630,insufficiency,I-Condition
9077,630,",",O
9078,630,(,O
9079,630,eGFR,O
9080,630,<,O
9081,630,25,O
9082,630,ml,O
9083,630,/,O
9084,630,min/1.73,O
9085,630,m²,O
9086,630,calculated,O
9087,630,according,O
9088,630,to,O
9089,630,MDRD,O
9090,630,formula,O
9091,630,),O
9092,630,",",O
9093,630,recent,O
9094,630,(,O
9095,630,less,O
9096,630,than,O
9097,630,3,O
9098,630,months,O
9099,630,),O
9100,630,cerebral,B-Condition
9101,630,trauma,I-Condition
9102,630,or,O
9103,630,recent,O
9104,630,(,O
9105,630,less,O
9106,630,than,O
9107,630,3,O
9108,630,months,O
9109,630,),O
9110,630,cerebrovascular,B-Condition
9111,630,incident,I-Condition
9112,630,",",O
9113,630,novel,O
9114,630,diagnosis,O
9115,630,or,O
9116,630,acute,B-Condition
9117,630,exacerbation,I-Condition
9118,630,of,I-Condition
9119,630,COPD,I-Condition
9120,630,within,O
9121,630,the,O
9122,630,last,O
9123,630,3,O
9124,630,months,O
9125,630,.,O
9126,631,Patients,O
9127,631,who,O
9128,631,are,O
9129,631,primarily,O
9130,631,managed,O
9131,631,and,O
9132,631,regularly,O
9133,631,followed,O
9134,631,-,O
9135,631,up,O
9136,631,by,O
9137,631,a,O
9138,631,cardiologist,O
9139,631,for,O
9140,631,their,O
9141,631,HF,O
9142,632,Highly,O
9143,632,frail,O
9144,632,patients,O
9145,632,whose,O
9146,632,estimated,O
9147,632,lifespan,B-Observation
9148,632,due,O
9149,632,to,O
9150,632,comorbidities,O
9151,632,by,O
9152,632,the,O
9153,632,judgement,O
9154,632,of,O
9155,632,the,O
9156,632,investigator,O
9157,632,is,O
9158,632,less,O
9159,632,than,O
9160,632,6,O
9161,632,months,O
9162,632,.,O
9163,633,Willing,O
9164,633,and,O
9165,633,able,O
9166,633,to,O
9167,633,provide,O
9168,633,written,O
9169,633,informed,O
9170,633,consent,O
9171,633,and,O
9172,633,accept,O
9173,633,study,O
9174,633,procedures,O
9175,633,and,O
9176,633,time,O
9177,633,schedule,O
9178,633,.,O
9179,634,Age,B-Person
9180,634,=,O
9181,634,18,O
9182,634,years,O
9183,634,.,O
9184,635,Patients,O
9185,635,suffering,O
9186,635,from,O
9187,635,chronic,B-Condition
9188,635,heart,I-Condition
9189,635,failure,I-Condition
9190,635,(,O
9191,635,the,O
9192,635,heart,O
9193,635,failure,O
9194,635,diagnosis,O
9195,635,must,O
9196,635,have,O
9197,635,been,O
9198,635,made,O
9199,635,or,O
9200,635,confirmed,O
9201,635,by,O
9202,635,a,O
9203,635,cardiologist,O
9204,635,and/or,O
9205,635,hospital,O
9206,635,physician,O
9207,635,at,O
9208,635,any,O
9209,635,time,O
9210,635,in,O
9211,635,the,O
9212,635,patient,O
9213,635,'s,O
9214,635,medical,O
9215,635,history,O
9216,635,),O
9217,635,.,O
9218,636,Patients,O
9219,636,with,O
9220,636,reduced,O
9221,636,ejection,O
9222,636,fraction,O
9223,636,(=,O
9224,636,40,O
9225,636,%,O
9226,636,),O
9227,636,as,O
9228,636,confirmed,O
9229,636,at,O
9230,636,any,O
9231,636,time,O
9232,636,point,O
9233,636,in,O
9234,636,the,O
9235,636,patient,O
9236,636,'s,O
9237,636,medical,O
9238,636,history,O
9239,636,.,O
9240,637,1,O
9241,637,.,O
9242,637,Comorbidity,O
9243,637,with,O
9244,637,other,O
9245,637,severe,O
9246,637,or,O
9247,637,chronic,O
9248,637,eye,B-Condition
9249,637,conditions,I-Condition
9250,637,that,O
9251,637,in,O
9252,637,the,O
9253,637,judgment,O
9254,637,of,O
9255,637,the,O
9256,637,investigator,O
9257,637,will,O
9258,637,interfere,O
9259,637,with,O
9260,637,study,O
9261,637,assessments,O
9262,637,",",O
9263,637,such,O
9264,637,as,O
9265,637,corneal,B-Condition
9266,637,opacities,I-Condition
9267,637,and,I-Condition
9268,637,scars,I-Condition
9269,637,",",O
9270,637,dystrophies,B-Condition
9271,637,",",O
9272,637,epithelial,B-Condition
9273,637,scarring,I-Condition
9274,637,",",O
9275,637,infections,B-Condition
9276,637,",",O
9277,637,blood,B-Condition
9278,637,clots,I-Condition
9279,637,",",O
9280,637,etc,O
9281,637,.,O
9282,638,2,O
9283,638,.,O
9284,638,Best,O
9285,638,corrected,O
9286,638,visual,O
9287,638,acuity,O
9288,638,(,O
9289,638,BCVA,O
9290,638,),O
9291,638,at,O
9292,638,baseline,O
9293,638,<,O
9294,638,20/200,O
9295,638,.,O
9296,639,3,O
9297,639,.,O
9298,639,Has,O
9299,639,a,O
9300,639,condition,O
9301,639,or,O
9302,639,history,O
9303,639,that,O
9304,639,",",O
9305,639,in,O
9306,639,the,O
9307,639,opinion,O
9308,639,of,O
9309,639,the,O
9310,639,investigator,O
9311,639,",",O
9312,639,may,O
9313,639,interfere,O
9314,639,significantly,O
9315,639,with,O
9316,639,the,O
9317,639,subject,O
9318,639,'s,O
9319,639,participation,O
9320,639,in,O
9321,639,the,O
9322,639,study,O
9323,639,.,O
9324,640,4,O
9325,640,.,O
9326,640,A,O
9327,640,woman,B-Person
9328,640,who,O
9329,640,is,O
9330,640,pregnant,B-Condition
9331,640,",",O
9332,640,nursing,B-Condition
9333,640,an,O
9334,640,infant,O
9335,640,",",O
9336,640,or,O
9337,640,planning,O
9338,640,a,O
9339,640,pregnancy,B-Condition
9340,640,.,O
9341,641,5,O
9342,641,.,O
9343,641,Has,O
9344,641,a,O
9345,641,known,O
9346,641,adverse,B-Condition
9347,641,reaction,I-Condition
9348,641,and/or,I-Condition
9349,641,sensitivity,I-Condition
9350,641,to,I-Condition
9351,641,the,I-Condition
9352,641,study,I-Condition
9353,641,drug,I-Condition
9354,641,or,I-Condition
9355,641,its,I-Condition
9356,641,components,I-Condition
9357,641,.,O
9358,642,6,O
9359,642,.,O
9360,642,Routine,O
9361,642,use,O
9362,642,(,O
9363,642,more,O
9364,642,than,O
9365,642,twice,O
9366,642,a,O
9367,642,week,O
9368,642,),O
9369,642,of,O
9370,642,a,O
9371,642,chlorinated,B-Observation
9372,642,swimming,I-Observation
9373,642,pool,I-Observation
9374,642,.,O
9375,643,7,O
9376,643,.,O
9377,643,Unwilling,O
9378,643,or,O
9379,643,unable,O
9380,643,to,O
9381,643,cease,O
9382,643,using,O
9383,643,the,O
9384,643,following,O
9385,643,medications,O
9386,643,during,O
9387,643,the,O
9388,643,study,O
9389,643,period,O
9390,643,:,O
9391,643,Topical,B-Drug
9392,643,ocular,I-Drug
9393,643,cyclosporine,I-Drug
9394,643,(,O
9395,643,e.g.,O
9396,643,Restasis,B-Drug
9397,643,®,I-Drug
9398,643,),O
9399,643,",",O
9400,643,anti,B-Drug
9401,643,-,I-Drug
9402,643,histamines,I-Drug
9403,643,",",O
9404,643,antipsychotics,B-Drug
9405,643,",",O
9406,643,or,O
9407,643,eye,B-Drug
9408,643,gels,I-Drug
9409,643,.,O
9410,644,8,O
9411,644,.,O
9412,644,Currently,O
9413,644,enrolled,O
9414,644,in,O
9415,644,an,O
9416,644,investigational,B-Drug
9417,644,drug,I-Drug
9418,644,or,O
9419,644,device,O
9420,644,study,O
9421,644,or,O
9422,644,have,O
9423,644,used,O
9424,644,an,O
9425,644,investigational,B-Drug
9426,644,drug,I-Drug
9427,644,or,O
9428,644,device,O
9429,644,within,O
9430,644,30,O
9431,644,days,O
9432,644,prior,O
9433,644,to,O
9434,644,Visit,O
9435,644,1,O
9436,644,.,O
9437,645,1,O
9438,645,.,O
9439,645,Male,B-Person
9440,645,or,O
9441,645,female,B-Person
9442,645,of,O
9443,645,any,O
9444,645,race,O
9445,645,",",O
9446,645,at,O
9447,645,least,O
9448,645,18,O
9449,645,years,O
9450,645,of,O
9451,645,age,B-Person
9452,645,at,O
9453,645,Visit,O
9454,645,1,O
9455,645,Screening,O
9456,645,.,O
9457,646,2,O
9458,646,.,O
9459,646,Has,O
9460,646,provided,O
9461,646,verbal,O
9462,646,and,O
9463,646,written,O
9464,646,informed,O
9465,646,consent,O
9466,646,.,O
9467,647,3,O
9468,647,.,O
9469,647,Be,O
9470,647,able,O
9471,647,and,O
9472,647,willing,O
9473,647,to,O
9474,647,follow,O
9475,647,instructions,O
9476,647,",",O
9477,647,including,O
9478,647,participation,O
9479,647,in,O
9480,647,all,O
9481,647,study,O
9482,647,assessments,O
9483,647,and,O
9484,647,visits,O
9485,647,.,O
9486,648,4,O
9487,648,.,O
9488,648,Currently,O
9489,648,being,O
9490,648,treated,B-Procedure
9491,648,for,O
9492,648,glaucoma,B-Condition
9493,648,using,O
9494,648,at,O
9495,648,least,O
9496,648,two,O
9497,648,medications,B-Drug
9498,648,",",O
9499,648,and,O
9500,648,be,O
9501,648,willing,O
9502,648,to,O
9503,648,continue,O
9504,648,on,O
9505,648,the,O
9506,648,same,O
9507,648,regime,O
9508,648,.,O
9509,649,5,O
9510,649,.,O
9511,649,Suffers,O
9512,649,from,O
9513,649,at,O
9514,649,least,O
9515,649,two,O
9516,649,of,O
9517,649,the,O
9518,649,symptoms,B-Condition
9519,649,in,O
9520,649,the,O
9521,649,GLIA,O
9522,649,™,O
9523,649,Glaucoma,O
9524,649,Medication,O
9525,649,Ocular,O
9526,649,Side,O
9527,649,Effect,O
9528,649,Symptoms,O
9529,649,Questionnaire,O
9530,649,at,O
9531,649,a,O
9532,649,severity,O
9533,649,of,O
9534,649,2,O
9535,649,(,O
9536,649,moderate,O
9537,649,),O
9538,649,or,O
9539,649,more,O
9540,649,.,O
9541,650,6,O
9542,650,.,O
9543,650,If,O
9544,650,a,O
9545,650,woman,B-Person
9546,650,of,O
9547,650,childbearing,B-Condition
9548,650,potential,I-Condition
9549,650,",",O
9550,650,have,O
9551,650,a,O
9552,650,negative,O
9553,650,urine,O
9554,650,pregnancy,O
9555,650,test,O
9556,650,at,O
9557,650,Visit,O
9558,650,1,O
9559,650,and,O
9560,650,be,O
9561,650,using,O
9562,650,an,O
9563,650,adequate,O
9564,650,method,O
9565,650,of,O
9566,650,birth,O
9567,650,control,O
9568,650,throughout,O
9569,650,the,O
9570,650,study,O
9571,650,period,O
9572,650,.,O
9573,651,Age,B-Person
9574,651,<,O
9575,651,20,O
9576,651,or,O
9577,651,>,O
9578,651,35,O
9579,651,years,O
9580,651,.,O
9581,652,Body,O
9582,652,mass,O
9583,652,index,O
9584,652,(,O
9585,652,BMI,O
9586,652,),O
9587,652,<,O
9588,652,18.5,O
9589,652,kg,O
9590,652,/,O
9591,652,m2,O
9592,652,or,O
9593,652,>,O
9594,652,25,O
9595,652,kg,O
9596,652,/,O
9597,652,m2,O
9598,652,.,O
9599,653,Presence,O
9600,653,of,O
9601,653,any,O
9602,653,infertility,B-Condition
9603,653,factor,I-Condition
9604,653,other,O
9605,653,than,O
9606,653,anovulatory,B-Condition
9607,653,PCOS,I-Condition
9608,653,.,O
9609,654,Previous,O
9610,654,history,O
9611,654,of,O
9612,654,ovarian,B-Procedure
9613,654,surgery,I-Procedure
9614,654,or,O
9615,654,surgical,B-Procedure
9616,654,removal,I-Procedure
9617,654,of,O
9618,654,one,O
9619,654,ovary,O
9620,654,.,O
9621,655,Previous,O
9622,655,exposure,B-Condition
9623,655,to,O
9624,655,cytotoxic,B-Drug
9625,655,drugs,I-Drug
9626,655,or,O
9627,655,pelvic,B-Procedure
9628,655,irradiation,I-Procedure
9629,655,.,O
9630,656,Oral,O
9631,656,hypoglycemic,B-Procedure
9632,656,or,I-Procedure
9633,656,hormonal,I-Procedure
9634,656,therapy,I-Procedure
9635,656,either,O
9636,656,currently,O
9637,656,or,O
9638,656,in,O
9639,656,the,O
9640,656,preceding,O
9641,656,3,O
9642,656,months,O
9643,656,.,O
9644,657,Metabolic,B-Condition
9645,657,or,I-Condition
9646,657,hormonal,I-Condition
9647,657,abnormalities,I-Condition
9648,658,Infertile,B-Condition
9649,658,lean,O
9650,658,women,B-Person
9651,658,with,O
9652,658,PCOS,B-Condition
9653,658,as,O
9654,658,defined,O
9655,658,by,O
9656,658,the,O
9657,658,Rotterdam,O
9658,658,criteria,O
9659,658,.,O
9660,659,CC,B-Drug
9661,659,resistance,B-Condition
9662,659,(,O
9663,659,defined,O
9664,659,as,O
9665,659,failure,O
9666,659,of,O
9667,659,ovulation,O
9668,659,after,O
9669,659,receiving,O
9670,659,150,O
9671,659,mg,O
9672,659,/,O
9673,659,day,O
9674,659,of,O
9675,659,CC,O
9676,659,for,O
9677,659,5,O
9678,659,consecutive,O
9679,659,days,O
9680,659,per,O
9681,659,cycle,O
9682,659,",",O
9683,659,for,O
9684,659,at,O
9685,659,least,O
9686,659,3,O
9687,659,consecutive,O
9688,659,cycles,O
9689,659,),O
9690,659,.,O
9691,660,Non,O
9692,660,survivable,O
9693,660,injury,B-Condition
9694,661,Multiple,O
9695,661,significant,O
9696,661,trauma,B-Condition
9697,661,(,O
9698,661,i.e.,O
9699,661,significant,O
9700,661,intracranial,B-Condition
9701,661,and,I-Condition
9702,661,extracranial,I-Condition
9703,661,injuries,I-Condition
9704,661,including,O
9705,661,limb,B-Condition
9706,661,fractures,I-Condition
9707,661,),O
9708,661,that,O
9709,661,would,O
9710,661,limit,O
9711,661,observation,O
9712,661,of,O
9713,661,recovery,O
9714,661,from,O
9715,661,spinal,O
9716,661,cord,O
9717,661,injury,O
9718,662,Other,O
9719,662,conditions,O
9720,662,that,O
9721,662,would,O
9722,662,limit,O
9723,662,clinical,O
9724,662,assessment,O
9725,662,of,O
9726,662,outcomes,O
9727,662,(,O
9728,662,e.g.,O
9729,662,dementia,B-Condition
9730,662,",",O
9731,662,demyelinating,B-Condition
9732,662,disease,I-Condition
9733,662,",",O
9734,662,autoimmune,B-Condition
9735,662,disease,I-Condition
9736,662,",",O
9737,662,etc,O
9738,662,),O
9739,663,Refusal,O
9740,663,of,O
9741,663,treatment,O
9742,663,or,O
9743,663,contraindication,B-Condition
9744,663,to,O
9745,663,NeuroAiD,B-Procedure
9746,664,Male,B-Person
9747,664,or,O
9748,664,female,B-Person
9749,665,Age,B-Person
9750,665,18,O
9751,665,to,O
9752,665,65,O
9753,665,years,O
9754,666,Diagnosed,O
9755,666,with,O
9756,666,spinal,B-Condition
9757,666,cord,I-Condition
9758,666,injury,I-Condition
9759,666,between,O
9760,666,3,O
9761,666,days,O
9762,666,and,O
9763,666,4,O
9764,666,weeks,O
9765,667,American,O
9766,667,Spinal,O
9767,667,Injury,O
9768,667,Association,O
9769,667,Impairment,O
9770,667,Scale,O
9771,667,A,O
9772,667,or,O
9773,667,B,O
9774,668,Informed,O
9775,668,consent,O
9776,668,for,O
9777,668,inclusion,O
9778,668,into,O
9779,668,the,O
9780,668,database,O
9781,668,is,O
9782,668,obtained,O
9783,669,Past,O
9784,669,history,O
9785,669,of,O
9786,669,hypersensitivity,B-Condition
9787,669,to,O
9788,669,the,O
9789,669,study,B-Drug
9790,669,drug,I-Drug
9791,669,;,O
9792,670,Diagnosed,O
9793,670,diabetes,B-Condition
9794,670,;,O
9795,671,Severe,O
9796,671,liver,B-Condition
9797,671,disease,I-Condition
9798,671,(,O
9799,671,including,O
9800,671,ALT,O
9801,671,or,O
9802,671,AST=2.5,O
9803,671,-,O
9804,671,fold,O
9805,671,the,O
9806,671,normal,O
9807,671,upper,O
9808,671,limit,O
9809,671,),O
9810,671,",",O
9811,671,biliary,B-Condition
9812,671,obstruction,I-Condition
9813,671,;,O
9814,672,Ongoing,O
9815,672,treatment,B-Procedure
9816,672,with,O
9817,672,cyclosporine,B-Drug
9818,672,within,O
9819,672,2,O
9820,672,weeks,O
9821,672,;,O
9822,673,Renal,B-Condition
9823,673,dysfunction,I-Condition
9824,673,",",O
9825,673,including,O
9826,673,endogenous,O
9827,673,creatinine,O
9828,673,clearance,O
9829,673,male<120ml,B-Person
9830,673,/,O
9831,673,min,O
9832,673,",",O
9833,673,female<105ml,B-Person
9834,673,/,O
9835,673,min,O
9836,673,",",O
9837,673,serum,O
9838,673,creatinine=2mg,O
9839,673,/,O
9840,673,dl,O
9841,673,(,O
9842,673,186umol,O
9843,673,/,O
9844,673,L,O
9845,673,),O
9846,673,",",O
9847,673,Renal,O
9848,673,function,O
9849,673,progressive,O
9850,673,decline,O
9851,673,",",O
9852,673,GFR<30ml•min-1•1.73m-2,O
9853,673,;,O
9854,674,Diagnosed,O
9855,674,or,O
9856,674,past,O
9857,674,history,O
9858,674,of,O
9859,674,ASCVD,B-Condition
9860,674,(,O
9861,674,including,O
9862,674,ACS,B-Condition
9863,674,",",O
9864,674,SCAD,B-Condition
9865,674,",",O
9866,674,revascularization,B-Procedure
9867,674,",",O
9868,674,ICM,B-Condition
9869,674,",",O
9870,674,ischemic,B-Condition
9871,674,stroke,I-Condition
9872,674,",",O
9873,674,TIA,B-Condition
9874,674,",",O
9875,674,PASD,B-Condition
9876,674,",",O
9877,674,etc,O
9878,674,.,O
9879,675,SBP=180mmHg,O
9880,675,",",O
9881,675,or,O
9882,675,DBP=110mmHg,O
9883,675,;,O
9884,676,Ongoing,O
9885,676,treatment,B-Procedure
9886,676,with,O
9887,676,Beta,B-Drug
9888,676,blockers,I-Drug
9889,676,",",O
9890,676,Diuretic,B-Drug
9891,676,;,O
9892,677,Secondary,B-Condition
9893,677,hypertension,I-Condition
9894,677,",",O
9895,677,including,O
9896,677,SAS,B-Condition
9897,677,",",O
9898,677,PA,B-Condition
9899,677,",",O
9900,677,RAS,B-Condition
9901,677,",",O
9902,677,pheochromocytoma,B-Condition
9903,677,",",O
9904,677,Cushing,B-Condition
9905,677,'s,I-Condition
9906,677,syndrome,I-Condition
9907,677,",",O
9908,677,aorta,B-Condition
9909,677,diseases,I-Condition
9910,677,",",O
9911,677,drug,O
9912,677,induced,O
9913,677,hypertension,B-Condition
9914,677,;,O
9915,678,Ongoing,O
9916,678,treatment,B-Procedure
9917,678,with,O
9918,678,statins,B-Drug
9919,678,",",O
9920,678,fibrates,B-Drug
9921,678,",",O
9922,678,and/or,O
9923,678,cation,B-Drug
9924,678,exchange,I-Drug
9925,678,resins,I-Drug
9926,678,within,O
9927,678,2,O
9928,678,weeks,O
9929,678,;,O
9930,679,Pancreatic,B-Condition
9931,679,disease,I-Condition
9932,679,;,O
9933,680,History,B-Observation
9934,680,of,O
9935,680,gastrectomy,B-Procedure
9936,680,",",O
9937,680,short,B-Condition
9938,680,bowel,I-Condition
9939,680,syndrome,I-Condition
9940,680,;,O
9941,681,Ongoing,O
9942,681,hormone,B-Procedure
9943,681,replacement,I-Procedure
9944,681,therapy,I-Procedure
9945,681,;,O
9946,682,Diagnosed,B-Mood
9947,682,or,O
9948,682,suspected,B-Mood
9949,682,malignant,B-Condition
9950,682,tumor,I-Condition
9951,682,;,O
9952,683,Familial,B-Condition
9953,683,hypercholesterolemia,I-Condition
9954,683,;,O
9955,684,Any,O
9956,684,diseases,O
9957,684,may,O
9958,684,limit,O
9959,684,the,O
9960,684,efficacy,O
9961,684,or,O
9962,684,safety,O
9963,684,of,O
9964,684,the,O
9965,684,study,O
9966,684,;,O
9967,685,Pregnant,O
9968,685,or,O
9969,685,possibly,O
9970,685,pregnant,O
9971,685,woman,O
9972,685,",",O
9973,685,or,O
9974,685,breastfeeding,O
9975,685,woman,O
9976,685,",",O
9977,685,or,O
9978,685,woman,O
9979,685,who,O
9980,685,wishes,O
9981,685,to,O
9982,685,become,O
9983,685,pregnant,O
9984,685,during,O
9985,685,study,O
9986,685,participation,O
9987,685,;,O
9988,686,IFG,O
9989,686,impaired,O
9990,686,fast,O
9991,686,glucose,O
9992,686,",",O
9993,686,FPG,O
9994,686,fasting,O
9995,686,plasma,O
9996,686,glucose,O
9997,686,",",O
9998,686,IGT,O
9999,686,impaired,O
10000,686,glucose,O
10001,686,tolerance,O
10002,686,",",O
10003,686,OGTT,O
10004,686,oral,O
10005,686,glucose,O
10006,686,tolerance,O
10007,686,test,O
10008,686,",",O
10009,686,PG,O
10010,686,plasma,O
10011,686,glucose,O
10012,686,",",O
10013,686,HbA1C,O
10014,686,hemoglobin,O
10015,686,A1C,O
10016,686,",",O
10017,686,LDL,O
10018,686,-,O
10019,686,C,O
10020,686,low,O
10021,686,-,O
10022,686,density,O
10023,686,lipoprotein,O
10024,686,cholesterol,O
10025,686,",",O
10026,686,TG,O
10027,686,triglycerides,O
10028,686,",",O
10029,686,SBP,O
10030,686,systolic,O
10031,686,blood,O
10032,686,pressure,O
10033,686,",",O
10034,686,DBP,O
10035,686,diastolic,O
10036,686,blood,O
10037,686,pressure,O
10038,686,",",O
10039,686,ALT,O
10040,686,alanine,O
10041,686,aminotransferase,O
10042,686,",",O
10043,686,AST,O
10044,686,aspartate,O
10045,686,aminotransferase,O
10046,686,",",O
10047,686,GFR,O
10048,686,glomerular,O
10049,686,filtration,O
10050,686,rate,O
10051,686,",",O
10052,686,ASCVD,O
10053,686,arteriosclerotic,O
10054,686,cardiovascular,O
10055,686,disease,O
10056,686,",",O
10057,686,ACS,O
10058,686,acute,O
10059,686,coronary,O
10060,686,syndrome,O
10061,686,",",O
10062,686,SCAD,O
10063,686,stable,O
10064,686,coronary,O
10065,686,artery,O
10066,686,disease,O
10067,686,",",O
10068,686,ICM,O
10069,686,ischemic,O
10070,686,cardiomyopathy,O
10071,686,",",O
10072,686,TIA,O
10073,686,transient,O
10074,686,ischemic,O
10075,686,attack,O
10076,686,",",O
10077,686,PASD,O
10078,686,peripheral,O
10079,686,atherosclerotic,O
10080,686,disease,O
10081,686,",",O
10082,686,SAS,O
10083,686,sleep,O
10084,686,apnea,O
10085,686,syndrome,O
10086,686,",",O
10087,686,PA,O
10088,686,primary,O
10089,686,aldosteronism,O
10090,686,",",O
10091,686,RAS,O
10092,686,renal,O
10093,686,arterial,O
10094,686,stenosis,O
10095,687,Age,B-Person
10096,687,18,O
10097,687,-,O
10098,687,80,O
10099,687,years,O
10100,687,old,O
10101,687,;,O
10102,688,IFG,B-Condition
10103,688,:,O
10104,688,5.6mmol,O
10105,688,/,O
10106,688,L,O
10107,688,(,O
10108,688,100mg,O
10109,688,/,O
10110,688,dl)=FPG<7.0mmol,O
10111,688,/,O
10112,688,L,O
10113,688,(,O
10114,688,126mg,O
10115,688,/,O
10116,688,dl,O
10117,688,),O
10118,688,",",O
10119,688,or,O
10120,688,IGT,B-Condition
10121,688,:,O
10122,688,7.8mmol,O
10123,688,/,O
10124,688,L,O
10125,688,(,O
10126,688,140mg,O
10127,688,/,O
10128,688,dl)=OGTT,O
10129,688,2,O
10130,688,-,O
10131,688,h,O
10132,688,PG<11.1mmol,O
10133,688,/,O
10134,688,L,O
10135,688,(,O
10136,688,200mg,O
10137,688,/,O
10138,688,dl,O
10139,688,),O
10140,688,",",O
10141,688,or,O
10142,688,HbA1C,O
10143,688,5.7,O
10144,688,-,O
10145,688,6.4,O
10146,688,%,O
10147,688,(,O
10148,688,39,O
10149,688,-,O
10150,688,47mmol,O
10151,688,/,O
10152,688,mol,O
10153,688,),O
10154,688,;,O
10155,689,2.6mmol,O
10156,689,/,O
10157,689,L,O
10158,689,(,O
10159,689,100mg,O
10160,689,/,O
10161,689,dl)=LDL,O
10162,689,-,O
10163,689,C=5.2mmol,O
10164,689,/,O
10165,689,L,O
10166,689,(,O
10167,689,200mg,O
10168,689,/,O
10169,689,dl,O
10170,689,),O
10171,689,",",O
10172,689,and,O
10173,689,TG<5.7mmol,O
10174,689,/,O
10175,689,L,O
10176,689,(,O
10177,689,500mg,O
10178,689,/,O
10179,689,dl,O
10180,689,),O
10181,689,;,O
10182,690,130mmHg,O
10183,690,=,O
10184,690,SBP<180mmHg,O
10185,690,",",O
10186,690,or,O
10187,690,80mmHg,O
10188,690,=,O
10189,690,DBP<110mmHg,O
10190,690,or,O
10191,690,ongoing,O
10192,690,anti,B-Procedure
10193,690,-,I-Procedure
10194,690,hypertensive,I-Procedure
10195,690,therapy,I-Procedure
10196,690,;,O
10197,691,Patients,O
10198,691,volunteered,O
10199,691,for,O
10200,691,the,O
10201,691,study,O
10202,691,and,O
10203,691,signed,O
10204,691,informed,O
10205,691,consent,O
10206,691,.,O
10207,692,Age,B-Person
10208,692,<,O
10209,692,20,O
10210,692,or,O
10211,692,>,O
10212,692,35,O
10213,692,years,O
10214,692,.,O
10215,693,Body,O
10216,693,mass,O
10217,693,index,O
10218,693,(,O
10219,693,BMI,O
10220,693,),O
10221,693,<,O
10222,693,18.5,O
10223,693,kg,O
10224,693,/,O
10225,693,m2,O
10226,693,or,O
10227,693,>,O
10228,693,25,O
10229,693,kg,O
10230,693,/,O
10231,693,m2,O
10232,693,.,O
10233,694,Presence,O
10234,694,of,O
10235,694,any,O
10236,694,infertility,B-Condition
10237,694,factor,I-Condition
10238,694,other,O
10239,694,than,O
10240,694,anovulation,B-Condition
10241,694,/,O
10242,694,oligoovulation,B-Condition
10243,694,.,O
10244,695,Previous,O
10245,695,history,O
10246,695,of,O
10247,695,ovarian,B-Procedure
10248,695,surgery,I-Procedure
10249,695,or,O
10250,695,surgical,B-Procedure
10251,695,removal,I-Procedure
10252,695,of,O
10253,695,one,O
10254,695,ovary,O
10255,695,.,O
10256,696,Previous,O
10257,696,exposure,O
10258,696,to,O
10259,696,cytotoxic,B-Drug
10260,696,drugs,I-Drug
10261,696,or,O
10262,696,pelvic,B-Procedure
10263,696,irradiation,I-Procedure
10264,696,.,O
10265,697,Metabolic,B-Condition
10266,697,or,I-Condition
10267,697,hormonal,I-Condition
10268,697,abnormalities,I-Condition
10269,697,.,O
10270,698,Infertile,B-Condition
10271,698,women,B-Person
10272,698,with,O
10273,698,eugonadotrophic,O
10274,698,anovulation,B-Condition
10275,698,/,O
10276,698,oligoovulation,B-Condition
10277,698,.,O
10278,699,Unexplained,O
10279,699,infertility,B-Condition
10280,699,.,O
10281,700,Acute,O
10282,700,critical,O
10283,700,limb,B-Condition
10284,700,ischemia,I-Condition
10285,701,Severe,O
10286,701,critical,O
10287,701,limb,B-Condition
10288,701,ischemia,I-Condition
10289,701,(,O
10290,701,Rutherford,O
10291,701,category,O
10292,701,6,O
10293,701,),O
10294,702,Major,B-Condition
10295,702,bleeding,I-Condition
10296,702,history,I-Condition
10297,702,within,O
10298,702,prior,O
10299,702,2,O
10300,702,months,O
10301,703,Known,O
10302,703,hypersensitivity,B-Condition
10303,703,or,O
10304,703,contraindication,B-Condition
10305,703,to,O
10306,703,any,O
10307,703,of,O
10308,703,the,O
10309,703,following,O
10310,703,medications,O
10311,703,:,O
10312,703,heparin,B-Drug
10313,703,",",O
10314,703,aspirin,B-Drug
10315,703,",",O
10316,703,clopidogrel,B-Drug
10317,703,or,O
10318,703,contrast,B-Drug
10319,703,agents,I-Drug
10320,704,Age,B-Person
10321,704,>,O
10322,704,85,O
10323,704,years,O
10324,705,Severe,O
10325,705,hepatic,B-Condition
10326,705,dysfunction,I-Condition
10327,705,(,O
10328,705,>,O
10329,705,3,O
10330,705,times,O
10331,705,normal,O
10332,705,reference,O
10333,705,values,O
10334,705,),O
10335,706,Significant,O
10336,706,renal,B-Condition
10337,706,dysfunction,I-Condition
10338,706,(,O
10339,706,Serum,O
10340,706,creatinine,O
10341,706,>,O
10342,706,2.0,O
10343,706,mg,O
10344,706,/,O
10345,706,dl,O
10346,707,Significant,O
10347,707,leucopenia,B-Condition
10348,707,",",O
10349,707,neutropenia,B-Condition
10350,707,",",O
10351,707,thrombocytopenia,B-Condition
10352,707,",",O
10353,707,anemia,B-Condition
10354,707,",",O
10355,707,or,O
10356,707,known,O
10357,707,bleeding,B-Condition
10358,707,diathesis,I-Condition
10359,708,LVEF,O
10360,708,<,O
10361,708,40,O
10362,708,%,O
10363,708,or,O
10364,708,clinically,O
10365,708,overt,O
10366,708,congestive,B-Condition
10367,708,heart,I-Condition
10368,708,failure,I-Condition
10369,709,Pregnant,B-Condition
10370,709,women,B-Person
10371,709,or,O
10372,709,women,B-Person
10373,709,with,O
10374,709,potential,B-Condition
10375,709,childbearing,I-Condition
10376,710,Life,B-Observation
10377,710,expectancy,I-Observation
10378,710,<,O
10379,710,1,O
10380,710,year,O
10381,710,due,O
10382,710,to,O
10383,710,comorbidity,B-Condition
10384,711,Previous,O
10385,711,bypass,B-Procedure
10386,711,surgery,I-Procedure
10387,711,or,O
10388,711,stenting,O
10389,711,of,O
10390,711,the,O
10391,711,superficial,O
10392,711,femoral,O
10393,711,artery,O
10394,712,Untreated,O
10395,712,inflow,B-Condition
10396,712,disease,I-Condition
10397,712,of,O
10398,712,the,O
10399,712,ipsilateral,O
10400,712,pelvic,O
10401,712,arteries,O
10402,712,(,O
10403,712,more,O
10404,712,than,O
10405,712,50%stenosis,O
10406,712,or,O
10407,712,or,O
10408,712,occlusion,O
10409,713,Popliteal,B-Condition
10410,713,artery,I-Condition
10411,713,stenosis,I-Condition
10412,713,>,O
10413,713,50,O
10414,713,%,O
10415,713,at,O
10416,713,P2,O
10417,713,or,O
10418,713,P3,O
10419,713,segment,O
10420,714,Age,B-Person
10421,714,19,O
10422,714,years,O
10423,714,of,O
10424,714,older,O
10425,715,Moderate,O
10426,715,or,O
10427,715,severe,O
10428,715,claudication,B-Condition
10429,715,(,O
10430,715,Rutherford,O
10431,715,category,O
10432,715,2,O
10433,715,or,O
10434,715,3,O
10435,715,),O
10436,716,Critical,O
10437,716,limb,B-Condition
10438,716,ischemia,I-Condition
10439,716,(,O
10440,716,Rutherford,O
10441,716,category,O
10442,716,4,O
10443,716,or,O
10444,716,5,O
10445,716,),O
10446,717,Patients,O
10447,717,with,O
10448,717,signed,O
10449,717,informed,O
10450,717,consent,O
10451,718,Target,B-Condition
10452,718,lesion,I-Condition
10453,718,length,O
10454,718,=,O
10455,718,150,O
10456,718,mm,O
10457,718,by,O
10458,718,angiographic,B-Procedure
10459,718,estimation,O
10460,719,Stenosis,B-Condition
10461,719,of,O
10462,719,more,O
10463,719,than,O
10464,719,50,O
10465,719,%,O
10466,719,in,O
10467,719,femoropopliteal,O
10468,719,artery,O
10469,720,At,O
10470,720,least,O
10471,720,one,O
10472,720,patent,B-Condition
10473,720,(,I-Condition
10474,720,less,I-Condition
10475,720,than,I-Condition
10476,720,50,I-Condition
10477,720,percent,I-Condition
10478,720,stenosed,I-Condition
10479,720,),I-Condition
10480,720,tibioperoneal,I-Condition
10481,720,runoff,I-Condition
10482,720,vessel,I-Condition
10483,720,.,O
10484,721,Prior,O
10485,721,treatment,O
10486,721,toxicities,O
10487,721,have,O
10488,721,not,O
10489,721,resolved,O
10490,721,to,O
10491,721,<,O
10492,721,Grade,O
10493,721,2,O
10494,721,according,O
10495,721,to,O
10496,721,NCI,O
10497,721,CTCAE,O
10498,721,Version,O
10499,721,4.0,O
10500,721,(,O
10501,721,except,O
10502,721,clinically,O
10503,721,insignificant,O
10504,721,toxicities,O
10505,721,such,O
10506,721,as,O
10507,721,alopecia,O
10508,721,),O
10509,721,.,O
10510,722,Subjects,O
10511,722,receiving,O
10512,722,any,O
10513,722,other,O
10514,722,investigational,O
10515,722,agents,O
10516,722,.,O
10517,723,Patients,O
10518,723,with,O
10519,723,active,O
10520,723,tumor,B-Condition
10521,723,lysis,I-Condition
10522,723,syndrome,I-Condition
10523,723,(,I-Condition
10524,723,TLS,I-Condition
10525,723,),I-Condition
10526,723,either,O
10527,723,from,O
10528,723,laboratory,O
10529,723,or,O
10530,723,clinical,O
10531,723,changes,O
10532,723,.,O
10533,724,Patients,O
10534,724,with,O
10535,724,active,O
10536,724,central,B-Condition
10537,724,nervous,I-Condition
10538,724,system,I-Condition
10539,724,(,I-Condition
10540,724,CNS,I-Condition
10541,724,),I-Condition
10542,724,disease,I-Condition
10543,724,defined,O
10544,724,as,O
10545,724,symptomatic,O
10546,724,meningeal,B-Condition
10547,724,lymphoma,I-Condition
10548,724,or,O
10549,724,known,O
10550,724,CNS,B-Condition
10551,724,parenchymal,I-Condition
10552,724,lymphoma,I-Condition
10553,724,.,O
10554,725,History,O
10555,725,of,O
10556,725,severe,O
10557,725,allergic,B-Condition
10558,725,reactions,I-Condition
10559,725,attributed,O
10560,725,to,O
10561,725,compounds,B-Drug
10562,725,of,I-Drug
10563,725,similar,I-Drug
10564,725,chemical,I-Drug
10565,725,or,I-Drug
10566,725,biologic,I-Drug
10567,725,composition,I-Drug
10568,725,to,I-Drug
10569,725,rituximab,I-Drug
10570,725,or,I-Drug
10571,725,other,I-Drug
10572,725,agents,I-Drug
10573,725,used,I-Drug
10574,725,in,I-Drug
10575,725,this,I-Drug
10576,725,study,I-Drug
10577,725,.,O
10578,726,Subjects,O
10579,726,with,O
10580,726,uncontrolled,O
10581,726,intercurrent,O
10582,726,illness,O
10583,726,.,O
10584,727,HIV,B-Condition
10585,727,-,I-Condition
10586,727,positive,I-Condition
10587,727,subjects,O
10588,727,on,O
10589,727,combination,B-Procedure
10590,727,antiretroviral,I-Procedure
10591,727,therapy,I-Procedure
10592,727,are,O
10593,727,ineligible,O
10594,727,because,O
10595,727,of,O
10596,727,the,O
10597,727,potential,O
10598,727,for,O
10599,727,pharmacokinetic,O
10600,727,interactions,O
10601,727,with,O
10602,727,Venetoclax,O
10603,727,.,O
10604,727,In,O
10605,727,addition,O
10606,727,",",O
10607,727,these,O
10608,727,subjects,O
10609,727,are,O
10610,727,at,O
10611,727,increased,O
10612,727,risk,O
10613,727,of,O
10614,727,lethal,O
10615,727,infections,O
10616,727,when,O
10617,727,treated,O
10618,727,with,O
10619,727,marrow,O
10620,727,suppressive,O
10621,727,therapy,O
10622,727,.,O
10623,727,Appropriate,O
10624,727,studies,O
10625,727,will,O
10626,727,be,O
10627,727,undertaken,O
10628,727,in,O
10629,727,subjects,O
10630,727,receiving,O
10631,727,combination,O
10632,727,antiretroviral,O
10633,727,therapy,O
10634,727,when,O
10635,727,indicated,O
10636,727,.,O
10637,727,HIV,O
10638,727,testing,O
10639,727,prior,O
10640,727,to,O
10641,727,enrollment,O
10642,727,is,O
10643,727,not,O
10644,727,required,O
10645,727,for,O
10646,727,screening,O
10647,727,but,O
10648,727,strongly,O
10649,727,encouraged,O
10650,727,for,O
10651,727,patients,O
10652,727,with,O
10653,727,no,O
10654,727,documented,O
10655,727,prior,O
10656,727,HIV,O
10657,727,assessment,O
10658,727,.,O
10659,728,Presence,O
10660,728,of,O
10661,728,positive,O
10662,728,test,O
10663,728,results,O
10664,728,for,O
10665,728,hepatitis,O
10666,728,B,O
10667,728,virus,O
10668,728,(,O
10669,728,HBV,O
10670,728,),O
10671,728,",",O
10672,728,hepatitis,O
10673,728,B,O
10674,728,surface,O
10675,728,antigen,O
10676,728,(,O
10677,728,HBsAg,O
10678,728,),O
10679,728,",",O
10680,728,or,O
10681,728,hepatitis,O
10682,728,C,O
10683,728,(,O
10684,728,HCV,O
10685,728,),O
10686,728,antibody,O
10687,728,.,O
10688,729,Patients,O
10689,729,who,O
10690,729,are,O
10691,729,positive,O
10692,729,for,O
10693,729,HCV,O
10694,729,antibody,O
10695,729,must,O
10696,729,be,O
10697,729,negative,O
10698,729,for,O
10699,729,HCV,O
10700,729,by,O
10701,729,polymerase,B-Procedure
10702,729,chain,I-Procedure
10703,729,reaction,I-Procedure
10704,729,(,I-Procedure
10705,729,PCR,I-Procedure
10706,729,),I-Procedure
10707,729,to,O
10708,729,be,O
10709,729,eligible,O
10710,729,for,O
10711,729,study,O
10712,729,participation,O
10713,730,Patients,O
10714,730,with,O
10715,730,occult,O
10716,730,or,O
10717,730,prior,O
10718,730,HBV,B-Condition
10719,730,infection,I-Condition
10720,730,(,O
10721,730,defined,O
10722,730,as,O
10723,730,positive,O
10724,730,total,O
10725,730,hepatitis,O
10726,730,B,O
10727,730,core,O
10728,730,antibody,O
10729,730,[,O
10730,730,HBcAb,O
10731,730,],O
10732,730,and,O
10733,730,negative,O
10734,730,HBsAg,O
10735,730,),O
10736,730,may,O
10737,730,be,O
10738,730,included,O
10739,730,if,O
10740,730,HBV,O
10741,730,DNA,O
10742,730,is,O
10743,730,undetectable,O
10744,730,.,O
10745,730,These,O
10746,730,patients,O
10747,730,must,O
10748,730,be,O
10749,730,willing,O
10750,730,to,O
10751,730,undergo,O
10752,730,monthly,O
10753,730,DNA,O
10754,730,testing,O
10755,730,.,O
10756,731,Women,B-Person
10757,731,who,O
10758,731,are,O
10759,731,pregnant,B-Condition
10760,731,or,O
10761,731,lactating,B-Condition
10762,732,Malabsorption,B-Condition
10763,732,syndrome,I-Condition
10764,732,or,O
10765,732,other,O
10766,732,condition,B-Condition
10767,732,that,I-Condition
10768,732,precludes,I-Condition
10769,732,enteral,I-Condition
10770,732,route,I-Condition
10771,732,of,I-Condition
10772,732,administration,I-Condition
10773,733,Chemotherapy,B-Drug
10774,733,or,O
10775,733,radiation,B-Procedure
10776,733,within,O
10777,733,3,O
10778,733,weeks,O
10779,733,of,O
10780,733,the,O
10781,733,first,O
10782,733,scheduled,O
10783,733,study,O
10784,733,treatment,O
10785,733,.,O
10786,734,Less,O
10787,734,than,O
10788,734,2,O
10789,734,-,O
10790,734,year,O
10791,734,disease,B-Condition
10792,734,free,I-Condition
10793,734,from,O
10794,734,another,O
10795,734,primary,B-Condition
10796,734,malignancy,I-Condition
10797,734,(,O
10798,734,other,O
10799,734,than,O
10800,734,squamous,B-Condition
10801,734,or,I-Condition
10802,734,basal,I-Condition
10803,734,cell,I-Condition
10804,734,carcinoma,I-Condition
10805,734,of,I-Condition
10806,734,the,I-Condition
10807,734,skin,I-Condition
10808,734,",",O
10809,734,"""",B-Condition
10810,734,in,I-Condition
10811,734,-,I-Condition
10812,734,situ,I-Condition
10813,734,"""",I-Condition
10814,734,carcinoma,I-Condition
10815,734,of,I-Condition
10816,734,the,I-Condition
10817,734,cervix,I-Condition
10818,734,or,I-Condition
10819,734,breast,I-Condition
10820,734,",",O
10821,734,superficial,B-Condition
10822,734,bladder,I-Condition
10823,734,carcinoma,I-Condition
10824,734,",",O
10825,734,or,O
10826,734,previously,O
10827,734,treated,O
10828,734,localized,B-Condition
10829,734,prostate,I-Condition
10830,734,cancer,I-Condition
10831,734,with,O
10832,734,normal,O
10833,734,prostate,O
10834,734,specific,O
10835,734,antigen,O
10836,734,(,O
10837,734,PSA,O
10838,734,),O
10839,734,levels,O
10840,734,),O
10841,734,.,O
10842,734,Patients,O
10843,734,who,O
10844,734,have,O
10845,734,had,O
10846,734,completed,O
10847,734,all,O
10848,734,anti,B-Procedure
10849,734,-,I-Procedure
10850,734,cancer,I-Procedure
10851,734,treatment,I-Procedure
10852,734,for,O
10853,734,another,O
10854,734,primary,B-Condition
10855,734,malignancy,I-Condition
10856,734,more,O
10857,734,than,O
10858,734,2,O
10859,734,years,O
10860,734,prior,O
10861,734,to,O
10862,734,screening,O
10863,734,are,O
10864,734,eligible,O
10865,734,if,O
10866,734,they,O
10867,734,are,O
10868,734,not,O
10869,734,considered,O
10870,734,to,O
10871,734,have,O
10872,734,a,O
10873,734,"""",O
10874,734,currently,O
10875,734,active,O
10876,734,"""",O
10877,734,malignancy,O
10878,734,based,O
10879,734,on,O
10880,734,having,O
10881,734,less,O
10882,734,than,O
10883,734,a,O
10884,734,30,O
10885,734,%,O
10886,734,risk,O
10887,734,of,O
10888,734,relapse,O
10889,734,.,O
10890,735,Major,B-Procedure
10891,735,surgery,I-Procedure
10892,735,",",O
10893,735,other,O
10894,735,than,O
10895,735,diagnostic,B-Procedure
10896,735,surgery,I-Procedure
10897,735,",",O
10898,735,within,O
10899,735,2,O
10900,735,weeks,O
10901,735,.,O
10902,736,Medical,B-Condition
10903,736,condition,I-Condition
10904,736,requiring,O
10905,736,chronic,O
10906,736,use,O
10907,736,of,O
10908,736,high,O
10909,736,dose,O
10910,736,systemic,B-Drug
10911,736,corticosteroids,I-Drug
10912,736,(,O
10913,736,i.e.,O
10914,736,",",O
10915,736,doses,O
10916,736,of,O
10917,736,prednisone,B-Drug
10918,736,higher,O
10919,736,than,O
10920,736,10,O
10921,736,mg,O
10922,736,/,O
10923,736,day,O
10924,736,or,O
10925,736,equivalent,O
10926,736,),O
10927,736,.,O
10928,736,Brief,O
10929,736,(,O
10930,736,<,O
10931,736,15,O
10932,736,days,O
10933,736,),O
10934,736,treatment,O
10935,736,with,O
10936,736,glucocorticoids,B-Drug
10937,736,(,O
10938,736,prednisone,B-Drug
10939,736,100,O
10940,736,mg,O
10941,736,by,O
10942,736,mouth,O
10943,736,daily,O
10944,736,",",O
10945,736,or,O
10946,736,equivalent,O
10947,736,),O
10948,736,is,O
10949,736,acceptable,O
10950,736,.,O
10951,737,Known,O
10952,737,allergy,B-Condition
10953,737,to,O
10954,737,both,O
10955,737,xanthine,B-Drug
10956,737,oxidase,I-Drug
10957,737,inhibitors,I-Drug
10958,737,and,O
10959,737,rasburicase,B-Drug
10960,737,.,O
10961,738,Use,O
10962,738,of,O
10963,738,warfarin,B-Drug
10964,738,is,O
10965,738,prohibited,O
10966,738,.,O
10967,738,Anticoagulation,B-Procedure
10968,738,with,O
10969,738,low,B-Drug
10970,738,-,I-Drug
10971,738,molecular,I-Drug
10972,738,weight,I-Drug
10973,738,heparin,I-Drug
10974,738,(,O
10975,738,i.e.,O
10976,738,enoxaparin,B-Drug
10977,738,),O
10978,738,or,O
10979,738,direct,B-Drug
10980,738,thrombin,I-Drug
10981,738,inhibitors,I-Drug
10982,738,is,O
10983,738,permitted,O
10984,738,.,O
10985,739,The,O
10986,739,following,O
10987,739,concomitant,O
10988,739,medications,O
10989,739,are,O
10990,739,not,O
10991,739,allowed,O
10992,739,from,O
10993,739,7,O
10994,739,days,O
10995,739,prior,O
10996,739,to,O
10997,739,the,O
10998,739,first,O
10999,739,dose,O
11000,739,of,O
11001,739,study,O
11002,739,drug,O
11003,739,and,O
11004,739,during,O
11005,739,venetoclax,B-Procedure
11006,739,administration,I-Procedure
11007,739,:,O
11008,739,Strong,B-Drug
11009,739,CYP3A4,I-Drug
11010,739,inhibitors,I-Drug
11011,739,including,O
11012,739,but,O
11013,739,not,O
11014,739,limited,O
11015,739,to,O
11016,739,fluconazole,B-Drug
11017,739,",",O
11018,739,ketoconazole,B-Drug
11019,739,",",O
11020,739,and,O
11021,739,clarithromycin,B-Drug
11022,739,or,O
11023,739,strong,B-Drug
11024,739,CYP3A4,I-Drug
11025,739,inducers,I-Drug
11026,739,included,O
11027,739,but,O
11028,739,not,O
11029,739,limited,O
11030,739,to,O
11031,739,rifampin,B-Drug
11032,739,",",O
11033,739,carbamazepine,B-Drug
11034,739,.,O
11035,740,Receipt,O
11036,740,of,O
11037,740,live,B-Drug
11038,740,-,I-Drug
11039,740,virus,I-Drug
11040,740,vaccines,I-Drug
11041,740,within,O
11042,740,28,O
11043,740,days,O
11044,740,prior,O
11045,740,to,O
11046,740,the,O
11047,740,initiation,O
11048,740,of,O
11049,740,study,O
11050,740,treatment,O
11051,740,or,O
11052,740,need,B-Observation
11053,740,for,I-Observation
11054,740,live,B-Drug
11055,740,-,I-Drug
11056,740,virus,I-Drug
11057,740,vaccines,I-Drug
11058,740,at,O
11059,740,any,O
11060,740,time,O
11061,740,during,O
11062,740,study,O
11063,740,treatment,O
11064,740,.,O
11065,741,Concomitant,O
11066,741,medications,O
11067,741,that,O
11068,741,fall,O
11069,741,into,O
11070,741,the,O
11071,741,categories,O
11072,741,below,O
11073,741,could,O
11074,741,potentially,O
11075,741,lead,O
11076,741,to,O
11077,741,adverse,O
11078,741,reactions,O
11079,741,and,O
11080,741,should,O
11081,741,be,O
11082,741,considered,O
11083,741,cautionary,O
11084,741,.,O
11085,742,Moderate,B-Drug
11086,742,/,I-Drug
11087,742,Weak,I-Drug
11088,742,CYP3A,I-Drug
11089,742,inducers,I-Drug
11090,742,such,O
11091,742,as,O
11092,742,efavirenz,B-Drug
11093,742,and,O
11094,742,oxcarbazepine,B-Drug
11095,743,CYP2C8,B-Drug
11096,743,substrates,I-Drug
11097,743,such,O
11098,743,as,O
11099,743,thiazolidinediones,B-Drug
11100,743,(,O
11101,743,glitazones,B-Drug
11102,743,),O
11103,743,and,O
11104,743,select,O
11105,743,statins,B-Drug
11106,743,(,O
11107,743,because,O
11108,743,of,O
11109,743,expected,O
11110,743,inhibition,O
11111,743,of,O
11112,743,the,O
11113,743,metabolism,O
11114,743,of,O
11115,743,CYP2C8,O
11116,743,substrates,O
11117,743,),O
11118,743,by,O
11119,743,venetoclax,O
11120,744,CYP2C9,B-Drug
11121,744,substrates,I-Drug
11122,744,such,O
11123,744,as,O
11124,744,tolbutamide,B-Drug
11125,744,(,O
11126,744,because,O
11127,744,of,O
11128,744,expected,O
11129,744,inhibition,O
11130,744,of,O
11131,744,the,O
11132,744,metabolism,O
11133,744,of,O
11134,744,CYP2C9,O
11135,744,substrates,O
11136,744,by,O
11137,744,venetoclax,O
11138,744,.,O
11139,744,It,O
11140,744,is,O
11141,744,recommended,O
11142,744,to,O
11143,744,exclude,O
11144,744,CYP2C9,B-Drug
11145,744,substrates,I-Drug
11146,744,with,O
11147,744,a,O
11148,744,narrow,O
11149,744,therapeutic,O
11150,744,index,O
11151,744,such,O
11152,744,as,O
11153,744,phenytoin,B-Drug
11154,744,.,O
11155,745,Histological,B-Procedure
11156,745,confirmation,O
11157,745,of,O
11158,745,relapsed,O
11159,745,/,O
11160,745,refractory,O
11161,745,diffuse,O
11162,745,large,O
11163,745,B,B-Condition
11164,745,-,I-Condition
11165,745,cell,I-Condition
11166,745,lymphoma,I-Condition
11167,745,after,O
11168,745,prior,O
11169,745,rituximab,B-Procedure
11170,745,and,I-Procedure
11171,745,anthracycline,I-Procedure
11172,745,-,I-Procedure
11173,745,containing,I-Procedure
11174,745,systemic,I-Procedure
11175,745,treatment,I-Procedure
11176,745,regimen,I-Procedure
11177,745,such,O
11178,745,as,O
11179,745,R,B-Drug
11180,745,-,I-Drug
11181,745,CHOP,I-Drug
11182,745,(,O
11183,745,rituximab,B-Drug
11184,745,",",O
11185,745,cyclophosphamide,B-Drug
11186,745,",",O
11187,745,doxorubicin,B-Drug
11188,745,",",O
11189,745,vincristine,B-Drug
11190,745,",",O
11191,745,and,O
11192,745,prednisone,B-Drug
11193,745,),O
11194,745,",",O
11195,745,R,B-Drug
11196,745,-,I-Drug
11197,745,EPOCH,I-Drug
11198,745,(,O
11199,745,rituximab,B-Drug
11200,745,",",O
11201,745,etoposide,B-Drug
11202,745,phosphate,I-Drug
11203,745,",",O
11204,745,prednisone,B-Drug
11205,745,",",O
11206,745,vincristine,B-Drug
11207,745,sulfate,I-Drug
11208,745,",",O
11209,745,cyclophosphamide,B-Drug
11210,745,",",O
11211,745,doxorubicin,B-Drug
11212,745,hydrochloride,I-Drug
11213,745,),O
11214,745,",",O
11215,745,R,B-Drug
11216,745,-,I-Drug
11217,745,HyperCVAD,I-Drug
11218,745,(,O
11219,745,rituximab,B-Drug
11220,745,",",O
11221,745,cyclophosphamide,B-Drug
11222,745,",",O
11223,745,vincristine,B-Drug
11224,745,sulfate,I-Drug
11225,745,",",O
11226,745,doxorubicin,B-Drug
11227,745,hydrochloride,I-Drug
11228,745,",",O
11229,745,dexamethasone,B-Drug
11230,745,),O
11231,745,etc,O
11232,745,.,O
11233,746,Subjects,O
11234,746,must,O
11235,746,have,O
11236,746,received,O
11237,746,no,O
11238,746,more,O
11239,746,than,O
11240,746,2,O
11241,746,prior,O
11242,746,systemic,B-Procedure
11243,746,therapies,I-Procedure
11244,746,for,I-Procedure
11245,746,lymphoma,I-Procedure
11246,746,.,O
11247,746,Prior,O
11248,746,therapy,O
11249,746,with,O
11250,746,systemic,B-Procedure
11251,746,rituximab,I-Procedure
11252,746,monotherapy,I-Procedure
11253,746,or,O
11254,746,conventional,B-Procedure
11255,746,chemotherapy,I-Procedure
11256,746,(,O
11257,746,i.e.,O
11258,746,bendamustine,B-Drug
11259,746,",",O
11260,746,CVP,B-Drug
11261,746,(,O
11262,746,Cyclophosphamide,B-Drug
11263,746,",",O
11264,746,Vincristine,B-Drug
11265,746,Sulfate,I-Drug
11266,746,",",O
11267,746,Prednisone,B-Drug
11268,746,),O
11269,746,or,O
11270,746,other,O
11271,746,),O
11272,746,±,O
11273,746,rituximab,B-Drug
11274,746,for,O
11275,746,indolent,O
11276,746,non,B-Condition
11277,746,-,I-Condition
11278,746,Hodgkin,I-Condition
11279,746,'s,I-Condition
11280,746,lymphoma,I-Condition
11281,746,(,I-Condition
11282,746,NHL,I-Condition
11283,746,),I-Condition
11284,746,±,O
11285,746,maintenance,O
11286,746,/,O
11287,746,extended,O
11288,746,-,O
11289,746,use,O
11290,746,rituximab,B-Drug
11291,746,will,O
11292,746,count,O
11293,746,as,O
11294,746,1,O
11295,746,line,O
11296,746,of,O
11297,746,systemic,O
11298,746,therapy,O
11299,746,.,O
11300,747,Eastern,O
11301,747,Cooperative,O
11302,747,Oncology,O
11303,747,Group,O
11304,747,(,O
11305,747,ECOG,O
11306,747,),O
11307,747,Performance,O
11308,747,status,O
11309,747,≤,O
11310,747,2,O
11311,748,Subjects,O
11312,748,must,O
11313,748,have,O
11314,748,normal,B-Condition
11315,748,organ,I-Condition
11316,748,and,I-Condition
11317,748,marrow,I-Condition
11318,748,function,I-Condition
11319,748,as,O
11320,748,defined,O
11321,748,below,O
11322,748,:,O
11323,749,Hemoglobin,O
11324,749,≥,O
11325,749,8.0,O
11326,749,g,O
11327,749,/,O
11328,749,dl,O
11329,750,Absolute,O
11330,750,neutrophil,O
11331,750,count,O
11332,750,≥,O
11333,750,"1,000",O
11334,750,/,O
11335,750,mcL,O
11336,751,Platelet,O
11337,751,count,O
11338,751,≥,O
11339,751,"75,000",O
11340,751,/,O
11341,751,mcL,O
11342,752,Total,O
11343,752,bilirubin,O
11344,752,≤,O
11345,752,1.5,O
11346,752,X,O
11347,752,the,O
11348,752,upper,O
11349,752,limit,O
11350,752,of,O
11351,752,normal,O
11352,752,(,O
11353,752,ULN,O
11354,752,),O
11355,752,unless,O
11356,752,a,O
11357,752,known,O
11358,752,history,O
11359,752,of,O
11360,752,impaired,B-Condition
11361,752,bilirubin,I-Condition
11362,752,conjugation,I-Condition
11363,752,such,O
11364,752,as,O
11365,752,Gilbert,B-Condition
11366,752,'s,I-Condition
11367,752,",",O
11368,752,for,O
11369,752,whom,O
11370,752,the,O
11371,752,maximum,O
11372,752,will,O
11373,752,be,O
11374,752,2.5,O
11375,752,ULN,O
11376,752,.,O
11377,753,Aspartate,O
11378,753,transaminase,O
11379,753,(,O
11380,753,AST,O
11381,753,),O
11382,753,(,O
11383,753,SGOT,O
11384,753,),O
11385,753,≤,O
11386,753,2.5,O
11387,753,X,O
11388,753,institutional,O
11389,753,ULN,O
11390,754,Alanine,O
11391,754,transaminase,O
11392,754,(,O
11393,754,ALT,O
11394,754,),O
11395,754,(,O
11396,754,SGPT,O
11397,754,),O
11398,754,≤,O
11399,754,2.5,O
11400,754,X,O
11401,754,institutional,O
11402,754,ULN,O
11403,755,International,O
11404,755,normalized,O
11405,755,ratio,O
11406,755,(,O
11407,755,INR,O
11408,755,),O
11409,755,>,O
11410,755,1.5,O
11411,755,×ULN,O
11412,756,Patients,O
11413,756,must,O
11414,756,have,O
11415,756,a,O
11416,756,calculated,O
11417,756,serum,O
11418,756,creatinine,O
11419,756,clearance,O
11420,756,>,O
11421,756,50,O
11422,756,mL,O
11423,756,/,O
11424,756,min,O
11425,756,using,O
11426,756,Cockcroft,O
11427,756,-,O
11428,756,Gault,O
11429,756,calculation,O
11430,756,or,O
11431,756,based,O
11432,756,on,O
11433,756,24,O
11434,756,-,O
11435,756,hour,O
11436,756,urine,O
11437,756,collection,O
11438,756,performed,O
11439,756,within,O
11440,756,7,O
11441,756,days,O
11442,756,prior,O
11443,756,to,O
11444,756,treatment,O
11445,756,.,O
11446,757,Specific,O
11447,757,guidelines,O
11448,757,will,O
11449,757,be,O
11450,757,followed,O
11451,757,regarding,O
11452,757,inclusion,O
11453,757,of,O
11454,757,relapsed,O
11455,757,/,O
11456,757,refractory,O
11457,757,DLBCL,O
11458,757,based,O
11459,757,on,O
11460,757,Hepatitis,O
11461,757,B,O
11462,757,serological,O
11463,757,testing,O
11464,757,as,O
11465,757,follow,O
11466,757,:,O
11467,758,HBsAg,O
11468,758,negative,O
11469,758,",",O
11470,758,HBcAb,O
11471,758,negative,O
11472,758,",",O
11473,758,HBsAb,O
11474,758,positive,O
11475,758,patients,O
11476,758,are,O
11477,758,eligible,O
11478,758,.,O
11479,759,Patients,O
11480,759,who,O
11481,759,test,O
11482,759,positive,O
11483,759,for,O
11484,759,HBsAg,O
11485,759,are,O
11486,759,ineligible,O
11487,760,Patients,O
11488,760,with,O
11489,760,HBsAg,O
11490,760,negative,O
11491,760,",",O
11492,760,but,O
11493,760,HBcAb,O
11494,760,positive,O
11495,760,(,O
11496,760,regardless,O
11497,760,of,O
11498,760,HBsAb,O
11499,760,status,O
11500,760,),O
11501,760,should,O
11502,760,have,O
11503,760,a,O
11504,760,HBV,B-Procedure
11505,760,DNA,I-Procedure
11506,760,testing,I-Procedure
11507,760,performed,O
11508,760,and,O
11509,760,protocol,O
11510,760,eligibility,O
11511,760,determined,O
11512,760,as,O
11513,760,follow,O
11514,760,:,O
11515,761,If,O
11516,761,HBV,O
11517,761,DNA,O
11518,761,is,O
11519,761,positive,O
11520,761,",",O
11521,761,the,O
11522,761,subject,O
11523,761,is,O
11524,761,ineligible,O
11525,761,.,O
11526,762,If,O
11527,762,HBV,O
11528,762,DNA,O
11529,762,is,O
11530,762,negative,O
11531,762,",",O
11532,762,the,O
11533,762,subject,O
11534,762,may,O
11535,762,be,O
11536,762,included,O
11537,762,but,O
11538,762,must,O
11539,762,undergo,O
11540,762,HBV,O
11541,762,DNA,O
11542,762,PCR,O
11543,762,testing,O
11544,762,monthly,O
11545,762,x,O
11546,762,3,O
11547,762,months,O
11548,762,beginning,O
11549,762,from,O
11550,762,the,O
11551,762,start,O
11552,762,of,O
11553,762,treatment,O
11554,763,Subjects,O
11555,763,must,O
11556,763,have,O
11557,763,the,O
11558,763,ability,O
11559,763,to,O
11560,763,understand,O
11561,763,and,O
11562,763,the,O
11563,763,willingness,O
11564,763,to,O
11565,763,sign,O
11566,763,a,O
11567,763,written,O
11568,763,informed,O
11569,763,consent,O
11570,763,document,O
11571,763,.,O
11572,764,For,O
11573,764,women,O
11574,764,of,O
11575,764,childbearing,O
11576,764,potential,O
11577,764,:,O
11578,764,agreement,O
11579,764,to,O
11580,764,remain,O
11581,764,abstinent,O
11582,764,(,O
11583,764,refrain,O
11584,764,from,O
11585,764,heterosexual,O
11586,764,intercourse,O
11587,764,),O
11588,764,or,O
11589,764,use,O
11590,764,a,O
11591,764,contraceptive,O
11592,764,method,O
11593,764,with,O
11594,764,a,O
11595,764,failure,O
11596,764,rate,O
11597,764,of,O
11598,764,<,O
11599,764,1,O
11600,764,%,O
11601,764,per,O
11602,764,year,O
11603,764,during,O
11604,764,the,O
11605,764,treatment,O
11606,764,period,O
11607,764,and,O
11608,764,for,O
11609,764,at,O
11610,764,least,O
11611,764,30,O
11612,764,days,O
11613,764,after,O
11614,764,the,O
11615,764,last,O
11616,764,dose,O
11617,764,of,O
11618,764,venetoclax,O
11619,764,or,O
11620,764,18,O
11621,764,months,O
11622,764,after,O
11623,764,the,O
11624,764,last,O
11625,764,dose,O
11626,764,of,O
11627,764,rituximab,O
11628,764,",",O
11629,764,whichever,O
11630,764,is,O
11631,764,longer,O
11632,764,.,O
11633,765,A,O
11634,765,woman,O
11635,765,is,O
11636,765,considered,O
11637,765,to,O
11638,765,be,O
11639,765,of,O
11640,765,childbearing,O
11641,765,potential,O
11642,765,if,O
11643,765,she,O
11644,765,is,O
11645,765,postmenarcheal,O
11646,765,",",O
11647,765,has,O
11648,765,not,O
11649,765,reached,O
11650,765,a,O
11651,765,postmenopausal,O
11652,765,state,O
11653,765,(,O
11654,765,<,O
11655,765,12,O
11656,765,continuous,O
11657,765,months,O
11658,765,of,O
11659,765,amenorrhea,O
11660,765,with,O
11661,765,no,O
11662,765,identified,O
11663,765,cause,O
11664,765,other,O
11665,765,than,O
11666,765,menopause,O
11667,765,),O
11668,765,",",O
11669,765,and,O
11670,765,has,O
11671,765,not,O
11672,765,undergone,O
11673,765,surgical,O
11674,765,sterilization,O
11675,765,(,O
11676,765,removal,O
11677,765,of,O
11678,765,ovaries,O
11679,765,and/or,O
11680,765,uterus,O
11681,765,),O
11682,765,.,O
11683,766,For,O
11684,766,men,O
11685,766,:,O
11686,766,agreement,O
11687,766,to,O
11688,766,remain,O
11689,766,abstinent,O
11690,766,(,O
11691,766,refrain,O
11692,766,from,O
11693,766,heterosexual,O
11694,766,intercourse,O
11695,766,),O
11696,766,or,O
11697,766,use,O
11698,766,contraceptive,O
11699,766,measures,O
11700,766,",",O
11701,766,and,O
11702,766,agreement,O
11703,766,to,O
11704,766,refrain,O
11705,766,from,O
11706,766,donating,O
11707,766,sperm,O
11708,766,",",O
11709,766,as,O
11710,766,defined,O
11711,766,below,O
11712,766,:,O
11713,767,With,O
11714,767,female,O
11715,767,partners,O
11716,767,of,O
11717,767,childbearing,O
11718,767,potential,O
11719,767,",",O
11720,767,men,O
11721,767,must,O
11722,767,remain,O
11723,767,abstinent,O
11724,767,or,O
11725,767,use,O
11726,767,a,O
11727,767,condom,O
11728,767,plus,O
11729,767,an,O
11730,767,additional,O
11731,767,contraceptive,O
11732,767,method,O
11733,767,that,O
11734,767,together,O
11735,767,result,O
11736,767,in,O
11737,767,a,O
11738,767,failure,O
11739,767,rate,O
11740,767,of,O
11741,767,<,O
11742,767,1,O
11743,767,%,O
11744,767,per,O
11745,767,year,O
11746,767,during,O
11747,767,the,O
11748,767,treatment,O
11749,767,period,O
11750,767,and,O
11751,767,for,O
11752,767,at,O
11753,767,least,O
11754,767,6,O
11755,767,months,O
11756,767,after,O
11757,767,the,O
11758,767,last,O
11759,767,dose,O
11760,767,of,O
11761,767,rituximab,O
11762,767,.,O
11763,767,Men,O
11764,767,must,O
11765,767,refrain,O
11766,767,from,O
11767,767,donating,O
11768,767,sperm,O
11769,767,during,O
11770,767,this,O
11771,767,same,O
11772,767,period,O
11773,767,.,O
11774,768,With,O
11775,768,pregnant,O
11776,768,female,O
11777,768,partners,O
11778,768,",",O
11779,768,men,O
11780,768,must,O
11781,768,remain,O
11782,768,abstinent,O
11783,768,or,O
11784,768,use,O
11785,768,a,O
11786,768,condom,O
11787,768,during,O
11788,768,the,O
11789,768,treatment,O
11790,768,period,O
11791,768,and,O
11792,768,for,O
11793,768,at,O
11794,768,least,O
11795,768,6,O
11796,768,months,O
11797,768,after,O
11798,768,the,O
11799,768,last,O
11800,768,dose,O
11801,768,of,O
11802,768,rituximab,O
11803,768,to,O
11804,768,avoid,O
11805,768,exposing,O
11806,768,the,O
11807,768,embryo,O
11808,768,.,O
11809,769,Concomitant,O
11810,769,antiplatelet,B-Drug
11811,769,or,O
11812,769,anticoagulant,B-Drug
11813,769,use,O
11814,770,Calculated,O
11815,770,creatinine,O
11816,770,clearance,O
11817,770,<,O
11818,770,30,O
11819,770,mL,O
11820,770,/,O
11821,770,min,O
11822,770,by,O
11823,770,Cockcroft,O
11824,770,-,O
11825,770,Gault,O
11826,770,formula,O
11827,771,Alanine,O
11828,771,aminotransferase,O
11829,771,(,O
11830,771,ALT,O
11831,771,),O
11832,771,or,O
11833,771,aspartate,O
11834,771,aminotransferase,O
11835,771,(,O
11836,771,AST,O
11837,771,),O
11838,771,>,O
11839,771,3,O
11840,771,times,O
11841,771,upper,O
11842,771,limit,O
11843,771,of,O
11844,771,normal,O
11845,771,(,O
11846,771,ULN,O
11847,771,),O
11848,772,Total,O
11849,772,bilirubin,O
11850,772,>,O
11851,772,2,O
11852,772,x,O
11853,772,ULN,O
11854,773,Thrombocytopenia,O
11855,773,<,O
11856,773,50,O
11857,773,x,O
11858,773,10,O
11859,773,gigalitres,O
11860,773,(,O
11861,773,Gl,O
11862,773,),O
11863,774,High,B-Condition
11864,774,bleeding,I-Condition
11865,774,risk,I-Condition
11866,774,or,O
11867,774,spontaneously,O
11868,774,prolonged,B-Condition
11869,774,prothrombin,I-Condition
11870,774,time,I-Condition
11871,774,or,O
11872,774,activated,O
11873,774,partial,O
11874,774,thromboplastin,O
11875,774,time,O
11876,774,>,O
11877,774,1.5,O
11878,774,x,O
11879,774,ULN,O
11880,775,Body,B-Condition
11881,775,weight,I-Condition
11882,775,<,O
11883,775,50,O
11884,775,or,O
11885,775,>,O
11886,775,120,O
11887,775,kg,O
11888,776,Concomitant,O
11889,776,use,O
11890,776,of,O
11891,776,CYP3A4,B-Drug
11892,776,or,O
11893,776,p,B-Drug
11894,776,-,I-Drug
11895,776,glycoprotein,I-Drug
11896,776,inducers,I-Drug
11897,776,or,I-Drug
11898,776,inhibitors,I-Drug
11899,777,Use,O
11900,777,of,O
11901,777,Ginkgo,B-Drug
11902,777,biloba,I-Drug
11903,777,or,O
11904,777,St.,B-Drug
11905,777,John,I-Drug
11906,777,'s,I-Drug
11907,777,Wort,I-Drug
11908,777,within,O
11909,777,14,O
11910,777,days,O
11911,777,before,O
11912,777,first,O
11913,777,dose,O
11914,777,of,O
11915,777,study,B-Drug
11916,777,drug,I-Drug
11917,778,Dexamethasone,B-Drug
11918,778,use,O
11919,778,within,O
11920,778,last,O
11921,778,3,O
11922,778,months,O
11923,779,Women,B-Person
11924,779,of,O
11925,779,Childbearing,B-Condition
11926,779,potential,I-Condition
11927,779,without,O
11928,779,proper,O
11929,779,contraceptive,B-Procedure
11930,779,measures,I-Procedure
11931,779,",",O
11932,779,pregnancy,B-Condition
11933,779,or,O
11934,779,breast,B-Observation
11935,779,feeding,I-Observation
11936,780,Life,B-Observation
11937,780,expectancy,I-Observation
11938,780,less,O
11939,780,than,O
11940,780,3,O
11941,780,months,O
11942,781,Inability,B-Condition
11943,781,to,I-Condition
11944,781,swallow,I-Condition
11945,781,or,O
11946,781,issues,B-Condition
11947,781,with,I-Condition
11948,781,malabsorption,I-Condition
11949,782,Any,O
11950,782,other,O
11951,782,medical,O
11952,782,",",O
11953,782,social,O
11954,782,",",O
11955,782,logistical,O
11956,782,",",O
11957,782,geographical,O
11958,782,or,O
11959,782,psychological,O
11960,782,factors,O
11961,782,",",O
11962,782,which,O
11963,782,in,O
11964,782,the,O
11965,782,opinion,O
11966,782,of,O
11967,782,the,O
11968,782,investigator,O
11969,782,",",O
11970,782,would,O
11971,782,prohibit,O
11972,782,follow,O
11973,782,-,O
11974,782,up,O
11975,782,",",O
11976,782,compliance,O
11977,782,and,O
11978,782,study,O
11979,782,completion,O
11980,783,Patients,O
11981,783,with,O
11982,783,diagnosis,O
11983,783,of,O
11984,783,multiple,B-Condition
11985,783,myeloma,I-Condition
11986,783,according,O
11987,783,to,O
11988,783,criteria,O
11989,783,of,O
11990,783,the,O
11991,783,International,O
11992,783,Myeloma,O
11993,783,Working,O
11994,783,Group,O
11995,784,Patients,O
11996,784,in,O
11997,784,whom,O
11998,784,a,O
11999,784,LEN,B-Drug
12000,784,-,O
12001,784,DEX,B-Drug
12002,784,-,O
12003,784,based,O
12004,784,treatment,B-Procedure
12005,784,regimen,I-Procedure
12006,784,is,B-Mood
12007,784,indicated,I-Mood
12008,785,Adult,B-Person
12009,785,patients,O
12010,785,≥,O
12011,785,19,O
12012,785,years,O
12013,785,of,O
12014,785,age,B-Person
12015,785,who,O
12016,785,are,O
12017,785,able,B-Observation
12018,785,to,I-Observation
12019,785,freely,I-Observation
12020,785,provide,I-Observation
12021,785,informed,I-Observation
12022,785,consent,I-Observation
12023,786,Pregnancy,B-Condition
12024,786,",",O
12025,786,coagulopathy,B-Condition
12026,786,",",O
12027,786,allergy,B-Condition
12028,786,to,O
12029,786,bupivacaine,B-Drug
12030,786,",",O
12031,786,renal,B-Condition
12032,786,failure,I-Condition
12033,786,",",O
12034,786,hepatic,B-Condition
12035,786,insufficiency,I-Condition
12036,786,",",O
12037,786,and/or,O
12038,786,inappropriate,B-Condition
12039,786,candidate,I-Condition
12040,786,for,O
12041,786,usual,B-Procedure
12042,786,therapy,I-Procedure
12043,786,(,O
12044,786,specifically,O
12045,786,",",O
12046,786,if,O
12047,786,unable,B-Mood
12048,786,to,I-Mood
12049,786,receive,I-Mood
12050,786,the,O
12051,786,usual,O
12052,786,preoperative,B-Procedure
12053,786,interscalene,I-Procedure
12054,786,nerve,I-Procedure
12055,786,block,I-Procedure
12056,786,:,O
12057,786,preexisting,O
12058,786,nerve,B-Condition
12059,786,injury,I-Condition
12060,786,on,O
12061,786,side,O
12062,786,of,O
12063,786,surgery,O
12064,786,",",O
12065,786,refusal,B-Condition
12066,786,of,I-Condition
12067,786,nerve,I-Condition
12068,786,block,I-Condition
12069,786,",",O
12070,786,infection,B-Condition
12071,786,at,O
12072,786,site,O
12073,786,of,O
12074,786,nerve,O
12075,786,block,O
12076,786,),O
12077,786,.,O
12078,787,Adult,B-Person
12079,787,patients,O
12080,787,up,O
12081,787,to,O
12082,787,age,B-Person
12083,787,75,O
12084,787,years,O
12085,787,",",O
12086,787,undergoing,O
12087,787,elective,O
12088,787,",",O
12089,787,ambulatory,O
12090,787,",",O
12091,787,arthroscopic,B-Procedure
12092,787,rotator,I-Procedure
12093,787,cuff,I-Procedure
12094,787,repair,I-Procedure
12095,787,.,O
12096,788,Current,O
12097,788,wheeze,B-Condition
12098,789,Underlying,O
12099,789,chronic,B-Condition
12100,789,illness,I-Condition
12101,789,other,O
12102,789,than,O
12103,789,asthma,B-Condition
12104,789,(,O
12105,789,e.g.,O
12106,789,bronchiectasis,B-Condition
12107,789,",",O
12108,789,cyanotic,B-Condition
12109,789,congenital,I-Condition
12110,789,heart,I-Condition
12111,789,disease,I-Condition
12112,789,or,O
12113,789,cardiac,B-Condition
12114,789,failure,I-Condition
12115,789,",",O
12116,789,neuromuscular,B-Condition
12117,789,disorders,I-Condition
12118,789,",",O
12119,789,immunodeficiency,B-Condition
12120,789,),O
12121,789,that,O
12122,789,could,O
12123,789,potentially,O
12124,789,influence,O
12125,789,the,O
12126,789,current,O
12127,789,illness,O
12128,790,Severe,O
12129,790,malnutrition,B-Condition
12130,790,(,O
12131,790,weight,O
12132,790,-,O
12133,790,for,O
12134,790,-,O
12135,790,height,O
12136,790,Z,O
12137,790,-,O
12138,790,score,O
12139,790,<,O
12140,790,-3,O
12141,790,),O
12142,791,Complicated,B-Condition
12143,791,(,I-Condition
12144,791,effusion,I-Condition
12145,791,",",I-Condition
12146,791,empyema,I-Condition
12147,791,or,I-Condition
12148,791,abscess,I-Condition
12149,791,),I-Condition
12150,791,pneumonia,I-Condition
12151,791,",",O
12152,791,including,O
12153,791,tuberculosis,B-Condition
12154,792,Extra,O
12155,792,-,O
12156,792,pulmonary,O
12157,792,infection,B-Condition
12158,792,requiring,O
12159,792,antibiotic,B-Procedure
12160,792,therapy,I-Procedure
12161,792,(,O
12162,792,e.g.,O
12163,792,meningitis,B-Condition
12164,792,),O
12165,793,Beta,B-Drug
12166,793,-,I-Drug
12167,793,lactam,I-Drug
12168,793,allergy,B-Condition
12169,794,Previously,O
12170,794,enrolled,O
12171,795,Lack,O
12172,795,a,O
12173,795,mobile,O
12174,795,phone,O
12175,795,and/or,O
12176,795,unable,O
12177,795,to,O
12178,795,return,O
12179,795,for,O
12180,795,follow,O
12181,795,-,O
12182,795,up,O
12183,795,clinic,O
12184,795,visits,O
12185,795,during,O
12186,795,the,O
12187,795,next,O
12188,795,24,O
12189,795,months,O
12190,796,Hospitalised,O
12191,796,children,B-Person
12192,796,aged,B-Person
12193,796,3,O
12194,796,-,O
12195,796,mo,O
12196,796,to,O
12197,796,5,O
12198,796,-,O
12199,796,yrs,O
12200,796,(,O
12201,796,in,O
12202,796,Darwin,O
12203,796,",",O
12204,796,children,O
12205,796,have,O
12206,796,to,O
12207,796,be,O
12208,796,Indigenous,O
12209,796,),O
12210,797,Have,O
12211,797,features,O
12212,797,of,O
12213,797,severe,O
12214,797,pneumonia,B-Condition
12215,797,on,O
12216,797,admission,O
12217,797,(,O
12218,797,temperature,O
12219,797,>,O
12220,797,37.5,O
12221,797,celsius,O
12222,797,or,O
12223,797,a,O
12224,797,history,O
12225,797,of,O
12226,797,fever,O
12227,797,at,O
12228,797,home,O
12229,797,or,O
12230,797,observed,O
12231,797,at,O
12232,797,the,O
12233,797,referring,O
12234,797,clinic,O
12235,797,",",O
12236,797,age,B-Person
12237,797,-,O
12238,797,adjusted,O
12239,797,tachypnoea,B-Condition
12240,797,[,O
12241,797,respiratory,O
12242,797,rate>50,O
12243,797,if,O
12244,797,<,O
12245,797,12,O
12246,797,-,O
12247,797,months,O
12248,797,;,O
12249,797,respiratory,O
12250,797,rate>40,O
12251,797,if,O
12252,797,>,O
12253,797,12,O
12254,797,-,O
12255,797,months,O
12256,797,],O
12257,797,with,O
12258,797,chest,B-Condition
12259,797,wall,I-Condition
12260,797,recession,I-Condition
12261,797,and/or,O
12262,797,oxygen,O
12263,797,saturation,O
12264,797,<,O
12265,797,92,O
12266,797,%,O
12267,797,in,O
12268,797,air,O
12269,797,),O
12270,797,",",O
12271,797,and,O
12272,797,consolidation,B-Condition
12273,797,on,O
12274,797,chest,B-Procedure
12275,797,X,I-Procedure
12276,797,-,I-Procedure
12277,797,ray,I-Procedure
12278,797,as,O
12279,797,diagnosed,O
12280,797,by,O
12281,797,treating,O
12282,797,clinician,O
12283,798,After,O
12284,798,1,O
12285,798,-,O
12286,798,3,O
12287,798,days,O
12288,798,of,O
12289,798,IV,O
12290,798,antibiotics,O
12291,798,",",O
12292,798,are,O
12293,798,afebrile,O
12294,798,",",O
12295,798,with,O
12296,798,improved,O
12297,798,respiratory,O
12298,798,symptoms,O
12299,798,and,O
12300,798,signs,O
12301,798,",",O
12302,798,oxygen,O
12303,798,saturation>90,O
12304,798,%,O
12305,798,in,O
12306,798,air,O
12307,798,and,O
12308,798,are,O
12309,798,ready,O
12310,798,to,O
12311,798,be,O
12312,798,switched,O
12313,798,to,O
12314,798,oral,O
12315,798,amoxicillin,O
12316,798,-,O
12317,798,clavulanate,O
12318,798,",",O
12319,798,and,O
12320,799,Have,O
12321,799,symptoms,B-Condition
12322,799,of,O
12323,799,no,O
12324,799,longer,O
12325,799,than,O
12326,799,7,O
12327,799,days,O
12328,799,at,O
12329,799,point,O
12330,799,of,O
12331,799,hospitalisation,O
12332,799,.,O
12333,800,Administration,O
12334,800,of,O
12335,800,HES,B-Drug
12336,800,",",O
12337,800,dextrane,B-Drug
12338,800,solutions,I-Drug
12339,800,or,O
12340,800,>,O
12341,800,500,O
12342,800,ml,O
12343,800,of,O
12344,800,Gelatin,B-Drug
12345,800,solutions,I-Drug
12346,800,within,O
12347,800,the,O
12348,800,24,O
12349,800,h,O
12350,800,prior,O
12351,800,to,O
12352,800,randomization,O
12353,801,Death,B-Observation
12354,801,expected,I-Observation
12355,801,within,O
12356,801,the,O
12357,801,next,O
12358,801,48,O
12359,801,h,O
12360,801,(,O
12361,801,moribund,B-Condition
12362,801,patients,O
12363,801,as,O
12364,801,defined,O
12365,801,by,O
12366,801,ASA,O
12367,801,=,O
12368,801,class,O
12369,801,V,O
12370,801,),O
12371,802,Patients,O
12372,802,whose,O
12373,802,medical,O
12374,802,condition,O
12375,802,does,O
12376,802,preclude,O
12377,802,the,O
12378,802,PLR,O
12379,802,manoeuvre,O
12380,803,Patients,O
12381,803,for,O
12382,803,whom,O
12383,803,the,O
12384,803,need,O
12385,803,of,O
12386,803,pressure,O
12387,803,infusions,O
12388,803,are,O
12389,803,expected,O
12390,804,Requirement,B-Mood
12391,804,for,I-Mood
12392,804,renal,B-Condition
12393,804,support,I-Condition
12394,804,(,O
12395,804,either,O
12396,804,continuous,O
12397,804,or,O
12398,804,discontinuous,O
12399,804,techniques,O
12400,804,",",O
12401,804,including,O
12402,804,intermittent,O
12403,804,haemodialysis,O
12404,804,",",O
12405,804,haemofiltration,O
12406,804,and,O
12407,804,haemodiafiltration,O
12408,804,),O
12409,805,Patients,O
12410,805,receiving,O
12411,805,therapeutic,O
12412,805,heparin,B-Drug
12413,805,medication,O
12414,805,due,O
12415,805,to,O
12416,805,chronic,B-Condition
12417,805,coagulation,I-Condition
12418,805,disease,I-Condition
12419,805,/,O
12420,805,anticoagulation,B-Drug
12421,805,medication,I-Drug
12422,805,(,O
12423,805,i.e.,O
12424,805,partial,O
12425,805,thromboplastin,O
12426,805,time,O
12427,805,>,O
12428,805,60,O
12429,805,sec,O
12430,805,),O
12431,806,Acutely,B-Condition
12432,806,burned,I-Condition
12433,806,patients,O
12434,807,Contraindications,O
12435,807,according,O
12436,807,to,O
12437,807,summary,O
12438,807,of,O
12439,807,product,O
12440,807,characteristics,O
12441,807,of,O
12442,807,investigational,O
12443,807,test,O
12444,807,and,O
12445,807,reference,O
12446,807,product,O
12447,808,Simultaneous,O
12448,808,participation,O
12449,808,in,O
12450,808,another,O
12451,808,interventional,O
12452,808,clinical,O
12453,808,trial,O
12454,808,(,O
12455,808,drugs,O
12456,808,or,O
12457,808,medical,O
12458,808,devices,O
12459,808,studies,O
12460,808,),O
12461,809,Male,B-Person
12462,809,or,O
12463,809,female,B-Person
12464,809,patients,O
12465,809,=,O
12466,809,18,O
12467,809,and,O
12468,809,=,O
12469,809,85,O
12470,809,years,O
12471,809,of,O
12472,809,age,B-Person
12473,810,Women,B-Person
12474,810,of,O
12475,810,child,B-Condition
12476,810,bearing,I-Condition
12477,810,potential,I-Condition
12478,810,must,O
12479,810,test,O
12480,810,negative,O
12481,810,on,O
12482,810,standard,O
12483,810,pregnancy,O
12484,810,test,O
12485,810,(,O
12486,810,urine,O
12487,810,or,O
12488,810,serum,O
12489,810,),O
12490,811,Patients,O
12491,811,with,O
12492,811,body,O
12493,811,weight,O
12494,811,=,O
12495,811,55,O
12496,811,kg,O
12497,811,and,O
12498,811,=,O
12499,811,140,O
12500,811,kg,O
12501,811,and,O
12502,811,body,O
12503,811,mass,O
12504,811,index,O
12505,811,(,O
12506,811,BMI,O
12507,811,),O
12508,811,=,O
12509,811,18,O
12510,811,kg,O
12511,811,/,O
12512,811,m2,O
12513,812,Patients,O
12514,812,diagnosed,O
12515,812,severe,B-Condition
12516,812,sepsis,I-Condition
12517,812,/,O
12518,812,septic,B-Condition
12519,812,shock,I-Condition
12520,812,at,O
12521,812,admission,O
12522,812,on,O
12523,812,Intensive,O
12524,812,Care,O
12525,812,Unit,O
12526,812,who,O
12527,812,can,O
12528,812,be,O
12529,812,enrolled,O
12530,812,within,O
12531,812,90,O
12532,812,min,O
12533,812,after,O
12534,812,admission,O
12535,812,OR,O
12536,812,patients,O
12537,812,diagnosed,O
12538,812,severe,O
12539,812,sepsis,O
12540,812,/,O
12541,812,septic,O
12542,812,shock,O
12543,812,during,O
12544,812,Intensive,O
12545,812,Care,O
12546,812,Unit,O
12547,812,stay,O
12548,812,who,O
12549,812,can,O
12550,812,be,O
12551,812,enrolled,O
12552,812,within,O
12553,812,90,O
12554,812,min,O
12555,812,after,O
12556,812,diagnosis,O
12557,813,Patients,O
12558,813,where,O
12559,813,antibiotic,B-Drug
12560,813,therapy,I-Drug
12561,813,has,O
12562,813,already,O
12563,813,been,O
12564,813,started,O
12565,813,(,O
12566,813,prior,O
12567,813,to,O
12568,813,randomization,O
12569,813,),O
12570,814,Patient,O
12571,814,who,O
12572,814,are,O
12573,814,fluid,B-Condition
12574,814,responsive,I-Condition
12575,814,.,O
12576,814,Fluid,O
12577,814,responsiveness,O
12578,814,is,O
12579,814,defined,O
12580,814,as,O
12581,814,increase,O
12582,814,of,O
12583,814,>,O
12584,814,10,O
12585,814,%,O
12586,814,in,O
12587,814,mean,O
12588,814,arterial,O
12589,814,pressure,O
12590,814,(,O
12591,814,MAP,O
12592,814,),O
12593,814,after,O
12594,814,passive,O
12595,814,leg,O
12596,814,raising,O
12597,814,(,O
12598,814,PLR,O
12599,814,),O
12600,815,Signed,O
12601,815,informed,O
12602,815,consent,O
12603,815,by,O
12604,815,patient,O
12605,815,",",O
12606,815,legal,O
12607,815,representative,O
12608,815,or,O
12609,815,authorized,O
12610,815,person,O
12611,815,or,O
12612,815,deferred,O
12613,815,consent,O
12614,816,Pregnant,B-Condition
12615,816,or,O
12616,816,nursing,B-Observation
12617,816,(,O
12618,816,lactating,B-Observation
12619,816,),O
12620,816,women,B-Person
12621,817,HIV,B-Condition
12622,817,positivity,I-Condition
12623,818,Need,B-Mood
12624,818,for,I-Mood
12625,818,dual,B-Procedure
12626,818,organ,I-Procedure
12627,818,transplant,I-Procedure
12628,819,Any,O
12629,819,contra,B-Condition
12630,819,-,I-Condition
12631,819,indication,I-Condition
12632,819,to,O
12633,819,liver,B-Procedure
12634,819,transplantation,I-Procedure
12635,819,per,O
12636,819,center,O
12637,819,protocol,O
12638,820,Recipient,O
12639,820,is,O
12640,820,Age,B-Person
12641,820,=,O
12642,820,18,O
12643,820,years,O
12644,821,Met,O
12645,821,MGH,O
12646,821,transplant,O
12647,821,center,O
12648,821,criteria,O
12649,821,",",O
12650,821,listed,O
12651,821,for,O
12652,821,liver,B-Procedure
12653,821,transplant,I-Procedure
12654,822,HCV,B-Condition
12655,822,naive,I-Condition
12656,823,Able,B-Observation
12657,823,to,I-Observation
12658,823,sign,I-Observation
12659,823,informed,I-Observation
12660,823,consent,I-Observation
12661,824,NA,O
12662,825,Patient,O
12663,825,'s,O
12664,825,written,O
12665,825,informed,O
12666,825,consent,O
12667,825,.,O
12668,825,Adequate,O
12669,825,cognitive,O
12670,825,capacity,O
12671,825,.,O
12672,826,Adequate,O
12673,826,family,O
12674,826,support,O
12675,827,No,O
12676,827,acute,O
12677,827,diverticulitis,B-Condition
12678,827,episode,O
12679,827,in,O
12680,827,the,O
12681,827,last,O
12682,827,3,O
12683,827,months,O
12684,828,mNeff,O
12685,828,0,O
12686,828,acute,O
12687,828,diverticulitis,B-Condition
12688,828,(,O
12689,828,abdominal,B-Procedure
12690,828,computed,I-Procedure
12691,828,tomography,I-Procedure
12692,828,scan,I-Procedure
12693,828,),O
12694,829,No,O
12695,829,antibiotic,B-Drug
12696,829,treatment,I-Drug
12697,829,in,O
12698,829,the,O
12699,829,last,O
12700,829,2,O
12701,829,weeks,O
12702,830,Immunocompetence,B-Condition
12703,830,*,O
12704,831,No,O
12705,831,significant,O
12706,831,comorbidities,B-Condition
12707,831,*,O
12708,831,*,O
12709,832,Good,O
12710,832,oral,B-Condition
12711,832,tolerance,I-Condition
12712,833,Good,O
12713,833,symptom,B-Condition
12714,833,control,I-Condition
12715,834,Maximum,O
12716,834,one,O
12717,834,of,O
12718,834,the,O
12719,834,following,O
12720,834,SIRS,O
12721,834,criteria,O
12722,834,(,O
12723,834,*,O
12724,834,T>38,O
12725,834,ºC,O
12726,834,or,O
12727,834,<,O
12728,834,36ºC,O
12729,834,",",O
12730,834,"L>12,000",O
12731,834,or,O
12732,834,<,O
12733,834,4000,O
12734,834,/,O
12735,834,uL,O
12736,834,",",O
12737,834,HR>90,O
12738,834,bpm,O
12739,834,",",O
12740,834,RR<20,O
12741,834,rpm,O
12742,834,),O
12743,834,or,O
12744,834,CRP>15,O
12745,834,mg,O
12746,834,/,O
12747,834,dL,O
12748,835,implanted,O
12749,835,hardware,O
12750,835,or,O
12751,835,other,O
12752,835,material,O
12753,835,that,O
12754,835,would,O
12755,835,prohibit,O
12756,835,treatment,O
12757,835,planning,O
12758,835,or,O
12759,835,delivery,O
12760,836,chemotherapy,B-Procedure
12761,836,for,O
12762,836,a,O
12763,836,malignancy,B-Condition
12764,836,within,O
12765,836,the,O
12766,836,previous,O
12767,836,5,O
12768,836,years,O
12769,837,history,O
12770,837,of,O
12771,837,an,O
12772,837,invasive,B-Condition
12773,837,malignancy,I-Condition
12774,837,(,O
12775,837,other,O
12776,837,than,O
12777,837,this,O
12778,837,prostate,B-Condition
12779,837,cancer,I-Condition
12780,837,",",O
12781,837,or,O
12782,837,basal,B-Condition
12783,837,or,I-Condition
12784,837,squamous,I-Condition
12785,837,skin,I-Condition
12786,837,cancers,I-Condition
12787,837,),O
12788,837,within,O
12789,837,prior,O
12790,837,5,O
12791,837,years,O
12792,838,hormone,B-Procedure
12793,838,ablation,I-Procedure
12794,838,for,O
12795,838,2,O
12796,838,months,O
12797,838,prior,O
12798,838,to,O
12799,838,treatment,O
12800,838,or,O
12801,838,during,O
12802,838,treatment,O
12803,839,histologically,O
12804,839,proven,O
12805,839,prostate,B-Condition
12806,839,adenocarcinoma,I-Condition
12807,839,within,O
12808,839,1,O
12809,839,year,O
12810,839,of,O
12811,839,enrollment,O
12812,840,Low,B-Observation
12813,840,risk,I-Observation
12814,840,:,O
12815,840,Gleason,O
12816,840,<,O
12817,840,or=6,O
12818,840,&,O
12819,840,PSA,O
12820,840,<,O
12821,840,or=10,O
12822,840,&,O
12823,840,Clinical,O
12824,840,Stage,O
12825,840,T1b,O
12826,840,-,O
12827,840,T2a,O
12828,840,",",O
12829,840,Nx,O
12830,840,or,O
12831,840,N0,O
12832,840,",",O
12833,840,Mx,O
12834,840,or,O
12835,840,M0,O
12836,841,Intermediate,B-Observation
12837,841,risk,I-Observation
12838,841,:,O
12839,841,Gleason,O
12840,841,<,O
12841,841,or=6,O
12842,841,&,O
12843,841,PSA,O
12844,841,<,O
12845,841,or=10,O
12846,841,&,O
12847,841,Clinical,O
12848,841,Stage,O
12849,841,T2b,O
12850,841,OR,O
12851,841,Gleason=7,O
12852,841,&,O
12853,841,PSA,O
12854,841,<,O
12855,841,or=10,O
12856,841,&,O
12857,841,Clinical,O
12858,841,Stage,O
12859,841,T1b,O
12860,841,-,O
12861,841,T2b,O
12862,841,OR,O
12863,841,Gleason,O
12864,841,<,O
12865,841,or=6,O
12866,841,&,O
12867,841,PSA,O
12868,841,>,O
12869,841,10,O
12870,841,&,O
12871,841,<,O
12872,841,or,O
12873,841,=,O
12874,841,20,O
12875,841,&,O
12876,841,Clinical,O
12877,841,Stage,O
12878,841,T1b-,O
12879,841,T2b,O
12880,841,",",O
12881,841,Nx,O
12882,841,or,O
12883,841,NO,O
12884,841,",",O
12885,841,Mx,O
12886,841,or,O
12887,841,M0,O
12888,842,ECOG,O
12889,842,Performance,O
12890,842,Status,O
12891,842,0,O
12892,842,-,O
12893,842,1,O
12894,843,No,O
12895,843,prior,O
12896,843,prostate,B-Procedure
12897,843,radiation,I-Procedure
12898,843,or,O
12899,843,other,O
12900,843,definitive,B-Procedure
12901,843,therapy,I-Procedure
12902,844,Type,B-Condition
12903,844,1,I-Condition
12904,844,diabetes,I-Condition
12905,845,Treatment,B-Procedure
12906,845,with,O
12907,845,insulin,B-Drug
12908,846,Body,O
12909,846,weight,O
12910,846,>,O
12911,846,140,O
12912,846,kg,O
12913,847,HbA1c,O
12914,847,>,O
12915,847,75,O
12916,847,mmol,O
12917,847,/,O
12918,847,mol,O
12919,848,Treatment,O
12920,848,with,O
12921,848,GLP-1,B-Drug
12922,848,analogues,I-Drug
12923,848,",",O
12924,848,Dipeptidyl,B-Drug
12925,848,peptidase-4,I-Drug
12926,848,inhibitors,I-Drug
12927,848,",",O
12928,848,or,O
12929,848,glitazones,B-Drug
12930,849,Chronic,B-Condition
12931,849,kidney,I-Condition
12932,849,disease,I-Condition
12933,850,Hepatic,B-Condition
12934,850,disease,I-Condition
12935,851,Pancreatitis,B-Condition
12936,852,Inflammatory,B-Condition
12937,852,bowel,I-Condition
12938,852,disease,I-Condition
12939,853,Osteoporosis,B-Condition
12940,854,Family,B-Observation
12941,854,or,O
12942,854,personal,B-Observation
12943,854,history,I-Observation
12944,854,of,O
12945,854,medullary,B-Condition
12946,854,thyroid,I-Condition
12947,854,carcinoma,I-Condition
12948,855,Treatment,B-Procedure
12949,855,with,O
12950,855,glucocorticoids,B-Drug
12951,856,Hormone,B-Procedure
12952,856,replacement,I-Procedure
12953,856,therapy,I-Procedure
12954,857,Diabetic,B-Condition
12955,857,gastroparesis,I-Condition
12956,858,Pregnancy,B-Condition
12957,858,or,O
12958,858,lactation,B-Condition
12959,859,Informed,O
12960,859,consent,O
12961,860,Diagnosis,O
12962,860,of,O
12963,860,type,B-Condition
12964,860,2,I-Condition
12965,860,diabetes,I-Condition
12966,860,(,O
12967,860,HbA1c,O
12968,860,>,O
12969,860,48,O
12970,860,mmol,O
12971,860,/,O
12972,860,mol,O
12973,860,),O
12974,861,Age,B-Person
12975,861,older,O
12976,861,than,O
12977,861,30,O
12978,861,years,O
12979,862,Upper,O
12980,862,limb,O
12981,862,bites,B-Condition
12982,863,Multiple,O
12983,863,(,O
12984,863,>,O
12985,863,1,O
12986,863,),O
12987,863,bites,B-Condition
12988,864,Wound,B-Observation
12989,864,manipulation,I-Observation
12990,865,Extensive,B-Condition
12991,865,local,I-Condition
12992,865,necrosis,I-Condition
12993,865,or,I-Condition
12994,865,blebs,I-Condition
12995,866,Seriously,B-Condition
12996,866,-,I-Condition
12997,866,ill,I-Condition
12998,866,patients,O
12999,866,with,O
13000,866,hypotension,B-Condition
13001,866,/,O
13002,866,capillary,B-Condition
13003,866,leak,I-Condition
13004,866,/,O
13005,866,life,O
13006,866,threatening,O
13007,866,bleeding,B-Condition
13008,866,.,O
13009,867,Suspected,B-Mood
13010,867,cobra,B-Condition
13011,867,bite,I-Condition
13012,867,",",O
13013,867,OR,O
13014,868,Pregnant,B-Condition
13015,868,/,O
13016,868,breast,B-Condition
13017,868,-,I-Condition
13018,868,feeding,I-Condition
13019,868,women,B-Person
13020,869,Age,B-Person
13021,869,18,O
13022,869,-,O
13023,869,65,O
13024,869,years,O
13025,870,History,O
13026,870,of,O
13027,870,snake,B-Condition
13028,870,bite,I-Condition
13029,870,with,O
13030,870,features,B-Mood
13031,870,of,I-Mood
13032,870,local,B-Condition
13033,870,envenomation,I-Condition
13034,870,with,O
13035,870,/,O
13036,870,without,O
13037,870,systemic,B-Condition
13038,870,features,I-Condition
13039,871,Less,O
13040,871,than,O
13041,871,24,O
13042,871,hours,O
13043,871,since,O
13044,871,bite,B-Condition
13045,871,",",O
13046,871,AND,O
13047,872,No,O
13048,872,prior,O
13049,872,antibiotic,B-Procedure
13050,872,treatment,I-Procedure
13051,873,Apnea,O
13052,873,-,O
13053,873,hypopnea,O
13054,873,index,O
13055,873,of,O
13056,873,less,O
13057,873,than,O
13058,873,5,O
13059,873,h-1,O
13060,873,or,O
13061,873,greater,O
13062,873,than,O
13063,873,30,O
13064,873,h-1,O
13065,873,.,O
13066,874,Predominance,B-Condition
13067,874,of,O
13068,874,central,B-Condition
13069,874,apneas,I-Condition
13070,874,and,I-Condition
13071,874,hypopneas,I-Condition
13072,874,",",O
13073,874,defined,O
13074,874,as,O
13075,874,more,O
13076,874,than,O
13077,874,25,O
13078,874,%,O
13079,874,of,O
13080,874,all,O
13081,874,respiratory,O
13082,874,events,O
13083,874,.,O
13084,875,Professional,B-Person
13085,875,drivers,I-Person
13086,875,",",O
13087,875,risk,B-Person
13088,875,profession,I-Person
13089,875,or,O
13090,875,respiratory,B-Condition
13091,875,failure,I-Condition
13092,875,(,O
13093,875,according,O
13094,875,to,O
13095,875,criteria,B-Procedure
13096,875,of,I-Procedure
13097,875,the,I-Procedure
13098,875,clinical,I-Procedure
13099,875,pathway,I-Procedure
13100,875,for,I-Procedure
13101,875,diagnosis,I-Procedure
13102,875,and,I-Procedure
13103,875,treatment,I-Procedure
13104,875,of,I-Procedure
13105,875,sleep,I-Procedure
13106,875,-,I-Procedure
13107,875,disordered,I-Procedure
13108,875,breathing,I-Procedure
13109,875,),O
13110,875,.,O
13111,876,Very,O
13112,876,excessive,O
13113,876,daytime,B-Condition
13114,876,sleepiness,I-Condition
13115,876,(,O
13116,876,Epworth,O
13117,876,Sleepiness,O
13118,876,Scale,O
13119,876,>,O
13120,876,18,O
13121,876,),O
13122,876,.,O
13123,877,Morbid,B-Condition
13124,877,obesity,I-Condition
13125,877,(,O
13126,877,BMI,O
13127,877,>,O
13128,877,40,O
13129,877,kg,O
13130,877,/,O
13131,877,m2,O
13132,877,),O
13133,877,.,O
13134,878,Prior,O
13135,878,treatment,O
13136,878,with,O
13137,878,CPAP,B-Procedure
13138,878,.,O
13139,879,Diagnosis,O
13140,879,of,O
13141,879,dyslipidemia,B-Condition
13142,879,:,O
13143,879,The,O
13144,879,existence,O
13145,879,of,O
13146,879,a,O
13147,879,previous,O
13148,879,clinical,O
13149,879,diagnostic,O
13150,879,of,O
13151,879,dyslipidemia,B-Condition
13152,879,associated,O
13153,879,with,O
13154,879,lipid,B-Procedure
13155,879,-,I-Procedure
13156,879,lowering,I-Procedure
13157,879,therapy,I-Procedure
13158,879,.,O
13159,879,It,O
13160,879,is,O
13161,879,also,O
13162,879,considered,O
13163,879,patients,O
13164,879,who,O
13165,879,have,O
13166,879,an,O
13167,879,altered,B-Condition
13168,879,analytical,I-Condition
13169,879,",",O
13170,879,using,O
13171,879,the,O
13172,879,following,O
13173,879,cutoffs,O
13174,879,:,O
13175,879,total,O
13176,879,cholesterol,O
13177,879,=,O
13178,879,200,O
13179,879,mg,O
13180,879,/,O
13181,879,dl,O
13182,879,",",O
13183,879,triglycerides,O
13184,879,=,O
13185,879,180,O
13186,879,mg,O
13187,879,/,O
13188,879,dl,O
13189,879,",",O
13190,879,HDL,O
13191,879,-,O
13192,879,cholesterol,O
13193,879,=,O
13194,879,40,O
13195,879,mg,O
13196,879,/,O
13197,879,dl,O
13198,879,or,O
13199,879,LDL,O
13200,879,-,O
13201,879,cholesterol,O
13202,879,=,O
13203,879,150,O
13204,879,mg,O
13205,879,/,O
13206,879,dl,O
13207,879,.,O
13208,879,Lipid,B-Procedure
13209,879,-,I-Procedure
13210,879,lowering,I-Procedure
13211,879,treatment,I-Procedure
13212,879,and,I-Procedure
13213,879,diet,I-Procedure
13214,879,",",O
13215,879,stable,O
13216,879,in,O
13217,879,the,O
13218,879,last,O
13219,879,month,O
13220,879,.,O
13221,880,A,O
13222,880,concentration,O
13223,880,of,O
13224,880,LDL,O
13225,880,-,O
13226,880,cholesterol,O
13227,880,above,O
13228,880,100,O
13229,880,mg,O
13230,880,/,O
13231,880,dl,O
13232,880,",",O
13233,880,in,O
13234,880,the,O
13235,880,month,O
13236,880,prior,O
13237,880,to,O
13238,880,inclusion,O
13239,880,.,O
13240,881,An,O
13241,881,apnea,O
13242,881,-,O
13243,881,hypopnea,O
13244,881,index,O
13245,881,between,O
13246,881,5,O
13247,881,-,O
13248,881,30,O
13249,881,h-1,O
13250,882,Allergy,B-Condition
13251,882,to,O
13252,882,porphyrins,B-Drug
13253,882,and,I-Drug
13254,882,analogues,I-Drug
13255,882,;,O
13256,882,Photosensitivity,B-Condition
13257,882,;,O
13258,882,Porphyria,B-Condition
13259,882,;,O
13260,882,Allergic,B-Condition
13261,882,constitution,I-Condition
13262,882,;,O
13263,883,Scar,B-Condition
13264,883,diathesis,I-Condition
13265,883,;,O
13266,884,Pregnancy,O
13267,884,or,O
13268,884,unwilling,O
13269,884,to,O
13270,884,adopt,O
13271,884,reliable,O
13272,884,contraceptive,O
13273,884,measures,O
13274,884,during,O
13275,884,the,O
13276,884,month,O
13277,884,after,O
13278,884,drug,O
13279,884,application,O
13280,884,;,O
13281,885,Be,O
13282,885,judged,O
13283,885,not,O
13284,885,suitable,O
13285,885,to,O
13286,885,participate,O
13287,885,the,O
13288,885,study,O
13289,885,by,O
13290,885,the,O
13291,885,investigators,O
13292,886,Age,B-Person
13293,886,range,O
13294,886,:,O
13295,886,14,O
13296,886,to,O
13297,886,65,O
13298,886,years,O
13299,886,-,O
13300,886,old,O
13301,886,;,O
13302,887,Clinically,O
13303,887,diagnosed,O
13304,887,of,O
13305,887,Port,B-Condition
13306,887,-,I-Condition
13307,887,wine,I-Condition
13308,887,Stain,I-Condition
13309,887,;,O
13310,888,Patients,O
13311,888,receiving,O
13312,888,hemoporfin,B-Drug
13313,888,based,O
13314,888,upon,O
13315,888,the,O
13316,888,clinical,O
13317,888,judgment,O
13318,888,of,O
13319,888,the,O
13320,888,investigator,O
13321,888,;,O
13322,889,Written,O
13323,889,informed,O
13324,889,consent,O
13325,889,signed,O
13326,889,and,O
13327,889,agreed,O
13328,889,to,O
13329,889,receive,O
13330,889,periodic,O
13331,889,follow,O
13332,889,-,O
13333,889,up,O
13334,890,Severe,O
13335,890,Iron,B-Condition
13336,890,deficiency,I-Condition
13337,890,anemia,I-Condition
13338,890,(,O
13339,890,hemoglobin,O
13340,890,<,O
13341,890,8.0,O
13342,890,g,O
13343,890,/,O
13344,890,dL,O
13345,890,),O
13346,890,.,O
13347,891,Parasitic,B-Condition
13348,891,worm,I-Condition
13349,891,infection,I-Condition
13350,891,e.g.,O
13351,891,schistosomiasis,B-Condition
13352,891,",",O
13353,891,and,O
13354,891,hook,B-Condition
13355,891,worm,I-Condition
13356,891,by,O
13357,891,stool,B-Procedure
13358,891,analysis,I-Procedure
13359,891,.,O
13360,892,Any,O
13361,892,cases,O
13362,892,giving,O
13363,892,clinical,B-Mood
13364,892,symptoms,I-Mood
13365,892,of,O
13366,892,gastritis,B-Condition
13367,892,e.g.,O
13368,892,nausea,B-Condition
13369,892,",",O
13370,892,vomiting,B-Condition
13371,892,",",O
13372,892,dull,B-Condition
13373,892,aching,I-Condition
13374,892,pain,I-Condition
13375,892,or,O
13376,892,soreness,B-Condition
13377,892,in,I-Condition
13378,892,the,I-Condition
13379,892,epigastrium,I-Condition
13380,892,.,O
13381,893,Cases,O
13382,893,with,O
13383,893,history,B-Observation
13384,893,of,O
13385,893,gastric,B-Condition
13386,893,ulcer,I-Condition
13387,893,diagnosed,O
13388,893,by,O
13389,893,upper,B-Procedure
13390,893,endoscopy,I-Procedure
13391,893,.,O
13392,894,Cases,O
13393,894,complaining,O
13394,894,of,O
13395,894,hematemesis,B-Condition
13396,894,.,O
13397,895,Diagnosed,O
13398,895,Iron,B-Condition
13399,895,deficiency,I-Condition
13400,895,anemia,I-Condition
13401,895,.,O
13402,896,H,B-Condition
13403,896,-,I-Condition
13404,896,pylori,I-Condition
13405,896,positive,I-Condition
13406,896,cases,O
13407,896,.,O
13408,897,Second,O
13409,897,trimester,O
13410,897,pregnancy,B-Condition
13411,897,.,O
13412,898,All,O
13413,898,patients,O
13414,898,who,O
13415,898,were,O
13416,898,wheelchair,B-Observation
13417,898,bound,I-Observation
13418,898,preoperatively,O
13419,899,All,O
13420,899,patients,O
13421,899,who,O
13422,899,can,O
13423,899,not,O
13424,899,participate,O
13425,899,in,O
13426,899,an,O
13427,899,outpatient,O
13428,899,physical,B-Procedure
13429,899,therapy,I-Procedure
13430,899,program,O
13431,899,for,O
13432,899,3,O
13433,899,days,O
13434,899,per,O
13435,899,week,O
13436,899,after,O
13437,899,surgery,O
13438,900,All,O
13439,900,patients,O
13440,900,will,O
13441,900,be,O
13442,900,undergoing,O
13443,900,a,O
13444,900,primary,O
13445,900,unilateral,B-Procedure
13446,900,total,I-Procedure
13447,900,knee,I-Procedure
13448,900,arthroplasty,I-Procedure
13449,900,for,O
13450,900,a,O
13451,900,diagnosis,O
13452,900,of,O
13453,900,osteoarthritis,B-Condition
13454,901,Pregnancy,B-Condition
13455,902,Patients,O
13456,902,with,O
13457,902,chronic,B-Condition
13458,902,kidney,I-Condition
13459,902,disease,I-Condition
13460,902,stage,O
13461,902,with,O
13462,902,eGFR,O
13463,902,<,O
13464,902,30,O
13465,902,ml,O
13466,902,/,O
13467,902,min,O
13468,902,(,O
13469,902,CKD,B-Condition
13470,902,stage,O
13471,902,IV,O
13472,902,and,O
13473,902,V,O
13474,902,),O
13475,903,Nephrotic,O
13476,903,range,O
13477,903,proteinuria,B-Condition
13478,903,(,O
13479,903,urinary,O
13480,903,protein,O
13481,903,>,O
13482,903,3.5,O
13483,903,gm,O
13484,903,/,O
13485,903,day,O
13486,903,),O
13487,904,History,B-Observation
13488,904,or,O
13489,904,renal,O
13490,904,transplantation,O
13491,905,History,B-Observation
13492,905,of,O
13493,905,multiple,B-Condition
13494,905,myeloma,I-Condition
13495,906,Known,O
13496,906,history,B-Observation
13497,906,of,O
13498,906,hypersensitivity,B-Condition
13499,906,reaction,I-Condition
13500,906,or,O
13501,906,intolerability,B-Condition
13502,906,to,O
13503,906,Ace,B-Drug
13504,906,Inh,I-Drug
13505,906,or,O
13506,906,ARB,B-Drug
13507,906,.,O
13508,907,Type,B-Condition
13509,907,2,I-Condition
13510,907,Diabetes,I-Condition
13511,908,Hypertension,B-Condition
13512,909,Estimated,O
13513,909,glomerular,O
13514,909,filtration,O
13515,909,rate,O
13516,909,(,O
13517,909,eGFR,O
13518,909,),O
13519,909,>,O
13520,909,30,O
13521,909,ml,O
13522,909,/,O
13523,909,min,O
13524,910,Use,O
13525,910,of,O
13526,910,Ace,B-Drug
13527,910,Inh,I-Drug
13528,910,and,O
13529,910,ARB,B-Drug
13530,910,for,O
13531,910,control,B-Procedure
13532,910,of,I-Procedure
13533,910,blood,I-Procedure
13534,910,pressure,I-Procedure
13535,910,who,O
13536,910,are,O
13537,910,willing,O
13538,910,to,O
13539,910,be,O
13540,910,placed,O
13541,910,on,O
13542,910,alternate,O
13543,910,drug(s,O
13544,910,),O
13545,910,in,O
13546,910,the,O
13547,910,washout,O
13548,910,period,O
13549,910,for,O
13550,910,blood,O
13551,910,pressure,O
13552,910,control,O
13553,911,Allergy,B-Condition
13554,911,or,O
13555,911,contraindication,B-Condition
13556,911,to,O
13557,911,paracetamol,B-Drug
13558,911,",",O
13559,911,Prasugrel,B-Drug
13560,911,or,O
13561,911,Ticagrelor,B-Drug
13562,912,Paracetamol,B-Drug
13563,912,ingestion,O
13564,912,in,O
13565,912,the,O
13566,912,previous,O
13567,912,48,O
13568,912,hours,O
13569,913,Patient,O
13570,913,treated,O
13571,913,with,O
13572,913,drugs,B-Drug
13573,913,supposed,I-Drug
13574,913,to,I-Drug
13575,913,alter,I-Drug
13576,913,gastric,I-Drug
13577,913,emptying,I-Drug
13578,913,times,I-Drug
13579,913,(,O
13580,913,calcium,B-Drug
13581,913,antagonists,I-Drug
13582,913,",",O
13583,913,Alimentary,B-Procedure
13584,913,tract,I-Procedure
13585,913,treatments,I-Procedure
13586,913,",",O
13587,913,opioid,B-Drug
13588,913,analgesics,I-Drug
13589,913,",",O
13590,913,tricyclic,B-Drug
13591,913,antidepressants,I-Drug
13592,913,",",O
13593,913,antibiotics,B-Drug
13594,913,),O
13595,913,.,O
13596,914,Conditions,B-Condition
13597,914,or,I-Condition
13598,914,pathologies,I-Condition
13599,914,supposed,I-Condition
13600,914,to,I-Condition
13601,914,alter,I-Condition
13602,914,gastric,I-Condition
13603,914,emptying,I-Condition
13604,914,times,I-Condition
13605,914,(,O
13606,914,Thyroid,B-Condition
13607,914,dysfunction,I-Condition
13608,914,",",O
13609,914,chronic,B-Condition
13610,914,renal,I-Condition
13611,914,failure,I-Condition
13612,914,",",O
13613,914,Parkinson,B-Condition
13614,914,'s,I-Condition
13615,914,disease,I-Condition
13616,914,",",O
13617,914,scleroderma,B-Condition
13618,914,",",O
13619,914,amyloidosis,B-Condition
13620,914,",",O
13621,914,any,O
13622,914,gastrointestinal,B-Condition
13623,914,disease,I-Condition
13624,914,",",O
13625,914,any,O
13626,914,not,O
13627,914,cured,O
13628,914,malignancy,B-Condition
13629,914,",",O
13630,914,and,O
13631,914,any,O
13632,914,advanced,O
13633,914,psychiatric,B-Condition
13634,914,or,I-Condition
13635,914,neurological,I-Condition
13636,914,disease,I-Condition
13637,914,),O
13638,914,.,O
13639,915,Presence,O
13640,915,of,O
13641,915,vomiting,B-Condition
13642,916,Cardiogenic,B-Condition
13643,916,shock,I-Condition
13644,916,",",O
13645,916,ventricular,B-Condition
13646,916,arrhythmia,I-Condition
13647,916,or,O
13648,916,resuscitated,O
13649,916,cardiac,B-Condition
13650,916,arrest,I-Condition
13651,917,Hepatic,B-Condition
13652,917,insufficiency,I-Condition
13653,918,Severe,O
13654,918,respiratory,B-Condition
13655,918,disease,I-Condition
13656,919,Pregnant,B-Condition
13657,919,or,O
13658,919,breastfeeding,B-Observation
13659,919,women,B-Person
13660,920,Patient,O
13661,920,over,O
13662,920,18,O
13663,920,years,B-Person
13664,920,weighing,O
13665,920,between,O
13666,920,65,O
13667,920,and,O
13668,920,85,O
13669,920,Kg,O
13670,921,Referred,O
13671,921,for,O
13672,921,STEMI,B-Condition
13673,921,within,O
13674,921,6,O
13675,921,hours,O
13676,921,from,O
13677,921,beginning,O
13678,921,of,O
13679,921,chest,B-Condition
13680,921,pain,I-Condition
13681,921,or,O
13682,921,stable,O
13683,921,coronary,B-Condition
13684,921,artery,I-Condition
13685,921,disease,I-Condition
13686,921,requiring,O
13687,921,a,O
13688,921,loading,O
13689,921,dose,O
13690,921,of,O
13691,921,Prasugrel,B-Drug
13692,921,or,O
13693,921,Ticagrelor,B-Drug
13694,921,according,O
13695,921,to,O
13696,921,the,O
13697,921,international,O
13698,921,recommendations,O
13699,921,.,O
13700,922,No,O
13701,922,previous,O
13702,922,treatment,B-Procedure
13703,922,with,O
13704,922,Clopidogrel,B-Drug
13705,922,",",O
13706,922,Prasugrel,B-Drug
13707,922,or,O
13708,922,Ticagrelor,B-Drug
13709,922,.,O
13710,923,Patient,O
13711,923,fasting,B-Observation
13712,923,for,O
13713,923,at,O
13714,923,least,O
13715,923,6,O
13716,923,hours,O
13717,923,.,O
13718,924,Affiliate,O
13719,924,or,O
13720,924,receiving,O
13721,924,a,O
13722,924,social,O
13723,924,security,O
13724,924,system,O
13725,924,.,O
13726,925,Written,B-Observation
13727,925,informed,I-Observation
13728,925,consent,I-Observation
13729,925,.,O
13730,926,PCOS,B-Condition
13731,926,patients,O
13732,927,Allergy,B-Condition
13733,927,to,O
13734,927,gonadotrophins,B-Drug
13735,928,Concomitant,O
13736,928,participation,O
13737,928,in,O
13738,928,other,O
13739,928,trial,O
13740,929,Premenopausal,B-Person
13741,929,women,B-Person
13742,930,18,O
13743,930,-,O
13744,930,35,O
13745,930,years,O
13746,930,old,B-Person
13747,931,FSH,O
13748,931,levels,O
13749,931,<,O
13750,931,10,O
13751,931,mIU,O
13752,931,/,O
13753,931,ml,O
13754,932,AFC,O
13755,932,>,O
13756,932,10,O
13757,933,Regular,B-Condition
13758,933,cycles,I-Condition
13759,934,BMI,O
13760,934,<,O
13761,934,28,O
13762,935,Signed,O
13763,935,informed,O
13764,935,consent,O
13765,936,Paroxysmal,B-Condition
13766,936,atrial,I-Condition
13767,936,fibrillation,I-Condition
13768,936,.,O
13769,937,Long,O
13770,937,-,O
13771,937,standing,O
13772,937,persistent,O
13773,937,or,O
13774,937,permanent,O
13775,937,atrial,B-Condition
13776,937,fibrillation,I-Condition
13777,937,.,O
13778,938,Previous,O
13779,938,pacemaker,O
13780,938,implantation,O
13781,938,.,O
13782,939,Previous,O
13783,939,atrial,B-Procedure
13784,939,ablation,I-Procedure
13785,939,.,O
13786,940,Patient,O
13787,940,is,O
13788,940,unable,B-Mood
13789,940,to,I-Mood
13790,940,take,I-Mood
13791,940,warfarin,B-Drug
13792,940,or,O
13793,940,other,O
13794,940,oral,B-Drug
13795,940,anti,I-Drug
13796,940,-,I-Drug
13797,940,coagulant,I-Drug
13798,940,medication,I-Drug
13799,940,.,O
13800,941,Patient,O
13801,941,is,O
13802,941,suffering,O
13803,941,with,O
13804,941,unstable,B-Condition
13805,941,angina,I-Condition
13806,941,in,O
13807,941,last,O
13808,941,one,O
13809,941,week,O
13810,941,.,O
13811,942,Patient,O
13812,942,has,O
13813,942,had,O
13814,942,a,O
13815,942,myocardial,B-Condition
13816,942,infarction,I-Condition
13817,942,within,O
13818,942,last,O
13819,942,two,O
13820,942,months,O
13821,942,.,O
13822,943,Patient,O
13823,943,is,O
13824,943,expecting,O
13825,943,or,O
13826,943,has,O
13827,943,had,O
13828,943,major,B-Procedure
13829,943,cardiac,I-Procedure
13830,943,surgery,I-Procedure
13831,943,within,O
13832,943,last,O
13833,943,two,O
13834,943,months,O
13835,943,.,O
13836,944,Patient,O
13837,944,is,O
13838,944,participating,O
13839,944,in,O
13840,944,a,O
13841,944,conflicting,O
13842,944,study,O
13843,944,.,O
13844,945,Patient,O
13845,945,is,O
13846,945,unable,O
13847,945,to,O
13848,945,perform,O
13849,945,exercise,O
13850,945,testing,O
13851,945,.,O
13852,946,Patient,O
13853,946,is,O
13854,946,mentally,O
13855,946,incapacitated,O
13856,946,and,O
13857,946,can,O
13858,946,not,O
13859,946,consent,O
13860,946,or,O
13861,946,comply,O
13862,946,with,O
13863,946,follow,O
13864,946,-,O
13865,946,up,O
13866,946,.,O
13867,947,Patient,O
13868,947,has,O
13869,947,New,O
13870,947,York,O
13871,947,Heart,O
13872,947,Association,O
13873,947,(,O
13874,947,NYHA,O
13875,947,),O
13876,947,class,O
13877,947,III,O
13878,947,/,O
13879,947,IV,O
13880,947,heart,B-Condition
13881,947,failure,I-Condition
13882,947,.,O
13883,948,Patient,O
13884,948,has,O
13885,948,left,O
13886,948,ventricular,O
13887,948,ejection,O
13888,948,fraction,O
13889,948,(,O
13890,948,LVEF,O
13891,948,),O
13892,948,less,O
13893,948,than,O
13894,948,35,O
13895,948,%,O
13896,948,not,B-Mood
13897,948,secondary,I-Mood
13898,948,to,I-Mood
13899,948,tachycardia,B-Condition
13900,948,.,O
13901,949,Pregnancy,B-Condition
13902,949,.,O
13903,950,Patient,O
13904,950,suffers,O
13905,950,with,O
13906,950,other,O
13907,950,cardiac,B-Condition
13908,950,rhythm,I-Condition
13909,950,disorders,I-Condition
13910,950,.,O
13911,951,Recent,O
13912,951,coronary,B-Procedure
13913,951,artery,I-Procedure
13914,951,intervention,I-Procedure
13915,951,or,O
13916,951,other,O
13917,951,factors,O
13918,951,suggesting,O
13919,951,clinical,O
13920,951,instability,O
13921,951,(,O
13922,951,ECG,O
13923,951,",",O
13924,951,clinical,O
13925,951,or,O
13926,951,laboratory,O
13927,951,findings,O
13928,951,),O
13929,951,.,O
13930,952,Patients,O
13931,952,with,O
13932,952,symptomatic,O
13933,952,persistent,O
13934,952,atrial,B-Condition
13935,952,fibrillation,I-Condition
13936,952,of,O
13937,952,less,O
13938,952,than,O
13939,952,1,O
13940,952,-,O
13941,952,year,O
13942,952,duration,O
13943,952,.,O
13944,953,Patients,O
13945,953,must,O
13946,953,be,O
13947,953,over,O
13948,953,65,O
13949,953,years,O
13950,953,old,B-Person
13951,953,.,O
13952,954,Patients,O
13953,954,give,O
13954,954,informed,O
13955,954,consent,O
13956,954,prior,O
13957,954,to,O
13958,954,participating,O
13959,954,in,O
13960,954,this,O
13961,954,study,O
13962,954,.,O
13963,955,Heart,B-Condition
13964,955,failure,I-Condition
13965,956,Signs,B-Mood
13966,956,of,I-Mood
13967,956,kidney,B-Condition
13968,956,injury,I-Condition
13969,956,/,I-Condition
13970,956,failure,I-Condition
13971,957,Severe,O
13972,957,allergies,B-Condition
13973,958,For,O
13974,958,healthy,B-Condition
13975,958,individuals,O
13976,958,:,O
13977,958,Healthy,B-Condition
13978,958,",",O
13979,958,without,O
13980,958,allergies,B-Condition
13981,958,and,O
13982,958,with,O
13983,958,the,O
13984,958,age,B-Person
13985,958,of,O
13986,958,18,O
13987,958,years,O
13988,958,or,O
13989,958,above,O
13990,958,.,O
13991,959,For,O
13992,959,patients,B-Person
13993,959,:,O
13994,959,Burn,B-Condition
13995,959,injury,I-Condition
13996,959,exceeding,O
13997,959,6,O
13998,959,-,O
13999,959,8,O
14000,959,Total,O
14001,959,Burned,O
14002,959,Surface,O
14003,959,Area,O
14004,959,%,O
14005,960,Subjects,O
14006,960,taking,O
14007,960,any,O
14008,960,lipid,B-Procedure
14009,960,modification,I-Procedure
14010,960,therapy,I-Procedure
14011,960,",",O
14012,960,including,O
14013,960,but,O
14014,960,not,O
14015,960,limited,O
14016,960,to,O
14017,960,statins,B-Drug
14018,960,",",O
14019,960,fibrates,B-Drug
14020,960,and,O
14021,960,bile,B-Drug
14022,960,acid,I-Drug
14023,960,sequestrants,I-Drug
14024,960,.,O
14025,961,Subjects,O
14026,961,taking,O
14027,961,fish,B-Drug
14028,961,oil,I-Drug
14029,961,or,O
14030,961,any,O
14031,961,other,O
14032,961,supplements,O
14033,961,",",O
14034,961,which,O
14035,961,in,O
14036,961,the,O
14037,961,investigator,O
14038,961,s,O
14039,961,opinion,O
14040,961,may,O
14041,961,interfere,O
14042,961,with,O
14043,961,the,O
14044,961,study,O
14045,961,.,O
14046,962,Subjects,O
14047,962,with,O
14048,962,acute,B-Condition
14049,962,liver,I-Condition
14050,962,disease,I-Condition
14051,962,or,O
14052,962,active,O
14053,962,peptic,B-Condition
14054,962,ulcer,I-Condition
14055,962,disease,I-Condition
14056,962,.,O
14057,963,Subjects,O
14058,963,with,O
14059,963,elevated,O
14060,963,uric,O
14061,963,acid,O
14062,963,levels,O
14063,963,greater,O
14064,963,than,O
14065,963,10,O
14066,963,mg,O
14067,963,/,O
14068,963,dL,O
14069,963,or,O
14070,963,gout,B-Condition
14071,964,Pregnancy,B-Condition
14072,964,or,O
14073,964,women,B-Person
14074,964,currently,O
14075,964,breastfeeding,B-Observation
14076,964,.,O
14077,965,Female,B-Person
14078,965,subjects,O
14079,965,taking,O
14080,965,hormonal,B-Drug
14081,965,contraceptives,I-Drug
14082,965,or,O
14083,965,hormone,B-Procedure
14084,965,replacement,I-Procedure
14085,965,therapy,I-Procedure
14086,965,may,O
14087,965,be,O
14088,965,included,O
14089,965,in,O
14090,965,this,O
14091,965,study,O
14092,965,only,O
14093,965,if,O
14094,965,they,O
14095,965,have,O
14096,965,been,O
14097,965,on,O
14098,965,a,O
14099,965,stable,O
14100,965,dose,O
14101,965,for,O
14102,965,at,O
14103,965,least,O
14104,965,3,O
14105,965,months,O
14106,965,.,O
14107,966,BMI,O
14108,966,less,O
14109,966,than,O
14110,966,18.5,O
14111,967,Subjects,O
14112,967,with,O
14113,967,weight,O
14114,967,that,O
14115,967,varies,O
14116,967,greater,O
14117,967,than,O
14118,967,20,O
14119,967,%,O
14120,967,over,O
14121,967,the,O
14122,967,past,O
14123,967,3,O
14124,967,months,O
14125,967,.,O
14126,968,Subjects,O
14127,968,taking,O
14128,968,the,O
14129,968,following,O
14130,968,medications,O
14131,968,for,O
14132,968,at,O
14133,968,least,O
14134,968,six,O
14135,968,weeks,O
14136,968,",",O
14137,968,which,O
14138,968,may,O
14139,968,interfere,O
14140,968,with,O
14141,968,the,O
14142,968,study,O
14143,968,",",O
14144,968,will,O
14145,968,be,O
14146,968,excluded,O
14147,968,:,O
14148,968,BAS,B-Drug
14149,968,",",O
14150,968,antibiotics,B-Drug
14151,968,",",O
14152,968,anticoagulants,B-Drug
14153,968,",",O
14154,968,anticonvulsants,B-Drug
14155,968,",",O
14156,968,antiarrhythmic,B-Drug
14157,968,",",O
14158,968,Cyclosporine,B-Drug
14159,968,",",O
14160,968,Mycophenolate,B-Drug
14161,968,and,O
14162,968,Synthroid,B-Drug
14163,968,.,O
14164,968,Subjects,O
14165,968,with,O
14166,968,chronic,B-Condition
14167,968,diarrhea,I-Condition
14168,968,",",O
14169,968,gastric,B-Procedure
14170,968,bypass,I-Procedure
14171,968,or,O
14172,968,lap,B-Procedure
14173,968,band,I-Procedure
14174,968,procedures,I-Procedure
14175,968,",",O
14176,968,ostomies,B-Procedure
14177,968,",",O
14178,968,bowel,B-Condition
14179,968,motility,I-Condition
14180,968,problems,I-Condition
14181,968,",",O
14182,968,or,O
14183,968,other,O
14184,968,conditions,B-Condition
14185,968,that,I-Condition
14186,968,could,I-Condition
14187,968,affect,I-Condition
14188,968,intestinal,I-Condition
14189,968,fat,I-Condition
14190,968,absorption,I-Condition
14191,968,.,O
14192,969,Subjects,O
14193,969,initiating,O
14194,969,new,O
14195,969,medications,O
14196,969,or,O
14197,969,patients,O
14198,969,on,O
14199,969,multiple,O
14200,969,medications,O
14201,969,may,O
14202,969,also,O
14203,969,be,O
14204,969,excluded,O
14205,969,.,O
14206,970,Inability,B-Condition
14207,970,to,I-Condition
14208,970,swallow,I-Condition
14209,970,capsules,I-Condition
14210,971,Patients,O
14211,971,with,O
14212,971,a,O
14213,971,history,B-Observation
14214,971,of,O
14215,971,type,B-Condition
14216,971,I,I-Condition
14217,971,or,I-Condition
14218,971,type,I-Condition
14219,971,II,I-Condition
14220,971,diabetes,I-Condition
14221,971,or,O
14222,971,HbA1c,O
14223,971,greater,O
14224,971,than,O
14225,971,6.5,O
14226,971,%,O
14227,971,.,O
14228,972,Volunteers,O
14229,972,may,O
14230,972,also,O
14231,972,be,O
14232,972,excluded,O
14233,972,",",O
14234,972,if,O
14235,972,in,O
14236,972,the,O
14237,972,opinion,O
14238,972,of,O
14239,972,the,O
14240,972,study,O
14241,972,investigators,O
14242,972,",",O
14243,972,they,O
14244,972,have,O
14245,972,some,O
14246,972,other,O
14247,972,condition,O
14248,972,or,O
14249,972,disorder,O
14250,972,that,O
14251,972,may,O
14252,972,adversely,O
14253,972,affect,O
14254,972,the,O
14255,972,outcome,O
14256,972,of,O
14257,972,the,O
14258,972,study,O
14259,972,or,O
14260,972,the,O
14261,972,safety,O
14262,972,of,O
14263,972,the,O
14264,972,volunteer,O
14265,972,.,O
14266,973,Males,B-Person
14267,973,and,O
14268,973,females,B-Person
14269,973,who,O
14270,973,are,O
14271,973,at,O
14272,973,least,O
14273,973,18,O
14274,973,years,O
14275,973,of,O
14276,973,age,B-Person
14277,973,at,O
14278,973,time,O
14279,973,of,O
14280,973,enrollment,O
14281,973,.,O
14282,974,Subject,O
14283,974,understands,O
14284,974,the,O
14285,974,investigational,O
14286,974,nature,O
14287,974,of,O
14288,974,the,O
14289,974,study,O
14290,974,and,O
14291,974,provides,O
14292,974,written,O
14293,974,",",O
14294,974,informed,O
14295,974,consent,O
14296,974,.,O
14297,975,Pregnant,B-Condition
14298,975,women,B-Person
14299,976,Claustrophobic,B-Condition
14300,976,patient,O
14301,976,unable,O
14302,976,to,O
14303,976,undergo,O
14304,976,the,O
14305,976,examination,B-Procedure
14306,977,Breastfeeding,O
14307,977,women,O
14308,977,unwilling,O
14309,977,to,O
14310,977,temporarily,O
14311,977,stop,O
14312,977,breastfeeding,O
14313,978,Patient,O
14314,978,with,O
14315,978,contra,B-Condition
14316,978,-,I-Condition
14317,978,indication,I-Condition
14318,978,to,O
14319,978,:,O
14320,978,dipyridamole,B-Drug
14321,978,",",O
14322,978,aminophylline,B-Drug
14323,978,",",O
14324,978,dobutamine,B-Drug
14325,978,or,O
14326,978,exercise,B-Procedure
14327,978,stress,I-Procedure
14328,978,test,I-Procedure
14329,978,(,O
14330,978,depending,O
14331,978,on,O
14332,978,the,O
14333,978,method,O
14334,978,of,O
14335,978,cardiovascular,O
14336,978,stress,O
14337,978,test,O
14338,978,chosen,O
14339,978,),O
14340,979,Adult,B-Person
14341,979,patient,O
14342,979,being,O
14343,979,referred,O
14344,979,for,O
14345,979,clinically,O
14346,979,indicated,O
14347,979,positron,B-Procedure
14348,979,emission,I-Procedure
14349,979,tomography,I-Procedure
14350,979,myocardial,I-Procedure
14351,979,perfusion,I-Procedure
14352,979,imaging,I-Procedure
14353,979,at,O
14354,979,the,O
14355,979,Centre,O
14356,979,hospitalier,O
14357,979,de,O
14358,979,l'Université,O
14359,979,de,O
14360,979,Montréal,O
14361,980,Patients,O
14362,980,attending,O
14363,980,for,O
14364,980,a,O
14365,980,therapeutic,B-Procedure
14366,980,endoscopic,I-Procedure
14367,980,procedure,I-Procedure
14368,980,e.g.,O
14369,980,variceal,B-Procedure
14370,980,banding,I-Procedure
14371,980,",",O
14372,980,stent,B-Procedure
14373,980,insertion,I-Procedure
14374,980,",",O
14375,980,balloon,B-Procedure
14376,980,dilatation,I-Procedure
14377,980,.,O
14378,981,Patients,O
14379,981,with,O
14380,981,a,O
14381,981,known,B-Condition
14382,981,diagnosis,I-Condition
14383,981,e.g.,O
14384,981,upper,B-Condition
14385,981,gastrointestinal,I-Condition
14386,981,cancer,I-Condition
14387,982,Patients,O
14388,982,previously,O
14389,982,treated,O
14390,982,with,O
14391,982,HP,B-Procedure
14392,982,eradication,I-Procedure
14393,982,therapy,I-Procedure
14394,983,Patients,O
14395,983,who,O
14396,983,had,O
14397,983,taken,O
14398,983,PPI,B-Drug
14399,983,",",O
14400,983,H2,B-Drug
14401,983,receptor,I-Drug
14402,983,antagonists,I-Drug
14403,983,and,O
14404,983,antibiotics,B-Drug
14405,983,within,O
14406,983,4,O
14407,983,weeks,O
14408,984,Patients,O
14409,984,with,O
14410,984,acute,O
14411,984,gastrointestinal,B-Condition
14412,984,bleeding,I-Condition
14413,985,Patients,O
14414,985,who,O
14415,985,'d,O
14416,985,had,O
14417,985,previous,O
14418,985,gastric,B-Procedure
14419,985,surgery,I-Procedure
14420,986,Patients,O
14421,986,with,O
14422,986,chronic,O
14423,986,liver,B-Procedure
14424,986,disease,I-Procedure
14425,987,Patients,O
14426,987,with,O
14427,987,abnormal,B-Condition
14428,987,coagulation,I-Condition
14429,987,or,O
14430,987,any,O
14431,987,other,O
14432,987,contra,B-Condition
14433,987,-,I-Condition
14434,987,indication,I-Condition
14435,987,to,O
14436,987,use,O
14437,987,of,O
14438,987,standard,B-Procedure
14439,987,biopsy,I-Procedure
14440,987,in,O
14441,987,routine,O
14442,987,diagnostic,B-Procedure
14443,987,endoscopic,I-Procedure
14444,987,procedures,I-Procedure
14445,988,Patients,O
14446,988,who,O
14447,988,are,O
14448,988,unable,O
14449,988,or,O
14450,988,unwilling,O
14451,988,to,O
14452,988,give,O
14453,988,informed,O
14454,988,consent,O
14455,989,Patients,O
14456,989,under,O
14457,989,the,O
14458,989,age,B-Person
14459,989,of,O
14460,989,18,O
14461,989,years,O
14462,990,•,O
14463,990,All,O
14464,990,patients,O
14465,990,attending,O
14466,990,for,O
14467,990,a,O
14468,990,routine,O
14469,990,diagnostic,B-Procedure
14470,990,endoscopic,I-Procedure
14471,990,procedure,I-Procedure
14472,990,at,O
14473,990,St,O
14474,990,Mary,O
14475,990,'s,O
14476,990,Hospital,O
14477,990,NHS,O
14478,990,Trust,O
14479,990,for,O
14480,990,dyspepsia,B-Condition
14481,990,and,O
14482,990,abdominal,B-Condition
14483,990,pain,I-Condition
14484,991,GCS,O
14485,991,less,O
14486,991,than,O
14487,991,15,O
14488,992,Preoperative,O
14489,992,Heart,O
14490,992,Rate,O
14491,992,less,O
14492,992,than,O
14493,992,50,O
14494,992,beat,O
14495,992,/,O
14496,992,min,O
14497,993,No,O
14498,993,Beta,B-Drug
14499,993,-,I-Drug
14500,993,Blockers,I-Drug
14501,994,Pregnant,B-Condition
14502,994,patients,O
14503,995,Take,O
14504,995,any,O
14505,995,Alpha,B-Drug
14506,995,-,I-Drug
14507,995,Methyldopa,I-Drug
14508,995,",",O
14509,995,Clonodine,B-Drug
14510,995,",",O
14511,995,Other,O
14512,995,Alpha-2,B-Drug
14513,995,Adrenergic,I-Drug
14514,995,Agonist,I-Drug
14515,996,Hemodynamic,B-Condition
14516,996,unstable,I-Condition
14517,997,Systolic,O
14518,997,BP,O
14519,997,more,O
14520,997,than,O
14521,997,160mmHg,O
14522,998,CAD,B-Condition
14523,999,Renal,B-Condition
14524,999,insuffuciency,I-Condition
14525,1000,Allergy,B-Condition
14526,1000,in,O
14527,1000,dexmedethomidine,B-Drug
14528,1000,and,O
14529,1000,opioid,B-Drug
14530,1001,BMI,O
14531,1001,more,O
14532,1001,than,O
14533,1001,30,O
14534,1002,Denied,O
14535,1002,consent,O
14536,1003,Age18,B-Person
14537,1003,-,O
14538,1003,65,O
14539,1004,ASA,O
14540,1004,1,O
14541,1004,-,O
14542,1004,2,O
14543,1005,Elective,O
14544,1005,TNTS,B-Procedure
14545,1005,resection,I-Procedure
14546,1005,of,O
14547,1005,Pituitary,B-Condition
14548,1005,Tumor,I-Condition
14549,1006,No,O
14550,1006,narcotic,B-Drug
14551,1006,before,O
14552,1006,surgery,B-Procedure
14553,1006,as,O
14554,1006,premedication,O
14555,1007,Able,B-Mood
14556,1007,to,I-Mood
14557,1007,Extubate,B-Procedure
14558,1008,Dementia,B-Condition
14559,1008,.,O
14560,1009,Gastroscopy,B-Procedure
14561,1009,planned,B-Mood
14562,1009,at,O
14563,1009,the,O
14564,1009,same,O
14565,1009,time,O
14566,1009,.,O
14567,1010,Allergies,B-Condition
14568,1010,to,O
14569,1010,propofol,B-Drug
14570,1011,All,O
14571,1011,cases,O
14572,1011,were,O
14573,1011,a,O
14574,1011,',O
14575,1011,full,O
14576,1011,stomach,O
14577,1011,',O
14578,1011,is,O
14579,1011,suspected,O
14580,1011,(,O
14581,1011,gastric,O
14582,1011,banding,O
14583,1011,),O
14584,1012,Pregnancy,B-Condition
14585,1013,All,O
14586,1013,patients,O
14587,1013,subjected,O
14588,1013,to,O
14589,1013,deep,B-Procedure
14590,1013,sedation,I-Procedure
14591,1013,in,O
14592,1013,ambulant,O
14593,1013,care,O
14594,1013,",",O
14595,1013,having,O
14596,1013,a,O
14597,1013,colonoscopy,B-Procedure
14598,1014,ASA,O
14599,1014,1,O
14600,1014,-,O
14601,1014,3,O
14602,1015,Age,B-Person
14603,1015,less,O
14604,1015,than,O
14605,1015,18,O
14606,1016,Clinical,O
14607,1016,or,O
14608,1016,laboratory,O
14609,1016,evidence,O
14610,1016,of,O
14611,1016,systemic,O
14612,1016,infection,O
14613,1017,Current,O
14614,1017,pregnancy,B-Condition
14615,1017,as,O
14616,1017,assessed,O
14617,1017,by,O
14618,1017,preoperative,O
14619,1017,urine,O
14620,1017,HCG,O
14621,1017,test,O
14622,1018,Serious,O
14623,1018,",",O
14624,1018,uncontrolled,O
14625,1018,",",O
14626,1018,non,B-Condition
14627,1018,-,I-Condition
14628,1018,malignant,I-Condition
14629,1018,illness,I-Condition
14630,1019,Malignant,B-Condition
14631,1019,illness,I-Condition
14632,1019,requiring,O
14633,1019,systemic,B-Procedure
14634,1019,chemotherapy,I-Procedure
14635,1019,in,O
14636,1019,the,O
14637,1019,last,O
14638,1019,6,O
14639,1019,months,O
14640,1020,Documented,O
14641,1020,allergy,B-Condition
14642,1020,to,O
14643,1020,oxycodone,B-Drug
14644,1020,",",O
14645,1020,morphine,B-Drug
14646,1020,sulfate,I-Drug
14647,1020,or,O
14648,1020,acetaminophen,B-Drug
14649,1021,Contraindication,B-Condition
14650,1021,to,I-Condition
14651,1021,peripheral,I-Condition
14652,1021,nerve,I-Condition
14653,1021,blockade,I-Condition
14654,1021,or,I-Condition
14655,1021,general,I-Condition
14656,1021,anesthesia,I-Condition
14657,1021,including,O
14658,1021,:,O
14659,1022,1,O
14660,1022,.,O
14661,1022,patient,O
14662,1022,refusal,O
14663,1023,2,O
14664,1023,.,O
14665,1023,active,O
14666,1023,infection,O
14667,1023,at,O
14668,1023,site,O
14669,1023,of,O
14670,1023,planned,O
14671,1023,block,O
14672,1024,3,O
14673,1024,.,O
14674,1024,documented,O
14675,1024,allergy,O
14676,1024,to,O
14677,1024,any,O
14678,1024,local,O
14679,1024,or,O
14680,1024,general,O
14681,1024,anesthetic,O
14682,1024,medications,O
14683,1025,4,O
14684,1025,.,O
14685,1025,significant,O
14686,1025,coagulopathy,B-Condition
14687,1025,(,O
14688,1025,prothrombin,O
14689,1025,time,O
14690,1025,>,O
14691,1025,15,O
14692,1025,seconds,O
14693,1025,",",O
14694,1025,INR>1.5,O
14695,1026,5,O
14696,1026,.,O
14697,1026,pre,O
14698,1026,-,O
14699,1026,existing,O
14700,1026,neuropathy,B-Condition
14701,1026,and,O
14702,1026,medical,O
14703,1026,conditions,O
14704,1026,or,O
14705,1026,deformities,O
14706,1026,which,O
14707,1026,would,O
14708,1026,compromise,O
14709,1026,block,O
14710,1026,or,O
14711,1026,anesthetic,O
14712,1026,safety,O
14713,1027,Planned,O
14714,1027,pleurodesis,B-Condition
14715,1028,Current,O
14716,1028,use,O
14717,1028,of,O
14718,1028,high,O
14719,1028,dose,O
14720,1028,inhaled,O
14721,1028,or,O
14722,1028,systemic,O
14723,1028,steroids,B-Drug
14724,1029,Current,O
14725,1029,use,O
14726,1029,of,O
14727,1029,Amiodarone,B-Drug
14728,1029,(,O
14729,1029,Cordarone,B-Drug
14730,1029,),O
14731,1030,Morbid,B-Condition
14732,1030,obesity,I-Condition
14733,1030,(,O
14734,1030,BMI=40kg,O
14735,1030,/,O
14736,1030,m2,O
14737,1030,),O
14738,1031,Patients,O
14739,1031,with,O
14740,1031,clinically,O
14741,1031,significant,O
14742,1031,mental,B-Condition
14743,1031,health,I-Condition
14744,1031,issues,I-Condition
14745,1031,such,O
14746,1031,as,O
14747,1031,psychosis,B-Condition
14748,1031,requiring,O
14749,1031,treatment,B-Procedure
14750,1031,with,O
14751,1031,antipsychotic,B-Drug
14752,1031,medications,I-Drug
14753,1031,.,O
14754,1032,Patients,O
14755,1032,unable,O
14756,1032,to,O
14757,1032,consent,O
14758,1033,Patients,O
14759,1033,with,O
14760,1033,active,O
14761,1033,infections,B-Condition
14762,1033,requiring,O
14763,1033,antibiotics,B-Drug
14764,1033,within,O
14765,1033,one,O
14766,1033,month,O
14767,1033,of,O
14768,1033,registration,O
14769,1034,Participation,O
14770,1034,in,O
14771,1034,other,O
14772,1034,clinical,O
14773,1034,trials,O
14774,1034,that,O
14775,1034,may,O
14776,1034,interfere,O
14777,1034,with,O
14778,1034,this,O
14779,1034,study,O
14780,1035,Age,B-Person
14781,1035,greater,O
14782,1035,than,O
14783,1035,18,O
14784,1036,Planned,O
14785,1036,thoracoscopy,B-Procedure
14786,1036,with,O
14787,1036,low,O
14788,1036,probability(by,O
14789,1036,surgeon,O
14790,1036,estimate,O
14791,1036,),O
14792,1036,of,O
14793,1036,conversion,O
14794,1036,to,O
14795,1036,open,O
14796,1036,procedure,O
14797,1037,Patients,B-Drug
14798,1037,with,O
14799,1037,severe,O
14800,1037,complications,B-Condition
14801,1037,or,O
14802,1037,severe,O
14803,1037,infection,B-Condition
14804,1037,;,O
14805,1038,Invasion,B-Condition
14806,1038,of,O
14807,1038,central,O
14808,1038,nervous,O
14809,1038,system,O
14810,1038,;,O
14811,1039,Patients,O
14812,1039,with,O
14813,1039,severe,O
14814,1039,heart,B-Condition
14815,1039,disease,I-Condition
14816,1039,history,O
14817,1039,",",O
14818,1039,including,O
14819,1039,ventricular,B-Condition
14820,1039,tachycardia,I-Condition
14821,1039,(,O
14822,1039,VT,B-Condition
14823,1039,),O
14824,1039,",",O
14825,1039,atrial,B-Condition
14826,1039,fibrillation,I-Condition
14827,1039,(,O
14828,1039,AF,B-Condition
14829,1039,),O
14830,1039,",",O
14831,1039,heart,B-Condition
14832,1039,block,I-Condition
14833,1039,",",O
14834,1039,myocardial,B-Condition
14835,1039,infarction,I-Condition
14836,1039,(,O
14837,1039,MI,B-Condition
14838,1039,),O
14839,1039,",",O
14840,1039,congestive,B-Condition
14841,1039,heart,I-Condition
14842,1039,failure,I-Condition
14843,1039,(,O
14844,1039,CHF,B-Condition
14845,1039,),O
14846,1039,",",O
14847,1039,coronary,B-Condition
14848,1039,heart,I-Condition
14849,1039,disease,I-Condition
14850,1039,patients,O
14851,1039,needed,O
14852,1039,therapy,O
14853,1039,;,O
14854,1040,patients,O
14855,1040,with,O
14856,1040,severe,O
14857,1040,allergic,B-Condition
14858,1040,constitution,O
14859,1040,",",O
14860,1040,or,O
14861,1040,those,O
14862,1040,who,O
14863,1040,are,O
14864,1040,allergic,B-Condition
14865,1040,to,O
14866,1040,or,O
14867,1040,intolerant,B-Condition
14868,1040,of,O
14869,1040,drug,O
14870,1040,composition,O
14871,1040,in,O
14872,1040,chemotherapy,B-Procedure
14873,1040,regimens,I-Procedure
14874,1040,;,O
14875,1040,with,O
14876,1040,other,O
14877,1040,malignant,B-Condition
14878,1040,tumors,I-Condition
14879,1040,in,O
14880,1040,the,O
14881,1040,past,O
14882,1040,5,O
14883,1040,years,O
14884,1040,;,O
14885,1041,patients,O
14886,1041,received,O
14887,1041,doxorubicin,B-Drug
14888,1041,therapy,O
14889,1041,",",O
14890,1041,total,O
14891,1041,cumulative,O
14892,1041,dose,O
14893,1041,of,O
14894,1041,adriamycin,B-Drug
14895,1041,was,O
14896,1041,more,O
14897,1041,than,O
14898,1041,300,O
14899,1041,mg,O
14900,1041,/,O
14901,1041,m2,O
14902,1041,",",O
14903,1041,total,O
14904,1041,cumulative,O
14905,1041,dose,O
14906,1041,of,O
14907,1041,epirubicin,B-Drug
14908,1041,was,O
14909,1041,more,O
14910,1041,than,O
14911,1041,450,O
14912,1041,mg,O
14913,1041,/,O
14914,1041,m2,O
14915,1041,;,O
14916,1042,Patients,O
14917,1042,participate,O
14918,1042,in,O
14919,1042,other,O
14920,1042,clinical,O
14921,1042,studies,O
14922,1042,;,O
14923,1043,Other,O
14924,1043,patients,O
14925,1043,who,O
14926,1043,are,O
14927,1043,not,O
14928,1043,suitable,O
14929,1043,for,O
14930,1043,the,O
14931,1043,study,O
14932,1043,.,O
14933,1044,Primary,B-Condition
14934,1044,B,I-Condition
14935,1044,-,I-Condition
14936,1044,NHL,I-Condition
14937,1044,",",O
14938,1044,PTCL,B-Condition
14939,1044,(,O
14940,1044,ALK+,B-Condition
14941,1044,anaplastic,I-Condition
14942,1044,large,I-Condition
14943,1044,cell,I-Condition
14944,1044,lymphoma,I-Condition
14945,1044,and,I-Condition
14946,1044,NK(natural,I-Condition
14947,1044,killer,I-Condition
14948,1044,cell,I-Condition
14949,1044,),I-Condition
14950,1044,/T,I-Condition
14951,1044,cell,I-Condition
14952,1044,lymphoma,I-Condition
14953,1044,were,O
14954,1044,excluded,O
14955,1044,),O
14956,1044,or,O
14957,1044,HL,B-Condition
14958,1044,patients,O
14959,1044,confirmed,O
14960,1044,by,O
14961,1044,histopathology,O
14962,1044,;,O
14963,1045,Ages,B-Person
14964,1045,=,O
14965,1045,18,O
14966,1045,years,O
14967,1045,old,O
14968,1045,",",O
14969,1045,<,O
14970,1045,80,O
14971,1045,years,O
14972,1045,old,O
14973,1045,;,O
14974,1046,ECOG,O
14975,1046,(,O
14976,1046,Eastern,O
14977,1046,Cooperative,O
14978,1046,Oncology,O
14979,1046,Group)score,O
14980,1046,:,O
14981,1046,0,O
14982,1046,-,O
14983,1046,2,O
14984,1047,At,O
14985,1047,least,O
14986,1047,one,O
14987,1047,measurable,O
14988,1047,lesion,B-Condition
14989,1047,;,O
14990,1048,Expected,B-Observation
14991,1048,survival,I-Observation
14992,1048,time=3,I-Observation
14993,1048,months,O
14994,1048,;,O
14995,1049,Liver,O
14996,1049,function,O
14997,1049,:,O
14998,1049,transaminase=2.5×,O
14999,1049,upper,O
15000,1049,limit,O
15001,1049,of,O
15002,1049,normal,O
15003,1049,value,O
15004,1049,",",O
15005,1049,bilirubin=1.5×upper,O
15006,1049,limit,O
15007,1049,of,O
15008,1049,normal,O
15009,1049,value,O
15010,1049,;,O
15011,1050,Renal,O
15012,1050,function,O
15013,1050,:,O
15014,1050,serum,O
15015,1050,creatinine,O
15016,1050,is,O
15017,1050,44,O
15018,1050,-,O
15019,1050,133,O
15020,1050,mmol,O
15021,1050,/,O
15022,1050,L,O
15023,1050,;,O
15024,1051,Routine,O
15025,1051,blood,O
15026,1051,test,O
15027,1051,:,O
15028,1051,WBC=3.0×109,O
15029,1051,/,O
15030,1051,L,O
15031,1051,",",O
15032,1051,Neutrophils=1.5×109,O
15033,1051,/,O
15034,1051,L,O
15035,1051,",",O
15036,1051,Hb=100g,O
15037,1051,/,O
15038,1051,L,O
15039,1051,",",O
15040,1051,Platelet=80×109,O
15041,1051,/,O
15042,1051,L,O
15043,1051,;,O
15044,1051,LVEF=50,O
15045,1051,%,O
15046,1051,;,O
15047,1052,New,O
15048,1052,York,O
15049,1052,Heart,O
15050,1052,Association,O
15051,1052,(,O
15052,1052,NYHA,O
15053,1052,),O
15054,1052,heart,O
15055,1052,function,O
15056,1052,classification,O
15057,1052,is,O
15058,1052,I,O
15059,1052,-,O
15060,1052,II,O
15061,1052,grade,O
15062,1053,signed,O
15063,1053,informed,O
15064,1053,consent,O
15065,1053,.,O
15066,1054,Allergic,B-Condition
15067,1054,to,O
15068,1054,study,B-Drug
15069,1054,drugs,I-Drug
15070,1055,Antiemetics,B-Drug
15071,1055,or,O
15072,1055,steroids,B-Drug
15073,1055,use,I-Drug
15074,1055,within,O
15075,1055,24,O
15076,1055,hrs,O
15077,1055,prior,O
15078,1055,to,O
15079,1055,surgery,B-Procedure
15080,1056,Dependence,B-Condition
15081,1056,upon,I-Condition
15082,1056,opioids,I-Condition
15083,1057,Insulin,B-Drug
15084,1057,dependent,O
15085,1057,Diabetes,B-Condition
15086,1057,Mellitus,I-Condition
15087,1058,Cardiovascular,B-Condition
15088,1058,or,I-Condition
15089,1058,pulmonary,I-Condition
15090,1058,disease,I-Condition
15091,1059,Renal,B-Condition
15092,1059,or,I-Condition
15093,1059,hepatic,I-Condition
15094,1059,insufficiency,I-Condition
15095,1060,BMI>=35kg,O
15096,1060,/,O
15097,1060,m2,O
15098,1061,History,B-Observation
15099,1061,of,O
15100,1061,motion,B-Condition
15101,1061,sickness,I-Condition
15102,1061,or,O
15103,1061,PONV,B-Condition
15104,1062,Cigarette,B-Observation
15105,1062,smoker,I-Observation
15106,1063,Conversion,B-Observation
15107,1063,to,O
15108,1063,open,B-Procedure
15109,1063,laparotomy,I-Procedure
15110,1063,from,O
15111,1063,laparoscopic,B-Procedure
15112,1063,surgery,I-Procedure
15113,1064,Pregnants,B-Condition
15114,1065,20,O
15115,1065,-,O
15116,1065,70,O
15117,1065,yrs,O
15118,1065,of,O
15119,1065,age,B-Person
15120,1066,ASA(American,O
15121,1066,Society,O
15122,1066,of,O
15123,1066,Anesthesiologists,O
15124,1066,),O
15125,1066,physical,O
15126,1066,status,O
15127,1066,class,O
15128,1066,I,O
15129,1066,or,O
15130,1066,II,O
15131,1067,Scheduled,B-Mood
15132,1067,for,O
15133,1067,gynecological,O
15134,1067,laparoscopic,B-Procedure
15135,1067,surgery,I-Procedure
15136,1068,1,O
15137,1068,.,O
15138,1068,A,O
15139,1068,medical,B-Condition
15140,1068,condition,I-Condition
15141,1068,",",O
15142,1068,other,O
15143,1068,than,O
15144,1068,PBC,B-Condition
15145,1068,",",O
15146,1068,that,O
15147,1068,in,O
15148,1068,the,O
15149,1068,investigator,O
15150,1068,'s,O
15151,1068,opinion,O
15152,1068,would,O
15153,1068,preclude,O
15154,1068,full,O
15155,1068,participation,O
15156,1068,in,O
15157,1068,the,O
15158,1068,study,O
15159,1068,or,O
15160,1068,confound,O
15161,1068,its,O
15162,1068,results,O
15163,1068,(,O
15164,1068,e.g.,O
15165,1068,",",O
15166,1068,cancer,O
15167,1068,on,O
15168,1068,active,O
15169,1068,treatment,O
15170,1068,),O
15171,1069,2,O
15172,1069,.,O
15173,1069,AST,O
15174,1069,or,O
15175,1069,ALT,O
15176,1069,>,O
15177,1069,3,O
15178,1069,×,O
15179,1069,ULN,O
15180,1070,3,O
15181,1070,.,O
15182,1070,Total,O
15183,1070,bilirubin,O
15184,1070,>,O
15185,1070,2,O
15186,1070,×,O
15187,1070,ULN,O
15188,1071,4,O
15189,1071,.,O
15190,1071,Auto,B-Condition
15191,1071,-,I-Condition
15192,1071,immune,I-Condition
15193,1071,hepatitis,I-Condition
15194,1072,5,O
15195,1072,.,O
15196,1072,Primary,B-Condition
15197,1072,sclerosing,I-Condition
15198,1072,cholangitis,I-Condition
15199,1073,6,O
15200,1073,.,O
15201,1073,Known,O
15202,1073,history,B-Observation
15203,1073,of,O
15204,1073,alpha-1,B-Condition
15205,1073,-,I-Condition
15206,1073,Antitrypsin,I-Condition
15207,1073,deficiency,I-Condition
15208,1074,7,O
15209,1074,.,O
15210,1074,Known,O
15211,1074,history,B-Observation
15212,1074,of,O
15213,1074,chronic,O
15214,1074,viral,B-Condition
15215,1074,hepatitis,I-Condition
15216,1075,8,O
15217,1075,.,O
15218,1075,Creatine,O
15219,1075,kinase,O
15220,1075,above,O
15221,1075,ULN,O
15222,1076,9,O
15223,1076,.,O
15224,1076,Serum,O
15225,1076,creatinine,O
15226,1076,above,O
15227,1076,ULN,O
15228,1077,10,O
15229,1077,.,O
15230,1077,For,O
15231,1077,females,B-Person
15232,1077,",",O
15233,1077,pregnancy,B-Condition
15234,1077,or,O
15235,1077,breast,B-Condition
15236,1077,-,I-Condition
15237,1077,feeding,I-Condition
15238,1078,11,O
15239,1078,.,O
15240,1078,Use,O
15241,1078,of,O
15242,1078,colchicine,B-Drug
15243,1078,",",O
15244,1078,methotrexate,B-Drug
15245,1078,",",O
15246,1078,azathioprine,B-Drug
15247,1078,",",O
15248,1078,or,O
15249,1078,systemic,B-Drug
15250,1078,steroids,I-Drug
15251,1078,in,O
15252,1078,the,O
15253,1078,two,O
15254,1078,months,O
15255,1078,preceding,O
15256,1078,screening,O
15257,1079,12,O
15258,1079,.,O
15259,1079,Current,O
15260,1079,use,O
15261,1079,of,O
15262,1079,fibrates,B-Drug
15263,1079,",",O
15264,1079,including,O
15265,1079,fenofibrates,B-Drug
15266,1079,",",O
15267,1079,or,O
15268,1079,simvastatin,B-Drug
15269,1080,13,O
15270,1080,.,O
15271,1080,Use,O
15272,1080,of,O
15273,1080,an,O
15274,1080,experimental,B-Procedure
15275,1080,treatment,I-Procedure
15276,1080,for,I-Procedure
15277,1080,PBC,I-Procedure
15278,1081,14,O
15279,1081,.,O
15280,1081,Use,O
15281,1081,of,O
15282,1081,experimental,O
15283,1081,or,O
15284,1081,unapproved,O
15285,1081,immunosuppressant,B-Drug
15286,1082,15,O
15287,1082,.,O
15288,1082,Any,O
15289,1082,other,O
15290,1082,condition(s,O
15291,1082,),O
15292,1082,that,O
15293,1082,would,O
15294,1082,compromise,O
15295,1082,the,O
15296,1082,safety,O
15297,1082,of,O
15298,1082,the,O
15299,1082,subject,O
15300,1082,or,O
15301,1082,compromise,O
15302,1082,the,O
15303,1082,quality,O
15304,1082,of,O
15305,1082,the,O
15306,1082,clinical,O
15307,1082,study,O
15308,1082,",",O
15309,1082,as,O
15310,1082,judged,O
15311,1082,by,O
15312,1082,the,O
15313,1082,Investigator,O
15314,1083,1,O
15315,1083,.,O
15316,1083,Must,O
15317,1083,have,O
15318,1083,given,O
15319,1083,written,O
15320,1083,informed,O
15321,1083,consent,O
15322,1083,(,O
15323,1083,signed,O
15324,1083,and,O
15325,1083,dated,O
15326,1083,),O
15327,1083,and,O
15328,1083,any,O
15329,1083,authorizations,O
15330,1083,required,O
15331,1083,by,O
15332,1083,local,O
15333,1083,law,O
15334,1084,2,O
15335,1084,.,O
15336,1084,18,O
15337,1084,to,O
15338,1084,75,O
15339,1084,years,B-Person
15340,1084,old,I-Person
15341,1084,(,O
15342,1084,inclusive,O
15343,1084,),O
15344,1085,3,O
15345,1085,.,O
15346,1085,Male,B-Person
15347,1085,or,O
15348,1085,female,B-Person
15349,1085,with,O
15350,1085,a,O
15351,1085,diagnosis,O
15352,1085,of,O
15353,1085,PBC,B-Condition
15354,1085,",",O
15355,1085,by,O
15356,1085,at,O
15357,1085,least,O
15358,1085,two,O
15359,1085,of,O
15360,1085,the,O
15361,1085,following,O
15362,1085,criteria,O
15363,1085,:,O
15364,1086,History,O
15365,1086,of,O
15366,1086,AP,O
15367,1086,above,O
15368,1086,ULN,O
15369,1086,for,O
15370,1086,at,O
15371,1086,least,O
15372,1086,six,O
15373,1086,months,O
15374,1087,Positive,O
15375,1087,Anti,O
15376,1087,-,O
15377,1087,Mitochondrial,O
15378,1087,Antibodies,O
15379,1087,(,O
15380,1087,AMA,O
15381,1087,),O
15382,1087,titers,O
15383,1087,(,O
15384,1087,>,O
15385,1087,1/40,O
15386,1087,on,O
15387,1087,immunofluorescence,O
15388,1087,or,O
15389,1087,M2,O
15390,1087,positive,O
15391,1087,by,O
15392,1087,enzyme,O
15393,1087,linked,O
15394,1087,immunosorbent,O
15395,1087,assay,O
15396,1087,(,O
15397,1087,ELISA,O
15398,1087,),O
15399,1087,or,O
15400,1087,positive,O
15401,1087,PBC,O
15402,1087,-,O
15403,1087,specific,O
15404,1087,antinuclear,O
15405,1087,antibodies,O
15406,1088,Documented,O
15407,1088,liver,B-Procedure
15408,1088,biopsy,I-Procedure
15409,1088,result,O
15410,1088,consistent,O
15411,1088,with,O
15412,1088,PBC,B-Condition
15413,1089,4,O
15414,1089,.,O
15415,1089,On,O
15416,1089,a,O
15417,1089,stable,O
15418,1089,and,O
15419,1089,recommended,O
15420,1089,dose,O
15421,1089,of,O
15422,1089,UDCA,B-Drug
15423,1089,for,O
15424,1089,the,O
15425,1089,past,O
15426,1089,twelve,O
15427,1089,months,O
15428,1090,5,O
15429,1090,.,O
15430,1090,AP,O
15431,1090,≥,O
15432,1090,1.67,O
15433,1090,×,O
15434,1090,ULN,O
15435,1091,6,O
15436,1091,.,O
15437,1091,For,O
15438,1091,females,B-Person
15439,1091,of,O
15440,1091,reproductive,B-Condition
15441,1091,potential,I-Condition
15442,1091,",",O
15443,1091,use,O
15444,1091,of,O
15445,1091,at,O
15446,1091,least,O
15447,1091,one,O
15448,1091,barrier,O
15449,1091,contraceptive,O
15450,1091,and,O
15451,1091,a,O
15452,1091,second,O
15453,1091,effective,O
15454,1091,birth,O
15455,1091,control,O
15456,1091,method,O
15457,1091,during,O
15458,1091,the,O
15459,1091,study,O
15460,1091,and,O
15461,1091,for,O
15462,1091,at,O
15463,1091,least,O
15464,1091,two,O
15465,1091,weeks,O
15466,1091,after,O
15467,1091,the,O
15468,1091,last,O
15469,1091,dose,O
15470,1091,.,O
15471,1091,For,O
15472,1091,male,B-Person
15473,1091,subjects,O
15474,1091,",",O
15475,1091,use,O
15476,1091,of,O
15477,1091,appropriate,O
15478,1091,contraception,O
15479,1091,(,O
15480,1091,e.g.,O
15481,1091,",",O
15482,1091,condoms,O
15483,1091,),O
15484,1091,",",O
15485,1091,so,O
15486,1091,their,O
15487,1091,female,B-Person
15488,1091,partners,O
15489,1091,of,O
15490,1091,reproductive,B-Condition
15491,1091,potential,I-Condition
15492,1091,do,O
15493,1091,not,O
15494,1091,become,O
15495,1091,pregnant,B-Condition
15496,1091,during,O
15497,1091,the,O
15498,1091,study,O
15499,1091,and,O
15500,1091,for,O
15501,1091,at,O
15502,1091,least,O
15503,1091,two,O
15504,1091,weeks,O
15505,1091,after,O
15506,1091,the,O
15507,1091,last,O
15508,1091,dose,O
15509,1092,Allergic,B-Condition
15510,1092,to,O
15511,1092,study,B-Drug
15512,1092,drugs,I-Drug
15513,1093,Patient,O
15514,1093,with,O
15515,1093,asthma,B-Condition
15516,1093,or,O
15517,1093,COPD,B-Condition
15518,1093,",",O
15519,1093,patient,O
15520,1093,who,O
15521,1093,is,O
15522,1093,severely,O
15523,1093,respiratory,B-Condition
15524,1093,depressed,I-Condition
15525,1094,Renal,B-Condition
15526,1094,of,I-Condition
15527,1094,hepatic,I-Condition
15528,1094,insufficiency,I-Condition
15529,1095,Epileptic,B-Condition
15530,1095,status,I-Condition
15531,1096,Intracranial,B-Condition
15532,1096,lesion,I-Condition
15533,1096,associated,O
15534,1096,with,O
15535,1096,increased,O
15536,1096,intracranial,O
15537,1096,pressure,O
15538,1097,Acute,B-Condition
15539,1097,abdomen,I-Condition
15540,1097,",",O
15541,1097,patient,O
15542,1097,who,O
15543,1097,has,O
15544,1097,diagnosed,O
15545,1097,paralytic,B-Condition
15546,1097,ileus,I-Condition
15547,1097,or,O
15548,1097,suspicious,B-Condition
15549,1097,ileus,I-Condition
15550,1098,Pregnant,B-Condition
15551,1098,or,O
15552,1098,lactating,B-Condition
15553,1098,women,B-Person
15554,1099,19,O
15555,1099,-,O
15556,1099,65,O
15557,1099,years,O
15558,1099,of,O
15559,1099,age,B-Person
15560,1100,ASA,O
15561,1100,physical,O
15562,1100,status,O
15563,1100,classification,O
15564,1100,I,O
15565,1100,or,O
15566,1100,II,O
15567,1101,Scheduled,B-Mood
15568,1101,for,I-Mood
15569,1101,total,B-Procedure
15570,1101,hip,I-Procedure
15571,1101,replacement,I-Procedure
15572,1101,surgery,I-Procedure
15573,1102,Patients,O
15574,1102,with,O
15575,1102,medical,B-Condition
15576,1102,comorbidities,I-Condition
15577,1102,preventing,B-Mood
15578,1102,them,I-Mood
15579,1102,from,I-Mood
15580,1102,definitive,B-Procedure
15581,1102,surgical,I-Procedure
15582,1102,therapy,I-Procedure
15583,1102,.,O
15584,1103,Patients,O
15585,1103,with,O
15586,1103,persistent,O
15587,1103,stone,B-Observation
15588,1103,burden,I-Observation
15589,1103,following,O
15590,1103,definitive,B-Procedure
15591,1103,surgical,I-Procedure
15592,1103,therapy,I-Procedure
15593,1103,.,O
15594,1104,Male,B-Person
15595,1104,or,O
15596,1104,Female,B-Person
15597,1104,.,O
15598,1105,No,O
15599,1105,age,O
15600,1105,restriction,O
15601,1105,.,O
15602,1106,Diagnosed,O
15603,1106,with,O
15604,1106,an,O
15605,1106,infection,O
15606,1106,related,O
15607,1106,stone,B-Condition
15608,1106,.,O
15609,1107,Medically,B-Mood
15610,1107,fit,I-Mood
15611,1107,for,I-Mood
15612,1107,definitive,B-Procedure
15613,1107,surgical,I-Procedure
15614,1107,management,I-Procedure
15615,1107,of,O
15616,1107,stone,B-Condition
15617,1107,.,O
15618,1108,Life,B-Observation
15619,1108,expectancy,I-Observation
15620,1108,greater,O
15621,1108,than,O
15622,1108,one,O
15623,1108,year,O
15624,1108,.,O
15625,1109,Stone,B-Condition
15626,1109,free,O
15627,1109,after,O
15628,1109,definitive,B-Procedure
15629,1109,surgical,I-Procedure
15630,1109,therapy,I-Procedure
15631,1109,defined,O
15632,1109,as,O
15633,1109,fragments,O
15634,1109,less,O
15635,1109,than,O
15636,1109,3,O
15637,1109,mm,O
15638,1109,.,O
15639,1110,Women,B-Person
15640,1110,who,O
15641,1110,are,O
15642,1110,pregnant,B-Condition
15643,1110,or,O
15644,1110,breastfeeding,B-Observation
15645,1110,(,O
15646,1110,pregnancy,O
15647,1110,defined,O
15648,1110,as,O
15649,1110,the,O
15650,1110,state,O
15651,1110,of,O
15652,1110,a,O
15653,1110,female,O
15654,1110,after,O
15655,1110,conception,O
15656,1110,until,O
15657,1110,the,O
15658,1110,termination,O
15659,1110,of,O
15660,1110,gestation,O
15661,1110,",",O
15662,1110,confirmed,O
15663,1110,by,O
15664,1110,a,O
15665,1110,positive,O
15666,1110,human,B-Procedure
15667,1110,chorionic,I-Procedure
15668,1110,gonadotropin,I-Procedure
15669,1110,laboratory,I-Procedure
15670,1110,test,I-Procedure
15671,1110,(,O
15672,1110,>,O
15673,1110,5mIU,O
15674,1110,/,O
15675,1110,mL,O
15676,1110,),O
15677,1111,Women,B-Person
15678,1111,of,O
15679,1111,child,B-Condition
15680,1111,bearing,I-Condition
15681,1111,potential,I-Condition
15682,1111,must,O
15683,1111,be,O
15684,1111,practicing,O
15685,1111,effective,O
15686,1111,contraception,B-Procedure
15687,1111,implemented,O
15688,1111,during,O
15689,1111,the,O
15690,1111,trial,O
15691,1111,and,O
15692,1111,for,O
15693,1111,at,O
15694,1111,least,O
15695,1111,28,O
15696,1111,days,O
15697,1111,following,O
15698,1111,the,O
15699,1111,last,O
15700,1111,dose,O
15701,1111,of,O
15702,1111,study,B-Drug
15703,1111,medication,I-Drug
15704,1112,Tromboembolic,B-Condition
15705,1112,event,I-Condition
15706,1112,(,O
15707,1112,CVA,B-Condition
15708,1112,or,O
15709,1112,transient,B-Condition
15710,1112,ischemic,I-Condition
15711,1112,attack,I-Condition
15712,1112,",",O
15713,1112,AMI,B-Condition
15714,1112,),O
15715,1112,less,O
15716,1112,than,O
15717,1112,3,O
15718,1112,months,O
15719,1112,prior,O
15720,1112,to,O
15721,1112,the,O
15722,1112,intravitreal,B-Procedure
15723,1112,injection,I-Procedure
15724,1112,of,O
15725,1112,bevacizumab,B-Drug
15726,1113,History,B-Observation
15727,1113,of,O
15728,1113,hypersensitivity,B-Condition
15729,1113,for,O
15730,1113,bevacizumab,B-Drug
15731,1113,.,O
15732,1114,Age,B-Person
15733,1114,=,O
15734,1114,18,O
15735,1114,years,O
15736,1114,of,O
15737,1114,either,B-Person
15738,1114,gender,I-Person
15739,1115,Written,O
15740,1115,informed,O
15741,1115,consent,O
15742,1115,must,O
15743,1115,be,O
15744,1115,obtained,O
15745,1115,before,O
15746,1115,any,O
15747,1115,intravitreal,O
15748,1115,injection,O
15749,1115,of,O
15750,1115,bevacizumab,O
15751,1115,is,O
15752,1115,performed,O
15753,1116,Visual,B-Condition
15754,1116,impairment,I-Condition
15755,1116,predominantly,O
15756,1116,due,O
15757,1116,to,O
15758,1116,abnormal,B-Condition
15759,1116,new,I-Condition
15760,1116,vessel,I-Condition
15761,1116,ingrowth,I-Condition
15762,1116,and/or,O
15763,1116,macular,B-Condition
15764,1116,edema,I-Condition
15765,1116,.,O
15766,1116,The,O
15767,1116,presence,O
15768,1116,of,O
15769,1116,fluid,B-Condition
15770,1116,(,O
15771,1116,intraretinal,O
15772,1116,",",O
15773,1116,subretinal,O
15774,1116,or,O
15775,1116,sub,O
15776,1116,-,O
15777,1116,RPE,O
15778,1116,),O
15779,1116,detected,O
15780,1116,clinically,O
15781,1116,or,O
15782,1116,on,O
15783,1116,the,O
15784,1116,ocular,B-Procedure
15785,1116,coherence,I-Procedure
15786,1116,tomography,I-Procedure
15787,1116,.,O
15788,1117,Unable,B-Observation
15789,1117,to,I-Observation
15790,1117,participate,I-Observation
15791,1117,for,O
15792,1117,administrative,O
15793,1117,reasons,O
15794,1118,Psychiatric,B-Condition
15795,1118,troubles,I-Condition
15796,1119,Pain,B-Condition
15797,1119,at,I-Condition
15798,1119,rest,I-Condition
15799,1119,or,O
15800,1119,critical,B-Condition
15801,1119,limb,I-Condition
15802,1119,ischemia,I-Condition
15803,1120,Unable,B-Condition
15804,1120,to,I-Condition
15805,1120,walk,I-Condition
15806,1120,(,O
15807,1120,ex,O
15808,1120,:,O
15809,1120,wheelchair,B-Observation
15810,1120,subjects,I-Observation
15811,1120,),O
15812,1121,French,B-Observation
15813,1121,Native,I-Observation
15814,1121,language,I-Observation
15815,1122,18,O
15816,1122,years,O
15817,1122,old,B-Person
15818,1122,or,O
15819,1122,older,O
15820,1123,Signed,O
15821,1123,consent,O
15822,1124,Covered,B-Observation
15823,1124,by,I-Observation
15824,1124,the,I-Observation
15825,1124,French,I-Observation
15826,1124,social,I-Observation
15827,1124,care,I-Observation
15828,1124,system,I-Observation
15829,1125,Any,O
15830,1125,previous,O
15831,1125,treatments,B-Procedure
15832,1125,for,O
15833,1125,active,O
15834,1125,CSC,B-Condition
15835,1125,;,O
15836,1126,Previous,O
15837,1126,prescription,O
15838,1126,of,O
15839,1126,mineralocorticoid,B-Drug
15840,1126,receptor,I-Drug
15841,1126,antagonists,I-Drug
15842,1126,",",O
15843,1126,for,O
15844,1126,cCSC,B-Condition
15845,1126,or,O
15846,1126,for,O
15847,1126,other,B-Condition
15848,1126,diseases,I-Condition
15849,1126,;,O
15850,1127,Current,O
15851,1127,treatment,O
15852,1127,with,O
15853,1127,corticosteroids,B-Drug
15854,1127,(,O
15855,1127,topical,O
15856,1127,or,O
15857,1127,systemic,O
15858,1127,),O
15859,1127,",",O
15860,1127,corticosteroid,B-Procedure
15861,1127,use,I-Procedure
15862,1127,within,O
15863,1127,3,O
15864,1127,months,O
15865,1127,before,O
15866,1127,possible,O
15867,1127,start,O
15868,1127,of,O
15869,1127,trial,O
15870,1127,treatment,O
15871,1127,",",O
15872,1127,or,O
15873,1127,anticipated,B-Mood
15874,1127,start,O
15875,1127,of,O
15876,1127,corticosteroid,B-Procedure
15877,1127,treatment,I-Procedure
15878,1127,within,O
15879,1127,the,O
15880,1127,first,O
15881,1127,2,O
15882,1127,years,O
15883,1127,from,O
15884,1127,the,O
15885,1127,start,O
15886,1127,of,O
15887,1127,the,O
15888,1127,trial,O
15889,1127,period,O
15890,1127,;,O
15891,1128,Evidence,O
15892,1128,of,O
15893,1128,another,O
15894,1128,diagnosis,O
15895,1128,that,O
15896,1128,can,O
15897,1128,explain,O
15898,1128,serous,O
15899,1128,SRF,O
15900,1128,or,O
15901,1128,visual,O
15902,1128,loss,O
15903,1128,;,O
15904,1129,Best,O
15905,1129,-,O
15906,1129,corrected,O
15907,1129,visual,O
15908,1129,acuity,O
15909,1129,<,O
15910,1129,20/200,O
15911,1129,(,O
15912,1129,Snellen,O
15913,1129,equivalent,O
15914,1129,),O
15915,1129,;,O
15916,1130,Profound,O
15917,1130,chorioretinal,B-Condition
15918,1130,atrophy,I-Condition
15919,1130,in,O
15920,1130,central,O
15921,1130,macular,O
15922,1130,area,O
15923,1130,on,O
15924,1130,ophthalmoscopy,B-Procedure
15925,1130,and,O
15926,1130,OCT,B-Procedure
15927,1130,;,O
15928,1131,Myopia,O
15929,1131,>,O
15930,1131,6D,O
15931,1131,;,O
15932,1132,Visual,B-Condition
15933,1132,loss,I-Condition
15934,1132,and/or,O
15935,1132,serous,B-Condition
15936,1132,detachment,I-Condition
15937,1132,on,O
15938,1132,OCT,B-Procedure
15939,1132,<,O
15940,1132,6,O
15941,1132,weeks,O
15942,1132,;,O
15943,1133,Continuous,O
15944,1133,and/or,O
15945,1133,progressive,O
15946,1133,visual,B-Condition
15947,1133,loss,I-Condition
15948,1133,>,O
15949,1133,18,O
15950,1133,months,O
15951,1133,or,O
15952,1133,serous,B-Condition
15953,1133,detachment,I-Condition
15954,1133,on,O
15955,1133,OCT,B-Procedure
15956,1133,>,O
15957,1133,18,O
15958,1133,months,O
15959,1133,;,O
15960,1134,No,O
15961,1134,hyperfluorescence,O
15962,1134,on,O
15963,1134,ICGA,O
15964,1134,;,O
15965,1135,Intraretinal,B-Condition
15966,1135,edema,I-Condition
15967,1135,on,O
15968,1135,OCT,B-Procedure
15969,1135,;,O
15970,1136,(,O
15971,1136,relative,O
15972,1136,),O
15973,1136,Contraindications,B-Condition
15974,1136,for,O
15975,1136,FA,B-Procedure
15976,1136,or,O
15977,1136,ICGA,B-Procedure
15978,1136,;,O
15979,1137,(,O
15980,1137,relative,O
15981,1137,),O
15982,1137,Contraindications,B-Condition
15983,1137,for,O
15984,1137,photodynamic,B-Procedure
15985,1137,treatment,I-Procedure
15986,1137,(,O
15987,1137,pregnancy,B-Condition
15988,1137,",",O
15989,1137,porphyria,B-Condition
15990,1137,",",O
15991,1137,severely,O
15992,1137,disturbed,B-Condition
15993,1137,liver,I-Condition
15994,1137,function,I-Condition
15995,1137,),O
15996,1137,.,O
15997,1137,Pregnancy,O
15998,1137,will,O
15999,1137,not,O
16000,1137,be,O
16001,1137,routinely,O
16002,1137,tested,O
16003,1137,in,O
16004,1137,female,O
16005,1137,patients,O
16006,1137,",",O
16007,1137,but,O
16008,1137,the,O
16009,1137,possibility,O
16010,1137,of,O
16011,1137,pregnancy,O
16012,1137,will,O
16013,1137,be,O
16014,1137,discussed,O
16015,1137,during,O
16016,1137,screening,O
16017,1138,(,O
16018,1138,relative,O
16019,1138,),O
16020,1138,Known,O
16021,1138,contraindications,B-Condition
16022,1138,for,O
16023,1138,initiation,O
16024,1138,of,O
16025,1138,eplerenone,B-Drug
16026,1138,treatment,O
16027,1138,(,O
16028,1138,hyperkalemia,B-Condition
16029,1138,",",O
16030,1138,abnormal,B-Condition
16031,1138,renal,I-Condition
16032,1138,clearance,I-Condition
16033,1138,",",O
16034,1138,severe,B-Condition
16035,1138,hepatic,I-Condition
16036,1138,insufficiency,I-Condition
16037,1138,(,O
16038,1138,Child,O
16039,1138,-,O
16040,1138,Pugh,O
16041,1138,C,O
16042,1138,),O
16043,1138,",",O
16044,1138,type,B-Condition
16045,1138,2,I-Condition
16046,1138,diabetes,I-Condition
16047,1138,mellitus,I-Condition
16048,1138,with,O
16049,1138,microalbuminuria,B-Condition
16050,1138,",",O
16051,1138,concomitant,O
16052,1138,use,O
16053,1138,of,O
16054,1138,potassium,B-Drug
16055,1138,supplements,I-Drug
16056,1138,",",O
16057,1138,potassium,B-Drug
16058,1138,-,I-Drug
16059,1138,sparing,I-Drug
16060,1138,diuretics,I-Drug
16061,1138,",",O
16062,1138,strong,B-Drug
16063,1138,CYP3A4,I-Drug
16064,1138,inhibitors,I-Drug
16065,1138,",",O
16066,1138,or,O
16067,1138,the,O
16068,1138,combination,O
16069,1138,of,O
16070,1138,an,O
16071,1138,ACE,B-Drug
16072,1138,-,I-Drug
16073,1138,inhibitor,I-Drug
16074,1138,and,O
16075,1138,an,O
16076,1138,angiotensin,B-Drug
16077,1138,receptor,I-Drug
16078,1138,blocking,I-Drug
16079,1138,agent,I-Drug
16080,1138,),O
16081,1138,.,O
16082,1138,Pregnancy,O
16083,1138,will,O
16084,1138,not,O
16085,1138,be,O
16086,1138,routinely,O
16087,1138,tested,O
16088,1138,in,O
16089,1138,female,O
16090,1138,patients,O
16091,1138,",",O
16092,1138,but,O
16093,1138,the,O
16094,1138,possibility,O
16095,1138,of,O
16096,1138,pregnancy,O
16097,1138,will,O
16098,1138,be,O
16099,1138,discussed,O
16100,1138,during,O
16101,1138,screening,O
16102,1138,;,O
16103,1139,Soft,B-Condition
16104,1139,drusen,I-Condition
16105,1139,in,O
16106,1139,treated,O
16107,1139,eye,O
16108,1139,or,O
16109,1139,fellow,O
16110,1139,eye,O
16111,1139,",",O
16112,1139,signs,O
16113,1139,of,O
16114,1139,choroidal,B-Condition
16115,1139,neovascularization,I-Condition
16116,1139,on,O
16117,1139,ophthalmoscopy,B-Procedure
16118,1139,and/or,O
16119,1139,FA,B-Procedure
16120,1139,/,O
16121,1139,ICGA,B-Procedure
16122,1139,of,O
16123,1139,the,O
16124,1139,study,O
16125,1139,eye,O
16126,1139,.,O
16127,1140,Age,B-Person
16128,1140,of,O
16129,1140,=,O
16130,1140,18,O
16131,1140,years,O
16132,1140,of,O
16133,1140,age,O
16134,1140,and,O
16135,1140,able,B-Observation
16136,1140,to,I-Observation
16137,1140,give,I-Observation
16138,1140,written,I-Observation
16139,1140,informed,I-Observation
16140,1140,consent,I-Observation
16141,1140,;,O
16142,1141,Active,O
16143,1141,chronic,O
16144,1141,central,B-Condition
16145,1141,serous,I-Condition
16146,1141,chorioretinopathy,I-Condition
16147,1141,(,I-Condition
16148,1141,cCSC,I-Condition
16149,1141,),I-Condition
16150,1141,;,O
16151,1142,Subjective,B-Condition
16152,1142,visual,I-Condition
16153,1142,loss,I-Condition
16154,1142,>,O
16155,1142,6,O
16156,1142,weeks,O
16157,1142,",",O
16158,1142,interpreted,O
16159,1142,as,O
16160,1142,onset,O
16161,1142,of,O
16162,1142,active,O
16163,1142,disease,O
16164,1142,;,O
16165,1143,Foveal,B-Condition
16166,1143,subretinal,I-Condition
16167,1143,fluid,I-Condition
16168,1143,(,I-Condition
16169,1143,SRF,I-Condition
16170,1143,),I-Condition
16171,1143,",",O
16172,1143,on,O
16173,1143,optical,B-Procedure
16174,1143,coherence,I-Procedure
16175,1143,tomography,I-Procedure
16176,1143,(,I-Procedure
16177,1143,OCT,I-Procedure
16178,1143,),I-Procedure
16179,1143,",",O
16180,1143,at,O
16181,1143,Baseline,O
16182,1143,Examination,O
16183,1143,;,O
16184,1144,=,O
16185,1144,1,O
16186,1144,ill,O
16187,1144,-,O
16188,1144,defined,O
16189,1144,hyperfluorescent,B-Condition
16190,1144,leakage,I-Condition
16191,1144,areas,I-Condition
16192,1144,on,O
16193,1144,fluorescein,B-Procedure
16194,1144,angiography,I-Procedure
16195,1144,(,I-Procedure
16196,1144,FA,I-Procedure
16197,1144,),I-Procedure
16198,1144,with,O
16199,1144,retinal,B-Condition
16200,1144,pigment,I-Condition
16201,1144,epithelial,I-Condition
16202,1144,window,I-Condition
16203,1144,defect(s,I-Condition
16204,1144,),I-Condition
16205,1144,that,O
16206,1144,are,O
16207,1144,compatible,O
16208,1144,with,O
16209,1144,cCSC,O
16210,1144,;,O
16211,1145,Hyperfluorescent,B-Condition
16212,1145,areas,I-Condition
16213,1145,on,O
16214,1145,indocyanine,B-Procedure
16215,1145,green,I-Procedure
16216,1145,angiography,I-Procedure
16217,1145,(,I-Procedure
16218,1145,ICGA,I-Procedure
16219,1145,),I-Procedure
16220,1145,.,O
16221,1146,A,O
16222,1146,diagnosis,O
16223,1146,of,O
16224,1146,sleep,B-Condition
16225,1146,disordered,I-Condition
16226,1146,breathing,I-Condition
16227,1146,;,O
16228,1147,Nocturnal,B-Procedure
16229,1147,oxygen,I-Procedure
16230,1147,therapy,I-Procedure
16231,1147,.,O
16232,1148,Moderate,O
16233,1148,to,O
16234,1148,severe,O
16235,1148,COPD,B-Condition
16236,1148,(,O
16237,1148,post,O
16238,1148,-,O
16239,1148,bronchodilator,O
16240,1148,forced,O
16241,1148,expiratory,O
16242,1148,volume,O
16243,1148,in,O
16244,1148,1,O
16245,1148,s,O
16246,1148,(,O
16247,1148,FEV1,O
16248,1148,),O
16249,1148,30,O
16250,1148,-,O
16251,1148,79%predicted,O
16252,1148,),O
16253,1148,;,O
16254,1149,Resting,O
16255,1149,functional,O
16256,1149,residual,O
16257,1149,capacity,O
16258,1149,(,O
16259,1149,FRC,O
16260,1149,),O
16261,1149,>,O
16262,1149,120,O
16263,1149,%,O
16264,1149,predicted,O
16265,1149,;,O
16266,1150,Clinically,B-Condition
16267,1150,stable,I-Condition
16268,1150,and,O
16269,1150,on,O
16270,1150,stable,B-Procedure
16271,1150,triple,I-Procedure
16272,1150,therapy,I-Procedure
16273,1150,with,O
16274,1150,an,O
16275,1150,ICS,B-Drug
16276,1150,/,I-Drug
16277,1150,LABA,I-Drug
16278,1150,and,O
16279,1150,tiotropium,B-Drug
16280,1150,;,O
16281,1151,Symptomatic,O
16282,1151,:,O
16283,1151,Baseline,O
16284,1151,Dyspnea,O
16285,1151,Index,O
16286,1151,=,O
16287,1151,8,O
16288,1151,and,O
16289,1151,answer,O
16290,1151,"""",O
16291,1151,in,O
16292,1151,the,O
16293,1151,morning,O
16294,1151,"""",O
16295,1151,when,O
16296,1151,asked,O
16297,1151,about,O
16298,1151,what,B-Observation
16299,1151,time,I-Observation
16300,1151,of,I-Observation
16301,1151,day,I-Observation
16302,1151,their,I-Observation
16303,1151,COPD,I-Observation
16304,1151,symptoms,I-Observation
16305,1151,are,I-Observation
16306,1151,worst,I-Observation
16307,1151,.,O
16308,1152,Suspected,B-Mood
16309,1152,or,O
16310,1152,known,B-Mood
16311,1152,gynecological,B-Condition
16312,1152,malignancy,I-Condition
16313,1152,.,O
16314,1153,uterine,O
16315,1153,size,O
16316,1153,>,O
16317,1153,12,O
16318,1153,weeks,O
16319,1153,.,O
16320,1154,Endometriosis,B-Condition
16321,1155,Presence,O
16322,1155,of,O
16323,1155,adnexal,B-Condition
16324,1155,mass,I-Condition
16325,1155,.,O
16326,1156,cervix,B-Condition
16327,1156,flushed,I-Condition
16328,1156,with,I-Condition
16329,1156,the,I-Condition
16330,1156,vagina,I-Condition
16331,1156,.,O
16332,1157,presence,O
16333,1157,of,O
16334,1157,significant,B-Condition
16335,1157,scarring,I-Condition
16336,1157,in,O
16337,1157,the,O
16338,1157,pelvic,O
16339,1157,area,O
16340,1157,from,O
16341,1157,previous,O
16342,1157,surgery,B-Procedure
16343,1157,.,O
16344,1158,uterine,O
16345,1158,size,O
16346,1158,<,O
16347,1158,12,O
16348,1158,weeks,O
16349,1158,.,O
16350,1159,presence,O
16351,1159,of,O
16352,1159,benign,B-Condition
16353,1159,cause,I-Condition
16354,1159,for,O
16355,1159,the,O
16356,1159,hysterectomy,B-Procedure
16357,1159,e.g.,O
16358,1159,fibroid,B-Condition
16359,1159,uterus,I-Condition
16360,1159,",",O
16361,1159,perimenopausal,B-Condition
16362,1159,beeding,I-Condition
16363,1159,not,O
16364,1159,responding,O
16365,1159,to,O
16366,1159,medical,B-Procedure
16367,1159,treatment,I-Procedure
16368,1159,or,O
16369,1159,complex,B-Condition
16370,1159,endometrial,I-Condition
16371,1159,hyperplasia,I-Condition
16372,1159,without,O
16373,1159,atypia,B-Condition
16374,1159,.,O
16375,1160,Absence,O
16376,1160,of,O
16377,1160,significant,B-Condition
16378,1160,scarring,I-Condition
16379,1160,in,O
16380,1160,the,O
16381,1160,pelvis,O
16382,1160,from,O
16383,1160,previous,O
16384,1160,surgeries,B-Procedure
16385,1160,.,O
16386,1161,OAT,B-Drug
16387,1161,required,O
16388,1161,for,O
16389,1161,reasons,O
16390,1161,not,O
16391,1161,related,O
16392,1161,to,O
16393,1161,AF,O
16394,1161,(,O
16395,1161,i.e.,O
16396,1161,",",O
16397,1161,prosthetic,O
16398,1161,valve,O
16399,1161,",",O
16400,1161,PV,B-Condition
16401,1161,stenosis,I-Condition
16402,1161,",",O
16403,1161,previous,O
16404,1161,pulmonary,B-Condition
16405,1161,embolism,I-Condition
16406,1161,",",O
16407,1161,presence,O
16408,1161,of,O
16409,1161,spontaneous,O
16410,1161,echo,O
16411,1161,contrast,O
16412,1161,[,O
16413,1161,SEC,O
16414,1161,],O
16415,1161,at,O
16416,1161,standard,O
16417,1161,echo,O
16418,1161,performed,O
16419,1161,at,O
16420,1161,3,O
16421,1161,-,O
16422,1161,months,O
16423,1161,follow,O
16424,1161,-,O
16425,1161,up,O
16426,1161,),O
16427,1161,.,O
16428,1162,Any,O
16429,1162,cardiac,B-Procedure
16430,1162,surgery,I-Procedure
16431,1162,within,O
16432,1162,the,O
16433,1162,past,O
16434,1162,60,O
16435,1162,days,O
16436,1162,(,O
16437,1162,2,O
16438,1162,months,O
16439,1162,),O
16440,1162,or,O
16441,1162,valvular,B-Procedure
16442,1162,cardiac,I-Procedure
16443,1162,surgical,I-Procedure
16444,1162,procedure,O
16445,1162,at,O
16446,1162,any,O
16447,1162,time,O
16448,1162,(,O
16449,1162,i.e.,O
16450,1162,",",O
16451,1162,ventriculotomy,B-Procedure
16452,1162,",",O
16453,1162,atriotomy,B-Procedure
16454,1162,",",O
16455,1162,and,O
16456,1162,valve,B-Procedure
16457,1162,repair,I-Procedure
16458,1162,or,I-Procedure
16459,1162,replacement,I-Procedure
16460,1162,and,O
16461,1162,presence,O
16462,1162,of,O
16463,1162,a,O
16464,1162,prosthetic,O
16465,1162,valve,O
16466,1162,),O
16467,1163,Previous,O
16468,1163,myocardial,B-Condition
16469,1163,infarction,I-Condition
16470,1163,(,O
16471,1163,MI,B-Condition
16472,1163,),O
16473,1163,or,O
16474,1163,a,O
16475,1163,percutaneous,B-Procedure
16476,1163,coronary,I-Procedure
16477,1163,intervention,I-Procedure
16478,1163,PCI,B-Procedure
16479,1163,within,O
16480,1163,the,O
16481,1163,past,O
16482,1163,3,O
16483,1163,months,O
16484,1164,Awaiting,B-Mood
16485,1164,cardiac,B-Procedure
16486,1164,transplantation,I-Procedure
16487,1164,or,O
16488,1164,other,O
16489,1164,cardiac,B-Procedure
16490,1164,surgery,I-Procedure
16491,1164,within,O
16492,1164,the,O
16493,1164,next,O
16494,1164,365,O
16495,1164,days,O
16496,1164,(,O
16497,1164,12,O
16498,1164,months,O
16499,1164,),O
16500,1165,Documented,O
16501,1165,left,B-Condition
16502,1165,atrial,I-Condition
16503,1165,thrombus,I-Condition
16504,1166,Significant,O
16505,1166,pulmonary,B-Condition
16506,1166,disease,I-Condition
16507,1166,",",O
16508,1166,(,O
16509,1166,e.g.,O
16510,1166,",",O
16511,1166,restrictive,B-Condition
16512,1166,pulmonary,I-Condition
16513,1166,disease,I-Condition
16514,1166,",",O
16515,1166,constrictive,O
16516,1166,or,O
16517,1166,COPD,B-Condition
16518,1166,),O
16519,1166,or,O
16520,1166,any,O
16521,1166,other,O
16522,1166,disease,O
16523,1166,or,O
16524,1166,malfunction,O
16525,1166,of,O
16526,1166,the,O
16527,1166,lungs,O
16528,1166,or,O
16529,1166,respiratory,O
16530,1166,system,O
16531,1166,that,O
16532,1166,produces,O
16533,1166,chronic,O
16534,1166,symptoms,O
16535,1167,Significant,O
16536,1167,medical,O
16537,1167,problem,O
16538,1167,that,O
16539,1167,in,O
16540,1167,the,O
16541,1167,opinion,O
16542,1167,of,O
16543,1167,the,O
16544,1167,investigator,O
16545,1167,would,O
16546,1167,preclude,O
16547,1167,enrollment,O
16548,1167,in,O
16549,1167,this,O
16550,1167,study,O
16551,1168,Women,O
16552,1168,who,O
16553,1168,are,O
16554,1168,pregnant,O
16555,1168,(,O
16556,1168,as,O
16557,1168,evidenced,O
16558,1168,by,O
16559,1168,pregnancy,O
16560,1168,test,O
16561,1168,if,O
16562,1168,pre,O
16563,1168,-,O
16564,1168,menopausal,O
16565,1168,),O
16566,1169,Acute,O
16567,1169,illness,O
16568,1169,or,O
16569,1169,active,O
16570,1169,systemic,B-Condition
16571,1169,infection,I-Condition
16572,1169,or,O
16573,1169,sepsis,B-Condition
16574,1170,Unstable,B-Condition
16575,1170,angina,I-Condition
16576,1171,Contraindication,B-Condition
16577,1171,to,O
16578,1171,anticoagulation,B-Drug
16579,1171,(,O
16580,1171,i.e.,O
16581,1171,",",O
16582,1171,heparin,B-Drug
16583,1171,",",O
16584,1171,warfarin,B-Drug
16585,1171,or,O
16586,1171,another,O
16587,1171,commercially,O
16588,1171,available,O
16589,1171,anticoagulation,O
16590,1171,medication,O
16591,1171,),O
16592,1172,History,O
16593,1172,of,O
16594,1172,blood,B-Condition
16595,1172,clotting,I-Condition
16596,1172,or,I-Condition
16597,1172,bleeding,I-Condition
16598,1172,abnormalities,I-Condition
16599,1173,Life,B-Observation
16600,1173,expectancy,I-Observation
16601,1173,less,O
16602,1173,than,O
16603,1173,360,O
16604,1173,days,O
16605,1173,(,O
16606,1173,12,O
16607,1173,months,O
16608,1173,),O
16609,1174,Uncontrolled,O
16610,1174,Heart,B-Condition
16611,1174,Failure,I-Condition
16612,1174,or,O
16613,1174,NYHA,O
16614,1174,Class,O
16615,1174,III,O
16616,1174,or,O
16617,1174,IV,O
16618,1174,heart,B-Condition
16619,1174,failure,I-Condition
16620,1175,Enrollment,O
16621,1175,in,O
16622,1175,a,O
16623,1175,clinical,O
16624,1175,study,O
16625,1175,evaluating,O
16626,1175,another,O
16627,1175,device,O
16628,1175,or,O
16629,1175,drug,O
16630,1175,",",O
16631,1175,within,O
16632,1175,the,O
16633,1175,past,O
16634,1175,6,O
16635,1175,months,O
16636,1176,Unable,O
16637,1176,or,O
16638,1176,unwilling,O
16639,1176,to,O
16640,1176,comply,O
16641,1176,with,O
16642,1176,protocol,O
16643,1176,requirements,O
16644,1177,Successful,O
16645,1177,cardiac,B-Procedure
16646,1177,ablation,I-Procedure
16647,1177,for,O
16648,1177,AF,B-Condition
16649,1178,Documented,O
16650,1178,freedom,O
16651,1178,from,O
16652,1178,AF,B-Condition
16653,1178,recurrence,I-Condition
16654,1178,(,O
16655,1178,symptomatic,O
16656,1178,or,O
16657,1178,asymptomatic,O
16658,1178,arrhythmic,B-Condition
16659,1178,recurrences,I-Condition
16660,1178,lasting,O
16661,1178,longer,O
16662,1178,than,O
16663,1178,30,O
16664,1178,seconds,O
16665,1178,),O
16666,1178,3,O
16667,1178,months,O
16668,1178,after,O
16669,1178,successful,O
16670,1178,cardiac,O
16671,1178,ablation,O
16672,1178,(,O
16673,1178,AF,O
16674,1178,recurrence,O
16675,1178,during,O
16676,1178,3,O
16677,1178,-,O
16678,1178,month,O
16679,1178,blanking,O
16680,1178,period,O
16681,1178,is,O
16682,1178,excluded,O
16683,1178,),O
16684,1178,.,O
16685,1179,Patient,O
16686,1179,must,O
16687,1179,have,O
16688,1179,been,O
16689,1179,on,O
16690,1179,a,O
16691,1179,commercially,O
16692,1179,approved,O
16693,1179,anticoagulation,B-Drug
16694,1179,therapy,I-Drug
16695,1179,for,O
16696,1179,at,O
16697,1179,least,O
16698,1179,two,O
16699,1179,(,O
16700,1179,2,O
16701,1179,),O
16702,1179,months,O
16703,1179,prior,O
16704,1179,to,O
16705,1179,randomization,O
16706,1179,in,O
16707,1179,the,O
16708,1179,OAT,O
16709,1179,Study,O
16710,1179,.,O
16711,1180,CHADS2,O
16712,1180,score,O
16713,1180,=,O
16714,1180,2,O
16715,1180,or,O
16716,1180,CHA2DS2,O
16717,1180,-,O
16718,1180,VASc,O
16719,1180,score,O
16720,1180,(,O
16721,1180,=3,O
16722,1180,),O
16723,1181,Left,O
16724,1181,ventricular,O
16725,1181,ejection,O
16726,1181,fraction,O
16727,1181,>,O
16728,1181,25,O
16729,1181,%,O
16730,1182,LA,O
16731,1182,size,O
16732,1182,<,O
16733,1182,65,O
16734,1183,High,O
16735,1183,risk,B-Observation
16736,1183,for,I-Observation
16737,1183,thromboembolic,I-Observation
16738,1183,events,I-Observation
16739,1183,(,O
16740,1183,i.e.,O
16741,1183,",",O
16742,1183,CHADS2,O
16743,1183,score,O
16744,1183,=,O
16745,1183,2,O
16746,1183,or,O
16747,1183,CHA2DS2,O
16748,1183,-,O
16749,1183,VASc,O
16750,1183,score,O
16751,1183,=,O
16752,1183,3,O
16753,1183,),O
16754,1183,and,O
16755,1183,require,O
16756,1183,OAT,B-Drug
16757,1183,before,O
16758,1183,undergoing,O
16759,1183,cardiac,O
16760,1183,ablation,O
16761,1184,Able,O
16762,1184,and,O
16763,1184,willing,O
16764,1184,to,O
16765,1184,comply,O
16766,1184,with,O
16767,1184,all,O
16768,1184,pre-,O
16769,1184,and,O
16770,1184,follow,O
16771,1184,-,O
16772,1184,up,O
16773,1184,testing,O
16774,1184,and,O
16775,1184,requirements,O
16776,1185,Signed,O
16777,1185,informed,O
16778,1185,consent,O
16779,1185,form,O
16780,1186,Age,B-Person
16781,1186,18,O
16782,1186,years,O
16783,1186,or,O
16784,1186,older,O
16785,1187,1,O
16786,1187,.,O
16787,1187,Patient,O
16788,1187,or,O
16789,1187,relatives,O
16790,1187,unable,O
16791,1187,or,O
16792,1187,unwilling,O
16793,1187,to,O
16794,1187,give,O
16795,1187,informed,O
16796,1187,consent,O
16797,1188,2,O
16798,1188,.,O
16799,1188,Contraindication,B-Condition
16800,1188,or,O
16801,1188,allergy,B-Condition
16802,1188,to,O
16803,1188,paracetamol,B-Drug
16804,1188,or,O
16805,1188,artesunate,B-Drug
16806,1188,therapy,O
16807,1189,3,O
16808,1189,.,O
16809,1189,Known,O
16810,1189,cirrhosis,B-Condition
16811,1189,",",O
16812,1189,or,O
16813,1189,>,B-Condition
16814,1189,6,I-Condition
16815,1189,standard,I-Condition
16816,1189,alcoholic,I-Condition
16817,1189,drinks,I-Condition
16818,1189,/,I-Condition
16819,1189,day,I-Condition
16820,1190,4,O
16821,1190,.,O
16822,1190,Pregnancy,B-Condition
16823,1191,1,O
16824,1191,.,O
16825,1191,Patient,O
16826,1191,age,B-Person
16827,1191,≥,O
16828,1191,12,O
16829,1191,years,O
16830,1192,2,O
16831,1192,.,O
16832,1192,Presence,O
16833,1192,of,O
16834,1192,P.,B-Condition
16835,1192,knowlesi,I-Condition
16836,1192,malaria,I-Condition
16837,1192,",",O
16838,1192,confirmed,O
16839,1192,by,O
16840,1192,positive,O
16841,1192,blood,O
16842,1192,smear,O
16843,1192,with,O
16844,1192,asexual,O
16845,1192,forms,O
16846,1192,of,O
16847,1192,P.,O
16848,1192,knowlesi,O
16849,1192,.,O
16850,1193,3,O
16851,1193,.,O
16852,1193,Temperature,O
16853,1193,>,O
16854,1193,38C,O
16855,1193,on,O
16856,1193,admission,O
16857,1193,or,O
16858,1193,fever,O
16859,1193,during,O
16860,1193,the,O
16861,1193,preceding,O
16862,1193,48,O
16863,1193,hours,O
16864,1194,4,O
16865,1194,.,O
16866,1194,Enrolled,B-Observation
16867,1194,within,O
16868,1194,18,O
16869,1194,hours,O
16870,1194,of,O
16871,1194,commencing,O
16872,1194,antimalarial,B-Procedure
16873,1194,treatment,I-Procedure
16874,1195,5,O
16875,1195,.,O
16876,1195,Written,O
16877,1195,informed,O
16878,1195,consent,O
16879,1195,from,O
16880,1195,patient,O
16881,1195,or,O
16882,1195,attending,O
16883,1195,relative,O
16884,1195,able,O
16885,1195,to,O
16886,1195,and,O
16887,1195,willing,O
16888,1195,to,O
16889,1195,give,O
16890,1195,informed,O
16891,1195,consent,O
16892,1195,.,O
16893,1195,Consent,O
16894,1195,form,O
16895,1195,and,O
16896,1195,information,O
16897,1195,sheets,O
16898,1195,will,O
16899,1195,be,O
16900,1195,translated,O
16901,1195,into,O
16902,1195,Malay,O
16903,1195,and,O
16904,1195,copies,O
16905,1195,provided,O
16906,1195,to,O
16907,1195,the,O
16908,1195,patient,O
16909,1195,.,O
16910,1196,patients,O
16911,1196,who,O
16912,1196,do,O
16913,1196,not,O
16914,1196,wish,O
16915,1196,to,O
16916,1196,participate,O
16917,1196,in,O
16918,1196,the,O
16919,1196,project,O
16920,1196,;,O
16921,1197,patients,O
16922,1197,with,O
16923,1197,ectopic,B-Condition
16924,1197,pregnancy,I-Condition
16925,1197,;,O
16926,1198,patients,O
16927,1198,with,O
16928,1198,comorbidities,B-Condition
16929,1198,(,O
16930,1198,heart,B-Condition
16931,1198,failure,I-Condition
16932,1198,congestive,I-Condition
16933,1198,",",O
16934,1198,chronic,B-Condition
16935,1198,obstructive,I-Condition
16936,1198,pulmonary,I-Condition
16937,1198,disease,I-Condition
16938,1198,),O
16939,1198,;,O
16940,1199,patients,O
16941,1199,with,O
16942,1199,hypovolemic,B-Condition
16943,1199,shock,I-Condition
16944,1199,;,O
16945,1200,patients,O
16946,1200,with,O
16947,1200,cervical,B-Condition
16948,1200,incompetence,I-Condition
16949,1200,;,O
16950,1201,patients,O
16951,1201,with,O
16952,1201,infected,O
16953,1201,miscarriage,B-Condition
16954,1201,/,O
16955,1201,abortion,B-Condition
16956,1201,(,O
16957,1201,presence,O
16958,1201,of,O
16959,1201,fever,B-Condition
16960,1201,",",O
16961,1201,pus,B-Condition
16962,1201,from,I-Condition
16963,1201,the,I-Condition
16964,1201,cervix,I-Condition
16965,1201,",",O
16966,1201,leukocytosis,O
16967,1201,[,O
16968,1201,>,O
16969,1201,14000,O
16970,1201,],O
16971,1201,),O
16972,1201,;,O
16973,1202,patients,O
16974,1202,with,O
16975,1202,twin,O
16976,1202,pregnancy,B-Condition
16977,1202,;,O
16978,1203,patients,O
16979,1203,with,O
16980,1203,Marfan,B-Condition
16981,1203,syndrome,I-Condition
16982,1203,;,O
16983,1204,patients,O
16984,1204,allergic,B-Condition
16985,1204,to,O
16986,1204,misoprostol,B-Drug
16987,1204,;,O
16988,1205,patients,O
16989,1205,with,O
16990,1205,coagulopathy,B-Condition
16991,1205,;,O
16992,1206,patients,O
16993,1206,with,O
16994,1206,opening,B-Observation
16995,1206,of,I-Observation
16996,1206,cervical,I-Observation
16997,1206,internal,I-Observation
16998,1206,os,I-Observation
16999,1206,(,O
17000,1206,4,O
17001,1206,mm,O
17002,1206,of,O
17003,1206,dilatation,O
17004,1206,at,O
17005,1206,the,O
17006,1206,time,O
17007,1206,of,O
17008,1206,consultation,O
17009,1206,),O
17010,1206,;,O
17011,1207,patients,O
17012,1207,with,O
17013,1207,previous,O
17014,1207,surgery,B-Procedure
17015,1207,of,O
17016,1207,the,O
17017,1207,cervix,O
17018,1207,(,O
17019,1207,conization,B-Procedure
17020,1207,),O
17021,1207,;,O
17022,1208,patients,O
17023,1208,with,O
17024,1208,concomitant,O
17025,1208,use,O
17026,1208,of,O
17027,1208,IUDs,B-Drug
17028,1208,.,O
17029,1209,All,O
17030,1209,patients,O
17031,1209,admitted,O
17032,1209,at,O
17033,1209,the,O
17034,1209,Gynecological,O
17035,1209,emergency,O
17036,1209,Unit,O
17037,1209,at,O
17038,1209,Hospital,O
17039,1209,de,O
17040,1209,Clínicas,O
17041,1209,de,O
17042,1209,Porto,O
17043,1209,Alegre,O
17044,1209,scheduled,O
17045,1209,for,O
17046,1209,uterine,B-Procedure
17047,1209,evacuation,I-Procedure
17048,1209,with,O
17049,1209,<,O
17050,1209,12,O
17051,1209,weeks,O
17052,1209,of,O
17053,1209,gestation,B-Condition
17054,1209,.,O
17055,1210,Non,O
17056,1210,-,O
17057,1210,English,O
17058,1210,speaking,O
17059,1210,patients,O
17060,1211,Pregnant,O
17061,1211,women,O
17062,1211,(,O
17063,1211,women,O
17064,1211,of,O
17065,1211,childbearing,O
17066,1211,potential,O
17067,1211,will,O
17068,1211,be,O
17069,1211,advised,O
17070,1211,to,O
17071,1211,undergo,O
17072,1211,regular,O
17073,1211,pregnancy,O
17074,1211,testing,O
17075,1211,),O
17076,1212,Patients,O
17077,1212,who,O
17078,1212,had,O
17079,1212,previously,O
17080,1212,undergone,O
17081,1212,operative,O
17082,1212,therapy,O
17083,1212,for,O
17084,1212,the,O
17085,1212,condition,O
17086,1213,Patient,O
17087,1213,must,O
17088,1213,be,O
17089,1213,18,O
17090,1213,years,B-Person
17091,1213,or,O
17092,1213,older,O
17093,1214,Must,O
17094,1214,meet,O
17095,1214,the,O
17096,1214,following,O
17097,1214,definition,O
17098,1214,for,O
17099,1214,adhesive,B-Condition
17100,1214,capsulitis,I-Condition
17101,1214,as,O
17102,1214,defined,O
17103,1214,by,O
17104,1214,the,O
17105,1214,American,O
17106,1214,Academy,O
17107,1214,of,O
17108,1214,Orthopedic,O
17109,1214,Surgeons,O
17110,1214,:,O
17111,1214,Self,O
17112,1214,-,O
17113,1214,limiting,O
17114,1214,condition,O
17115,1214,resulting,O
17116,1214,from,O
17117,1214,any,O
17118,1214,inflammatory,O
17119,1214,process,O
17120,1214,about,O
17121,1214,the,O
17122,1214,shoulder,O
17123,1214,in,O
17124,1214,which,O
17125,1214,capsular,O
17126,1214,scar,O
17127,1214,tissue,O
17128,1214,is,O
17129,1214,produced,O
17130,1214,",",O
17131,1214,resulting,O
17132,1214,in,O
17133,1214,pain,O
17134,1214,and,O
17135,1214,limited,O
17136,1214,range,O
17137,1214,of,O
17138,1214,motion,O
17139,1214,;,O
17140,1214,also,O
17141,1214,called,O
17142,1214,frozen,O
17143,1214,shoulder,O
17144,1215,Must,O
17145,1215,be,O
17146,1215,amenable,O
17147,1215,to,O
17148,1215,randomization,O
17149,1215,into,O
17150,1215,either,O
17151,1215,cohort,O
17152,1216,Severe,O
17153,1216,co,B-Condition
17154,1216,-,I-Condition
17155,1216,morbid,I-Condition
17156,1216,illness,I-Condition
17157,1216,such,O
17158,1216,as,O
17159,1216,untreatable,O
17160,1216,other,O
17161,1216,malignancy,B-Condition
17162,1216,and/or,O
17163,1216,active,O
17164,1216,infections,B-Condition
17165,1216,.,O
17166,1217,Pregnant,B-Condition
17167,1217,or,O
17168,1217,lactating,B-Condition
17169,1217,women,B-Person
17170,1218,Hypersensitivity,B-Condition
17171,1218,to,O
17172,1218,Sandostatin,B-Drug
17173,1218,or,O
17174,1218,any,O
17175,1218,component,B-Drug
17176,1218,of,I-Drug
17177,1218,the,I-Drug
17178,1218,formulation,I-Drug
17179,1218,.,O
17180,1219,Age,B-Person
17181,1219,18,O
17182,1219,or,O
17183,1219,older,O
17184,1219,.,O
17185,1220,Patients,O
17186,1220,diagnosed,O
17187,1220,with,O
17188,1220,acromegaly,B-Condition
17189,1220,with,O
17190,1220,GH,B-Condition
17191,1220,-,I-Condition
17192,1220,secreting,I-Condition
17193,1220,pituitary,I-Condition
17194,1220,adenoma,I-Condition
17195,1220,on,O
17196,1220,sellar,B-Procedure
17197,1220,MRI,I-Procedure
17198,1220,",",O
17199,1220,meeting,O
17200,1220,the,O
17201,1220,biochemical,O
17202,1220,criteria,O
17203,1220,outlined,O
17204,1220,above,O
17205,1220,(,O
17206,1220,refer,O
17207,1220,to,O
17208,1220,1,O
17209,1220,.,O
17210,1220,Diagnosis,O
17211,1220,of,O
17212,1220,acromegaly,O
17213,1220,),O
17214,1220,and,O
17215,1220,with,O
17216,1220,typical,O
17217,1220,acromegalic,B-Condition
17218,1220,features,I-Condition
17219,1220,.,O
17220,1221,No,O
17221,1221,prior,O
17222,1221,use,O
17223,1221,of,O
17224,1221,somatostatin,B-Drug
17225,1221,analogues,I-Drug
17226,1221,.,O
17227,1222,Adequate,B-Condition
17228,1222,hepatic,I-Condition
17229,1222,and,I-Condition
17230,1222,renal,I-Condition
17231,1222,function,I-Condition
17232,1223,Provision,O
17233,1223,of,O
17234,1223,a,O
17235,1223,signed,O
17236,1223,written,O
17237,1223,informed,O
17238,1223,consent,O
17239,1224,1,O
17240,1224,.,O
17241,1224,Subject,O
17242,1224,is,O
17243,1224,a,O
17244,1224,post,B-Condition
17245,1224,-,I-Condition
17246,1224,menopausal,I-Condition
17247,1224,woman,B-Person
17248,1224,",",O
17249,1224,defined,O
17250,1224,as,O
17251,1224,either,O
17252,1224,;,O
17253,1224,six,O
17254,1224,(,O
17255,1224,6,O
17256,1224,),O
17257,1224,months,O
17258,1224,or,O
17259,1224,more,O
17260,1224,(,O
17261,1224,immediately,O
17262,1224,prior,O
17263,1224,to,O
17264,1224,screening,O
17265,1224,visit,O
17266,1224,),O
17267,1224,without,O
17268,1224,a,O
17269,1224,menstrual,B-Condition
17270,1224,period,I-Condition
17271,1224,",",O
17272,1224,or,O
17273,1224,prior,O
17274,1224,hysterectomy,B-Procedure
17275,1224,and/or,O
17276,1224,oophorectomy,B-Procedure
17277,1225,2,O
17278,1225,.,O
17279,1225,Subject,O
17280,1225,is,O
17281,1225,pregnant,B-Condition
17282,1225,or,O
17283,1225,lactating,B-Condition
17284,1225,or,O
17285,1225,is,O
17286,1225,attempting,O
17287,1225,or,O
17288,1225,expecting,O
17289,1225,to,O
17290,1225,become,O
17291,1225,pregnant,O
17292,1225,during,O
17293,1225,the,O
17294,1225,study,O
17295,1226,3,O
17296,1226,.,O
17297,1226,Women,B-Person
17298,1226,with,O
17299,1226,abnormally,O
17300,1226,high,O
17301,1226,liver,O
17302,1226,enzymes,O
17303,1226,or,O
17304,1226,liver,B-Condition
17305,1226,disease,I-Condition
17306,1226,.,O
17307,1226,(,O
17308,1226,ALT,O
17309,1226,or,O
17310,1226,AST,O
17311,1226,exceeding,O
17312,1226,2.0,O
17313,1226,x,O
17314,1226,ULN,O
17315,1226,AND,O
17316,1226,total,O
17317,1226,bilirubin,O
17318,1226,exceeding,O
17319,1226,1.5,O
17320,1226,x,O
17321,1226,ULN,O
17322,1226,at,O
17323,1226,screening,O
17324,1226,and,O
17325,1226,confirmed,O
17326,1226,on,O
17327,1226,repeat,O
17328,1226,),O
17329,1226,.,O
17330,1227,4,O
17331,1227,.,O
17332,1227,Received,O
17333,1227,an,O
17334,1227,investigational,B-Drug
17335,1227,drug,I-Drug
17336,1227,in,O
17337,1227,the,O
17338,1227,30,O
17339,1227,days,O
17340,1227,prior,O
17341,1227,to,O
17342,1227,the,O
17343,1227,screening,O
17344,1227,for,O
17345,1227,this,O
17346,1227,study,O
17347,1228,5,O
17348,1228,.,O
17349,1228,Women,B-Person
17350,1228,with,O
17351,1228,a,O
17352,1228,history,B-Observation
17353,1228,of,O
17354,1228,PCOS,B-Condition
17355,1229,6,O
17356,1229,.,O
17357,1229,Concurrent,O
17358,1229,use,O
17359,1229,of,O
17360,1229,any,O
17361,1229,testosterone,B-Drug
17362,1229,",",O
17363,1229,progestin,B-Drug
17364,1229,",",O
17365,1229,androgen,B-Drug
17366,1229,",",O
17367,1229,estrogen,B-Drug
17368,1229,",",O
17369,1229,anabolic,B-Drug
17370,1229,steroids,I-Drug
17371,1229,",",O
17372,1229,DHEA,B-Drug
17373,1229,or,O
17374,1229,hormonal,B-Drug
17375,1229,products,I-Drug
17376,1229,for,O
17377,1229,at,O
17378,1229,least,O
17379,1229,2,O
17380,1229,weeks,O
17381,1229,prior,O
17382,1229,to,O
17383,1229,screening,O
17384,1229,and,O
17385,1229,during,O
17386,1229,the,O
17387,1229,study,O
17388,1229,.,O
17389,1230,7,O
17390,1230,.,O
17391,1230,Use,O
17392,1230,of,O
17393,1230,oral,B-Drug
17394,1230,contraceptives,I-Drug
17395,1230,in,O
17396,1230,the,O
17397,1230,preceding,O
17398,1230,2,O
17399,1230,weeks,O
17400,1230,.,O
17401,1230,Use,O
17402,1230,of,O
17403,1230,Depo,B-Drug
17404,1230,-,I-Drug
17405,1230,Provera,I-Drug
17406,1230,®,I-Drug
17407,1230,in,O
17408,1230,the,O
17409,1230,preceding,O
17410,1230,10,O
17411,1230,months,O
17412,1230,.,O
17413,1231,8,O
17414,1231,.,O
17415,1231,Has,O
17416,1231,an,O
17417,1231,IUD,O
17418,1231,in,O
17419,1231,place,O
17420,1232,9,O
17421,1232,.,O
17422,1232,Women,B-Person
17423,1232,currently,O
17424,1232,using,O
17425,1232,narcotics,B-Drug
17426,1233,10,O
17427,1233,.,O
17428,1233,Women,B-Person
17429,1233,currently,O
17430,1233,taking,O
17431,1233,spironolactone,B-Drug
17432,1234,11,O
17433,1234,.,O
17434,1234,Infectious,O
17435,1234,disease,O
17436,1234,screen,O
17437,1234,is,O
17438,1234,positive,O
17439,1234,for,O
17440,1234,HIV,B-Condition
17441,1234,or,O
17442,1234,Hepatitis,B-Condition
17443,1234,A,I-Condition
17444,1234,",",I-Condition
17445,1234,B,I-Condition
17446,1234,or,I-Condition
17447,1234,C.,I-Condition
17448,1235,12,O
17449,1235,.,O
17450,1235,Clinically,O
17451,1235,significant,O
17452,1235,abnormal,O
17453,1235,findings,O
17454,1235,on,O
17455,1235,screening,O
17456,1235,examination,O
17457,1235,or,O
17458,1235,any,O
17459,1235,condition,O
17460,1235,which,O
17461,1235,in,O
17462,1235,the,O
17463,1235,opinion,O
17464,1235,of,O
17465,1235,the,O
17466,1235,investigator,O
17467,1235,would,O
17468,1235,interfere,O
17469,1235,with,O
17470,1235,the,O
17471,1235,participant,O
17472,1235,'s,O
17473,1235,ability,O
17474,1235,to,O
17475,1235,comply,O
17476,1235,with,O
17477,1235,the,O
17478,1235,study,O
17479,1235,instructions,O
17480,1235,or,O
17481,1235,endanger,O
17482,1235,the,O
17483,1235,participant,O
17484,1235,if,O
17485,1235,she,O
17486,1235,took,O
17487,1235,part,O
17488,1235,in,O
17489,1235,the,O
17490,1235,study,O
17491,1236,1,O
17492,1236,.,O
17493,1236,Speak,O
17494,1236,",",O
17495,1236,read,O
17496,1236,",",O
17497,1236,and,O
17498,1236,understand,O
17499,1236,English,O
17500,1236,or,O
17501,1236,Spanish,O
17502,1236,and,O
17503,1236,is,O
17504,1236,willing,O
17505,1236,and,O
17506,1236,able,O
17507,1236,to,O
17508,1236,provide,O
17509,1236,written,O
17510,1236,informed,O
17511,1236,consent,O
17512,1236,on,O
17513,1236,an,O
17514,1236,IRB,O
17515,1236,-,O
17516,1236,approved,O
17517,1236,form,O
17518,1236,prior,O
17519,1236,to,O
17520,1236,the,O
17521,1236,initiation,O
17522,1236,of,O
17523,1236,any,O
17524,1236,study,O
17525,1236,procedures,O
17526,1236,;,O
17527,1237,2,O
17528,1237,.,O
17529,1237,Healthy,B-Condition
17530,1237,",",O
17531,1237,premenopausal,B-Condition
17532,1237,female,B-Person
17533,1237,age,B-Person
17534,1237,18,O
17535,1237,-,O
17536,1237,47,O
17537,1237,;,O
17538,1238,3,O
17539,1238,.,O
17540,1238,History,B-Observation
17541,1238,of,O
17542,1238,menstrual,B-Condition
17543,1238,events,I-Condition
17544,1238,that,I-Condition
17545,1238,occur,I-Condition
17546,1238,in,I-Condition
17547,1238,regular,I-Condition
17548,1238,cycles,I-Condition
17549,1239,4,O
17550,1239,.,O
17551,1239,Agreement,O
17552,1239,not,O
17553,1239,to,O
17554,1239,attempt,O
17555,1239,to,O
17556,1239,become,O
17557,1239,pregnant,O
17558,1240,5,O
17559,1240,.,O
17560,1240,Agrees,O
17561,1240,to,O
17562,1240,use,O
17563,1240,double,O
17564,1240,-,O
17565,1240,barrier,O
17566,1240,contraception,O
17567,1240,during,O
17568,1240,the,O
17569,1240,study,O
17570,1240,and,O
17571,1240,for,O
17572,1240,30,O
17573,1240,days,O
17574,1240,after,O
17575,1240,discontinuation,O
17576,1240,of,O
17577,1240,study,O
17578,1240,medication,O
17579,1240,.,O
17580,1240,Acceptable,O
17581,1240,double,O
17582,1240,-,O
17583,1240,barrier,O
17584,1240,methods,O
17585,1240,are,O
17586,1240,:,O
17587,1240,male,O
17588,1240,condom,O
17589,1240,with,O
17590,1240,spermicide,O
17591,1240,;,O
17592,1240,male,O
17593,1240,condom,O
17594,1240,with,O
17595,1240,diaphragm,O
17596,1240,;,O
17597,1240,diaphragm,O
17598,1240,containing,O
17599,1240,spermicide,O
17600,1240,plus,O
17601,1240,additional,O
17602,1240,intra,O
17603,1240,-,O
17604,1240,vaginal,O
17605,1240,spermicide,O
17606,1240,;,O
17607,1241,6,O
17608,1241,.,O
17609,1241,Has,O
17610,1241,a,O
17611,1241,negative,O
17612,1241,pregnancy,O
17613,1241,test,O
17614,1241,at,O
17615,1241,the,O
17616,1241,Screening,O
17617,1241,visit,O
17618,1241,.,O
17619,1241,An,O
17620,1241,exception,O
17621,1241,for,O
17622,1241,the,O
17623,1241,pregnancy,O
17624,1241,test,O
17625,1241,requirement,O
17626,1241,will,O
17627,1241,be,O
17628,1241,granted,O
17629,1241,for,O
17630,1241,subjects,O
17631,1241,reporting,O
17632,1241,surgical,O
17633,1241,sterilization,O
17634,1241,in,O
17635,1241,medical,O
17636,1241,history,O
17637,1242,7,O
17638,1242,.,O
17639,1242,Normal,B-Condition
17640,1242,laboratory,I-Condition
17641,1242,values,I-Condition
17642,1242,or,O
17643,1242,clinically,O
17644,1242,insignificant,O
17645,1242,findings,B-Condition
17646,1242,at,O
17647,1242,screening,O
17648,1242,as,O
17649,1242,determined,O
17650,1242,by,O
17651,1242,the,O
17652,1242,Investigator,O
17653,1242,;,O
17654,1243,8,O
17655,1243,.,O
17656,1243,Subject,O
17657,1243,is,O
17658,1243,willing,O
17659,1243,to,O
17660,1243,remain,O
17661,1243,in,O
17662,1243,the,O
17663,1243,clinic,O
17664,1243,overnight,O
17665,1243,for,O
17666,1243,PK,O
17667,1243,assessment,O
17668,1243,on,O
17669,1243,Days,O
17670,1243,0,O
17671,1243,and,O
17672,1243,8,O
17673,1244,9,O
17674,1244,.,O
17675,1244,Ability,O
17676,1244,to,O
17677,1244,complete,O
17678,1244,the,O
17679,1244,study,O
17680,1244,procedures,O
17681,1244,in,O
17682,1244,compliance,O
17683,1244,with,O
17684,1244,the,O
17685,1244,protocol,O
17686,1244,.,O
17687,1245,congenital,O
17688,1245,or,O
17689,1245,acquired,O
17690,1245,bleeding,B-Condition
17691,1245,tendency,I-Condition
17692,1246,platelet,O
17693,1246,count,O
17694,1246,<,O
17695,1246,"50,000/",O
17696,1246,µL,O
17697,1247,hypersensitivity,B-Condition
17698,1247,to,O
17699,1247,shrimps,O
17700,1247,",",O
17701,1247,lobsters,O
17702,1247,or,O
17703,1247,beetles,O
17704,1248,age,B-Person
17705,1248,18,O
17706,1248,years,O
17707,1248,or,O
17708,1248,older,O
17709,1249,patients,O
17710,1249,undergoing,O
17711,1249,invasive,B-Procedure
17712,1249,procedures,I-Procedure
17713,1249,via,O
17714,1249,the,O
17715,1249,radial,O
17716,1249,or,O
17717,1249,femoral,O
17718,1249,arteries,O
17719,1250,Hemodynamically,B-Condition
17720,1250,unstable,I-Condition
17721,1250,in,O
17722,1250,need,O
17723,1250,of,O
17724,1250,acute,O
17725,1250,treatment,O
17726,1251,Most,O
17727,1251,recent,O
17728,1251,hCG,O
17729,1251,>,O
17730,1251,5000,O
17731,1251,mIU,O
17732,1251,/,O
17733,1251,mL,O
17734,1252,Patient,O
17735,1252,obtaining,O
17736,1252,care,O
17737,1252,in,O
17738,1252,relation,O
17739,1252,to,O
17740,1252,a,O
17741,1252,recently,O
17742,1252,completed,O
17743,1252,pregnancy,O
17744,1252,(,O
17745,1252,delivery,O
17746,1252,",",O
17747,1252,spontaneous,O
17748,1252,or,O
17749,1252,elective,O
17750,1252,abortion,O
17751,1252,),O
17752,1253,Diagnosis,O
17753,1253,of,O
17754,1253,gestational,B-Condition
17755,1253,trophoblastic,I-Condition
17756,1253,disease,I-Condition
17757,1254,Subject,O
17758,1254,unwilling,O
17759,1254,or,O
17760,1254,unable,O
17761,1254,to,O
17762,1254,comply,O
17763,1254,with,O
17764,1254,study,O
17765,1254,procedures,O
17766,1255,Known,O
17767,1255,hypersensitivity,B-Condition
17768,1255,to,I-Condition
17769,1255,MTX,I-Condition
17770,1256,Presence,O
17771,1256,of,O
17772,1256,clinical,O
17773,1256,contraindications,O
17774,1256,for,O
17775,1256,treatment,O
17776,1256,with,O
17777,1256,MTX,O
17778,1257,Prior,O
17779,1257,medical,B-Procedure
17780,1257,or,I-Procedure
17781,1257,surgical,I-Procedure
17782,1257,management,I-Procedure
17783,1257,of,O
17784,1257,this,O
17785,1257,gestation,B-Condition
17786,1258,Subject,O
17787,1258,unwilling,O
17788,1258,to,O
17789,1258,accept,O
17790,1258,a,O
17791,1258,blood,O
17792,1258,transfusion,O
17793,1259,Female,B-Person
17794,1259,with,O
17795,1259,a,O
17796,1259,persisting,O
17797,1259,pregnancy,B-Condition
17798,1259,of,O
17799,1259,unknown,O
17800,1259,location,O
17801,1259,:,O
17802,1260,A,O
17803,1260,pregnancy,B-Condition
17804,1260,of,O
17805,1260,unknown,O
17806,1260,location,O
17807,1260,is,O
17808,1260,defined,O
17809,1260,as,O
17810,1260,a,O
17811,1260,pregnancy,B-Condition
17812,1260,in,O
17813,1260,a,O
17814,1260,woman,B-Person
17815,1260,with,O
17816,1260,a,O
17817,1260,positive,O
17818,1260,pregnancy,O
17819,1260,test,O
17820,1260,but,O
17821,1260,no,O
17822,1260,definitive,O
17823,1260,signs,O
17824,1260,of,O
17825,1260,pregnancy,O
17826,1260,in,O
17827,1260,the,O
17828,1260,uterus,O
17829,1260,or,O
17830,1260,adnexa,O
17831,1260,on,O
17832,1260,ultrasound,O
17833,1260,imaging,O
17834,1260,.,O
17835,1260,A,O
17836,1260,definitive,O
17837,1260,sign,O
17838,1260,of,O
17839,1260,gestation,O
17840,1260,includes,O
17841,1260,ultrasound,O
17842,1260,visualization,O
17843,1260,of,O
17844,1260,a,O
17845,1260,gestational,O
17846,1260,sac,O
17847,1260,with,O
17848,1260,a,O
17849,1260,yolk,O
17850,1260,sac,O
17851,1260,(,O
17852,1260,with,O
17853,1260,or,O
17854,1260,without,O
17855,1260,an,O
17856,1260,embryo,O
17857,1260,),O
17858,1260,in,O
17859,1260,the,O
17860,1260,uterus,O
17861,1260,or,O
17862,1260,in,O
17863,1260,the,O
17864,1260,adnexa,O
17865,1260,.,O
17866,1260,Ultrasound,B-Procedure
17867,1260,must,O
17868,1260,be,O
17869,1260,performed,O
17870,1260,within,O
17871,1260,7,O
17872,1260,days,O
17873,1260,prior,O
17874,1260,to,O
17875,1260,randomization,O
17876,1260,.,O
17877,1261,Persistence,B-Condition
17878,1261,of,I-Condition
17879,1261,hCG,I-Condition
17880,1261,is,O
17881,1261,defined,O
17882,1261,as,O
17883,1261,at,O
17884,1261,least,O
17885,1261,2,O
17886,1261,serial,O
17887,1261,hCG,O
17888,1261,values,O
17889,1261,(,O
17890,1261,over,O
17891,1261,2,O
17892,1261,-,O
17893,1261,14,O
17894,1261,days,O
17895,1261,),O
17896,1261,",",O
17897,1261,showing,O
17898,1261,<,O
17899,1261,15,O
17900,1261,%,O
17901,1261,rise,O
17902,1261,per,O
17903,1261,day,O
17904,1261,",",O
17905,1261,or,O
17906,1261,<,O
17907,1261,50,O
17908,1261,%,O
17909,1261,fall,O
17910,1261,between,O
17911,1261,the,O
17912,1261,first,O
17913,1261,and,O
17914,1261,last,O
17915,1261,value,O
17916,1261,.,O
17917,1262,Patient,O
17918,1262,is,O
17919,1262,hemodynamically,B-Condition
17920,1262,stable,I-Condition
17921,1262,",",O
17922,1262,hemoglobin,O
17923,1262,>,O
17924,1262,10,O
17925,1262,mg,O
17926,1262,/,O
17927,1262,dL,O
17928,1263,Greater,O
17929,1263,than,O
17930,1263,or,O
17931,1263,18,O
17932,1263,years,O
17933,1263,of,O
17934,1263,age,B-Person
17935,1264,Patients,O
17936,1264,who,O
17937,1264,have,O
17938,1264,received,O
17939,1264,prior,O
17940,1264,chemotherapy,B-Procedure
17941,1264,for,O
17942,1264,unresectable,B-Condition
17943,1264,disease,I-Condition
17944,1265,Patients,O
17945,1265,with,O
17946,1265,any,O
17947,1265,active,O
17948,1265,or,O
17949,1265,uncontrolled,O
17950,1265,infection,B-Condition
17951,1265,",",O
17952,1265,including,O
17953,1265,known,O
17954,1265,HIV,B-Procedure
17955,1265,infection,I-Procedure
17956,1265,.,O
17957,1265,(,O
17958,1265,Patients,O
17959,1265,with,O
17960,1265,active,O
17961,1265,hepatitis,B-Condition
17962,1265,B,I-Condition
17963,1265,will,O
17964,1265,be,O
17965,1265,placed,O
17966,1265,on,O
17967,1265,lamivudine,B-Drug
17968,1265,.,O
17969,1265,Patients,O
17970,1265,with,O
17971,1265,active,O
17972,1265,hepatitis,B-Condition
17973,1265,C,I-Condition
17974,1265,will,O
17975,1265,be,O
17976,1265,eligible,O
17977,1265,if,O
17978,1265,liver,O
17979,1265,tests,O
17980,1265,qualify,O
17981,1265,(,O
17982,1265,5.1.9,O
17983,1265,),O
17984,1266,Patients,O
17985,1266,with,O
17986,1266,psychiatric,B-Condition
17987,1266,disorders,I-Condition
17988,1266,that,O
17989,1266,would,O
17990,1266,interfere,O
17991,1266,with,O
17992,1266,consent,O
17993,1266,or,O
17994,1266,follow,O
17995,1266,-,O
17996,1266,up,O
17997,1266,.,O
17998,1266,Pregnant,B-Condition
17999,1266,or,O
18000,1266,lactating,B-Condition
18001,1266,women,B-Person
18002,1266,.,O
18003,1266,Men,O
18004,1266,and,O
18005,1266,women,O
18006,1266,of,O
18007,1266,reproductive,B-Condition
18008,1266,potential,I-Condition
18009,1266,may,O
18010,1266,not,O
18011,1266,participate,O
18012,1266,unless,O
18013,1266,they,O
18014,1266,have,O
18015,1266,agreed,O
18016,1266,to,O
18017,1266,use,O
18018,1266,an,O
18019,1266,effective,B-Procedure
18020,1266,contraceptive,I-Procedure
18021,1266,method,I-Procedure
18022,1266,.,O
18023,1267,Patients,O
18024,1267,with,O
18025,1267,any,O
18026,1267,other,O
18027,1267,severe,O
18028,1267,concurrent,B-Condition
18029,1267,disease,I-Condition
18030,1267,",",O
18031,1267,which,O
18032,1267,in,O
18033,1267,the,O
18034,1267,judgment,O
18035,1267,of,O
18036,1267,the,O
18037,1267,investigator,O
18038,1267,",",O
18039,1267,would,O
18040,1267,make,O
18041,1267,the,O
18042,1267,patient,O
18043,1267,inappropriate,B-Mood
18044,1267,for,I-Mood
18045,1267,entry,B-Observation
18046,1267,into,I-Observation
18047,1267,this,I-Observation
18048,1267,study,I-Observation
18049,1267,.,O
18050,1268,Unresectable,O
18051,1268,",",O
18052,1268,histologically,O
18053,1268,confirmed,O
18054,1268,hepatocellular,B-Condition
18055,1268,carcinoma,I-Condition
18056,1268,with,O
18057,1268,evident,O
18058,1268,disease,O
18059,1268,limited,O
18060,1268,to,O
18061,1268,liver,O
18062,1268,.,O
18063,1269,Tissue,O
18064,1269,from,O
18065,1269,tumor,O
18066,1269,must,O
18067,1269,be,O
18068,1269,available,O
18069,1269,.,O
18070,1269,This,O
18071,1269,may,O
18072,1269,be,O
18073,1269,paraffin,O
18074,1269,embedded,O
18075,1269,tissue,O
18076,1269,from,O
18077,1269,previous,O
18078,1269,biopsy,O
18079,1269,/,O
18080,1269,resection,O
18081,1269,or,O
18082,1269,if,O
18083,1269,it,O
18084,1269,is,O
18085,1269,not,O
18086,1269,available,O
18087,1269,",",O
18088,1269,a,O
18089,1269,repeat,O
18090,1269,biopsy,O
18091,1269,must,O
18092,1269,be,O
18093,1269,performed,O
18094,1269,.,O
18095,1269,The,O
18096,1269,requirement,O
18097,1269,for,O
18098,1269,biopsy,B-Procedure
18099,1269,may,O
18100,1269,be,O
18101,1269,waived,O
18102,1269,if,O
18103,1269,alpha,O
18104,1269,-,O
18105,1269,fetoprotein,O
18106,1269,is,O
18107,1269,greater,O
18108,1269,than,O
18109,1269,500,O
18110,1269,ng,O
18111,1269,/,O
18112,1269,mL,O
18113,1269,and,O
18114,1269,in,O
18115,1269,the,O
18116,1269,investigators,O
18117,1269,opinion,O
18118,1269,not,O
18119,1269,explained,O
18120,1269,by,O
18121,1269,a,O
18122,1269,concurrent,O
18123,1269,hepatic,O
18124,1269,inflammatory,O
18125,1269,process,O
18126,1269,.,O
18127,1270,Patients,O
18128,1270,must,O
18129,1270,agree,O
18130,1270,to,O
18131,1270,have,O
18132,1270,a,O
18133,1270,20,O
18134,1270,cc,O
18135,1270,blood,B-Procedure
18136,1270,sample,I-Procedure
18137,1270,drawn,I-Procedure
18138,1270,in,O
18139,1270,addition,O
18140,1270,to,O
18141,1270,routine,B-Procedure
18142,1270,labs,I-Procedure
18143,1270,with,O
18144,1270,each,O
18145,1270,cycle,O
18146,1270,of,O
18147,1270,chemotherapy,O
18148,1270,.,O
18149,1271,Patients,O
18150,1271,must,O
18151,1271,have,O
18152,1271,measurable,O
18153,1271,disease,O
18154,1271,.,O
18155,1271,If,O
18156,1271,prior,O
18157,1271,radiation,B-Procedure
18158,1271,therapy,I-Procedure
18159,1271,was,O
18160,1271,administered,O
18161,1271,",",O
18162,1271,measurable,O
18163,1271,disease,O
18164,1271,must,O
18165,1271,be,O
18166,1271,outside,O
18167,1271,the,O
18168,1271,radiation,O
18169,1271,field,O
18170,1271,.,O
18171,1272,Patients,O
18172,1272,must,O
18173,1272,have,O
18174,1272,a,O
18175,1272,Zubrod,O
18176,1272,performance,O
18177,1272,status,O
18178,1272,of,O
18179,1272,0,O
18180,1272,-,O
18181,1272,2,O
18182,1272,.,O
18183,1273,Patients,O
18184,1273,must,O
18185,1273,have,O
18186,1273,a,O
18187,1273,predicted,O
18188,1273,life,O
18189,1273,expectancy,O
18190,1273,of,O
18191,1273,at,O
18192,1273,least,O
18193,1273,12,O
18194,1273,weeks,O
18195,1273,.,O
18196,1274,Patients,O
18197,1274,must,O
18198,1274,have,O
18199,1274,a,O
18200,1274,pre,O
18201,1274,-,O
18202,1274,treatment,O
18203,1274,granulocyte,O
18204,1274,count,O
18205,1274,(,O
18206,1274,i.e.,O
18207,1274,",",O
18208,1274,segmented,O
18209,1274,neutrophils,O
18210,1274,+,O
18211,1274,bands,O
18212,1274,),O
18213,1274,of,O
18214,1274,greater,O
18215,1274,than,O
18216,1274,or,O
18217,1274,equal,O
18218,1274,to,O
18219,1274,"1,500",O
18220,1274,/,O
18221,1274,mm3,O
18222,1274,",",O
18223,1274,a,O
18224,1274,hemoglobin,O
18225,1274,level,O
18226,1274,of,O
18227,1274,greater,O
18228,1274,than,O
18229,1274,or,O
18230,1274,equal,O
18231,1274,to,O
18232,1274,9,O
18233,1274,gm,O
18234,1274,/,O
18235,1274,dl,O
18236,1274,",",O
18237,1274,and,O
18238,1274,platelet,O
18239,1274,count,O
18240,1274,greater,O
18241,1274,than,O
18242,1274,or,O
18243,1274,equal,O
18244,1274,to,O
18245,1274,"50,000",O
18246,1274,/,O
18247,1274,mm3,O
18248,1274,.,O
18249,1274,The,O
18250,1274,granulocyte,O
18251,1274,requirement,O
18252,1274,may,O
18253,1274,be,O
18254,1274,waived,O
18255,1274,if,O
18256,1274,in,O
18257,1274,the,O
18258,1274,investigator,O
18259,1274,'s,O
18260,1274,opinion,O
18261,1274,the,O
18262,1274,lower,O
18263,1274,count,O
18264,1274,reflects,O
18265,1274,hypersplenism,O
18266,1274,with,O
18267,1274,adequate,O
18268,1274,bone,O
18269,1274,marrow,O
18270,1274,reserves,O
18271,1274,.,O
18272,1275,Patients,O
18273,1275,must,O
18274,1275,have,O
18275,1275,adequate,O
18276,1275,renal,O
18277,1275,function,O
18278,1275,as,O
18279,1275,documented,O
18280,1275,by,O
18281,1275,a,O
18282,1275,calculated,O
18283,1275,creatinine,O
18284,1275,clearance,O
18285,1275,≥,O
18286,1275,60,O
18287,1275,.,O
18288,1276,Patients,O
18289,1276,must,O
18290,1276,have,O
18291,1276,adequate,O
18292,1276,hepatic,O
18293,1276,function,O
18294,1276,as,O
18295,1276,documented,O
18296,1276,by,O
18297,1276,a,O
18298,1276,serum,O
18299,1276,bilirubin,O
18300,1276,less,O
18301,1276,than,O
18302,1276,or,O
18303,1276,equal,O
18304,1276,to,O
18305,1276,2x,O
18306,1276,the,O
18307,1276,institutional,O
18308,1276,upper,O
18309,1276,limit,O
18310,1276,of,O
18311,1276,normal,O
18312,1276,",",O
18313,1276,regardless,O
18314,1276,of,O
18315,1276,whether,O
18316,1276,patients,O
18317,1276,have,O
18318,1276,liver,O
18319,1276,involvement,O
18320,1276,secondary,O
18321,1276,to,O
18322,1276,tumor,O
18323,1276,.,O
18324,1276,Patients,O
18325,1276,may,O
18326,1276,not,O
18327,1276,have,O
18328,1276,ascites,B-Condition
18329,1276,or,O
18330,1276,the,O
18331,1276,ascites,B-Condition
18332,1276,must,O
18333,1276,be,O
18334,1276,responsive,O
18335,1276,to,O
18336,1276,diuretics,O
18337,1276,.,O
18338,1277,Previous,O
18339,1277,or,O
18340,1277,concurrent,O
18341,1277,hormonal,B-Procedure
18342,1277,management,I-Procedure
18343,1277,of,O
18344,1277,prostate,B-Condition
18345,1277,cancer,I-Condition
18346,1278,Contraindication,B-Condition
18347,1278,for,O
18348,1278,prescription,O
18349,1278,of,O
18350,1278,Firmagon,B-Drug
18351,1278,®,O
18352,1279,Concurrent,O
18353,1279,treatment,O
18354,1279,with,O
18355,1279,a,O
18356,1279,5,B-Drug
18357,1279,-,I-Drug
18358,1279,a,I-Drug
18359,1279,-,I-Drug
18360,1279,reductase,I-Drug
18361,1279,inhibitor,I-Drug
18362,1280,Considered,O
18363,1280,as,O
18364,1280,a,O
18365,1280,candidate,O
18366,1280,for,O
18367,1280,curative,B-Procedure
18368,1280,therapy,I-Procedure
18369,1281,History,O
18370,1281,of,O
18371,1281,severe,O
18372,1281,untreated,O
18373,1281,asthma,B-Condition
18374,1281,",",O
18375,1281,anaphylactic,B-Condition
18376,1281,reactions,I-Condition
18377,1281,or,O
18378,1281,severe,O
18379,1281,urticaria,B-Condition
18380,1281,and/or,O
18381,1281,angioedema,B-Condition
18382,1282,QTc,O
18383,1282,interval,O
18384,1282,over,O
18385,1282,450,O
18386,1282,msec,O
18387,1282,or,O
18388,1282,risk,B-Observation
18389,1282,factors,I-Observation
18390,1282,for,I-Observation
18391,1282,torsades,I-Observation
18392,1282,de,I-Observation
18393,1282,pointes,I-Observation
18394,1282,or,O
18395,1282,on,O
18396,1282,Class,B-Drug
18397,1282,IA,I-Drug
18398,1282,and,I-Drug
18399,1282,Class,I-Drug
18400,1282,III,I-Drug
18401,1282,anti,I-Drug
18402,1282,arrhythmic,I-Drug
18403,1282,medications,I-Drug
18404,1283,Cancer,B-Condition
18405,1283,within,O
18406,1283,the,O
18407,1283,last,O
18408,1283,5,O
18409,1283,years,O
18410,1283,except,O
18411,1283,prostate,B-Condition
18412,1283,cancer,I-Condition
18413,1283,and,O
18414,1283,surgically,B-Procedure
18415,1283,removed,O
18416,1283,basal,B-Condition
18417,1283,or,I-Condition
18418,1283,squamous,I-Condition
18419,1283,cell,I-Condition
18420,1283,carcinoma,I-Condition
18421,1283,of,I-Condition
18422,1283,the,I-Condition
18423,1283,skin,I-Condition
18424,1284,Known,O
18425,1284,or,O
18426,1284,suspected,O
18427,1284,hepatic,B-Condition
18428,1284,",",I-Condition
18429,1284,symptomatic,I-Condition
18430,1284,biliary,I-Condition
18431,1284,disease,I-Condition
18432,1284,(,O
18433,1284,this,O
18434,1284,includes,O
18435,1284,moderate,O
18436,1284,to,O
18437,1284,severe,O
18438,1284,chronic,B-Condition
18439,1284,hepatic,I-Condition
18440,1284,impairment,I-Condition
18441,1284,),O
18442,1285,Patients,O
18443,1285,with,O
18444,1285,clinically,O
18445,1285,significant,O
18446,1285,laboratory,O
18447,1285,abnormalities,O
18448,1285,/,O
18449,1285,disorders,O
18450,1285,other,O
18451,1285,than,O
18452,1285,prostate,O
18453,1285,cancer,O
18454,1286,Patient,O
18455,1286,with,O
18456,1286,Hepatitis,B-Condition
18457,1286,B,I-Condition
18458,1286,Virus,I-Condition
18459,1286,(,I-Condition
18460,1286,HBV,I-Condition
18461,1286,),I-Condition
18462,1286,",",I-Condition
18463,1286,Hepatitis,I-Condition
18464,1286,C,I-Condition
18465,1286,Virus,I-Condition
18466,1286,(,I-Condition
18467,1286,HCV,I-Condition
18468,1286,),I-Condition
18469,1286,and,I-Condition
18470,1286,Human,I-Condition
18471,1286,Immunodeficiency,I-Condition
18472,1286,Virus,I-Condition
18473,1286,(,I-Condition
18474,1286,HIV,I-Condition
18475,1286,),I-Condition
18476,1286,infections,I-Condition
18477,1287,Has,O
18478,1287,given,O
18479,1287,written,O
18480,1287,informed,O
18481,1287,consent,O
18482,1287,before,O
18483,1287,any,O
18484,1287,study,O
18485,1287,-,O
18486,1287,related,O
18487,1287,activity,O
18488,1287,is,O
18489,1287,performed,O
18490,1288,Advanced,O
18491,1288,hormone,O
18492,1288,-,O
18493,1288,dependent,O
18494,1288,prostate,B-Condition
18495,1288,cancer,I-Condition
18496,1288,for,O
18497,1288,which,O
18498,1288,androgen,B-Procedure
18499,1288,deprivation,I-Procedure
18500,1288,therapy,I-Procedure
18501,1288,is,O
18502,1288,indicated,O
18503,1288,",",O
18504,1288,and,O
18505,1288,independently,O
18506,1288,from,O
18507,1288,this,O
18508,1288,trial,O
18509,1288,",",O
18510,1288,Firmagon,B-Drug
18511,1288,®,O
18512,1288,is,O
18513,1288,intended,B-Mood
18514,1288,to,O
18515,1288,be,O
18516,1288,used,O
18517,1288,for,O
18518,1288,treatment,O
18519,1289,Age,B-Person
18520,1289,greater,O
18521,1289,than,O
18522,1289,or,O
18523,1289,equal,O
18524,1289,to,O
18525,1289,18,O
18526,1289,years,O
18527,1289,and,O
18528,1289,less,O
18529,1289,than,O
18530,1289,80,O
18531,1289,years,O
18532,1290,Advanced,O
18533,1290,hormone,O
18534,1290,-,O
18535,1290,dependent,O
18536,1290,prostate,B-Condition
18537,1290,cancer,I-Condition
18538,1290,without,O
18539,1290,any,O
18540,1290,other,O
18541,1290,clinically,O
18542,1290,significant,O
18543,1290,disorder,O
18544,1291,Easten,O
18545,1291,Cooperative,O
18546,1291,Oncology,O
18547,1291,Group,O
18548,1291,score,O
18549,1291,=,O
18550,1291,2,O
18551,1292,PSA,O
18552,1292,=,O
18553,1292,2,O
18554,1292,ng,O
18555,1292,/,O
18556,1292,mL,O
18557,1292,at,O
18558,1292,screening,O
18559,1293,Life,B-Observation
18560,1293,expectancy,I-Observation
18561,1293,of,O
18562,1293,at,O
18563,1293,least,O
18564,1293,12,O
18565,1293,months,O
18566,1293,as,O
18567,1293,per,O
18568,1293,the,O
18569,1293,investigator,O
18570,1293,'s,O
18571,1293,judgement,O
18572,1294,Have,O
18573,1294,a,O
18574,1294,history,O
18575,1294,of,O
18576,1294,myocardial,B-Condition
18577,1294,infarction,I-Condition
18578,1294,in,I-Condition
18579,1294,the,O
18580,1294,past,O
18581,1294,6,O
18582,1294,months,O
18583,1295,Have,O
18584,1295,a,O
18585,1295,contraindication,B-Condition
18586,1295,to,O
18587,1295,NRT,B-Procedure
18588,1295,with,O
18589,1295,no,O
18590,1295,medical,O
18591,1295,clearance,O
18592,1295,from,O
18593,1295,the,O
18594,1295,primary,O
18595,1295,care,O
18596,1295,provider,O
18597,1295,or,O
18598,1295,study,O
18599,1295,physician,O
18600,1296,Use,O
18601,1296,and,O
18602,1296,unwillingness,O
18603,1296,to,O
18604,1296,stop,O
18605,1296,use,O
18606,1296,of,O
18607,1296,other,O
18608,1296,forms,O
18609,1296,of,O
18610,1296,nicotine,O
18611,1296,such,O
18612,1296,as,O
18613,1296,cigars,O
18614,1296,",",O
18615,1296,pipes,O
18616,1296,",",O
18617,1296,or,O
18618,1296,chewing,O
18619,1296,tobacco,O
18620,1297,Are,O
18621,1297,pregnant,B-Condition
18622,1298,Meet,O
18623,1298,criteria,O
18624,1298,for,O
18625,1298,a,O
18626,1298,current,O
18627,1298,manic,B-Condition
18628,1298,episode,I-Condition
18629,1298,based,O
18630,1298,on,O
18631,1298,structured,O
18632,1298,clinical,O
18633,1298,interview,O
18634,1299,Are,O
18635,1299,currently,O
18636,1299,enrolled,O
18637,1299,in,O
18638,1299,another,O
18639,1299,smoking,O
18640,1299,cessation,O
18641,1299,trial,O
18642,1300,Are,O
18643,1300,currently,O
18644,1300,imprisoned,B-Person
18645,1300,or,O
18646,1300,in,O
18647,1300,psychiatric,B-Observation
18648,1300,hospitalization,I-Observation
18649,1301,Currently,O
18650,1301,smoke,B-Observation
18651,1301,at,O
18652,1301,least,O
18653,1301,ten,O
18654,1301,cigarettes,O
18655,1301,a,O
18656,1301,day,O
18657,1302,Have,O
18658,1302,been,O
18659,1302,smoking,B-Observation
18660,1302,for,O
18661,1302,at,O
18662,1302,least,O
18663,1302,one,O
18664,1302,year,O
18665,1303,Meet,O
18666,1303,criteria,O
18667,1303,for,O
18668,1303,schizophrenia,B-Condition
18669,1303,",",O
18670,1303,schizoaffective,B-Condition
18671,1303,disorder,I-Condition
18672,1303,",",O
18673,1303,or,O
18674,1303,another,O
18675,1303,psychotic,B-Condition
18676,1303,disorder,I-Condition
18677,1303,based,O
18678,1303,on,O
18679,1303,structured,O
18680,1303,clinical,O
18681,1303,interview,O
18682,1304,Can,O
18683,1304,speak,O
18684,1304,and,O
18685,1304,write,O
18686,1304,fluent,O
18687,1304,conversational,O
18688,1304,English,O
18689,1305,Are,O
18690,1305,between,O
18691,1305,18,O
18692,1305,and,O
18693,1305,70,O
18694,1305,years,O
18695,1305,of,O
18696,1305,age,B-Person
18697,1306,Are,O
18698,1306,willing,O
18699,1306,to,O
18700,1306,make,O
18701,1306,a,O
18702,1306,smoking,O
18703,1306,cessation,O
18704,1306,attempt,O
18705,1307,Score,O
18706,1307,26,O
18707,1307,or,O
18708,1307,higher,O
18709,1307,on,O
18710,1307,the,O
18711,1307,Montreal,O
18712,1307,Cognitive,O
18713,1307,Assessment,O
18714,1308,Are,O
18715,1308,pregnant,B-Condition
18716,1308,or,O
18717,1308,lactating,B-Condition
18718,1308,.,O
18719,1309,Have,B-Observation
18720,1309,participated,I-Observation
18721,1309,in,I-Observation
18722,1309,any,I-Observation
18723,1309,other,I-Observation
18724,1309,studies,I-Observation
18725,1309,involving,I-Observation
18726,1309,investigational,I-Observation
18727,1309,products,I-Observation
18728,1309,within,O
18729,1309,30,O
18730,1309,days,O
18731,1309,prior,O
18732,1309,to,O
18733,1309,entry,O
18734,1309,into,O
18735,1309,this,O
18736,1309,study,O
18737,1309,.,O
18738,1310,Are,O
18739,1310,undergoing,O
18740,1310,an,O
18741,1310,acute,B-Condition
18742,1310,withdrawal,I-Condition
18743,1310,syndrome,I-Condition
18744,1310,from,O
18745,1310,drugs,B-Drug
18746,1310,or,O
18747,1310,alcohol,B-Drug
18748,1310,.,O
18749,1311,Have,O
18750,1311,an,O
18751,1311,Axis,O
18752,1311,I,O
18753,1311,diagnosis,O
18754,1311,of,O
18755,1311,Schizophrenia,B-Condition
18756,1311,",",O
18757,1311,Schizoaffective,B-Condition
18758,1311,Disorder,I-Condition
18759,1311,",",O
18760,1311,Schizophreniform,B-Condition
18761,1311,Disorder,I-Condition
18762,1311,or,O
18763,1311,Bipolar,B-Condition
18764,1311,I,I-Condition
18765,1311,Disorder,I-Condition
18766,1311,as,O
18767,1311,diagnosed,O
18768,1311,by,O
18769,1311,the,O
18770,1311,Structured,B-Procedure
18771,1311,Clinical,I-Procedure
18772,1311,Interview,I-Procedure
18773,1311,for,I-Procedure
18774,1311,DSM,I-Procedure
18775,1311,-,I-Procedure
18776,1311,IV,I-Procedure
18777,1311,Axis,I-Procedure
18778,1311,I,I-Procedure
18779,1311,Disorders,I-Procedure
18780,1311,(,I-Procedure
18781,1311,SCID,I-Procedure
18782,1311,-,I-Procedure
18783,1311,I,I-Procedure
18784,1311,),I-Procedure
18785,1311,",",O
18786,1311,and,O
18787,1311,pertinent,O
18788,1311,subsequent,O
18789,1311,for,O
18790,1311,ruling,O
18791,1311,out,O
18792,1311,exclusionary,O
18793,1311,diagnoses,O
18794,1311,.,O
18795,1312,Have,O
18796,1312,an,O
18797,1312,unstable,O
18798,1312,medical,O
18799,1312,disorder,O
18800,1312,as,O
18801,1312,determined,O
18802,1312,by,O
18803,1312,physical,O
18804,1312,examination,O
18805,1312,or,O
18806,1312,laboratory,O
18807,1312,testing,O
18808,1312,.,O
18809,1312,The,O
18810,1312,primary,O
18811,1312,investigator,O
18812,1312,will,O
18813,1312,be,O
18814,1312,responsible,O
18815,1312,for,O
18816,1312,making,O
18817,1312,this,O
18818,1312,judgment,O
18819,1312,based,O
18820,1312,on,O
18821,1312,the,O
18822,1312,above,O
18823,1312,.,O
18824,1313,Had,O
18825,1313,an,O
18826,1313,unsatisfactory,O
18827,1313,response,O
18828,1313,to,O
18829,1313,a,O
18830,1313,previous,O
18831,1313,adequate,O
18832,1313,trial,O
18833,1313,of,O
18834,1313,quetiapine,O
18835,1313,as,O
18836,1313,judged,O
18837,1313,by,O
18838,1313,a,O
18839,1313,study,O
18840,1313,investigator,O
18841,1313,.,O
18842,1314,Patients,O
18843,1314,can,O
18844,1314,not,O
18845,1314,begin,O
18846,1314,psychotherapy,O
18847,1314,during,O
18848,1314,the,O
18849,1314,study,O
18850,1314,period,O
18851,1314,",",O
18852,1314,but,O
18853,1314,may,O
18854,1314,continue,O
18855,1314,if,O
18856,1314,started,O
18857,1314,prior,O
18858,1314,to,O
18859,1314,the,O
18860,1314,study,O
18861,1314,.,O
18862,1315,Patients,O
18863,1315,who,O
18864,1315,are,O
18865,1315,currently,O
18866,1315,receiving,O
18867,1315,quetiapine,O
18868,1315,therapy,O
18869,1315,may,O
18870,1315,not,O
18871,1315,undergo,O
18872,1315,a,O
18873,1315,washout,O
18874,1315,period,O
18875,1315,and,O
18876,1315,then,O
18877,1315,restart,O
18878,1315,quetiapine,O
18879,1315,in,O
18880,1315,the,O
18881,1315,study,O
18882,1315,.,O
18883,1316,Provide,O
18884,1316,written,B-Observation
18885,1316,informed,I-Observation
18886,1316,consent,I-Observation
18887,1316,before,O
18888,1316,beginning,O
18889,1316,any,O
18890,1316,study,O
18891,1316,related,O
18892,1316,activities,O
18893,1317,Be,O
18894,1317,between,O
18895,1317,age,B-Person
18896,1317,18,O
18897,1317,and,O
18898,1317,55,O
18899,1317,years,O
18900,1318,Be,O
18901,1318,able,B-Observation
18902,1318,to,I-Observation
18903,1318,speak,I-Observation
18904,1318,",",I-Observation
18905,1318,read,I-Observation
18906,1318,and,I-Observation
18907,1318,write,I-Observation
18908,1318,English,I-Observation
18909,1318,and,I-Observation
18910,1318,follow,I-Observation
18911,1318,simple,I-Observation
18912,1318,instructions,I-Observation
18913,1318,for,O
18914,1318,completing,O
18915,1318,self,O
18916,1318,-,O
18917,1318,rated,O
18918,1318,scales,O
18919,1319,Meet,O
18920,1319,DSM,O
18921,1319,-,O
18922,1319,IV,O
18923,1319,criteria,O
18924,1319,for,O
18925,1319,BPD,B-Condition
18926,1319,as,O
18927,1319,assessed,O
18928,1319,by,O
18929,1319,the,O
18930,1319,Structured,B-Procedure
18931,1319,Clinical,I-Procedure
18932,1319,Interview,I-Procedure
18933,1319,for,I-Procedure
18934,1319,DSM,I-Procedure
18935,1319,-,I-Procedure
18936,1319,IV,I-Procedure
18937,1319,Personality,I-Procedure
18938,1319,Disorders,I-Procedure
18939,1319,(,I-Procedure
18940,1319,SCID,I-Procedure
18941,1319,-,I-Procedure
18942,1319,II,I-Procedure
18943,1319,),I-Procedure
18944,1319,.,O
